activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	34277	CHEMBL811933	Selectivity for Vascular endothelial growth factor receptor 1 over (KDR) kinase insert domain receptor	B	Cc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL330621	=	Selectivity		5.0	CHEMBL1868	Homo sapiens	Selectivity		5.0
	34277	CHEMBL811933	Selectivity for Vascular endothelial growth factor receptor 1 over (KDR) kinase insert domain receptor	B	Cc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL330621	=	Selectivity		5.0	CHEMBL1868	Homo sapiens	Selectivity		5.0
	37863	CHEMBL811933	Selectivity for Vascular endothelial growth factor receptor 1 over (KDR) kinase insert domain receptor	B	Cc1ccnc(Nc2ncc(-c3ccccc3)s2)c1		CHEMBL319065	=	Selectivity		7.0	CHEMBL1868	Homo sapiens	Selectivity		7.0
	40258	CHEMBL811933	Selectivity for Vascular endothelial growth factor receptor 1 over (KDR) kinase insert domain receptor	B	Cc1cccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL98385	=	Selectivity		8.0	CHEMBL1868	Homo sapiens	Selectivity		8.0
	42684	CHEMBL811933	Selectivity for Vascular endothelial growth factor receptor 1 over (KDR) kinase insert domain receptor	B	O=C(Nc1ncc(-c2ccccc2)s1)c1ccccc1		CHEMBL98633	=	Selectivity		4.0	CHEMBL1868	Homo sapiens	Selectivity		4.0
	46269	CHEMBL811933	Selectivity for Vascular endothelial growth factor receptor 1 over (KDR) kinase insert domain receptor	B	Cc1cccnc1Nc1ncc(-c2ccccc2)s1		CHEMBL329713	=	Selectivity		16.0	CHEMBL1868	Homo sapiens	Selectivity		16.0
	48769	CHEMBL811933	Selectivity for Vascular endothelial growth factor receptor 1 over (KDR) kinase insert domain receptor	B	CCCCN(C)c1ccc(/N=N/c2ncc([N+](=O)[O-])s2)c(C)c1		CHEMBL100174	>	Selectivity		130.0	CHEMBL1868	Homo sapiens	Selectivity		130.0
	50203	CHEMBL811933	Selectivity for Vascular endothelial growth factor receptor 1 over (KDR) kinase insert domain receptor	B	c1ccc(-c2cnc(Nc3ccccn3)s2)cc1		CHEMBL98538	=	Selectivity		3.0	CHEMBL1868	Homo sapiens	Selectivity		3.0
	53968	CHEMBL811933	Selectivity for Vascular endothelial growth factor receptor 1 over (KDR) kinase insert domain receptor	B	Brc1cccc(Nc2ncc(-c3ccccc3)s2)n1		CHEMBL101464	=	Selectivity		12.0	CHEMBL1868	Homo sapiens	Selectivity		12.0
	55131	CHEMBL811933	Selectivity for Vascular endothelial growth factor receptor 1 over (KDR) kinase insert domain receptor	B	Clc1ccc(Nc2ncc(-c3ccccc3)s2)nc1		CHEMBL319789	=	Selectivity		6.0	CHEMBL1868	Homo sapiens	Selectivity		6.0
	66858	CHEMBL811933	Selectivity for Vascular endothelial growth factor receptor 1 over (KDR) kinase insert domain receptor	B	N#Cc1cnc(Nc2ccccn2)s1		CHEMBL101544	=	Selectivity		30.0	CHEMBL1868	Homo sapiens	Selectivity		30.0
	307856	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CCNCC1.Cl		CHEMBL2448064	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	309314	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN(C)c1ccncc1		CHEMBL25579	=	IC50	nM	100.0	CHEMBL1868	Homo sapiens	IC50	uM	0.1
	309323	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(C#N)cc3F)ncnc2cc1OC/C=C/CN1CCCC1		CHEMBL24026	=	IC50	nM	3900.0	CHEMBL1868	Homo sapiens	IC50	uM	3.9
	309330	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OC1CCN(C)CC1		CHEMBL26050	=	IC50	nM	1500.0	CHEMBL1868	Homo sapiens	IC50	uM	1.5
	314569	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(C)cc3F)ncnc2cc1OCC1CCNCC1		CHEMBL428534	=	IC50	nM	700.0	CHEMBL1868	Homo sapiens	IC50	uM	0.7
	316937	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1		CHEMBL281872	=	IC50	nM	700.0	CHEMBL1868	Homo sapiens	IC50	uM	0.7
	316965	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(C)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL281990	=	IC50	nM	500.0	CHEMBL1868	Homo sapiens	IC50	uM	0.5
	316972	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3c(F)cc(Cl)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL422758	=	IC50	nM	300.0	CHEMBL1868	Homo sapiens	IC50	uM	0.3
	316979	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3c(F)cc(Cl)cc3F)ncnc2cc1OCC1CCNCC1		CHEMBL25450	=	IC50	nM	450.0	CHEMBL1868	Homo sapiens	IC50	uM	0.45
	316986	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OC[C@@H]1CCCN(C)C1		CHEMBL1907763	=	IC50	nM	700.0	CHEMBL1868	Homo sapiens	IC50	uM	0.7
	316993	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCN1CCOCC1		CHEMBL24137	=	IC50	nM	200.0	CHEMBL1868	Homo sapiens	IC50	uM	0.2
	318306	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	900.0	CHEMBL1868	Homo sapiens	IC50	uM	0.9
	321868	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OC/C=C/CN1CCCC1.Cl		CHEMBL1744349	=	IC50	nM	750.0	CHEMBL1868	Homo sapiens	IC50	uM	0.75
	321876	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCC1CCN(C)CC1		CHEMBL24979	=	IC50	nM	150.0	CHEMBL1868	Homo sapiens	IC50	uM	0.15
	321885	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl		CHEMBL2448065	=	IC50	nM	2000.0	CHEMBL1868	Homo sapiens	IC50	uM	2.0
	323340	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC[C@@H]1CCCN(C)C1		CHEMBL1907764	=	IC50	nM	500.0	CHEMBL1868	Homo sapiens	IC50	uM	0.5
	324426	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN1CCN(C)CC1		CHEMBL283088	=	IC50	nM	300.0	CHEMBL1868	Homo sapiens	IC50	uM	0.3
	324433	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCN1CCCC1.Cl		CHEMBL2448067	=	IC50	nM	200.0	CHEMBL1868	Homo sapiens	IC50	uM	0.2
	325572	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCCN1CCN(C)CC1.Cl		CHEMBL1202477	=	IC50	nM	550.0	CHEMBL1868	Homo sapiens	IC50	uM	0.55
	326802	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3c(F)cc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL416191	=	IC50	nM	500.0	CHEMBL1868	Homo sapiens	IC50	uM	0.5
	328339	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl		CHEMBL533849	=	IC50	nM	1600.0	CHEMBL1868	Homo sapiens	IC50	uM	1.6
	328370	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC[C@H]1CCCN(C)C1		CHEMBL1907944	=	IC50	nM	500.0	CHEMBL1868	Homo sapiens	IC50	uM	0.5
	330833	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCN1CCN(C)CC1.Cl		CHEMBL1744347	=	IC50	nM	600.0	CHEMBL1868	Homo sapiens	IC50	uM	0.6
	332168	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN1CCOCC1		CHEMBL25610	=	IC50	nM	1100.0	CHEMBL1868	Homo sapiens	IC50	uM	1.1
	334914	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCC1CCNCC1		CHEMBL26641	=	IC50	nM	200.0	CHEMBL1868	Homo sapiens	IC50	uM	0.2
	337409	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3c(F)cc(Br)cc3F)ncnc2cc1OCC1CCNCC1		CHEMBL279459	=	IC50	nM	800.0	CHEMBL1868	Homo sapiens	IC50	uM	0.8
	338666	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3cc(O)c(C)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl		CHEMBL1202473	=	IC50	nM	25.0	CHEMBL1868	Homo sapiens	IC50	uM	0.025
	338673	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCC1CCN(C)CC1		CHEMBL25425	=	IC50	nM	500.0	CHEMBL1868	Homo sapiens	IC50	uM	0.5
	340145	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COCCOc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL286160	=	IC50	nM	400.0	CHEMBL1868	Homo sapiens	IC50	uM	0.4
	340160	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3cc(O)c(Cl)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl		CHEMBL2448066	=	IC50	nM	20.0	CHEMBL1868	Homo sapiens	IC50	uM	0.02
	342466	CHEMBL678756	Inhibition of fms-like tyrosine kinase receptor (Flt-1) kinase activity at a concentration of 2 uM of ATP	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OC/C=C/CN1CCCC1.Cl		CHEMBL1202478	=	IC50	nM	650.0	CHEMBL1868	Homo sapiens	IC50	uM	0.65
	506176	CHEMBL811938	Inhibition of Vascular endothelial growth factor receptor 1	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	IC50	nM	1520.0	CHEMBL1868	Homo sapiens	IC50	uM	1.52
	572154	CHEMBL770280	Inhibition of Protein kinase Flt-1 at 10 uM	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Inhibition	%	21.0	CHEMBL1868	Homo sapiens	Inhibition	%	21.0
	672813	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	CCCNC(=O)c1cc2ncnc(Nc3ccc4[nH]ccc4c3)c2s1		CHEMBL421329	=	IC50	nM	2000.0	CHEMBL1868	Homo sapiens	IC50	uM	2.0
	672815	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	c1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1		CHEMBL76432	=	IC50	nM	48.0	CHEMBL1868	Homo sapiens	IC50	uM	0.048
	674225	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	c1ccc(CCCN(c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)n2ccnc2)cc1		CHEMBL312818	=	IC50	nM	4.0	CHEMBL1868	Homo sapiens	IC50	uM	0.004
	674228	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	Cc1cc2cc(Nc3ccnc4cc(-c5ccc(CN6CCOCC6)cc5)sc34)ccc2[nH]1		CHEMBL311111	=	IC50	nM	5.0	CHEMBL1868	Homo sapiens	IC50	uM	0.005
	675592	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	c1cc(Nc2ccc3[nH]ccc3c2)c2sc(-c3ccc(CNCCN4CCNCC4)cc3)cc2n1		CHEMBL80540	=	IC50	nM	7.0	CHEMBL1868	Homo sapiens	IC50	uM	0.007
	678268	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	OCc1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1		CHEMBL312753	=	IC50	nM	56.0	CHEMBL1868	Homo sapiens	IC50	uM	0.056
	678270	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	CC(=O)NCCNCc1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1		CHEMBL80809	=	IC50	nM	4.0	CHEMBL1868	Homo sapiens	IC50	uM	0.004
	679309	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	CNc1ccc(Nc2ncnc3cc(-c4ccccc4)sc23)cc1		CHEMBL312678	=	IC50	nM	190.0	CHEMBL1868	Homo sapiens	IC50	uM	0.19
	680620	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	Nc1ncnc2cc(-c3ccccc3)sc12		CHEMBL311108	>	IC50	nM	1250.0	CHEMBL1868	Homo sapiens	IC50	uM	1.25
	680622	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	c1ccc(CCCN(c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)n2ccnc2)cc1		CHEMBL312818	=	IC50	nM	36.0	CHEMBL1868	Homo sapiens	IC50	uM	0.036
	683568	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	OCCNCc1ccc(-c2cc3nccc(Nc4ccc5[nH]ccc5c4)c3s2)cc1		CHEMBL310740	=	IC50	nM	6.0	CHEMBL1868	Homo sapiens	IC50	uM	0.006
	685054	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	c1ccc(Nc2ccc(Nc3ncnc4cc(-c5ccccc5)sc34)cc2)cc1		CHEMBL310724	=	IC50	nM	390.0	CHEMBL1868	Homo sapiens	IC50	uM	0.39
	685056	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	CC(C)(CO)NCc1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1		CHEMBL308498	=	IC50	nM	25.0	CHEMBL1868	Homo sapiens	IC50	uM	0.025
	685059	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	NCc1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1		CHEMBL78018	=	IC50	nM	18.0	CHEMBL1868	Homo sapiens	IC50	uM	0.018
	689126	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	OCCOCCNCc1ccc(-c2cc3nccc(Nc4ccc5[nH]ccc5c4)c3s2)cc1		CHEMBL421326	=	IC50	nM	4.0	CHEMBL1868	Homo sapiens	IC50	uM	0.004
	689129	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	Cc1cc2cc(Nc3ccnc4cc(-c5ccc(CNCCN6CCNCC6)cc5)sc34)ccc2[nH]1		CHEMBL79060	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	uM	0.003
	692854	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	CN(CCO)Cc1ccc(-c2cc3nccc(Nc4ccc5[nH]ccc5c4)c3s2)cc1		CHEMBL79206	=	IC50	nM	4.0	CHEMBL1868	Homo sapiens	IC50	uM	0.004
	694026	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	c1csc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)c1		CHEMBL76751	=	IC50	nM	130.0	CHEMBL1868	Homo sapiens	IC50	uM	0.13
	694028	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	NC(=O)C1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc6[nH]ccc6c5)c4s3)cc2)CC1		CHEMBL311109	=	IC50	nM	2.0	CHEMBL1868	Homo sapiens	IC50	uM	0.002
	695401	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	c1cc(Nc2ccc3[nH]ccc3c2)c2sc(-c3ccc(CN4CCOCC4)cc3)cc2n1		CHEMBL312482	=	IC50	nM	5.0	CHEMBL1868	Homo sapiens	IC50	uM	0.005
	696921	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	c1ccc(NCCN(c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)n2cccc2)cc1		CHEMBL79215	=	IC50	nM	43.0	CHEMBL1868	Homo sapiens	IC50	uM	0.043
	696923	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	NC(=O)C1CCN(Cc2ccc(-c3cc4nccc(Nc5ccc6[nH]ccc6c5)c4s3)cc2)CC1		CHEMBL431977	=	IC50	nM	17.0	CHEMBL1868	Homo sapiens	IC50	uM	0.017
	698440	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	O=C(c1ccccc1)c1cc2ncnc(Nc3ccc4[nH]ccc4c3)c2s1		CHEMBL81712	=	IC50	nM	770.0	CHEMBL1868	Homo sapiens	IC50	uM	0.77
	698442	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	c1csc(-c2cc3nccc(Nc4ccc5[nH]ccc5c4)c3s2)c1		CHEMBL310853	=	IC50	nM	132.0	CHEMBL1868	Homo sapiens	IC50	uM	0.132
	699833	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	Cc1cc2cc(Nc3ncnc4cc(-c5ccccc5)sc34)ccc2[nH]1		CHEMBL80302	=	IC50	nM	140.0	CHEMBL1868	Homo sapiens	IC50	uM	0.14
	701049	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	Cc1c[nH]c2ccc(Nc3ncnc4cc(-c5ccccc5)sc34)cc12		CHEMBL310827	=	IC50	nM	290.0	CHEMBL1868	Homo sapiens	IC50	uM	0.29
	701051	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	Cc1cc2cc(Nc3ccnc4cc(-c5ccc(CN(C)CCO)cc5)sc34)ccc2[nH]1		CHEMBL81375	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	uM	0.003
	701054	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	Cc1cc2cc(Nc3ccnc4cc(-c5ccc(CNCCOCCO)cc5)sc34)ccc2[nH]1		CHEMBL77342	=	IC50	nM	5.0	CHEMBL1868	Homo sapiens	IC50	uM	0.005
	702346	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	O/C(=C/c1cc2ncnc(Nc3ccc4[nH]ccc4c3)c2s1)c1ccccc1		CHEMBL309833	=	IC50	nM	2210.0	CHEMBL1868	Homo sapiens	IC50	uM	2.21
	702348	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	CC(C)(CO)NCc1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1		CHEMBL308498	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	uM	0.003
	703657	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	c1ccc(-c2cc3ncnc(Nc4ccc5[nH]nnc5c4)c3s2)cc1		CHEMBL78982	=	IC50	nM	470.0	CHEMBL1868	Homo sapiens	IC50	uM	0.47
	703659	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	CN(C)CCc1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1		CHEMBL77782	=	IC50	nM	22.0	CHEMBL1868	Homo sapiens	IC50	uM	0.022
	703661	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	Cc1cc2cc(Nc3ccnc4cc(-c5ccc(CNCCCO)cc5)sc34)ccc2[nH]1		CHEMBL78700	=	IC50	nM	5.0	CHEMBL1868	Homo sapiens	IC50	uM	0.005
	704939	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	c1ccc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)cc1		CHEMBL76432	=	IC50	nM	80.0	CHEMBL1868	Homo sapiens	IC50	uM	0.08
	704941	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	CN(C)c1ccc(Nc2ncnc3cc(-c4ccccc4)sc23)cc1		CHEMBL306732	=	IC50	nM	500.0	CHEMBL1868	Homo sapiens	IC50	uM	0.5
	704943	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	CC(=O)NCCNCc1ccc(-c2cc3nccc(Nc4ccc5[nH]ccc5c4)c3s2)cc1		CHEMBL418909	=	IC50	nM	24.0	CHEMBL1868	Homo sapiens	IC50	uM	0.024
	706261	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	c1ccc(-c2cc3ncnc(Nc4ccc5[nH]ncc5c4)c3s2)cc1		CHEMBL78685	=	IC50	nM	620.0	CHEMBL1868	Homo sapiens	IC50	uM	0.62
	706263	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	OCCCNCc1ccc(-c2cc3nccc(Nc4ccc5[nH]ccc5c4)c3s2)cc1		CHEMBL77452	=	IC50	nM	4.0	CHEMBL1868	Homo sapiens	IC50	uM	0.004
	707616	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	c1ccc(CNc2ncnc3cc(-c4ccccc4)sc23)cc1		CHEMBL78537	>	IC50	nM	2500.0	CHEMBL1868	Homo sapiens	IC50	uM	2.5
	707618	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	Cn1ccc2cc(Nc3ncnc4cc(-c5ccccc5)sc34)ccc21		CHEMBL80990	>	IC50	nM	2500.0	CHEMBL1868	Homo sapiens	IC50	uM	2.5
	708835	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	c1nc(Nc2ccc3[nH]ccc3c2)c2sccc2n1		CHEMBL442749	=	IC50	nM	1410.0	CHEMBL1868	Homo sapiens	IC50	uM	1.41
	708837	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	Brc1cc2ncnc(Nc3ccc4[nH]ccc4c3)c2s1		CHEMBL311798	=	IC50	nM	220.0	CHEMBL1868	Homo sapiens	IC50	uM	0.22
	708839	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	Cc1cc2cc(Nc3ccnc4cc(-c5ccc(CNCCO)cc5)sc34)ccc2[nH]1		CHEMBL80164	=	IC50	nM	4.0	CHEMBL1868	Homo sapiens	IC50	uM	0.004
	710212	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	c1csc(-c2cc3ncnc(Nc4ccc5[nH]ccc5c4)c3s2)c1		CHEMBL76751	=	IC50	nM	55.0	CHEMBL1868	Homo sapiens	IC50	uM	0.055
	711476	CHEMBL811929	Inhibitory activity against Vascular endothelial growth factor receptor	B	NC(=O)c1ccc(Nc2ncnc3cc(-c4ccccc4)sc23)cc1		CHEMBL80734	=	IC50	nM	250.0	CHEMBL1868	Homo sapiens	IC50	uM	0.25
	1006303	CHEMBL811932	Inhibition of Flt-1 tyrosine kinase.	B	O=C(Nc1ccccn1)Nc1cccc2c1[C@H]1CCCN1C2=O		CHEMBL141247	=	IC50	nM	2800.0	CHEMBL1868	Homo sapiens	IC50	uM	2.8
	1038863	CHEMBL811941	Inhibition of Vascular endothelial growth factor receptor 1	B	CC(C)OCc1ccc2c(c1)c1c3c(c4c(c1n2CCCO)Cc1ccccc1-4)C(=O)NC3		CHEMBL150894	=	IC50	nM	16.0	CHEMBL1868	Homo sapiens	IC50	nM	16.0
	1068010	CHEMBL811937	Inhibition of vascular endothelial growth factor receptor 1	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	IC50	nM	180.0	CHEMBL1868	Homo sapiens	IC50	uM	0.18
	1070525	CHEMBL811937	Inhibition of vascular endothelial growth factor receptor 1	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	IC50	nM	77.0	CHEMBL1868	Homo sapiens	IC50	uM	0.077
	1085417	CHEMBL811937	Inhibition of vascular endothelial growth factor receptor 1	B	O=C(Nc1ccccc1F)c1ccccc1NCc1ccc(F)cc1		CHEMBL101682	=	IC50	nM	23000.0	CHEMBL1868	Homo sapiens	IC50	uM	23.0
	1104967	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COCCOc1cc2nccc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150817	=	IC50	nM	300.0	CHEMBL1868	Homo sapiens	IC50	uM	0.3
	1107487	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	IC50	nM	200.0	CHEMBL1868	Homo sapiens	IC50	uM	0.2
	1110885	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCc1ccncc1		CHEMBL345943	=	IC50	nM	1200.0	CHEMBL1868	Homo sapiens	IC50	uM	1.2
	1110904	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN(C)c1ccncc1		CHEMBL25579	=	IC50	nM	100.0	CHEMBL1868	Homo sapiens	IC50	uM	0.1
	1111972	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COCCOc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL286160	=	IC50	nM	400.0	CHEMBL1868	Homo sapiens	IC50	uM	0.4
	1113206	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150315	=	IC50	nM	2000.0	CHEMBL1868	Homo sapiens	IC50	uM	2.0
	1116824	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COCCOc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OCCOC		CHEMBL148869	=	IC50	nM	900.0	CHEMBL1868	Homo sapiens	IC50	uM	0.9
	1118073	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2ncnc(Nc3ccccc3F)c2cc1OC		CHEMBL150581	=	IC50	nM	26000.0	CHEMBL1868	Homo sapiens	IC50	uM	26.0
	1119358	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COCC(=O)Nc1cc2ncnc(Nc3cc(O)c(C)cc3F)c2cc1OC		CHEMBL151015	=	IC50	nM	300.0	CHEMBL1868	Homo sapiens	IC50	uM	0.3
	1121547	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COCCOc1cc2ncnc(Nc3cc(O)c(Cl)cc3F)c2cc1OC		CHEMBL347086	<	IC50	nM	2.0	CHEMBL1868	Homo sapiens	IC50	uM	0.002
	1121619	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COCC(=O)Nc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL151948	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	1121622	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1		CHEMBL281872	=	IC50	nM	700.0	CHEMBL1868	Homo sapiens	IC50	uM	0.7
	1121630	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2ncnc(Nc3ccc(I)cc3F)c2cc1OC		CHEMBL151942	=	IC50	nM	800.0	CHEMBL1868	Homo sapiens	IC50	uM	0.8
	1121631	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2ncnc(Nc3ccc(F)cc3F)c2cc1OC		CHEMBL346200	=	IC50	nM	22000.0	CHEMBL1868	Homo sapiens	IC50	uM	22.0
	1122748	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COCCOc1ccc2c(Nc3ccc(Cl)cc3F)ncnc2c1		CHEMBL150657	=	IC50	nM	1500.0	CHEMBL1868	Homo sapiens	IC50	uM	1.5
	1122781	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2c(Nc3c(F)cc(Br)cc3F)ncnc2cc1OCCn1ccnn1		CHEMBL150187	=	IC50	nM	800.0	CHEMBL1868	Homo sapiens	IC50	uM	0.8
	1123977	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OC1CCN(C)CC1		CHEMBL26050	=	IC50	nM	15000.0	CHEMBL1868	Homo sapiens	IC50	uM	15.0
	1123982	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2ncnc(Nc3ccc(I)cc3Cl)c2cc1OC		CHEMBL151418	>	IC50	nM	33000.0	CHEMBL1868	Homo sapiens	IC50	uM	33.0
	1125128	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCOCCN1CCOCC1		CHEMBL356658	=	IC50	nM	500.0	CHEMBL1868	Homo sapiens	IC50	uM	0.5
	1125183	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COCCOc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL421961	=	IC50	nM	30.0	CHEMBL1868	Homo sapiens	IC50	uM	0.03
	1127637	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COCCOc1cc2nccc(Nc3cc(O)c(Cl)cc3F)c2cc1OC		CHEMBL433936	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	uM	0.003
	1127642	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COCCOc1cc2nncc(Nc3cc(O)c(Cl)cc3F)c2cc1OC		CHEMBL150826	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	uM	0.05
	1127647	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCn1ccnc1		CHEMBL147192	=	IC50	nM	100.0	CHEMBL1868	Homo sapiens	IC50	uM	0.1
	1130031	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COCCOc1cc2nncc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150825	=	IC50	nM	63000.0	CHEMBL1868	Homo sapiens	IC50	uM	63.0
	1135050	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2ncnc(Nc3ccc(Cl)cc3)c2cc1OC		CHEMBL147138	=	IC50	nM	11000.0	CHEMBL1868	Homo sapiens	IC50	uM	11.0
	1135079	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN1CCOCC1		CHEMBL25610	=	IC50	nM	1100.0	CHEMBL1868	Homo sapiens	IC50	uM	1.1
	1135084	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCn1ccnn1		CHEMBL357815	=	IC50	nM	300.0	CHEMBL1868	Homo sapiens	IC50	uM	0.3
	1135094	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2c(Nc3ccc(C#N)cc3F)ncnc2cc1OCCn1ccnn1		CHEMBL358672	=	IC50	nM	8100.0	CHEMBL1868	Homo sapiens	IC50	uM	8.1
	1135100	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OC		CHEMBL301018	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	1137563	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCn1cncn1		CHEMBL150606	=	IC50	nM	500.0	CHEMBL1868	Homo sapiens	IC50	uM	0.5
	1137568	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2ncnc(Nc3cc(O)c(C)cc3F)c2cc1OC		CHEMBL440727	=	IC50	nM	30.0	CHEMBL1868	Homo sapiens	IC50	uM	0.03
	1138814	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCN1CCCC1		CHEMBL147180	=	IC50	nM	300.0	CHEMBL1868	Homo sapiens	IC50	uM	0.3
	1140147	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCc1ccsc1		CHEMBL151067	=	IC50	nM	800.0	CHEMBL1868	Homo sapiens	IC50	uM	0.8
	1140176	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCCN1CCOCC1		CHEMBL434311	=	IC50	nM	300.0	CHEMBL1868	Homo sapiens	IC50	uM	0.3
	1141414	CHEMBL811931	In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP.	B	COc1cc2c(Nc3ccc(Cl)cc3F)ncnc2cc1OCCCN1CCOCC1		CHEMBL24137	=	IC50	nM	200.0	CHEMBL1868	Homo sapiens	IC50	uM	0.2
	1142531	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Clc1ccc(Oc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL74850	=	IC50	nM	60.0	CHEMBL1868	Homo sapiens	IC50	uM	0.06
	1142533	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Clc1ccc(Nc2nnc(NCc3ccncc3)c3ccccc23)cc1		CHEMBL74034	=	IC50	nM	2600.0	CHEMBL1868	Homo sapiens	IC50	uM	2.6
	1143849	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3c2CCCC3)cc1		CHEMBL75076	=	IC50	nM	3600.0	CHEMBL1868	Homo sapiens	IC50	uM	3.6
	1144046	CHEMBL811934	Inhibition of Vascular endothelial growth factor receptor 1	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCOCC1		CHEMBL369360	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	1147930	CHEMBL677133	Inhibition of VEGF-receptor 1, Flt-1	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	8.0	CHEMBL1868	Homo sapiens	IC50	uM	0.008
	1151499	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Cc1cccc(Nc2nnc(Cc3ccncc3)c3ccccc23)c1		CHEMBL78303	=	IC50	nM	40.0	CHEMBL1868	Homo sapiens	IC50	uM	0.04
	1152809	CHEMBL811935	In vitro inhibition of Vascular endothelial growth factor receptor 1 (VEGFR-1) expressed in baculovirus	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	IC50	nM	130.0	CHEMBL1868	Homo sapiens	IC50	nM	130.0
	1152864	CHEMBL811939	Inhibition of Vascular endothelial growth factor receptor 1	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCCCN1CCCCC1		CHEMBL169186	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	1153964	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Clc1ccc(Sc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL74391	=	IC50	nM	70.0	CHEMBL1868	Homo sapiens	IC50	uM	0.07
	1155306	CHEMBL677134	Inhibitory activity against Flt-kinase	B	FC(F)(F)c1cc(Nc2nnc(Cc3ccncc3)c3ccccc23)ccc1Cl		CHEMBL77555	=	IC50	nM	600.0	CHEMBL1868	Homo sapiens	IC50	uM	0.6
	1157854	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccncc23)cc1		CHEMBL433321	=	IC50	nM	470.0	CHEMBL1868	Homo sapiens	IC50	uM	0.47
	1160547	CHEMBL677134	Inhibitory activity against Flt-kinase	B	c1ccc(-c2ccc(Nc3nnc(Cc4ccncc4)c4ccccc34)cc2)cc1		CHEMBL309331	=	IC50	nM	230.0	CHEMBL1868	Homo sapiens	IC50	uM	0.23
	1161915	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Cc1c(Cc2ccncc2)nnc(Nc2ccc(Cl)cc2)c1C		CHEMBL306707	=	IC50	nM	260.0	CHEMBL1868	Homo sapiens	IC50	uM	0.26
	1163436	CHEMBL677134	Inhibitory activity against Flt-kinase	B	COc1cc(Nc2nnc(Cc3ccncc3)c3ccccc23)ccc1Cl		CHEMBL75034	=	IC50	nM	260.0	CHEMBL1868	Homo sapiens	IC50	uM	0.26
	1164807	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Clc1ccc(Nc2nnc(Cc3ccccn3)c3ccccc23)cc1		CHEMBL312789	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1164809	CHEMBL677134	Inhibitory activity against Flt-kinase	B	CC(c1ccncc1)c1nnc(Nc2ccc(Cl)cc2)c2ccccc12		CHEMBL78160	=	IC50	nM	420.0	CHEMBL1868	Homo sapiens	IC50	uM	0.42
	1164811	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Nc1ccc2c(Cc3ccncc3)nnc(Nc3ccc(Cl)cc3)c2c1		CHEMBL74143	=	IC50	nM	650.0	CHEMBL1868	Homo sapiens	IC50	uM	0.65
	1164813	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Oc1cccc(Nc2nnc(Cc3ccncc3)c3ccccc23)c1		CHEMBL306295	=	IC50	nM	80.0	CHEMBL1868	Homo sapiens	IC50	uM	0.08
	1166091	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1.O=C(O)CCC(=O)O		CHEMBL75232	=	IC50	nM	77.0	CHEMBL1868	Homo sapiens	IC50	uM	0.077
	1167463	CHEMBL677134	Inhibitory activity against Flt-kinase	B	CN(c1ccc(Cl)cc1)c1nnc(Cc2ccncc2)c2ccccc12		CHEMBL307476	=	IC50	nM	2300.0	CHEMBL1868	Homo sapiens	IC50	uM	2.3
	1167465	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Cc1cc(Cc2nnc(Nc3ccc(Cl)cc3)c3ccccc23)cc(C)n1		CHEMBL75130	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1167467	CHEMBL677134	Inhibitory activity against Flt-kinase	B	c1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL74587	=	IC50	nM	60.0	CHEMBL1868	Homo sapiens	IC50	uM	0.06
	1168750	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Clc1ccc(Nc2nnc(Cc3ccncn3)c3ccccc23)cc1		CHEMBL419458	=	IC50	nM	760.0	CHEMBL1868	Homo sapiens	IC50	uM	0.76
	1168752	CHEMBL677134	Inhibitory activity against Flt-kinase	B	FC(F)(F)c1cc(Br)cc(Nc2nnc(Cc3ccncc3)c3ccccc23)c1		CHEMBL77933	=	IC50	nM	600.0	CHEMBL1868	Homo sapiens	IC50	uM	0.6
	1168759	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Fc1cc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc(C(F)(F)F)c1		CHEMBL74646	=	IC50	nM	350.0	CHEMBL1868	Homo sapiens	IC50	uM	0.35
	1170095	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1Cl		CHEMBL75196	=	IC50	nM	70.0	CHEMBL1868	Homo sapiens	IC50	uM	0.07
	1173842	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3cnccc23)cc1		CHEMBL74550	=	IC50	nM	230.0	CHEMBL1868	Homo sapiens	IC50	uM	0.23
	1175199	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Cc1ccc2c(Cc3ccncc3)nnc(Nc3ccc(Cl)cc3)c2c1		CHEMBL306512	=	IC50	nM	3000.0	CHEMBL1868	Homo sapiens	IC50	uM	3.0
	1175201	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3cccnc23)cc1		CHEMBL306284	=	IC50	nM	1700.0	CHEMBL1868	Homo sapiens	IC50	uM	1.7
	1175203	CHEMBL677134	Inhibitory activity against Flt-kinase	B	CC(C)(C)c1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL431006	=	IC50	nM	240.0	CHEMBL1868	Homo sapiens	IC50	uM	0.24
	1175316	CHEMBL811935	In vitro inhibition of Vascular endothelial growth factor receptor 1 (VEGFR-1) expressed in baculovirus	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	90.0	CHEMBL1868	Homo sapiens	IC50	nM	90.0
	1175335	CHEMBL811936	In vitro inhibition of Vascular endothelial growth factor receptor 1 (VEGFR-1) expressed in baculovirus	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	1600.0	CHEMBL1868	Homo sapiens	IC50	nM	1600.0
	1175341	CHEMBL811935	In vitro inhibition of Vascular endothelial growth factor receptor 1 (VEGFR-1) expressed in baculovirus	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	43.0	CHEMBL1868	Homo sapiens	IC50	nM	43.0
	1176718	CHEMBL811939	Inhibition of Vascular endothelial growth factor receptor 1	B	COc1cc2c(Nc3c(Cl)ccc4c3OCO4)ncnc2cc1OCC1CCN(C)CC1		CHEMBL170984	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	1177824	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ncccc23)cc1		CHEMBL75077	=	IC50	nM	240.0	CHEMBL1868	Homo sapiens	IC50	uM	0.24
	1179007	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Cc1cc(C)cc(Nc2nnc(Cc3ccncc3)c3ccccc23)c1		CHEMBL74197	=	IC50	nM	150.0	CHEMBL1868	Homo sapiens	IC50	uM	0.15
	1180412	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Clc1ccc(Nc2nnc(Cc3cccnc3)c3ccccc23)cc1		CHEMBL74848	=	IC50	nM	9800.0	CHEMBL1868	Homo sapiens	IC50	uM	9.8
	1180530	CHEMBL811935	In vitro inhibition of Vascular endothelial growth factor receptor 1 (VEGFR-1) expressed in baculovirus	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1.O=C(O)CCC(=O)O		CHEMBL75232	=	IC50	nM	110.0	CHEMBL1868	Homo sapiens	IC50	nM	110.0
	1181737	CHEMBL677134	Inhibitory activity against Flt-kinase	B	Cc1cc(Cc2nnc(Nc3ccc(Cl)cc3)c3ccccc23)ccn1		CHEMBL312526	=	IC50	nM	620.0	CHEMBL1868	Homo sapiens	IC50	uM	0.62
	1181739	CHEMBL677134	Inhibitory activity against Flt-kinase	B	COc1cccc(Nc2nnc(Cc3ccncc3)c3ccccc23)c1		CHEMBL75462	=	IC50	nM	330.0	CHEMBL1868	Homo sapiens	IC50	uM	0.33
	1183182	CHEMBL811935	In vitro inhibition of Vascular endothelial growth factor receptor 1 (VEGFR-1) expressed in baculovirus	B	O=C(Nc1cccc(-c2cncc3ccccc23)c1)c1ccccc1NCc1ccncc1		CHEMBL347537	=	IC50	nM	130.0	CHEMBL1868	Homo sapiens	IC50	nM	130.0
	1493572	CHEMBL875601	Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 10 ug/mL	B	O=C1NCc2c1c1c3ccc(O)cc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL190546	=	Inhibition	%	80.0	CHEMBL1868	Homo sapiens	Inhibition	%	80.0
	1493574	CHEMBL836005	Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 1 ug/mL	B	O=C1NCc2c1c1c3ccc(O)cc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL190546	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	Inhibition	%	50.0
	1493575	CHEMBL836009	Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 0.1 ug/mL	B	O=C1NCc2c1c1c3ccc(O)cc3[nH]c1c1[nH]c3ccccc3c21		CHEMBL190546	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	Inhibition	%	50.0
	1516924	CHEMBL830766	Selectivity for Vascular endothelial growth factor receptor 1 by homologous time-resolved fluorescence assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccn4)c3)o2)c1		CHEMBL194176	=	Selectivity	uM	0.073	CHEMBL1868	Homo sapiens	Selectivity	uM	0.073
	1517058	CHEMBL830766	Selectivity for Vascular endothelial growth factor receptor 1 by homologous time-resolved fluorescence assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Selectivity	uM	0.4	CHEMBL1868	Homo sapiens	Selectivity	uM	0.4
	1517173	CHEMBL830766	Selectivity for Vascular endothelial growth factor receptor 1 by homologous time-resolved fluorescence assay	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4Cl)c3)o2)c1		CHEMBL191993	=	Selectivity	uM	0.11	CHEMBL1868	Homo sapiens	Selectivity	uM	0.11
	1517311	CHEMBL875601	Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 10 ug/mL	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(O)c(O)cc3c21		CHEMBL193468	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	Inhibition	%	50.0
	1517313	CHEMBL836005	Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 1 ug/mL	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(O)c(O)cc3c21		CHEMBL193468	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	Inhibition	%	50.0
	1517314	CHEMBL836009	Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 0.1 ug/mL	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(O)c(O)cc3c21		CHEMBL193468	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	Inhibition	%	50.0
	1520134	CHEMBL875601	Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 10 ug/mL	B	COC(=O)c1[nH]c(C(=O)OC)c(-c2c[nH]c3ccc(O)cc23)c1-c1c[nH]c2ccccc12		CHEMBL439675	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	Inhibition	%	50.0
	1520135	CHEMBL836005	Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 1 ug/mL	B	COC(=O)c1[nH]c(C(=O)OC)c(-c2c[nH]c3ccc(O)cc23)c1-c1c[nH]c2ccccc12		CHEMBL439675	=	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	Inhibition	%	50.0
	1520137	CHEMBL836009	Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 0.1 ug/mL	B	COC(=O)c1[nH]c(C(=O)OC)c(-c2c[nH]c3ccc(O)cc23)c1-c1c[nH]c2ccccc12		CHEMBL439675	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	Inhibition	%	50.0
	1523041	CHEMBL875601	Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 10 ug/mL	B	COC(=O)c1[nH]c(C(=O)OC)c(-c2c[nH]c3ccccc23)c1-c1c[nH]c2ccccc12		CHEMBL371472	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	Inhibition	%	50.0
	1523042	CHEMBL836005	Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 1 ug/mL	B	COC(=O)c1[nH]c(C(=O)OC)c(-c2c[nH]c3ccccc23)c1-c1c[nH]c2ccccc12		CHEMBL371472	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	Inhibition	%	50.0
	1523044	CHEMBL836009	Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 0.1 ug/mL	B	COC(=O)c1[nH]c(C(=O)OC)c(-c2c[nH]c3ccccc23)c1-c1c[nH]c2ccccc12		CHEMBL371472	<	Inhibition	%		CHEMBL1868	Homo sapiens	Inhibition	%	
	1523820	CHEMBL875601	Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 10 ug/mL	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	Inhibition	%	50.0
	1523821	CHEMBL836005	Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 1 ug/mL	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	Inhibition	%	50.0
	1523823	CHEMBL836009	Inhibition of Vascular endothelial growth factor receptor 1 mediated [gamma-32P]-ATP incorporation at 0.1 ug/mL	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	Inhibition	%	50.0
	1600072	CHEMBL884286	Percent inhibition of Vascular endothelial growth factor receptor 1 at 10 uM	B	CC(C)(C)c1cccc(Nc2nnc(-c3ccc(C(N)=O)cc3)c3ccccc23)c1		CHEMBL196668	=	Inhibition	%	60.0	CHEMBL1868	Homo sapiens	Inhibition	%	60.0
	1600075	CHEMBL884286	Percent inhibition of Vascular endothelial growth factor receptor 1 at 10 uM	B	CC(C)(C)c1ccc(Nc2nnc(-c3ccc(C(N)=O)cc3)c3ccccc23)cc1		CHEMBL370586	=	Inhibition	%	73.0	CHEMBL1868	Homo sapiens	Inhibition	%	73.0
	1600078	CHEMBL884286	Percent inhibition of Vascular endothelial growth factor receptor 1 at 10 uM	B	NC(=O)c1ccc(-c2nnc(Nc3ccc(Br)cc3)c3ccccc23)cc1		CHEMBL197158	=	Inhibition	%	53.0	CHEMBL1868	Homo sapiens	Inhibition	%	53.0
	1600084	CHEMBL884286	Percent inhibition of Vascular endothelial growth factor receptor 1 at 10 uM	B	NC(=O)c1ccc(-c2nnc(Nc3cccc(Br)c3)c3ccccc23)cc1		CHEMBL370193	=	Inhibition	%	51.0	CHEMBL1868	Homo sapiens	Inhibition	%	51.0
	1609150	CHEMBL882597	Inhibitory concentration against FLT1 with 4 uM Biotin-Ahx-AEEEYFFLFA-amide for 1 hr at ambient temperature	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	IC50	nM	2.0	CHEMBL1868	Homo sapiens	IC50	nM	2.0
	1609235	CHEMBL871634	Inhibitory concentration against Vascular endothelial growth factor receptor 1 with 4 uM Biotin-Ahx-AEEEYFFLFA-amide for 1 hr at ambient temperature with 1 mM ATP at pH 7.5	B	Cc1sc2ncnc(N)c2c1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL381207	=	IC50	nM	170.0	CHEMBL1868	Homo sapiens	IC50	nM	170.0
Not Active	1661753	CHEMBL867554	Inhibitory activity against FLT1 at 25 uM	B	O=C(Nc1ccc2c(c1)C=Nc1c(Cl)ncnc1O2)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL199886		Activity			CHEMBL1868	Homo sapiens	Activity		
	1663069	CHEMBL863866	Inhibitory activity against flt kinase	B	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150315	=	IC50	nM	2000.0	CHEMBL1868	Homo sapiens	IC50	uM	2.0
	1677085	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1scnc1CCc1cnoc1		CHEMBL203095	=	IC50	nM	4600.0	CHEMBL1868	Homo sapiens	IC50	uM	4.6
	1677117	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(Cc2ccccc2)cc1)c1scnc1CCc1ccncc1		CHEMBL383575	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1677118	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(Oc2ccccc2)cc1)c1scnc1CCc1ccncc1		CHEMBL201303	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1677119	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(-c2ccccc2)cc1)c1scnc1CCc1ccncc1		CHEMBL425930	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1677120	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(Br)cc1)c1scnc1CCc1ccncc1		CHEMBL201713	=	IC50	nM	3850.0	CHEMBL1868	Homo sapiens	IC50	uM	3.85
	1677121	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc2c(c1)OCO2)c1scnc1CCc1ccncc1		CHEMBL370600	=	IC50	nM	750.0	CHEMBL1868	Homo sapiens	IC50	uM	0.75
	1677122	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	Cc1ccc(NC(=O)c2scnc2CCc2ccncc2)c(F)c1		CHEMBL202153	=	IC50	nM	630.0	CHEMBL1868	Homo sapiens	IC50	uM	0.63
	1677123	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	Cc1ccc(NC(=O)c2scnc2CCc2cnoc2)c(F)c1		CHEMBL382308	=	IC50	nM	3020.0	CHEMBL1868	Homo sapiens	IC50	uM	3.02
	1677124	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1scnc1CCc1ccncc1		CHEMBL202466	=	IC50	nM	720.0	CHEMBL1868	Homo sapiens	IC50	uM	0.72
	1677125	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1scnc1CCc1cnoc1		CHEMBL202109	=	IC50	nM	5320.0	CHEMBL1868	Homo sapiens	IC50	uM	5.32
	1677126	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1scnc1CCc1ccncc1		CHEMBL383215	=	IC50	nM	590.0	CHEMBL1868	Homo sapiens	IC50	uM	0.59
	1677127	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1scnc1CCc1cnoc1		CHEMBL202714	=	IC50	nM	5420.0	CHEMBL1868	Homo sapiens	IC50	uM	5.42
	1677128	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(N2CCOCC2)cc1)c1scnc1CCc1ccncc1		CHEMBL202408	=	IC50	nM	2330.0	CHEMBL1868	Homo sapiens	IC50	uM	2.33
	1677129	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(N2CCOCC2)cc1)c1scnc1CCc1cnoc1		CHEMBL382647	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1677130	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	Cc1ccccc1NC(=O)c1scnc1CCc1ccncc1		CHEMBL203698	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1677131	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	Cc1ccccc1NC(=O)c1scnc1CCc1cnoc1		CHEMBL382184	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1677132	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	Cc1cccc(NC(=O)c2scnc2CCc2ccncc2)c1		CHEMBL380700	=	IC50	nM	4660.0	CHEMBL1868	Homo sapiens	IC50	uM	4.66
	1677133	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	Cc1cccc(NC(=O)c2scnc2CCc2cnoc2)c1		CHEMBL377921	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1677134	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1scnc1CCc1ccncc1		CHEMBL379674	=	IC50	nM	760.0	CHEMBL1868	Homo sapiens	IC50	uM	0.76
	1677135	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1scnc1CCc1cnoc1		CHEMBL424672	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1677136	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	CC(C)c1ccc(NC(=O)c2scnc2CCc2ccncc2)cc1		CHEMBL201906	=	IC50	nM	840.0	CHEMBL1868	Homo sapiens	IC50	uM	0.84
	1677137	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	CC(C)c1ccc(NC(=O)c2scnc2CCc2cnoc2)cc1		CHEMBL201659	=	IC50	nM	6410.0	CHEMBL1868	Homo sapiens	IC50	uM	6.41
	1677138	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	CC(C)(C)c1ccc(NC(=O)c2scnc2CCc2ccc3ccccc3n2)cc1		CHEMBL201712	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1677139	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	CC(C)(C)c1ccc(NC(=O)c2scnc2CCc2ccnc3ccccc23)cc1		CHEMBL201014	=	IC50	nM	5460.0	CHEMBL1868	Homo sapiens	IC50	uM	5.46
	1677140	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	CC(C)(C)c1ccc(NC(=O)c2scnc2CCc2ccncc2)cc1		CHEMBL202384	=	IC50	nM	720.0	CHEMBL1868	Homo sapiens	IC50	uM	0.72
	1677141	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	CC(C)(C)c1ccc(NC(=O)c2scnc2CCc2noc3ccccc23)cc1		CHEMBL202383	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1677142	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	CC(C)(C)c1ccc(NC(=O)c2scnc2CCc2cnoc2)cc1		CHEMBL202234	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1677143	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1scnc1CCc1ccc2ccccc2n1		CHEMBL381300	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1677144	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1scnc1CCc1ccnc2ccccc12		CHEMBL203149	=	IC50	nM	6850.0	CHEMBL1868	Homo sapiens	IC50	uM	6.85
	1677145	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1scnc1CCc1ccncc1		CHEMBL205114	=	IC50	nM	310.0	CHEMBL1868	Homo sapiens	IC50	uM	0.31
	1677146	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1scnc1CCc1noc2ccccc12		CHEMBL205113	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1677619	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1cnc2ccccc2c1)c1ccccc1NCc1ccncc1		CHEMBL202011	=	IC50	nM	160.0	CHEMBL1868	Homo sapiens	IC50	uM	0.16
	1677620	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	IC50	nM	170.0	CHEMBL1868	Homo sapiens	IC50	uM	0.17
	1677621	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	100.0	CHEMBL1868	Homo sapiens	IC50	uM	0.1
	1677622	CHEMBL861908	Inhibitory activity against VEGFR1 by HTRF assay	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	IC50	nM	140.0	CHEMBL1868	Homo sapiens	IC50	uM	0.14
	1694649	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	IC50	nM	140.0	CHEMBL1868	Homo sapiens	IC50	uM	0.14
	1694655	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL203056	=	IC50	nM	340.0	CHEMBL1868	Homo sapiens	IC50	uM	0.34
	1694656	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	O=C(Nc1cnc2ccccc2c1)c1ccccc1NCc1ccncc1		CHEMBL202011	=	IC50	nM	160.0	CHEMBL1868	Homo sapiens	IC50	uM	0.16
	1694657	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	IC50	nM	170.0	CHEMBL1868	Homo sapiens	IC50	uM	0.17
	1694658	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	100.0	CHEMBL1868	Homo sapiens	IC50	uM	0.1
	1694664	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2cccnc2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL206742	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1694669	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cc3ccccc3)cc2)o1		CHEMBL383126	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1694670	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Oc3ccccc3)cc2)o1		CHEMBL206267	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1694671	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(-c3ccccc3)cc2)o1		CHEMBL205464	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1694672	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cc1ccccc1Nc1nnc(-c2c(NCc3ccncc3)ncn2C)o1		CHEMBL379239	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1694673	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	COc1ccccc1Nc1nnc(-c2c(NCc3ccncc3)ncn2C)o1		CHEMBL204312	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1694674	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2cccc3ncccc23)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL378165	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1694675	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccc3ccccc3n2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL204718	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1694676	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccc3[nH]ncc3c2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL206118	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1694677	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccccn2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL202904	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1694682	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCCc2ccc3c(c2)OCO3)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL382672	=	IC50	nM	1470.0	CHEMBL1868	Homo sapiens	IC50	uM	1.47
	1694701	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)c(C(F)(F)F)c2)o1		CHEMBL205127	=	IC50	nM	510.0	CHEMBL1868	Homo sapiens	IC50	uM	0.51
	1694702	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	COc1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)cc1OC		CHEMBL378592	=	IC50	nM	590.0	CHEMBL1868	Homo sapiens	IC50	uM	0.59
	1694703	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Cl)c(Cl)c2)o1		CHEMBL204874	=	IC50	nM	490.0	CHEMBL1868	Homo sapiens	IC50	uM	0.49
	1694704	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	COc1cccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c1		CHEMBL203796	=	IC50	nM	670.0	CHEMBL1868	Homo sapiens	IC50	uM	0.67
	1694705	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cc1cccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c1		CHEMBL203789	=	IC50	nM	1260.0	CHEMBL1868	Homo sapiens	IC50	uM	1.26
	1694706	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2cccc(OC(F)(F)F)c2)o1		CHEMBL206538	=	IC50	nM	560.0	CHEMBL1868	Homo sapiens	IC50	uM	0.56
	1694707	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(C(F)(F)F)cc2)o1		CHEMBL380131	=	IC50	nM	120.0	CHEMBL1868	Homo sapiens	IC50	uM	0.12
	1694708	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(OC(F)(F)F)cc2)o1		CHEMBL383255	=	IC50	nM	160.0	CHEMBL1868	Homo sapiens	IC50	uM	0.16
	1694709	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(OC(F)(F)Cl)cc2)o1		CHEMBL205884	=	IC50	nM	460.0	CHEMBL1868	Homo sapiens	IC50	uM	0.46
	1694710	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	CC(C)c1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)cc1		CHEMBL203119	=	IC50	nM	770.0	CHEMBL1868	Homo sapiens	IC50	uM	0.77
	1694711	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(C(C)(C)C)cc2)o1		CHEMBL203731	=	IC50	nM	890.0	CHEMBL1868	Homo sapiens	IC50	uM	0.89
	1694712	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccc(F)c(F)c2)c1-c1nnc(Nc2ccc(Cl)cc2)o1		CHEMBL203394	=	IC50	nM	3310.0	CHEMBL1868	Homo sapiens	IC50	uM	3.31
	1694713	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(Nc2ccc(Br)cc2)o1		CHEMBL205463	=	IC50	nM	1470.0	CHEMBL1868	Homo sapiens	IC50	uM	1.47
	1694714	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cn1cnc(NCc2ccncc2)c1-c1nnc(NCc2ccc3c(c2)OCO3)o1		CHEMBL202892	=	IC50	nM	440.0	CHEMBL1868	Homo sapiens	IC50	uM	0.44
	1694715	CHEMBL862190	Inhibition of VEGFR1 by enzymatic assay	B	Cc1ccc(Nc2nnc(-c3c(NCc4ccncc4)ncn3C)o2)c(F)c1		CHEMBL379908	=	IC50	nM	590.0	CHEMBL1868	Homo sapiens	IC50	uM	0.59
	1698168	CHEMBL866515	Inhibition of VEGFR1 at 10 uM by HTRF assay	B	Clc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1		CHEMBL380316	=	Inhibition	%	91.0	CHEMBL1868	Homo sapiens	Inhibition	%	91.0
	1698170	CHEMBL866515	Inhibition of VEGFR1 at 10 uM by HTRF assay	B	CC(C)(C)c1ccc(Nc2nnc(-c3cccc4ncccc34)c3ccccc23)cc1		CHEMBL202950	=	Inhibition	%	31.0	CHEMBL1868	Homo sapiens	Inhibition	%	31.0
	1698171	CHEMBL866515	Inhibition of VEGFR1 at 10 uM by HTRF assay	B	Clc1ccc(Nc2nnc(-c3cccc4ncccc34)c3ccccc23)cc1		CHEMBL206846	=	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	Inhibition	%	40.0
	1698172	CHEMBL866515	Inhibition of VEGFR1 at 10 uM by HTRF assay	B	Cc1cc2cc(Nc3nnc(-c4cccc5cnccc45)c4ccccc34)ccc2[nH]1		CHEMBL206658	=	Inhibition	%	57.0	CHEMBL1868	Homo sapiens	Inhibition	%	57.0
	1698173	CHEMBL866515	Inhibition of VEGFR1 at 10 uM by HTRF assay	B	Cc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)c(F)c1		CHEMBL380508	=	Inhibition	%	92.0	CHEMBL1868	Homo sapiens	Inhibition	%	92.0
	1698174	CHEMBL866515	Inhibition of VEGFR1 at 10 uM by HTRF assay	B	FC(F)(F)c1cc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)ccc1Cl		CHEMBL383616	=	Inhibition	%	92.0	CHEMBL1868	Homo sapiens	Inhibition	%	92.0
	1698175	CHEMBL866515	Inhibition of VEGFR1 at 10 uM by HTRF assay	B	Clc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1Cl		CHEMBL205823	=	Inhibition	%	84.0	CHEMBL1868	Homo sapiens	Inhibition	%	84.0
	1698176	CHEMBL866515	Inhibition of VEGFR1 at 10 uM by HTRF assay	B	c1cc(-c2nnc(Nc3ccc(N4CCOCC4)cc3)c3ccccc23)c2ccncc2c1		CHEMBL203438	=	Inhibition	%	54.0	CHEMBL1868	Homo sapiens	Inhibition	%	54.0
	1698177	CHEMBL866515	Inhibition of VEGFR1 at 10 uM by HTRF assay	B	Cc1ccccc1Nc1nnc(-c2cccc3cnccc23)c2ccccc12		CHEMBL204220	=	Inhibition	%	60.0	CHEMBL1868	Homo sapiens	Inhibition	%	60.0
	1698178	CHEMBL866515	Inhibition of VEGFR1 at 10 uM by HTRF assay	B	Cc1cccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)c1		CHEMBL202998	=	Inhibition	%	89.0	CHEMBL1868	Homo sapiens	Inhibition	%	89.0
	1698179	CHEMBL866515	Inhibition of VEGFR1 at 10 uM by HTRF assay	B	FC(F)(Cl)Oc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1		CHEMBL382818	=	Inhibition	%	88.0	CHEMBL1868	Homo sapiens	Inhibition	%	88.0
	1698180	CHEMBL866515	Inhibition of VEGFR1 at 10 uM by HTRF assay	B	CC(C)c1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1		CHEMBL203346	=	Inhibition	%	91.0	CHEMBL1868	Homo sapiens	Inhibition	%	91.0
	1698181	CHEMBL866515	Inhibition of VEGFR1 at 10 uM by HTRF assay	B	CC(C)(C)c1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1		CHEMBL206536	=	Inhibition	%	86.0	CHEMBL1868	Homo sapiens	Inhibition	%	86.0
	1698238	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	IC50	nM	140.0	CHEMBL1868	Homo sapiens	IC50	uM	0.14
	1698239	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cc2ccccc2)cc1)c1ccccc1Cn1ccc2ncnc-2c1		CHEMBL203429	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1698240	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Oc2ccccc2)cc1)c1ccccc1Cn1ccc2ncnc-2c1		CHEMBL380503	=	IC50	nM	2530.0	CHEMBL1868	Homo sapiens	IC50	uM	2.53
	1698241	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(-c2ccccc2)cc1)c1ccccc1Cn1ccc2ncnc-2c1		CHEMBL382478	=	IC50	nM	1140.0	CHEMBL1868	Homo sapiens	IC50	uM	1.14
	1698242	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Br)cc1)c1ccccc1Cn1ccc2ncnc-2c1		CHEMBL382584	=	IC50	nM	770.0	CHEMBL1868	Homo sapiens	IC50	uM	0.77
	1698243	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Br)cc1)c1ccccc1Cn1ccc2cnccc21		CHEMBL203063	=	IC50	nM	950.0	CHEMBL1868	Homo sapiens	IC50	uM	0.95
	1698244	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc2c(c1)OCO2)c1ccccc1Cn1ccc2ncnc-2c1		CHEMBL203167	=	IC50	nM	360.0	CHEMBL1868	Homo sapiens	IC50	uM	0.36
	1698245	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc2c(c1)OCO2)c1ccccc1Cn1ccc2cnccc21		CHEMBL425587	=	IC50	nM	180.0	CHEMBL1868	Homo sapiens	IC50	uM	0.18
	1698246	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	Cc1ccc(NC(=O)c2ccccc2Cn2ccc3ncnc-3c2)c(F)c1		CHEMBL206403	=	IC50	nM	490.0	CHEMBL1868	Homo sapiens	IC50	uM	0.49
	1698247	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	Cc1ccc(NC(=O)c2ccccc2Cn2ccc3cnccc32)c(F)c1		CHEMBL206348	=	IC50	nM	340.0	CHEMBL1868	Homo sapiens	IC50	uM	0.34
	1698248	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1ccccc1Cn1ccc2ncnc-2c1		CHEMBL206185	=	IC50	nM	690.0	CHEMBL1868	Homo sapiens	IC50	uM	0.69
	1698249	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1ccccc1Cn1ccc2cnccc21		CHEMBL437889	=	IC50	nM	410.0	CHEMBL1868	Homo sapiens	IC50	uM	0.41
	1698250	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1ccccc1Cn1ccc2ncnc-2c1		CHEMBL205984	=	IC50	nM	260.0	CHEMBL1868	Homo sapiens	IC50	uM	0.26
	1698251	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1ccccc1Cn1ccc2cnccc21		CHEMBL204548	=	IC50	nM	220.0	CHEMBL1868	Homo sapiens	IC50	uM	0.22
	1698252	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(N2CCOCC2)cc1)c1ccccc1Cn1ccc2ncnc-2c1		CHEMBL206279	=	IC50	nM	300.0	CHEMBL1868	Homo sapiens	IC50	uM	0.3
	1698253	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(N2CCOCC2)cc1)c1ccccc1Cn1ccc2cnccc21		CHEMBL377081	=	IC50	nM	340.0	CHEMBL1868	Homo sapiens	IC50	uM	0.34
	1698254	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	Cc1ccccc1NC(=O)c1ccccc1Cn1ccc2ncnc-2c1		CHEMBL377952	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1698255	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	Cc1ccccc1NC(=O)c1ccccc1Cn1ccc2cnccc21		CHEMBL205401	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1698256	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	Cc1cccc(NC(=O)c2ccccc2Cn2ccc3ncnc-3c2)c1		CHEMBL202643	=	IC50	nM	570.0	CHEMBL1868	Homo sapiens	IC50	uM	0.57
	1698257	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	Cc1cccc(NC(=O)c2ccccc2Cn2ccc3cnccc32)c1		CHEMBL202805	=	IC50	nM	740.0	CHEMBL1868	Homo sapiens	IC50	uM	0.74
	1698258	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1ccccc1Cn1ccc2ncnc-2c1		CHEMBL205413	=	IC50	nM	1160.0	CHEMBL1868	Homo sapiens	IC50	uM	1.16
	1698259	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(OC(F)(F)Cl)cc1)c1ccccc1Cn1ccc2cnccc21		CHEMBL205610	=	IC50	nM	1250.0	CHEMBL1868	Homo sapiens	IC50	uM	1.25
	1698260	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	CC(C)c1ccc(NC(=O)c2ccccc2Cn2ccc3ncnc-3c2)cc1		CHEMBL204099	=	IC50	nM	440.0	CHEMBL1868	Homo sapiens	IC50	uM	0.44
	1698261	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	CC(C)c1ccc(NC(=O)c2ccccc2Cn2ccc3cnccc32)cc1		CHEMBL203243	=	IC50	nM	540.0	CHEMBL1868	Homo sapiens	IC50	uM	0.54
	1698262	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	CC(C)(C)c1ccc(NC(=O)c2ccccc2Cn2ccc3ncnc-3c2)cc1		CHEMBL380932	=	IC50	nM	610.0	CHEMBL1868	Homo sapiens	IC50	uM	0.61
	1698263	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	CC(C)(C)c1ccc(NC(=O)c2ccccc2Cn2ccc3cnccc32)cc1		CHEMBL203965	=	IC50	nM	760.0	CHEMBL1868	Homo sapiens	IC50	uM	0.76
	1698264	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1Cn1cc(-c2cccnc2)cn1		CHEMBL206215	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1698265	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1Cn1cc(-c2ccncc2)cn1		CHEMBL202682	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1698266	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1Cn1ccc2ncnc-2c1		CHEMBL382855	=	IC50	nM	140.0	CHEMBL1868	Homo sapiens	IC50	uM	0.14
	1698267	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1Cn1ccc2cnccc21		CHEMBL203003	=	IC50	nM	220.0	CHEMBL1868	Homo sapiens	IC50	uM	0.22
	1698268	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1Cn1ccc2cccnc21		CHEMBL205876	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1698269	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	COc1cc2ncn(Cc3ccccc3C(=O)Nc3ccc(Cl)cc3)c2cc1OC		CHEMBL206567	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1698270	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1Cn1cnc2ccccc21		CHEMBL381786	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1698271	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1Cn1ccc2cc(Cl)ccc21		CHEMBL206388	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1698272	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	COc1ccc2c(ccn2Cc2ccccc2C(=O)Nc2ccc(Cl)cc2)c1		CHEMBL379888	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1698273	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1Cn1ccc2ccccc21		CHEMBL382256	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1698274	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1cnc2ccccc2c1)c1ccccc1NCc1ccncc1		CHEMBL202011	=	IC50	nM	160.0	CHEMBL1868	Homo sapiens	IC50	uM	0.16
	1698275	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	IC50	nM	170.0	CHEMBL1868	Homo sapiens	IC50	uM	0.17
	1698276	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	100.0	CHEMBL1868	Homo sapiens	IC50	uM	0.1
	1699821	CHEMBL859793	Inhibitory activity against VEGFR1	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	IC50	nM	380.0	CHEMBL1868	Homo sapiens	IC50	nM	380.0
	1701769	CHEMBL859793	Inhibitory activity against VEGFR1	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Ki	nM	60.0	CHEMBL1868	Homo sapiens	Ki	nM	60.0
	1706299	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)c1cccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)c1		CHEMBL205421	=	IC50	nM	1220.0	CHEMBL1868	Homo sapiens	IC50	uM	1.22
	1706300	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)c1cccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)c1		CHEMBL381577	=	IC50	nM	760.0	CHEMBL1868	Homo sapiens	IC50	uM	0.76
	1706301	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)c1		CHEMBL383334	=	IC50	nM	220.0	CHEMBL1868	Homo sapiens	IC50	uM	0.22
	1706302	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1cnc2ccccc2c1)c1ccccc1NCc1ccncc1		CHEMBL202011	=	IC50	nM	160.0	CHEMBL1868	Homo sapiens	IC50	uM	0.16
	1706303	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	IC50	nM	140.0	CHEMBL1868	Homo sapiens	IC50	uM	0.14
	1706304	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	IC50	nM	170.0	CHEMBL1868	Homo sapiens	IC50	uM	0.17
	1706999	CHEMBL865651	Inhibitory activity against VEGFR1	B	O=c1[nH]c2ccccc2c(O)c1-c1nc2ccccc2[nH]1		CHEMBL377345	=	IC50	nM	162.0	CHEMBL1868	Homo sapiens	IC50	uM	0.162
	1707008	CHEMBL865651	Inhibitory activity against VEGFR1	B	Cn1ncc2c(N)c(-c3nc4ccccc4[nH]3)c(O)nc21		CHEMBL383261	=	IC50	nM	4300.0	CHEMBL1868	Homo sapiens	IC50	uM	4.3
	1707009	CHEMBL865651	Inhibitory activity against VEGFR1	B	Nc1c2cnnc-2[nH]c(O)c1-c1nc2ccccc2[nH]1		CHEMBL205305	=	IC50	nM	691.0	CHEMBL1868	Homo sapiens	IC50	uM	0.691
	1707010	CHEMBL865651	Inhibitory activity against VEGFR1	B	Nc1c2ncnc-2[nH]c(O)c1-c1nc2ccccc2[nH]1		CHEMBL383299	=	IC50	nM	602.0	CHEMBL1868	Homo sapiens	IC50	uM	0.602
	1707011	CHEMBL865651	Inhibitory activity against VEGFR1	B	Nc1c(-c2nc3ccccc3[nH]2)c(O)nc2sccc12		CHEMBL205406	=	IC50	nM	132.0	CHEMBL1868	Homo sapiens	IC50	uM	0.132
	1707012	CHEMBL865651	Inhibitory activity against VEGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(O)nc5ccccc5c4N)nc3n2)CC1		CHEMBL204524	=	IC50	nM	14.0	CHEMBL1868	Homo sapiens	IC50	uM	0.014
	1707013	CHEMBL865651	Inhibitory activity against VEGFR1	B	Nc1c(-c2nc3ccc(N4CCOCC4)[nH]c-3n2)c(O)nc2ccccc12		CHEMBL380702	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	uM	0.01
	1707014	CHEMBL865651	Inhibitory activity against VEGFR1	B	Nc1c(-c2nc3ccc[nH]c-3n2)c(O)nc2cnccc12		CHEMBL204985	=	IC50	nM	6.0	CHEMBL1868	Homo sapiens	IC50	uM	0.006
	1707015	CHEMBL865651	Inhibitory activity against VEGFR1	B	Nc1c(-c2nc3ccc[nH]c-3n2)c(O)nc2ccccc12		CHEMBL204727	=	IC50	nM	22.0	CHEMBL1868	Homo sapiens	IC50	uM	0.022
	1707016	CHEMBL865651	Inhibitory activity against VEGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(O)nc5cccnc5c4N)nc3c2)CC1		CHEMBL205405	=	IC50	nM	74.0	CHEMBL1868	Homo sapiens	IC50	uM	0.074
	1707017	CHEMBL865651	Inhibitory activity against VEGFR1	B	Nc1c(-c2nc3cc(N4CCOCC4)ccc3[nH]2)c(O)nc2ccncc12		CHEMBL381283	=	IC50	nM	37.0	CHEMBL1868	Homo sapiens	IC50	uM	0.037
	1707018	CHEMBL865651	Inhibitory activity against VEGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(O)nc5cnccc5c4N)nc3c2)CC1		CHEMBL205893	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	uM	0.003
	1707019	CHEMBL865651	Inhibitory activity against VEGFR1	B	Nc1c(-c2nc3cc(N4CCOCC4)ccc3[nH]2)c(O)nc2cnccc12		CHEMBL205108	=	IC50	nM	4.0	CHEMBL1868	Homo sapiens	IC50	uM	0.004
	1707020	CHEMBL865651	Inhibitory activity against VEGFR1	B	Nc1c(-c2nc3ccccc3[nH]2)c(O)nc2cnccc12		CHEMBL383618	=	IC50	nM	4.0	CHEMBL1868	Homo sapiens	IC50	uM	0.004
	1707021	CHEMBL865651	Inhibitory activity against VEGFR1	B	Oc1nc2cnccc2c(O)c1-c1nc2ccccc2[nH]1		CHEMBL206410	=	IC50	nM	184.0	CHEMBL1868	Homo sapiens	IC50	uM	0.184
	1707022	CHEMBL865651	Inhibitory activity against VEGFR1	B	Oc1nc2ncccc2c(O)c1-c1nc2ccccc2[nH]1		CHEMBL207061	=	IC50	nM	3940.0	CHEMBL1868	Homo sapiens	IC50	uM	3.94
	1707023	CHEMBL865651	Inhibitory activity against VEGFR1	B	CN1CCN(c2ccc3[nH]c(-c4c(N)c5ccccc5[nH]c4=O)nc3c2)CC1		CHEMBL204427	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	uM	0.01
	1707024	CHEMBL865651	Inhibitory activity against VEGFR1	B	Nc1c(-c2nc3cc(N4CCOCC4)ccc3[nH]2)c(=O)[nH]c2ccccc12		CHEMBL204426	=	IC50	nM	12.0	CHEMBL1868	Homo sapiens	IC50	uM	0.012
	1707025	CHEMBL865651	Inhibitory activity against VEGFR1	B	Nc1c(-c2nc3ccccc3[nH]2)c(=O)[nH]c2ccccc12		CHEMBL383417	=	IC50	nM	28.0	CHEMBL1868	Homo sapiens	IC50	uM	0.028
	1707904	CHEMBL866852	Inhibition of VEGFR1 at 10 uM in presence of 0.1 uM ATP	B	O=C1Nc2ccccc2C(=O)[C@@H]2[C@@H](c3cccc(Cl)c3)C[C@](O)(c3ccccc3)[C@@H]12		CHEMBL382654	>	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	Inhibition	%	50.0
	1708052	CHEMBL865024	Inhibition of VEGFR1 at 300 nM	B	Cn1cc(/C=C2\C(=O)NN=C2c2nccs2)c2cc3c(cc21)OCO3		CHEMBL206627	=	Inhibition	%	25.0	CHEMBL1868	Homo sapiens	Inhibition	%	25.0
	1708907	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	100.0	CHEMBL1868	Homo sapiens	IC50	uM	0.1
	1708908	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)c1cccc(Nc2nnc(-c3cc4ccccc4nc3CCc3ccncc3)o2)c1		CHEMBL205901	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1708909	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	c1ccc(-c2ccc(Nc3nnc(-c4cccnc4CCc4ccncc4)o3)cc2)cc1		CHEMBL208229	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1708910	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	Cc1ccccc1Nc1nnc(-c2cccnc2CCc2ccncc2)o1		CHEMBL205869	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1708911	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	COc1ccccc1Nc1nnc(-c2cccnc2CCc2ccncc2)o1		CHEMBL381704	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1708912	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	CC(C)(C)c1ccc(Nc2nnc(-c3cc4ccccc4nc3CCc3ccncc3)o2)cc1		CHEMBL204846	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1708913	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	c1ccc2ncc(Nc3nnc(-c4cc5ccccc5nc4CCc4ccncc4)o3)cc2c1		CHEMBL206670	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1708914	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCc3cccc4ncccc34)o2)c1		CHEMBL205647	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1708915	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCc3ccc4ccccc4n3)o2)c1		CHEMBL206089	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1708916	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCc3ccc4[nH]ncc4c3)o2)c1		CHEMBL382797	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1708917	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)c1cccc(Nc2nnc(-c3ccncc3CCCc3ccc4c(c3)OCO4)o2)c1		CHEMBL205684	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1708918	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	Fc1ccc(CCc2ncccc2-c2nnc(Nc3cccc(C(F)(F)F)c3)o2)cc1F		CHEMBL207099	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1708919	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCCc3ccc4c(c3)OCO4)o2)c1		CHEMBL207049	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1708920	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCc3ccccn3)o2)c1		CHEMBL207821	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1708921	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)c1cccc(Nc2nnc(-c3cccnc3CCc3cccnc3)o2)c1		CHEMBL380421	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1708922	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	c1cnc(CCc2ccncc2)c(-c2nnc(NCc3ccc4c(c3)OCO4)o2)c1		CHEMBL383123	=	IC50	nM	140.0	CHEMBL1868	Homo sapiens	IC50	uM	0.14
	1708923	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	Cc1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1C(F)(F)F		CHEMBL382218	=	IC50	nM	120.0	CHEMBL1868	Homo sapiens	IC50	uM	0.12
	1708924	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	COc1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1OC		CHEMBL382610	=	IC50	nM	180.0	CHEMBL1868	Homo sapiens	IC50	uM	0.18
	1708925	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	Clc1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1Cl		CHEMBL204621	=	IC50	nM	270.0	CHEMBL1868	Homo sapiens	IC50	uM	0.27
	1708926	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	COc1cccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)c1		CHEMBL205050	=	IC50	nM	500.0	CHEMBL1868	Homo sapiens	IC50	uM	0.5
	1708927	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	Cc1cccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)c1		CHEMBL204425	=	IC50	nM	1070.0	CHEMBL1868	Homo sapiens	IC50	uM	1.07
	1708928	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)Oc1cccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)c1		CHEMBL381293	=	IC50	nM	740.0	CHEMBL1868	Homo sapiens	IC50	uM	0.74
	1708929	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)Oc1cccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)c1		CHEMBL205639	=	IC50	nM	710.0	CHEMBL1868	Homo sapiens	IC50	uM	0.71
	1708930	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)Oc1cccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)c1		CHEMBL206123	=	IC50	nM	260.0	CHEMBL1868	Homo sapiens	IC50	uM	0.26
	1708931	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)c1ccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)cc1		CHEMBL205244	=	IC50	nM	670.0	CHEMBL1868	Homo sapiens	IC50	uM	0.67
	1708932	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)Oc1ccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)cc1		CHEMBL207772	=	IC50	nM	470.0	CHEMBL1868	Homo sapiens	IC50	uM	0.47
	1708933	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(Cl)Oc1ccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)cc1		CHEMBL382142	=	IC50	nM	530.0	CHEMBL1868	Homo sapiens	IC50	uM	0.53
	1708934	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)c1ccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)cc1		CHEMBL208363	=	IC50	nM	840.0	CHEMBL1868	Homo sapiens	IC50	uM	0.84
	1708935	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)Oc1ccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)cc1		CHEMBL383434	=	IC50	nM	930.0	CHEMBL1868	Homo sapiens	IC50	uM	0.93
	1708936	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(Cl)Oc1ccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)cc1		CHEMBL205544	=	IC50	nM	810.0	CHEMBL1868	Homo sapiens	IC50	uM	0.81
	1708937	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)c1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1		CHEMBL381182	=	IC50	nM	320.0	CHEMBL1868	Homo sapiens	IC50	uM	0.32
	1708938	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(F)Oc1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1		CHEMBL380536	=	IC50	nM	560.0	CHEMBL1868	Homo sapiens	IC50	uM	0.56
	1708940	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	FC(F)(Cl)Oc1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1		CHEMBL205502	=	IC50	nM	730.0	CHEMBL1868	Homo sapiens	IC50	uM	0.73
	1708941	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	CC(C)(C)c1ccc(Nc2nnc(-c3cnccc3CCc3ccncc3)o2)cc1		CHEMBL383333	=	IC50	nM	480.0	CHEMBL1868	Homo sapiens	IC50	uM	0.48
	1708942	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	CC(C)c1ccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)cc1		CHEMBL207975	=	IC50	nM	270.0	CHEMBL1868	Homo sapiens	IC50	uM	0.27
	1708943	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	CC(C)(C)c1ccc(Nc2nnc(-c3ccncc3CCc3ccncc3)o2)cc1		CHEMBL204984	=	IC50	nM	220.0	CHEMBL1868	Homo sapiens	IC50	uM	0.22
	1708944	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	CC(C)c1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1		CHEMBL377995	=	IC50	nM	620.0	CHEMBL1868	Homo sapiens	IC50	uM	0.62
	1708945	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	CC(C)(C)c1ccc(Nc2nnc(-c3cccnc3CCc3ccncc3)o2)cc1		CHEMBL205325	=	IC50	nM	770.0	CHEMBL1868	Homo sapiens	IC50	uM	0.77
	1708946	CHEMBL864972	Inhibition of VEGFR1 phosphorylation in presence of 2 uM ATP by HTRF assay	B	c1cnc(CCc2ccncc2)c(-c2nnc(Nc3cnc4ccccc4c3)o2)c1		CHEMBL206136	=	IC50	nM	440.0	CHEMBL1868	Homo sapiens	IC50	uM	0.44
	1723191	CHEMBL860212	Inhibition of Flt1	B	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	>	Ki	nM	440.0	CHEMBL1868	Homo sapiens	Ki	nM	440.0
	1723201	CHEMBL860212	Inhibition of Flt1	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	>	Ki	nM	440.0	CHEMBL1868	Homo sapiens	Ki	nM	440.0
	1723202	CHEMBL860212	Inhibition of Flt1	B	CC(=O)Nc1cc(N)c(C#N)c(-c2ccccc2)n1		CHEMBL210032	>	Ki	nM	440.0	CHEMBL1868	Homo sapiens	Ki	nM	440.0
	1723203	CHEMBL860212	Inhibition of Flt1	B	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	>	Ki	nM	440.0	CHEMBL1868	Homo sapiens	Ki	nM	440.0
	1723204	CHEMBL860212	Inhibition of Flt1	B	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	>	Ki	nM	440.0	CHEMBL1868	Homo sapiens	Ki	nM	440.0
	1723205	CHEMBL860212	Inhibition of Flt1	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	>	Ki	nM	440.0	CHEMBL1868	Homo sapiens	Ki	nM	440.0
Not Determined	1730613	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	O=C(c1ccccc1CNc1ccc(Cl)cc1)n1ccc2cnccc21		CHEMBL382596		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	1730749	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	CC(C)(C)c1ccc(NCc2ccccc2Cn2ccc3cnccc32)cc1		CHEMBL203110		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	1731013	CHEMBL867220	Inhibitory activity against VEGFR-1 using 2 uM ATP by HTRF assay	B	CC(C)(C)c1ccc(NC(=O)c2c(Cn3ccc4cnccc43)ccc3ccccc23)cc1		CHEMBL205138		IC50			CHEMBL1868	Homo sapiens	IC50		
	1739100	CHEMBL866216	Inhibition of FLT1	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Ki	nM	2200.0	CHEMBL1868	Homo sapiens	Ki	nM	2200.0
	1739490	CHEMBL862849	Inhibition of VEGFR1	B	CC(C)(C)NC(=O)Nc1cccc2c(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)[nH]nc12		CHEMBL212262	>	IC50	nM	3000.0	CHEMBL1868	Homo sapiens	IC50	uM	3.0
	1739502	CHEMBL862849	Inhibition of VEGFR1	B	c1ccc(COc2cccc3c(-c4nc5cc(N6CCC(N7CCCCC7)CC6)ccc5[nH]4)[nH]nc23)cc1		CHEMBL379995	>	IC50	nM	3000.0	CHEMBL1868	Homo sapiens	IC50	uM	3.0
	1739517	CHEMBL862849	Inhibition of VEGFR1	B	Fc1cccc2c(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)[nH]nc12		CHEMBL211940	=	IC50	nM	150.0	CHEMBL1868	Homo sapiens	IC50	uM	0.15
	1739530	CHEMBL862849	Inhibition of VEGFR1	B	FC(F)(F)c1ccc2c(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)[nH]nc2c1		CHEMBL377230	=	IC50	nM	2.0	CHEMBL1868	Homo sapiens	IC50	uM	0.002
	1739543	CHEMBL862849	Inhibition of VEGFR1	B	c1ccc(COc2ccc3c(-c4nc5cc(N6CCC(N7CCCCC7)CC6)ccc5[nH]4)[nH]nc3c2)cc1		CHEMBL209704	=	IC50	nM	11.0	CHEMBL1868	Homo sapiens	IC50	uM	0.011
	1739561	CHEMBL862849	Inhibition of VEGFR1	B	Fc1ccc2c(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)[nH]nc2c1		CHEMBL212054	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	uM	0.01
	1739576	CHEMBL862849	Inhibition of VEGFR1	B	COC(=O)c1ccc2[nH]nc(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)c2c1		CHEMBL380372	=	IC50	nM	15.0	CHEMBL1868	Homo sapiens	IC50	uM	0.015
	1739592	CHEMBL862849	Inhibition of VEGFR1	B	CC(C)(C)NC(=O)Nc1ccc2[nH]nc(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)c2c1		CHEMBL378024	=	IC50	nM	1.0	CHEMBL1868	Homo sapiens	IC50	uM	0.001
	1739608	CHEMBL862849	Inhibition of VEGFR1	B	c1cc2[nH]nc(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)c2cc1NCC1CCCCC1		CHEMBL379108	=	IC50	nM	21.0	CHEMBL1868	Homo sapiens	IC50	uM	0.021
	1739623	CHEMBL862849	Inhibition of VEGFR1	B	c1ccc(Oc2ccc3n[nH]c(-c4nc5cc(N6CCC(N7CCCCC7)CC6)ccc5[nH]4)c3c2)cc1		CHEMBL211662	=	IC50	nM	28.0	CHEMBL1868	Homo sapiens	IC50	uM	0.028
	1739640	CHEMBL862849	Inhibition of VEGFR1	B	c1ccc(COc2ccc3[nH]nc(-c4nc5cc(N6CCC(N7CCCCC7)CC6)ccc5[nH]4)c3c2)cc1		CHEMBL377346	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	uM	0.003
	1739661	CHEMBL862849	Inhibition of VEGFR1	B	CC(C)(C)NC(=O)Nc1cccc2[nH]nc(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)c12		CHEMBL379740	=	IC50	nM	4.0	CHEMBL1868	Homo sapiens	IC50	uM	0.004
	1739682	CHEMBL862849	Inhibition of VEGFR1	B	c1ccc(COc2cccc3[nH]nc(-c4nc5cc(N6CCC(N7CCCCC7)CC6)ccc5[nH]4)c23)cc1		CHEMBL425247	=	IC50	nM	63.0	CHEMBL1868	Homo sapiens	IC50	uM	0.063
	1739715	CHEMBL862849	Inhibition of VEGFR1	B	CN1CCN(Cc2ccc3[nH]c(-c4[nH]nc5ccccc45)nc3c2)CC1		CHEMBL209265	=	IC50	nM	170.0	CHEMBL1868	Homo sapiens	IC50	uM	0.17
	1739737	CHEMBL862849	Inhibition of VEGFR1	B	c1ccc2c(-c3nc4cc(OCCCN5CCCC5)ccc4[nH]3)[nH]nc2c1		CHEMBL208775	=	IC50	nM	48.0	CHEMBL1868	Homo sapiens	IC50	uM	0.048
	1739759	CHEMBL862849	Inhibition of VEGFR1	B	c1ccc2c(-c3nc4cc(-n5ccnc5)ccc4[nH]3)[nH]nc2c1		CHEMBL378003	=	IC50	nM	96.0	CHEMBL1868	Homo sapiens	IC50	uM	0.096
	1739775	CHEMBL862849	Inhibition of VEGFR1	B	CN1CCC(N(C)c2ccc3[nH]c(-c4[nH]nc5ccccc45)nc3c2)CC1		CHEMBL212429	=	IC50	nM	8.0	CHEMBL1868	Homo sapiens	IC50	uM	0.008
	1739790	CHEMBL862849	Inhibition of VEGFR1	B	c1ccc2c(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)[nH]nc2c1		CHEMBL378299	=	IC50	nM	28.0	CHEMBL1868	Homo sapiens	IC50	uM	0.028
	1739805	CHEMBL862849	Inhibition of VEGFR1	B	CN1CCN(c2ccc3[nH]c(-c4[nH]nc5ccccc45)nc3c2)CC1		CHEMBL208600	=	IC50	nM	44.0	CHEMBL1868	Homo sapiens	IC50	uM	0.044
	1739823	CHEMBL862849	Inhibition of VEGFR1	B	c1ccc2c(-c3nc4cc(N5CCOCC5)ccc4[nH]3)[nH]nc2c1		CHEMBL209783	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	uM	0.05
	1739838	CHEMBL862849	Inhibition of VEGFR1	B	c1ccc2c(-c3nc4c(N5CCOCC5)cccc4[nH]3)[nH]nc2c1		CHEMBL211708	>	IC50	nM	3000.0	CHEMBL1868	Homo sapiens	IC50	uM	3.0
	1739848	CHEMBL862849	Inhibition of VEGFR1	B	c1ccc2[nH]c(-c3n[nH]c4ccccc34)nc2c1		CHEMBL383990	=	IC50	nM	720.0	CHEMBL1868	Homo sapiens	IC50	uM	0.72
	1744469	CHEMBL867313	Inhibition of Flt1	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	440.0	CHEMBL1868	Homo sapiens	Ki	uM	0.44
	1744648	CHEMBL866821	Inhibition of VEGFR1	B	O=C(NC1CC1)c1cc(NCc2cnc(Nc3ccccn3)s2)c(F)cc1F		CHEMBL377734	=	IC50	nM	400.0	CHEMBL1868	Homo sapiens	IC50	nM	400.0
	1752796	CHEMBL866108	Inhibition of FLT1 by HTRF assay	B	c1cn(Cc2ccc3c(c2)-c2[nH]nc(-c4ccsc4)c2C3)cn1		CHEMBL212084	=	IC50	nM	601.0	CHEMBL1868	Homo sapiens	IC50	nM	601.0
	1752980	CHEMBL866108	Inhibition of FLT1 by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)-c2[nH]nc(-c4ccsc4)c2C3)CC1		CHEMBL213743	=	IC50	nM	970.0	CHEMBL1868	Homo sapiens	IC50	nM	970.0
	1753630	CHEMBL864251	Inhibition of FLT1	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	uM	0.01
	1753646	CHEMBL864251	Inhibition of FLT1	B	Nc1ncnc2snc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL214258	=	IC50	nM	75.0	CHEMBL1868	Homo sapiens	IC50	uM	0.075
	1753650	CHEMBL864251	Inhibition of FLT1	B	Nc1ncnc2snc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213504	=	IC50	nM	39.0	CHEMBL1868	Homo sapiens	IC50	uM	0.039
	1753654	CHEMBL864251	Inhibition of FLT1	B	Cc1cccc(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL376951	=	IC50	nM	79.0	CHEMBL1868	Homo sapiens	IC50	uM	0.079
	1753658	CHEMBL864251	Inhibition of FLT1	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	=	IC50	nM	2.0	CHEMBL1868	Homo sapiens	IC50	uM	0.002
	1755468	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)NCc2ccc(-c3n[nH]c4c3Cc3ccc(CN5CCN(C)CC5)cc3-4)s2)c1		CHEMBL214161	=	IC50	nM	592.0	CHEMBL1868	Homo sapiens	IC50	nM	592.0
	1755469	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)NCc2ccc(-c3n[nH]c4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)s2)c1		CHEMBL213507	=	IC50	nM	2897.0	CHEMBL1868	Homo sapiens	IC50	nM	2897.0
	1755470	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1ccc(NC(=O)NCc2ccc(-c3n[nH]c4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)s2)cc1		CHEMBL415047	=	IC50	nM	11483.0	CHEMBL1868	Homo sapiens	IC50	nM	11483.0
	1755471	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4ccc(CNC(=O)Nc5ccccc5C(F)(F)F)s4)n[nH]c2-3)CC1		CHEMBL215417	>	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	nM	50000.0
	1755472	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4ccc(CNC(=O)Nc5cccc(C(F)(F)F)c5)s4)n[nH]c2-3)CC1		CHEMBL212986	=	IC50	nM	863.0	CHEMBL1868	Homo sapiens	IC50	nM	863.0
	1755473	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4ccc(CNC(=O)Nc5ccc(C(F)(F)F)cc5)s4)n[nH]c2-3)CC1		CHEMBL212762	=	IC50	nM	4201.0	CHEMBL1868	Homo sapiens	IC50	nM	4201.0
	1755474	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4ccc(CNC(=O)Nc5ccccc5Cl)s4)n[nH]c2-3)CC1		CHEMBL209922	>	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	nM	50000.0
	1755475	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1cc(C)cc(NC(=O)NCc2ccc(-c3n[nH]c4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)s2)c1		CHEMBL209919	=	IC50	nM	1668.0	CHEMBL1868	Homo sapiens	IC50	nM	1668.0
	1755476	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4ccc(CNC(=O)Nc5cc(Cl)cc(Cl)c5)s4)n[nH]c2-3)CC1		CHEMBL380397	=	IC50	nM	2275.0	CHEMBL1868	Homo sapiens	IC50	nM	2275.0
	1755477	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)N(C)Cc2ccc(-c3n[nH]c4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)s2)c1		CHEMBL225248	=	IC50	nM	4718.0	CHEMBL1868	Homo sapiens	IC50	nM	4718.0
	1755478	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1cccc(N(C)C(=O)NCc2ccc(-c3[nH]nc4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)s2)c1		CHEMBL425262	=	IC50	nM	14581.0	CHEMBL1868	Homo sapiens	IC50	nM	14581.0
	1755479	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1cccc(N(C)C(=O)N(C)Cc2ccc(-c3[nH]nc4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)s2)c1		CHEMBL212987	=	IC50	nM	27894.0	CHEMBL1868	Homo sapiens	IC50	nM	27894.0
	1755480	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1ccccc1NC(=O)N(C)Cc1ccc(-c2[nH]nc3c2Cc2cc(CN4CCN(C)CC4)ccc2-3)s1		CHEMBL209421	=	IC50	nM	4953.0	CHEMBL1868	Homo sapiens	IC50	nM	4953.0
	1755481	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)Cc2c-3n[nH]c2-c2ccc(CN(C)C(=O)Nc3ccccc3Cl)s2)CC1		CHEMBL209971	=	IC50	nM	3842.0	CHEMBL1868	Homo sapiens	IC50	nM	3842.0
	1755482	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)Cc2c-3n[nH]c2-c2ccc(CN(C)C(=O)Nc3cc(F)cc(C(F)(F)F)c3)s2)CC1		CHEMBL378895	=	IC50	nM	33.0	CHEMBL1868	Homo sapiens	IC50	nM	33.0
	1755483	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)Cc2c-3n[nH]c2-c2ccc(CN(C)C(=O)Nc3cccc(OC(F)(F)F)c3)s2)CC1		CHEMBL379088	=	IC50	nM	19.0	CHEMBL1868	Homo sapiens	IC50	nM	19.0
	1755484	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CCN(Cc1ccc(-c2[nH]nc3c2Cc2cc(CN4CCN(C)CC4)ccc2-3)s1)C(=O)Nc1cccc(C)c1		CHEMBL213430	=	IC50	nM	131.0	CHEMBL1868	Homo sapiens	IC50	nM	131.0
	1755485	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CCCN(Cc1ccc(-c2[nH]nc3c2Cc2cc(CN4CCN(C)CC4)ccc2-3)s1)C(=O)Nc1cccc(C)c1		CHEMBL380068	=	IC50	nM	59.0	CHEMBL1868	Homo sapiens	IC50	nM	59.0
	1755486	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)N(Cc2ccc(-c3[nH]nc4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)s2)C(C)C)c1		CHEMBL377400	=	IC50	nM	2824.0	CHEMBL1868	Homo sapiens	IC50	nM	2824.0
	1755487	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)N(Cc2ccc(-c3n[nH]c4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)s2)C2CC2)c1		CHEMBL214063	=	IC50	nM	38.0	CHEMBL1868	Homo sapiens	IC50	nM	38.0
	1755488	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)N(Cc2ccc(-c3[nH]nc4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)s2)CC(C)C)c1		CHEMBL210070	=	IC50	nM	1590.0	CHEMBL1868	Homo sapiens	IC50	nM	1590.0
	1755489	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)N(CCC(C)C)Cc2ccc(-c3[nH]nc4c3Cc3cc(CN5CCN(C)CC5)ccc3-4)s2)c1		CHEMBL213909	=	IC50	nM	3615.0	CHEMBL1868	Homo sapiens	IC50	nM	3615.0
	1755490	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CON(Cc1ccc(-c2[nH]nc3c2Cc2cc(CN4CCN(C)CC4)ccc2-3)s1)C(=O)Nc1cccc(C)c1		CHEMBL214109	=	IC50	nM	1351.0	CHEMBL1868	Homo sapiens	IC50	nM	1351.0
	1755491	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	COCCN(Cc1ccc(-c2[nH]nc3c2Cc2cc(CN4CCN(C)CC4)ccc2-3)s1)C(=O)Nc1cccc(C)c1		CHEMBL213270	=	IC50	nM	2263.0	CHEMBL1868	Homo sapiens	IC50	nM	2263.0
	1755492	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)-c2[nH]nc(-c4ccc(CNC(=O)Nc5ccccc5)s4)c2C3)CC1		CHEMBL210113	=	IC50	nM	3785.0	CHEMBL1868	Homo sapiens	IC50	nM	3785.0
	1755493	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1ccccc1NC(=O)NCc1ccc(-c2n[nH]c3c2Cc2ccc(CN4CCN(C)CC4)cc2-3)s1		CHEMBL212985	=	IC50	nM	2056.0	CHEMBL1868	Homo sapiens	IC50	nM	2056.0
	1755494	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1ccc(NC(=O)NCc2ccc(-c3n[nH]c4c3Cc3ccc(CN5CCN(C)CC5)cc3-4)s2)cc1		CHEMBL2096839	=	IC50	nM	613.0	CHEMBL1868	Homo sapiens	IC50	nM	613.0
	1755495	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1cccc(NC(=O)N(C)Cc2ccc(-c3n[nH]c4c3Cc3ccc(CN5CCN(C)CC5)cc3-4)s2)c1		CHEMBL223220	=	IC50	nM	44.0	CHEMBL1868	Homo sapiens	IC50	nM	44.0
	1755496	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)-c2n[nH]c(-c4ccc(CN(C)C(=O)Nc5cccc(C(F)(F)F)c5)s4)c2C3)CC1		CHEMBL213910	=	IC50	nM	14.0	CHEMBL1868	Homo sapiens	IC50	nM	14.0
	1755497	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)-c2n[nH]c(-c4ccc(CN(C)C(=O)Nc5cccc(Cl)c5)s4)c2C3)CC1		CHEMBL378831	=	IC50	nM	20.0	CHEMBL1868	Homo sapiens	IC50	nM	20.0
	1755498	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)-c2n[nH]c(-c4ccc(CN(C)C(=O)Nc5ccc(F)cc5)s4)c2C3)CC1		CHEMBL384294	=	IC50	nM	83.0	CHEMBL1868	Homo sapiens	IC50	nM	83.0
	1755499	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)-c2n[nH]c(-c4ccc(CN(C)C(=O)Nc5ccc(OC(F)(F)F)cc5)s4)c2C3)CC1		CHEMBL212932	=	IC50	nM	25.0	CHEMBL1868	Homo sapiens	IC50	nM	25.0
	1755500	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)-c2n[nH]c(-c4ccc(CN(C)C(=O)Nc5ccc(Cl)c(Cl)c5)s4)c2C3)CC1		CHEMBL215948	=	IC50	nM	36.0	CHEMBL1868	Homo sapiens	IC50	nM	36.0
	1755501	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)-c2n[nH]c(-c4ccc(CN(C)C(=O)Nc5ccc(Br)cc5)s4)c2C3)CC1		CHEMBL211464	=	IC50	nM	38.0	CHEMBL1868	Homo sapiens	IC50	nM	38.0
	1755502	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	CN1CCN(Cc2ccc3c(c2)-c2n[nH]c(-c4ccc(CN(C)C(=O)Nc5ccc(Cl)cc5)s4)c2C3)CC1		CHEMBL380243	=	IC50	nM	64.0	CHEMBL1868	Homo sapiens	IC50	nM	64.0
	1755504	CHEMBL869848	Inhibition of FLT1 at 1 mM ATP by HTRF assay	B	Cc1ccccc1NC(=O)NCc1ccc(-c2n[nH]c3c2Cc2cc(CN4CCN(C)CC4)ccc2-3)s1		CHEMBL425615	=	IC50	nM	24996.0	CHEMBL1868	Homo sapiens	IC50	nM	24996.0
	1768993	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	O=C(Nc1ncccn1)c1ccccc1NCc1ccncc1		CHEMBL215978	=	Inhibition	%	12.0	CHEMBL1868	Homo sapiens	Inhibition	%	12.0
	1769012	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	Inhibition	%	34.0	CHEMBL1868	Homo sapiens	Inhibition	%	34.0
	1769013	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	COc1cc(OCc2ccncc2)c(C(=O)Nc2ccc(Cl)cc2)cc1OC		CHEMBL214973	=	Inhibition	%	3.0	CHEMBL1868	Homo sapiens	Inhibition	%	3.0
	1769014	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	O=C(Nc1ccccc1C(F)(F)F)c1ccccc1OCc1ccncc1		CHEMBL216043	=	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	Inhibition	%	50.0
Not Active	1769073	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	O=C(Nc1ccccn1)c1ccccc1NCc1ccncc1		CHEMBL216216		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769075	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	COc1cc(OCc2ccncc2)c(C(=N)Nc2ccccc2Cl)cc1OC		CHEMBL384222		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769076	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	COc1cc(OCc2ccncc2)c(C(=N)Nc2ccc(Cl)cc2)cc1OC		CHEMBL215984		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769077	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	COc1cc(OCc2ccncc2)c(C(=N)Nc2ccccc2C(F)(F)F)cc1OC		CHEMBL436958		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769078	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	N=C(Nc1ccccc1Cl)c1ccccc1OCc1ccncc1		CHEMBL215528		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769079	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	N=C(Nc1ccc(Cl)cc1)c1ccccc1OCc1ccncc1		CHEMBL216003		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769080	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	N=C(Nc1ccccc1C(F)(F)F)c1ccccc1OCc1ccncc1		CHEMBL212079		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769081	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	COc1cc(NCc2ccncc2)c(C(=N)Nc2ccccc2Cl)cc1OC		CHEMBL214095		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769082	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	COc1cc(NCc2ccncc2)c(C(=N)Nc2ccc(Cl)cc2)cc1OC		CHEMBL387303		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769083	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	COc1cc(NCc2ccncc2)c(C(=N)Nc2ccccc2C(F)(F)F)cc1OC		CHEMBL215547		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769084	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	N=C(Nc1ccccc1Cl)c1ccccc1NCc1ccncc1		CHEMBL216297		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769085	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	N=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL387249		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769086	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	N=C(Nc1ccccc1C(F)(F)F)c1ccccc1NCc1ccncc1		CHEMBL214714		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769087	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	COc1cc(OCc2ccncc2)c(C(=O)Nc2ccccn2)cc1OC		CHEMBL215000		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769088	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	COc1cc(OCc2ccncc2)c(C(=O)Nc2cnccn2)cc1OC		CHEMBL215954		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769089	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	COc1cc(OCc2ccncc2)c(C(=O)Nc2ncccn2)cc1OC		CHEMBL269443		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769090	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	COc1cc(OCc2ccncc2)c(C(=O)Nc2ccccc2Cl)cc1OC		CHEMBL213174		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769091	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	COc1cc(OCc2ccncc2)c(C(=O)Nc2ccccc2C(F)(F)F)cc1OC		CHEMBL385609		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769092	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	O=C(Nc1ccccc1Cl)c1ccccc1OCc1ccncc1		CHEMBL216013		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769093	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	COc1cc(NCc2ccncc2)c(C(=O)Nc2cnccn2)cc1OC		CHEMBL385610		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769094	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	COc1cc(NCc2ccncc2)c(C(=O)Nc2ncccn2)cc1OC		CHEMBL214807		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769095	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	COc1cc(NCc2ccncc2)c(C(=O)Nc2ccccn2)cc1OC		CHEMBL214939		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	1769096	CHEMBL906910	Inhibition of recombinant FLT1 at 10 uM by ELISA	B	O=C(Nc1cnccn1)c1ccccc1NCc1ccncc1		CHEMBL214496		Activity			CHEMBL1868	Homo sapiens	Activity		
	1769390	CHEMBL910910	Inhibition of FLT1	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	1779357	CHEMBL854967	Inhibition of recombinant FLT1 by ELISA	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2		CHEMBL217090	>	IC50	nM	33000.0	CHEMBL1868	Homo sapiens	IC50	uM	33.0
	1779379	CHEMBL854967	Inhibition of recombinant FLT1 by ELISA	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	1824550	CHEMBL914314	Inhibition of Flt1	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL1868	Homo sapiens	Ki	uM	10.0
	1824721	CHEMBL914314	Inhibition of Flt1	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	>	Ki	nM	10000.0	CHEMBL1868	Homo sapiens	Ki	uM	10.0
	1824795	CHEMBL914314	Inhibition of Flt1	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	>	Ki	nM	10000.0	CHEMBL1868	Homo sapiens	Ki	uM	10.0
	1826430	CHEMBL919908	Inhibition of FLT1 by HTRF assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	nM	3.0
	1849888	CHEMBL914193	Inhibition of Flt1	B	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOc5ccccc5)c4)n[nH]c2-3)CC1		CHEMBL390156	=	IC50	nM	2.0	CHEMBL1868	Homo sapiens	IC50	nM	2.0
	1849900	CHEMBL914193	Inhibition of Flt1	B	COCCOCC#Cc1cc(-c2n[nH]c3c2Cc2ccc(Cn4cncn4)cc2-3)cs1		CHEMBL223971	<	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	nM	3.0
	1916319	CHEMBL894115	Inhibition of recombinant Flt1 by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(CC(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL395080	>	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	uM	50.0
	1916371	CHEMBL894115	Inhibition of recombinant Flt1 by radiometric assay	B	COc1cc(-c2ccc3c(c2)Nc2ccc(C(C)(C)C(=O)Nc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1N		CHEMBL389745	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
Active	1929726	CHEMBL897009	Antagonist activity at VEGFR1 assessed as inhibition of VEGF165-induced activation of ERK phosphorylation in HUVEC at 100 uM	F	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2cc(=O)oc3cc(O)ccc23)NC(=O)[C@H](CCc2ccccc2)NC(=O)CC[C@@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL410408		Activity			CHEMBL1868	Homo sapiens	Activity		
Active	1929767	CHEMBL897009	Antagonist activity at VEGFR1 assessed as inhibition of VEGF165-induced activation of ERK phosphorylation in HUVEC at 100 uM	F	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL389147		Activity			CHEMBL1868	Homo sapiens	Activity		
	1930235	CHEMBL897007	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 400 uM by chemiluminescent assay	B	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1cnc[nH]1)C(N)=O)C(C)C		CHEMBL389146	=	Activity	%	47.3	CHEMBL1868	Homo sapiens	Activity	%	47.3
	1930236	CHEMBL897007	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 400 uM by chemiluminescent assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C		CHEMBL430206	=	Activity	%	99.2	CHEMBL1868	Homo sapiens	Activity	%	99.2
	1930237	CHEMBL897007	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 400 uM by chemiluminescent assay	B	CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CO)C(=O)O		CHEMBL389145	=	Activity	%	24.3	CHEMBL1868	Homo sapiens	Activity	%	24.3
	1941809	CHEMBL897007	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 400 uM by chemiluminescent assay	B	CC(=O)N[C@H]1CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)C[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(N)=O)NC1=O		CHEMBL242553	=	Activity	%	39.8	CHEMBL1868	Homo sapiens	Activity	%	39.8
	1941831	CHEMBL897008	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCc2ccccc2)NC(=O)[C@H](CCc2ccccc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL2304253	=	Activity	%	0.0	CHEMBL1868	Homo sapiens	Activity	%	0.0
	1941834	CHEMBL897008	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2cc(=O)oc3cc(O)ccc23)NC(=O)[C@H](CCc2ccccc2)NC(=O)CC[C@@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL410408	=	Activity	%	87.3	CHEMBL1868	Homo sapiens	Activity	%	87.3
	1941835	CHEMBL897008	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2cc(=O)oc3cc(O)ccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL411594	=	Activity	%	1.7	CHEMBL1868	Homo sapiens	Activity	%	1.7
	1941836	CHEMBL897008	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM by chemiluminescent assay	B	NC(=O)[C@@H]1CCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCC(=O)O)C(=O)N1		CHEMBL390867	=	Activity	%	16.6	CHEMBL1868	Homo sapiens	Activity	%	16.6
	1941837	CHEMBL897008	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL411593	=	Activity	%	0.6	CHEMBL1868	Homo sapiens	Activity	%	0.6
	1941838	CHEMBL897008	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL269750	=	Activity	%	4.8	CHEMBL1868	Homo sapiens	Activity	%	4.8
	1941839	CHEMBL897008	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL389147	=	Activity	%	57.1	CHEMBL1868	Homo sapiens	Activity	%	57.1
	1941840	CHEMBL897008	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL411370	=	Activity	%	0.0	CHEMBL1868	Homo sapiens	Activity	%	0.0
	1941841	CHEMBL897008	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCc2ccccc2)NC(=O)[C@H](CCc2ccccc2)NC(=O)CC[C@@H](CC(N)=O)NC1=O		CHEMBL411369	=	Activity	%	34.9	CHEMBL1868	Homo sapiens	Activity	%	34.9
Active	1941887	CHEMBL897009	Antagonist activity at VEGFR1 assessed as inhibition of VEGF165-induced activation of ERK phosphorylation in HUVEC at 100 uM	F	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C		CHEMBL430206		Activity			CHEMBL1868	Homo sapiens	Activity		
	1943294	CHEMBL897013	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 by chemiluminescent assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C		CHEMBL430206	=	IC50	nM	28000.0	CHEMBL1868	Homo sapiens	IC50	uM	28.0
	1943307	CHEMBL897013	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL389147	=	IC50	nM	39900.0	CHEMBL1868	Homo sapiens	IC50	uM	39.9
	1943309	CHEMBL897013	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2cc(=O)oc3cc(O)ccc23)NC(=O)[C@H](CCc2ccccc2)NC(=O)CC[C@@H](CC(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL410408	=	IC50	nM	19300.0	CHEMBL1868	Homo sapiens	IC50	uM	19.3
Not Determined	1943313	CHEMBL897013	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCc2ccccc2)NC(=O)[C@H](CCc2ccccc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL2304253		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	1943315	CHEMBL897013	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2cc(=O)oc3cc(O)ccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL411594		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	1943316	CHEMBL897013	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 by chemiluminescent assay	B	NC(=O)[C@@H]1CCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@@H](CCC(=O)O)C(=O)N1		CHEMBL390867		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	1943317	CHEMBL897013	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL411593		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	1943318	CHEMBL897013	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL269750		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	1943319	CHEMBL897013	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL411370		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	1943320	CHEMBL897013	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 by chemiluminescent assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCc2ccccc2)NC(=O)[C@H](CCc2ccccc2)NC(=O)CC[C@@H](CC(N)=O)NC1=O		CHEMBL411369		IC50			CHEMBL1868	Homo sapiens	IC50		
	1965881	CHEMBL897422	Inhibition of human VEGFR1	B	O=C(NCCCN1CCCC1=O)c1cnccc1Nc1nc(-c2cc(Br)ccc2F)nc2nccnc12		CHEMBL234655	=	IC50	nM	47.0	CHEMBL1868	Homo sapiens	IC50	nM	47.0
	1966169	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccccn1		CHEMBL232800	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966188	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nnnn1CCc1ccncc1		CHEMBL233829	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966189	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	CC(C)(C)c1ccc(NC(=O)c2nnnn2CCc2ccncc2)cc1		CHEMBL233828	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966190	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nc2ccccc2n1CCc1ccncc1		CHEMBL234013	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966191	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nc2ccccc2n1CCc1ccncc1		CHEMBL234012	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966192	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(Cl)cc1)c1nc2ccccc2n1CCc1ccncc1		CHEMBL233826	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966193	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(OC(F)(F)F)cc1)c1cc2ccccc2n1CCc1ccncc1		CHEMBL391103	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966194	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(Cl)cc1)c1cc2ccccc2n1CCc1ccncc1		CHEMBL234201	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966195	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	Cc1nn(CCc2ccncc2)c(C(=O)Nc2ccc(OC(F)(F)F)cc2)c1C		CHEMBL234011	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966196	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	Cc1nn(CCc2ccncc2)c(C(=O)Nc2ccc(Cl)cc2)c1C		CHEMBL391102	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966197	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccnn1CCc1ccncc1		CHEMBL392329	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966198	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccnn1CCc1ccncc1		CHEMBL233821	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966199	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(OCc2ccccc2)cc1)c1ccnn1CCc1ccncc1		CHEMBL233631	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966200	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1c[nH]cn1		CHEMBL237680	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966201	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1noc2ccccc12		CHEMBL237679	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966202	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1cnoc1		CHEMBL232802	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966203	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	COc1ccc(CCn2nccc2C(=O)Nc2ccc(Cl)cc2)cc1OC		CHEMBL234864	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966204	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccc(F)c(F)c1		CHEMBL393006	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966205	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	CC1C=C2OCOC2=C(CCn2nccc2C(=O)Nc2ccc(Cl)cc2)C1		CHEMBL234863	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966206	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1cccnc1		CHEMBL397322	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1966226	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(Cl)cc1)c1ccnn1CCc1ccncc1		CHEMBL397323	=	IC50	nM	97.0	CHEMBL1868	Homo sapiens	IC50	uM	0.097
	1966251	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nnnn1CCc1ccncc1		CHEMBL233827	=	IC50	nM	3880.0	CHEMBL1868	Homo sapiens	IC50	uM	3.88
	1966252	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(C(F)(F)F)cc1)c1nnnn1CCc1ccncc1		CHEMBL234205	=	IC50	nM	1080.0	CHEMBL1868	Homo sapiens	IC50	uM	1.08
	1966253	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(Cl)cc1)c1nnnn1CCc1ccncc1		CHEMBL393001	=	IC50	nM	890.0	CHEMBL1868	Homo sapiens	IC50	uM	0.89
	1966254	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nccn1CCc1ccncc1		CHEMBL233825	=	IC50	nM	4560.0	CHEMBL1868	Homo sapiens	IC50	uM	4.56
	1966255	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	CC(C)(C)c1ccc(NC(=O)c2nccn2CCc2ccncc2)cc1		CHEMBL233824	=	IC50	nM	3860.0	CHEMBL1868	Homo sapiens	IC50	uM	3.86
	1966256	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nccn1CCc1ccncc1		CHEMBL391104	=	IC50	nM	4270.0	CHEMBL1868	Homo sapiens	IC50	uM	4.27
	1966257	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(C(F)(F)F)cc1)c1nccn1CCc1ccncc1		CHEMBL234203	=	IC50	nM	790.0	CHEMBL1868	Homo sapiens	IC50	uM	0.79
	1966258	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(Cl)cc1)c1nccn1CCc1ccncc1		CHEMBL234202	=	IC50	nM	940.0	CHEMBL1868	Homo sapiens	IC50	uM	0.94
	1966259	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	Cc1cc(C(=O)Nc2ccc(OC(F)(F)F)cc2)n(CCc2ccncc2)n1		CHEMBL392331	=	IC50	nM	2250.0	CHEMBL1868	Homo sapiens	IC50	uM	2.25
	1966260	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	Cc1cc(C(=O)Nc2ccc(Cl)cc2)n(CCc2ccncc2)n1		CHEMBL234010	=	IC50	nM	1220.0	CHEMBL1868	Homo sapiens	IC50	uM	1.22
	1966261	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	COc1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1OC		CHEMBL234009	=	IC50	nM	1230.0	CHEMBL1868	Homo sapiens	IC50	uM	1.23
	1966262	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(Cl)c(Cl)c1)c1ccnn1CCc1ccncc1		CHEMBL392330	=	IC50	nM	860.0	CHEMBL1868	Homo sapiens	IC50	uM	0.86
	1966263	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1ccnn1CCc1ccncc1		CHEMBL233823	=	IC50	nM	980.0	CHEMBL1868	Homo sapiens	IC50	uM	0.98
	1966264	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1ccnn1CCc1ccncc1		CHEMBL233822	=	IC50	nM	2330.0	CHEMBL1868	Homo sapiens	IC50	uM	2.33
	1966265	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1cnc2ccccc2c1)c1ccnn1CCc1ccncc1		CHEMBL391069	=	IC50	nM	380.0	CHEMBL1868	Homo sapiens	IC50	uM	0.38
	1966266	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(Oc2ccccc2)cc1)c1ccnn1CCc1ccncc1		CHEMBL392313	=	IC50	nM	5250.0	CHEMBL1868	Homo sapiens	IC50	uM	5.25
	1966267	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(-c2ccccc2)cc1)c1ccnn1CCc1ccncc1		CHEMBL399606	=	IC50	nM	2250.0	CHEMBL1868	Homo sapiens	IC50	uM	2.25
	1966268	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	CC(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1		CHEMBL236420	=	IC50	nM	440.0	CHEMBL1868	Homo sapiens	IC50	uM	0.44
	1966269	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	CC(C)(C)c1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1		CHEMBL399605	=	IC50	nM	590.0	CHEMBL1868	Homo sapiens	IC50	uM	0.59
	1966270	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1cccc(OC(F)(F)Cl)c1)c1ccnn1CCc1ccncc1		CHEMBL236419	=	IC50	nM	320.0	CHEMBL1868	Homo sapiens	IC50	uM	0.32
	1966271	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1cccc(OC(F)(F)F)c1)c1ccnn1CCc1ccncc1		CHEMBL236206	=	IC50	nM	450.0	CHEMBL1868	Homo sapiens	IC50	uM	0.45
	1966272	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(OC(F)(F)F)cc1)c1ccnn1CCc1ccncc1		CHEMBL236205	=	IC50	nM	190.0	CHEMBL1868	Homo sapiens	IC50	uM	0.19
	1966273	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	CCc1ccc(NC(=O)c2ccnn2CCc2ccncc2)cc1		CHEMBL392935	=	IC50	nM	220.0	CHEMBL1868	Homo sapiens	IC50	uM	0.22
	1966274	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	O=C(Nc1ccc(C(F)(F)F)cc1)c1ccnn1CCc1ccncc1		CHEMBL392934	=	IC50	nM	380.0	CHEMBL1868	Homo sapiens	IC50	uM	0.38
	1967003	CHEMBL897501	Inhibition of VEGFR1 assessed as inhibition of phosphorylation in presence of 2 uM ATP by HTRF assay	F	CN(C(=O)c1ccnn1CCc1ccncc1)c1ccc(Cl)cc1		CHEMBL395824	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	1968063	CHEMBL895283	Inhibition of VEGFR1	B	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1cccs1)n2CCCN		CHEMBL233338	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2018037	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1cc(NC(=O)c2c(C)noc2NCc2ccncc2)ccc1C(F)(F)F		CHEMBL240818	=	IC50	nM	870.0	CHEMBL1868	Homo sapiens	IC50	uM	0.87
	2018039	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	IC50	nM	54.0	CHEMBL1868	Homo sapiens	IC50	uM	0.054
	2018041	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(C(F)(F)F)c(C(F)(F)F)c1		CHEMBL393964	=	IC50	nM	4230.0	CHEMBL1868	Homo sapiens	IC50	uM	4.23
	2018042	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	COc1ccc(NC(=O)c2c(C)noc2NCc2ccncc2)cc1OC		CHEMBL240608	=	IC50	nM	1190.0	CHEMBL1868	Homo sapiens	IC50	uM	1.19
	2018043	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)c(Cl)c1		CHEMBL240607	=	IC50	nM	970.0	CHEMBL1868	Homo sapiens	IC50	uM	0.97
	2018044	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(C(F)(F)F)c(Cl)c1		CHEMBL393963	=	IC50	nM	560.0	CHEMBL1868	Homo sapiens	IC50	uM	0.56
	2018045	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL240606	=	IC50	nM	3270.0	CHEMBL1868	Homo sapiens	IC50	uM	3.27
	2018046	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1cnc2ccccc2c1		CHEMBL240406	=	IC50	nM	940.0	CHEMBL1868	Homo sapiens	IC50	uM	0.94
	2018047	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(Cc2ccccc2)cc1		CHEMBL240405	=	IC50	nM	5800.0	CHEMBL1868	Homo sapiens	IC50	uM	5.8
	2018048	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(C(C)C)cc1		CHEMBL238720	=	IC50	nM	440.0	CHEMBL1868	Homo sapiens	IC50	uM	0.44
	2018049	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(C(C)(C)C)cc1		CHEMBL238719	=	IC50	nM	280.0	CHEMBL1868	Homo sapiens	IC50	uM	0.28
	2018050	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1cccc(OC(F)(F)F)c1		CHEMBL391671	=	IC50	nM	5660.0	CHEMBL1868	Homo sapiens	IC50	uM	5.66
	2018051	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL429455	=	IC50	nM	2120.0	CHEMBL1868	Homo sapiens	IC50	uM	2.12
	2018052	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL392513	=	IC50	nM	370.0	CHEMBL1868	Homo sapiens	IC50	uM	0.37
	2018053	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL241492	=	IC50	nM	1560.0	CHEMBL1868	Homo sapiens	IC50	uM	1.56
	2018054	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1cc(NC(=O)c2c(NCc3ccncc3)cnn2C)ccc1C(F)(F)F		CHEMBL241314	=	IC50	nM	330.0	CHEMBL1868	Homo sapiens	IC50	uM	0.33
	2018055	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1ccc(NC(=O)c2c(NCc3ccncc3)cnn2C)cc1C(F)(F)F		CHEMBL400216	=	IC50	nM	660.0	CHEMBL1868	Homo sapiens	IC50	uM	0.66
	2018056	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL241313	=	IC50	nM	1120.0	CHEMBL1868	Homo sapiens	IC50	uM	1.12
	2018057	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(C(F)(F)F)c(C(F)(F)F)c1		CHEMBL240209	=	IC50	nM	840.0	CHEMBL1868	Homo sapiens	IC50	uM	0.84
	2018058	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	COc1ccc(NC(=O)c2c(NCc3ccncc3)cnn2C)cc1OC		CHEMBL241084	=	IC50	nM	350.0	CHEMBL1868	Homo sapiens	IC50	uM	0.35
	2018059	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)c(Cl)c1		CHEMBL391127	=	IC50	nM	250.0	CHEMBL1868	Homo sapiens	IC50	uM	0.25
	2018060	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(C(F)(F)F)c(Cl)c1		CHEMBL241265	=	IC50	nM	210.0	CHEMBL1868	Homo sapiens	IC50	uM	0.21
	2018061	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL429643	=	IC50	nM	1130.0	CHEMBL1868	Homo sapiens	IC50	uM	1.13
	2018062	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1cnc2ccccc2c1		CHEMBL393924	=	IC50	nM	280.0	CHEMBL1868	Homo sapiens	IC50	uM	0.28
	2018063	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(Cc2ccccc2)cc1		CHEMBL241075	=	IC50	nM	5570.0	CHEMBL1868	Homo sapiens	IC50	uM	5.57
	2018064	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	CC(C)c1ccc(NC(=O)c2c(NCc3ccncc3)cnn2C)cc1		CHEMBL240643	=	IC50	nM	290.0	CHEMBL1868	Homo sapiens	IC50	uM	0.29
	2018065	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(C(C)(C)C)cc1		CHEMBL401041	=	IC50	nM	130.0	CHEMBL1868	Homo sapiens	IC50	uM	0.13
	2018066	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1cccc(Cl)c1		CHEMBL394436	=	IC50	nM	2060.0	CHEMBL1868	Homo sapiens	IC50	uM	2.06
	2018067	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)cc1		CHEMBL240642	=	IC50	nM	4580.0	CHEMBL1868	Homo sapiens	IC50	uM	4.58
	2018068	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1cccc(OC(F)(F)F)c1		CHEMBL240456	=	IC50	nM	2060.0	CHEMBL1868	Homo sapiens	IC50	uM	2.06
	2018069	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL401040	=	IC50	nM	730.0	CHEMBL1868	Homo sapiens	IC50	uM	0.73
	2018070	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL240455	=	IC50	nM	280.0	CHEMBL1868	Homo sapiens	IC50	uM	0.28
	2018071	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL238531	=	IC50	nM	750.0	CHEMBL1868	Homo sapiens	IC50	uM	0.75
	2018072	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCCc2ccc3c(c2)OCO3)c1C(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL238939	=	IC50	nM	5290.0	CHEMBL1868	Homo sapiens	IC50	uM	5.29
	2018073	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)NCc1ccc2c(c1)OCO2		CHEMBL393418	=	IC50	nM	650.0	CHEMBL1868	Homo sapiens	IC50	uM	0.65
	2018074	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1ccc(NC(=O)c2c(NCc3ccncc3)ncn2C)c(F)c1		CHEMBL392789	=	IC50	nM	840.0	CHEMBL1868	Homo sapiens	IC50	uM	0.84
	2018075	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1cc(NC(=O)c2c(NCc3ccncc3)ncn2C)ccc1C(F)(F)F		CHEMBL238737	=	IC50	nM	210.0	CHEMBL1868	Homo sapiens	IC50	uM	0.21
	2018076	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1ccc(NC(=O)c2c(NCc3ccncc3)ncn2C)cc1C(F)(F)F		CHEMBL394204	=	IC50	nM	340.0	CHEMBL1868	Homo sapiens	IC50	uM	0.34
	2018077	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1		CHEMBL394203	=	IC50	nM	740.0	CHEMBL1868	Homo sapiens	IC50	uM	0.74
	2018078	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(C(F)(F)F)c(C(F)(F)F)c1		CHEMBL238530	=	IC50	nM	580.0	CHEMBL1868	Homo sapiens	IC50	uM	0.58
	2018079	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	COc1ccc(NC(=O)c2c(NCc3ccncc3)ncn2C)cc1OC		CHEMBL238529	=	IC50	nM	210.0	CHEMBL1868	Homo sapiens	IC50	uM	0.21
	2018080	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)c(Cl)c1		CHEMBL238528	=	IC50	nM	370.0	CHEMBL1868	Homo sapiens	IC50	uM	0.37
	2018081	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(C(F)(F)F)c(Cl)c1		CHEMBL394020	=	IC50	nM	290.0	CHEMBL1868	Homo sapiens	IC50	uM	0.29
	2018082	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL238735	=	IC50	nM	950.0	CHEMBL1868	Homo sapiens	IC50	uM	0.95
	2018083	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc2cn[nH]c2c1		CHEMBL238734	=	IC50	nM	5730.0	CHEMBL1868	Homo sapiens	IC50	uM	5.73
	2018084	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc2c(c1)CN=N2		CHEMBL392767	=	IC50	nM	6020.0	CHEMBL1868	Homo sapiens	IC50	uM	6.02
	2018085	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1cnc2ccccc2c1		CHEMBL238526	=	IC50	nM	230.0	CHEMBL1868	Homo sapiens	IC50	uM	0.23
	2018086	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(Cc2ccccc2)cc1		CHEMBL393409	=	IC50	nM	5570.0	CHEMBL1868	Homo sapiens	IC50	uM	5.57
	2018087	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(Oc2ccccc2)cc1		CHEMBL238525	=	IC50	nM	4290.0	CHEMBL1868	Homo sapiens	IC50	uM	4.29
	2018088	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(-c2ccccc2)cc1		CHEMBL238523	=	IC50	nM	3770.0	CHEMBL1868	Homo sapiens	IC50	uM	3.77
	2018089	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	CC(C)c1ccc(NC(=O)c2c(NCc3ccncc3)ncn2C)cc1		CHEMBL238522	=	IC50	nM	180.0	CHEMBL1868	Homo sapiens	IC50	uM	0.18
	2018090	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(C(C)(C)C)cc1		CHEMBL393779	=	IC50	nM	87.0	CHEMBL1868	Homo sapiens	IC50	uM	0.087
	2018091	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1cccc(Cl)c1		CHEMBL396144	=	IC50	nM	2060.0	CHEMBL1868	Homo sapiens	IC50	uM	2.06
	2018092	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)cc1		CHEMBL238521	=	IC50	nM	250.0	CHEMBL1868	Homo sapiens	IC50	uM	0.25
	2018093	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1cccc(OC(F)(F)F)c1		CHEMBL241669	=	IC50	nM	760.0	CHEMBL1868	Homo sapiens	IC50	uM	0.76
	2018094	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL392987	=	IC50	nM	1150.0	CHEMBL1868	Homo sapiens	IC50	uM	1.15
	2018095	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL241668	=	IC50	nM	1980.0	CHEMBL1868	Homo sapiens	IC50	uM	1.98
	2018096	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2ccncc2)c1C(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL241667	=	IC50	nM	650.0	CHEMBL1868	Homo sapiens	IC50	uM	0.65
	2018097	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCCc2ccc3c(c2)OCO3)c1C(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL241466	=	IC50	nM	1680.0	CHEMBL1868	Homo sapiens	IC50	uM	1.68
	2018098	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCCc2ccc3c(c2)OCO3)c1C(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL241465	=	IC50	nM	2270.0	CHEMBL1868	Homo sapiens	IC50	uM	2.27
	2018099	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2cccnc2)c1C(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL392985	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2018100	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	O=C(Nc1cnc2ccccc2c1)c1ccccc1NCc1ccncc1		CHEMBL202011	=	IC50	nM	15.0	CHEMBL1868	Homo sapiens	IC50	uM	0.015
	2018101	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	IC50	nM	32.0	CHEMBL1868	Homo sapiens	IC50	uM	0.032
	2018102	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	IC50	nM	22.0	CHEMBL1868	Homo sapiens	IC50	uM	0.022
	2018200	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(Oc2ccccc2)cc1		CHEMBL392944	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2018201	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(-c2ccccc2)cc1		CHEMBL428028	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2018202	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1cccc(Cl)c1		CHEMBL238508	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2018203	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cc1noc(NCc2ccncc2)c1C(=O)Nc1ccc(Cl)cc1		CHEMBL438142	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2018204	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(Oc2ccccc2)cc1		CHEMBL241073	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2018205	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2ccncc2)c1C(=O)Nc1ccc(-c2ccccc2)cc1		CHEMBL240644	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2018206	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2cccnc2)c1C(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL238940	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2018207	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCCc2ccc3c(c2)OCO3)c1C(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL392964	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2018208	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1ncc(NCc2cccnc2)c1C(=O)Nc1cccc(C(F)(F)F)c1		CHEMBL238938	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2018209	CHEMBL885899	Inhibition of VEGFR1 by HTRF assay	B	Cn1cnc(NCc2cccnc2)c1C(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL392986	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2019928	CHEMBL903331	Inhibition of VEGFR1	B	CCOc1cccc2c1c(/C=C1\C(=O)NN=C1c1snnc1C)cn2C		CHEMBL398610	>	IC50	nM	3000.0	CHEMBL1868	Homo sapiens	IC50	nM	3000.0
	2021659	CHEMBL902486	Inhibition of human VEGFR2 by HTRF method	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	IC50	nM	7.762	CHEMBL1868	Homo sapiens	Log IC50		-8.11
	2021667	CHEMBL902486	Inhibition of human VEGFR2 by HTRF method	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4ccc5ccccc5c4)cc3)c12		CHEMBL436806	=	IC50	nM	23.99	CHEMBL1868	Homo sapiens	Log IC50		-7.62
	2021668	CHEMBL902486	Inhibition of human VEGFR2 by HTRF method	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc5ccccc45)cc3)c12		CHEMBL247252	=	IC50	nM	446.68	CHEMBL1868	Homo sapiens	Log IC50		-6.35
	2021669	CHEMBL902486	Inhibition of human VEGFR2 by HTRF method	B	COc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL391184	=	IC50	nM	331.13	CHEMBL1868	Homo sapiens	Log IC50		-6.48
	2021670	CHEMBL902486	Inhibition of human VEGFR2 by HTRF method	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4Cl)cc3)c12		CHEMBL437369	=	IC50	nM	186.21	CHEMBL1868	Homo sapiens	Log IC50		-6.73
	2021671	CHEMBL902486	Inhibition of human VEGFR2 by HTRF method	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	IC50	nM	7.079	CHEMBL1868	Homo sapiens	Log IC50		-8.15
	2021672	CHEMBL902486	Inhibition of human VEGFR2 by HTRF method	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(Oc5ccccc5)c4)cc3)c12		CHEMBL247790	=	IC50	nM	1737.8	CHEMBL1868	Homo sapiens	Log IC50		-5.76
	2021673	CHEMBL902486	Inhibition of human VEGFR2 by HTRF method	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	IC50	nM	138.04	CHEMBL1868	Homo sapiens	Log IC50		-6.86
	2021674	CHEMBL902486	Inhibition of human VEGFR2 by HTRF method	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1		CHEMBL194911	=	IC50	nM	15.49	CHEMBL1868	Homo sapiens	Log IC50		-7.81
	2021695	CHEMBL903571	Inhibition of human VEGFR1	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	IC50	nM	8.511	CHEMBL1868	Homo sapiens	Log IC50		-8.07
	2027265	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	O=C(O)C1CCN(C(=O)c2cccc3c2Cc2c-3n[nH]c2-c2ccsc2)CC1		CHEMBL393862	=	IC50	nM	3470.0	CHEMBL1868	Homo sapiens	IC50	uM	3.47
	2027281	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	CN1CCN(CC(=O)Nc2cccc3c2Cc2c-3n[nH]c2-c2ccsc2)CC1		CHEMBL245768	=	IC50	nM	710.0	CHEMBL1868	Homo sapiens	IC50	uM	0.71
	2027282	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	O=C(Nc1cccc2c1Cc1c-2n[nH]c1-c1ccsc1)c1ccccc1		CHEMBL247585	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	uM	0.05
	2027283	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	Cc1cc(C(=O)Nc2cccc3c2Cc2c-3n[nH]c2-c2ccsc2)no1		CHEMBL395695	=	IC50	nM	70.0	CHEMBL1868	Homo sapiens	IC50	uM	0.07
	2027284	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	O=C(Nc1cccc2c1Cc1c-2n[nH]c1-c1ccsc1)c1ccco1		CHEMBL247389	=	IC50	nM	90.0	CHEMBL1868	Homo sapiens	IC50	uM	0.09
	2027285	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	COC(=O)C(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1ccsc1		CHEMBL247388	=	IC50	nM	80.0	CHEMBL1868	Homo sapiens	IC50	uM	0.08
	2027286	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	CCS(=O)(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1ccsc1		CHEMBL395694	=	IC50	nM	290.0	CHEMBL1868	Homo sapiens	IC50	uM	0.29
	2027287	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	CCOC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1ccsc1		CHEMBL396586	=	IC50	nM	450.0	CHEMBL1868	Homo sapiens	IC50	uM	0.45
	2027288	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	COCC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1ccsc1		CHEMBL442273	=	IC50	nM	30.0	CHEMBL1868	Homo sapiens	IC50	uM	0.03
	2027289	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	CCCC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1ccsc1		CHEMBL245362	=	IC50	nM	290.0	CHEMBL1868	Homo sapiens	IC50	uM	0.29
	2027290	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	OCCNCc1cccc2c1Cc1c-2n[nH]c1-c1ccsc1		CHEMBL246546	=	IC50	nM	270.0	CHEMBL1868	Homo sapiens	IC50	uM	0.27
	2027291	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	O=C(O)CNC(=O)c1cccc2c1Cc1c-2n[nH]c1-c1ccsc1		CHEMBL246343	=	IC50	nM	240.0	CHEMBL1868	Homo sapiens	IC50	uM	0.24
	2027292	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	O=C(O)CCNC(=O)c1cccc2c1Cc1c-2n[nH]c1-c1ccsc1		CHEMBL246342	=	IC50	nM	370.0	CHEMBL1868	Homo sapiens	IC50	uM	0.37
	2027293	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	OCC1CCN(Cc2cccc3c2Cc2c-3n[nH]c2-c2ccsc2)CC1		CHEMBL245934	=	IC50	nM	17570.0	CHEMBL1868	Homo sapiens	IC50	uM	17.57
	2027294	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	O=C(O)C1CCCN(C(=O)c2cccc3c2Cc2c-3n[nH]c2-c2ccsc2)C1		CHEMBL245734	=	IC50	nM	3080.0	CHEMBL1868	Homo sapiens	IC50	uM	3.08
	2027314	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	CN1CCN(CC(=O)Nc2cccc3c2Cc2c-3n[nH]c2-c2csc(C#CCOc3ccccc3)c2)CC1		CHEMBL245377	=	IC50	nM	6.0	CHEMBL1868	Homo sapiens	IC50	uM	0.006
	2027315	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	CCOC(=O)CC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL395427	=	IC50	nM	153.0	CHEMBL1868	Homo sapiens	IC50	uM	0.153
	2027316	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	COC(=O)C(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL246166	=	IC50	nM	20.0	CHEMBL1868	Homo sapiens	IC50	uM	0.02
	2027317	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	COCCOCC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL245968	=	IC50	nM	136.0	CHEMBL1868	Homo sapiens	IC50	uM	0.136
	2027318	CHEMBL906390	Inhibition of Flt1 by HTRF assay	B	COCC(=O)Nc1cccc2c1Cc1c-2n[nH]c1-c1csc(C#CCOc2ccccc2)c1		CHEMBL245769	=	IC50	nM	710.0	CHEMBL1868	Homo sapiens	IC50	uM	0.71
Not Determined	2044817	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	C#CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCc1ccccc1)NC(=O)CN=[N+]=[N-])C(N)=O		CHEMBL3037889		IC50			CHEMBL1868	Homo sapiens	IC50		
	2044818	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	C#CC[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CN=[N+]=[N-])C(N)=O		CHEMBL2372108	=	Activity	%	67.0	CHEMBL1868	Homo sapiens	Activity	%	67.0
	2044819	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	C#CC[C@@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)CN=[N+]=[N-])C(N)=O		CHEMBL2372108	=	IC50	nM	19400.0	CHEMBL1868	Homo sapiens	IC50	uM	19.4
	2044820	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C		CHEMBL430206	=	Activity	%	99.0	CHEMBL1868	Homo sapiens	Activity	%	99.0
	2044821	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)Nn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL399245	=	Activity	%	28.0	CHEMBL1868	Homo sapiens	Activity	%	28.0
	2044822	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	C#CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)N=[N+]=[N-])C(N)=O		CHEMBL2372116	=	Activity	%	27.0	CHEMBL1868	Homo sapiens	Activity	%	27.0
	2044823	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)Nn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL401189	=	Activity	%	7.0	CHEMBL1868	Homo sapiens	Activity	%	7.0
	2044824	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	C#CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)N=[N+]=[N-])C(N)=O		CHEMBL2372115	=	Activity	%	6.0	CHEMBL1868	Homo sapiens	Activity	%	6.0
	2044825	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(N)=O)Nn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](CC(=O)O)NC1=O		CHEMBL398967	=	Activity	%	0.0	CHEMBL1868	Homo sapiens	Activity	%	0.0
	2044826	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	C#CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)N=[N+]=[N-])C(N)=O		CHEMBL2372114	=	Activity	%	0.0	CHEMBL1868	Homo sapiens	Activity	%	0.0
	2044827	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	CC(C)C[C@@H]1NC(=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccccc2)Nn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL399914	=	Activity	%	61.0	CHEMBL1868	Homo sapiens	Activity	%	61.0
	2044828	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	C#CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N=[N+]=[N-])c1ccccc1)C(N)=O		CHEMBL2372113	=	Activity	%	55.0	CHEMBL1868	Homo sapiens	Activity	%	55.0
	2044829	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)Nn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)C(=O)NC1=O		CHEMBL398672	=	Activity	%	0.0	CHEMBL1868	Homo sapiens	Activity	%	0.0
	2044830	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	C#CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N=[N+]=[N-])c1ccc(O)cc1)C(N)=O		CHEMBL2372112	=	Activity	%	0.0	CHEMBL1868	Homo sapiens	Activity	%	0.0
	2044831	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCc2ccccc2)NC(=O)CNn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL401113	=	Activity	%	29.0	CHEMBL1868	Homo sapiens	Activity	%	29.0
	2044832	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	C#CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCc1ccccc1)NC(=O)CN=[N+]=[N-])C(N)=O		CHEMBL2372111	=	Activity	%	0.0	CHEMBL1868	Homo sapiens	Activity	%	0.0
	2044833	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCc2ccccc2)NC(=O)CNn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL251738	=	Activity	%	10.0	CHEMBL1868	Homo sapiens	Activity	%	10.0
	2044834	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	C#CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCc1ccccc1)NC(=O)CN=[N+]=[N-])C(N)=O		CHEMBL3037889	=	Activity	%	0.0	CHEMBL1868	Homo sapiens	Activity	%	0.0
	2044835	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC1=O		CHEMBL398243	=	Activity	%	83.0	CHEMBL1868	Homo sapiens	Activity	%	83.0
	2044836	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	C#CC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CN=[N+]=[N-])[C@@H](C)CC)C(N)=O		CHEMBL2372109	=	Activity	%	95.0	CHEMBL1868	Homo sapiens	Activity	%	95.0
	2044837	CHEMBL922762	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 at 100 uM	B	CSCCC[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccccc2)NC1=O		CHEMBL249743	=	Activity	%	35.0	CHEMBL1868	Homo sapiens	Activity	%	35.0
	2044838	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC1=O		CHEMBL398243	=	IC50	nM	31100.0	CHEMBL1868	Homo sapiens	IC50	uM	31.1
	2044839	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	C#CC[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCSC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CN=[N+]=[N-])[C@@H](C)CC)C(N)=O		CHEMBL2372109	=	IC50	nM	22900.0	CHEMBL1868	Homo sapiens	IC50	uM	22.9
	2044840	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	CSCCC[C@@H]1NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)CNn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccccc2)NC1=O	Outside typical range	CHEMBL249743	=	IC50	nM	121000.0	CHEMBL1868	Homo sapiens	IC50	uM	121.0
	2044841	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	CC(C)C[C@@H]1NC(=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccccc2)Nn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL399914	=	IC50	nM	93000.0	CHEMBL1868	Homo sapiens	IC50	uM	93.0
	2044842	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	C#CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N=[N+]=[N-])c1ccccc1)C(N)=O		CHEMBL2372113	=	IC50	nM	96000.0	CHEMBL1868	Homo sapiens	IC50	uM	96.0
	2044843	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)CNC(=O)[C@@H](N)CC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)[C@@H](C)O)C(C)C		CHEMBL430206	=	IC50	nM	28000.0	CHEMBL1868	Homo sapiens	IC50	uM	28.0
	2044844	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCCCN)Nn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O	Outside typical range	CHEMBL399245	=	IC50	nM	162000.0	CHEMBL1868	Homo sapiens	IC50	uM	162.0
	2044845	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	C#CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)N=[N+]=[N-])C(N)=O	Outside typical range	CHEMBL2372116	=	IC50	nM	151000.0	CHEMBL1868	Homo sapiens	IC50	uM	151.0
Not Determined	2044846	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCc2ccccc2)NC(=O)CNn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL251738		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	2044847	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	C#CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCc1ccccc1)NC(=O)CN=[N+]=[N-])C(N)=O		CHEMBL2372111		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	2044848	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCc2ccccc2)NC(=O)CNn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL401113		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	2044849	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	C#CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](N=[N+]=[N-])c1ccc(O)cc1)C(N)=O		CHEMBL2372112		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	2044850	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)Nn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)C(=O)NC1=O		CHEMBL398672		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	2044851	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	C#CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(N)=O)N=[N+]=[N-])C(N)=O		CHEMBL2372114		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	2044852	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(N)=O)Nn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](CC(=O)O)NC1=O		CHEMBL398967		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	2044853	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	C#CC[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCC(=O)O)N=[N+]=[N-])C(N)=O		CHEMBL2372115		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	2044854	CHEMBL922761	Displacement of biotinylated VEGF165 from human recombinant VEGFR1	B	CC(C)C[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)Nn2cc(nn2)C[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL401189		IC50			CHEMBL1868	Homo sapiens	IC50		
	2045400	CHEMBL923925	Inhibition of Flt1	B	COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OC		CHEMBL248044	=	Ki	nM	1600.0	CHEMBL1868	Homo sapiens	Ki	uM	1.6
	2045420	CHEMBL923925	Inhibition of Flt1	B	N#Cc1cnc2ccc(-c3ccc(CN4CCOCC4)cc3)cc2c1N[C@@H]1C[C@H]1c1ccccc1		CHEMBL247024	>	Ki	nM	10000.0	CHEMBL1868	Homo sapiens	Ki	uM	10.0
	2045421	CHEMBL923925	Inhibition of Flt1	B	N#Cc1cnc2ccc(-c3cccc(CN4CCOCC4)c3)cc2c1N[C@@H]1C[C@H]1c1ccccc1		CHEMBL245799	>	Ki	nM	10000.0	CHEMBL1868	Homo sapiens	Ki	uM	10.0
	2045422	CHEMBL923925	Inhibition of Flt1	B	COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OCCN1CCOCC1		CHEMBL401054	>	Ki	nM	10000.0	CHEMBL1868	Homo sapiens	Ki	uM	10.0
	2045423	CHEMBL923925	Inhibition of Flt1	B	COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OCc1ccccc1		CHEMBL248220	>	Ki	nM	10000.0	CHEMBL1868	Homo sapiens	Ki	uM	10.0
	2045424	CHEMBL923925	Inhibition of Flt1	B	COc1ccc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2c1		CHEMBL401644	>	Ki	nM	10000.0	CHEMBL1868	Homo sapiens	Ki	uM	10.0
	2045425	CHEMBL923925	Inhibition of Flt1	B	COc1ccc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2c1		CHEMBL248045	>	Ki	nM	10000.0	CHEMBL1868	Homo sapiens	Ki	uM	10.0
	2045448	CHEMBL923925	Inhibition of Flt1	B	N#Cc1cnc2cc(-c3ccc(CN4CCOCC4)cc3)ccc2c1N[C@@H]1C[C@H]1c1ccccc1		CHEMBL399438	=	Ki	nM	920.0	CHEMBL1868	Homo sapiens	Ki	uM	0.92
	2045449	CHEMBL923925	Inhibition of Flt1	B	N#Cc1cnc2ccc(-c3ccc(CN)cc3)cc2c1N[C@@H]1C[C@H]1c1ccccc1		CHEMBL245800	=	Ki	nM	1400.0	CHEMBL1868	Homo sapiens	Ki	uM	1.4
	2045450	CHEMBL923925	Inhibition of Flt1	B	COc1cc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2cc1OC1CCN(C)CC1		CHEMBL245798	=	Ki	nM	1500.0	CHEMBL1868	Homo sapiens	Ki	uM	1.5
	2045451	CHEMBL923925	Inhibition of Flt1	B	COc1cc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2cc1OCCCN1CCN(C)CC1		CHEMBL248393	=	Ki	nM	110.0	CHEMBL1868	Homo sapiens	Ki	uM	0.11
	2045452	CHEMBL923925	Inhibition of Flt1	B	COc1cc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2cc1OCCCN1CCOCC1		CHEMBL248392	=	Ki	nM	350.0	CHEMBL1868	Homo sapiens	Ki	uM	0.35
	2045453	CHEMBL923925	Inhibition of Flt1	B	COCCOc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OC		CHEMBL401251	=	Ki	nM	2900.0	CHEMBL1868	Homo sapiens	Ki	uM	2.9
	2045454	CHEMBL923925	Inhibition of Flt1	B	COc1cc2c(N[C@@H]3C[C@H]3c3ccccc3)c(C#N)cnc2cc1OCCCc1cccnc1		CHEMBL248391	=	Ki	nM	1900.0	CHEMBL1868	Homo sapiens	Ki	uM	1.9
	2045455	CHEMBL923925	Inhibition of Flt1	B	COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OCCCc1cccnc1		CHEMBL248222	=	Ki	nM	1710.0	CHEMBL1868	Homo sapiens	Ki	uM	1.71
	2045456	CHEMBL923925	Inhibition of Flt1	B	COc1cc2ncc(C#N)c(N[C@@H]3C[C@H]3c3ccccc3)c2cc1OCCCN1CCOCC1		CHEMBL248221	=	Ki	nM	910.0	CHEMBL1868	Homo sapiens	Ki	uM	0.91
	2051622	CHEMBL941760	Inhibition of FLT1	B	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	>	Ki	nM	440.0	CHEMBL1868	Homo sapiens	Ki	uM	0.44
	2071557	CHEMBL928530	Inhibition of Flt1 at 1 uM	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	Inhibition	%	34.0	CHEMBL1868	Homo sapiens	Inhibition	%	34.0
	2071563	CHEMBL928530	Inhibition of Flt1 at 1 uM	B	COc1ccc(-c2[nH]nc3c2C(=O)c2c(NC(=O)Nc4ccc(N)cc4)cccc2-3)cc1		CHEMBL252392	=	Inhibition	%	16.0	CHEMBL1868	Homo sapiens	Inhibition	%	16.0
	2071584	CHEMBL928530	Inhibition of Flt1 at 1 uM	B	Nc1ccc(NC(=O)Nc2cccc3c2C(=O)c2c-3n[nH]c2-c2ccc(O)c(O)c2)cc1		CHEMBL254913	=	Inhibition	%	10.0	CHEMBL1868	Homo sapiens	Inhibition	%	10.0
	2071585	CHEMBL928530	Inhibition of Flt1 at 1 uM	B	Nc1ccc(NC(=O)Nc2cccc3c2C(=O)c2c-3n[nH]c2-c2ccc(O)cc2)cc1		CHEMBL254704	=	Inhibition	%	36.0	CHEMBL1868	Homo sapiens	Inhibition	%	36.0
	2071586	CHEMBL928530	Inhibition of Flt1 at 1 uM	B	O=C(Nc1ccc(O)cc1)Nc1cccc2c1C(=O)c1c-2n[nH]c1-c1ccc2c(c1)OCO2		CHEMBL254494	=	Inhibition	%	13.0	CHEMBL1868	Homo sapiens	Inhibition	%	13.0
	2071587	CHEMBL928530	Inhibition of Flt1 at 1 uM	B	COc1ccc(-c2[nH]nc3c2C(=O)c2c(NC(=O)Nc4ccc(O)cc4)cccc2-3)cc1		CHEMBL251803	=	Inhibition	%	9.0	CHEMBL1868	Homo sapiens	Inhibition	%	9.0
	2071588	CHEMBL928530	Inhibition of Flt1 at 1 uM	B	Nc1ccc(NC(=O)Nc2cccc3c2C(=O)c2c-3n[nH]c2-c2ccc3c(c2)OCO3)cc1		CHEMBL253429	=	Inhibition	%	60.0	CHEMBL1868	Homo sapiens	Inhibition	%	60.0
	2081991	CHEMBL929891	Inhibition of VEGFR1	B	CO/N=C(\C)c1ccc2c(c1)c1c3c(c4c(c1n2CC(C)C)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL258015	=	IC50	nM	8.0	CHEMBL1868	Homo sapiens	IC50	nM	8.0
	2088335	CHEMBL930125	Inhibition of FLT1 by HTRF assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	IC50	nM	7.0	CHEMBL1868	Homo sapiens	IC50	nM	7.0
	2088341	CHEMBL930125	Inhibition of FLT1 by HTRF assay	B	Nc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL255955	=	IC50	nM	5.0	CHEMBL1868	Homo sapiens	IC50	nM	5.0
	2109084	CHEMBL949295	Inhibition of FLT1 by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cc(C)ccc3F)cc2)c2c(N)noc12		CHEMBL270084	=	IC50	nM	24.0	CHEMBL1868	Homo sapiens	IC50	nM	24.0
	2109092	CHEMBL949295	Inhibition of FLT1 by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)c2c(N)noc12		CHEMBL269884	=	IC50	nM	38.0	CHEMBL1868	Homo sapiens	IC50	nM	38.0
	2109093	CHEMBL949295	Inhibition of FLT1 by HTRF assay	B	COc1ccc(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)c2c(N)noc12		CHEMBL430090	=	IC50	nM	16.0	CHEMBL1868	Homo sapiens	IC50	nM	16.0
Active	2120834	CHEMBL950232	Inhibition of human VEGFR1	B	COc1cc2nccc(Oc3ccc4c(C(=O)NC5CC5)cccc4c3)c2cc1OC		CHEMBL272198		Activity			CHEMBL1868	Homo sapiens	Activity		
Active	2120836	CHEMBL950232	Inhibition of human VEGFR1	B	COc1cc2nccc(Oc3ccc4c(C(N)=O)cccc4c3)c2cc1OC		CHEMBL271984		Activity			CHEMBL1868	Homo sapiens	Activity		
	2120939	CHEMBL950232	Inhibition of human VEGFR1	B	COCCNC(=O)c1cccc2cc(Oc3ccnc4cc(OC)c(OC)cc34)ccc12		CHEMBL271188	=	IC50	nM	73.0	CHEMBL1868	Homo sapiens	IC50	nM	73.0
	2121189	CHEMBL933144	Inhibition of VEGFR1	B	COc1cc2nccc(Oc3ccc4c(C(=O)Nc5ccc(Cl)cc5)cccc4c3)c2cc1OC		CHEMBL429743	=	IC50	nM	0.5	CHEMBL1868	Homo sapiens	IC50	nM	0.5
	2137112	CHEMBL939202	Inhibition of VEGFR1	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	IC50	nM	170.0	CHEMBL1868	Homo sapiens	IC50	nM	170.0
	2137117	CHEMBL921718	Inhibition of human VEGFR1 in HUVEC cells	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	IC50	nM	1.0	CHEMBL1868	Homo sapiens	IC50	nM	1.0
	2147266	CHEMBL921856	Activity of human Flt1 kinase at 1 uM	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Activity	%	65.0	CHEMBL1868	Homo sapiens	Activity	%	65.0
Not Determined	2164833	CHEMBL929423	Inhibition of VEGFR1	B	Cc1nnc(-c2cn3ncnc(Nc4cnc5[nH]ccc5c4)c3c2C(C)C)o1		CHEMBL258694		IC50			CHEMBL1868	Homo sapiens	IC50		
	2164868	CHEMBL929423	Inhibition of VEGFR1	B	Cc1cc2cc(Nc3ncnn4cc(-c5nnc(C)o5)c(C(C)C)c34)cnc2[nH]1		CHEMBL261592	=	IC50	nM	268.0	CHEMBL1868	Homo sapiens	IC50	nM	268.0
	2167935	CHEMBL924786	Inhibition of VEGFR1 at 100 nM	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	=	Inhibition	%	91.0	CHEMBL1868	Homo sapiens	Inhibition	%	91.0
Not Active	2170365	CHEMBL930320	Activity at VEGFR1 at 10 uM	B	COc1c(NC(=O)c2ccc(C)c(N3C=C(C(=O)NCC(C)(C)CN(C)C)NN3)c2)cc(C(C)(C)C)cc1NS(C)(=O)=O		CHEMBL254992		Activity			CHEMBL1868	Homo sapiens	Activity		
	2198003	CHEMBL1005545	Inhibition of Tel-fused FLT1 kinase-mediated mouse BaF3 cell proliferation	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	IC50	nM	872.0	CHEMBL1868	Homo sapiens	IC50	uM	0.872
	2206895	CHEMBL973092	Inhibition of Flt1 by cellular assay	B	Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1N1Cc2cnc(N)nc2N(C)C1=O		CHEMBL459850	=	EC50	nM	236.0	CHEMBL1868	Homo sapiens	EC50	nM	236.0
	2206934	CHEMBL973092	Inhibition of Flt1 by cellular assay	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	EC50	nM	872.0	CHEMBL1868	Homo sapiens	EC50	nM	872.0
	2227907	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1		CHEMBL497114	=	IC50	nM	30000.0	CHEMBL1868	Homo sapiens	IC50	uM	30.0
	2227908	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1C#Cc1ccnc(N)n1		CHEMBL499864	=	IC50	nM	36000.0	CHEMBL1868	Homo sapiens	IC50	uM	36.0
	2227909	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1C1CC1c1ccnc(N)n1		CHEMBL526880	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	2227910	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1NCCc1ccnc(N)n1		CHEMBL499863	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	2227911	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1CNc1ccnc(N)n1		CHEMBL450886	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	2227912	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1NC(=O)c1ccnc(N)n1		CHEMBL525048	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	2227913	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1C(=O)Nc1ccnc(N)n1		CHEMBL500152	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	2227914	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1Nc1ccnc(N)n1		CHEMBL525047	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	2227915	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(-c3ccccc3)ncn2Cc2ccccc2)n1		CHEMBL499891	=	IC50	nM	31000.0	CHEMBL1868	Homo sapiens	IC50	uM	31.0
	2227916	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(-c3ccccc3)ncn2CCN2CCCC2)n1		CHEMBL500153	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
Not Determined	2227917	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(-c3ccccc3)ncn2CC(=O)O)n1		CHEMBL451173		IC50			CHEMBL1868	Homo sapiens	IC50		
	2227918	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Cn1cnc(-c2ccccc2)c1/C=C/c1ccnc(N)n1		CHEMBL526925	=	IC50	nM	34000.0	CHEMBL1868	Homo sapiens	IC50	uM	34.0
	2227919	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Cn1cnc(/C=C/c2ccnc(N)n2)c1-c1ccccc1		CHEMBL453195	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	2227920	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2[nH]cnc2-c2ccccc2)n1		CHEMBL502279	=	IC50	nM	68000.0	CHEMBL1868	Homo sapiens	IC50	uM	68.0
	2227921	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2ccsc2-c2ccccc2)n1		CHEMBL499883	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	2227922	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(-c3ccccc3)nc3n2CCS3)n1		CHEMBL524322	=	IC50	nM	23000.0	CHEMBL1868	Homo sapiens	IC50	uM	23.0
	2227923	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(-c3ccccc3)nc3ccccn23)n1		CHEMBL525065	=	IC50	nM	79000.0	CHEMBL1868	Homo sapiens	IC50	uM	79.0
	2227924	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2sccc2-c2ccccc2)n1		CHEMBL500930	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	2227925	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2[nH]ncc2-c2ccccc2)n1		CHEMBL500929	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
Not Determined	2227926	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Cn1c(-c2ccccc2)c(/C=C/c2ccnc(N)n2)c2ccccc21		CHEMBL527111		IC50			CHEMBL1868	Homo sapiens	IC50		
	2227927	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Nc1cc(/C=C/c2c(-c3ccccc3)nc3sccn23)ncn1		CHEMBL502543	=	IC50	nM	5200.0	CHEMBL1868	Homo sapiens	IC50	uM	5.2
	2227928	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Nc1ccnc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1		CHEMBL527110	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	2227929	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	C(=C/c1c(-c2ccccc2)nc2sccn12)\c1ccncn1		CHEMBL505610	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	2227930	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Clc1nccc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1		CHEMBL501444	=	IC50	nM	66000.0	CHEMBL1868	Homo sapiens	IC50	uM	66.0
	2227931	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	CC(C)(C)C(=O)Nc1nccc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1		CHEMBL524708	=	IC50	nM	96000.0	CHEMBL1868	Homo sapiens	IC50	uM	96.0
	2227932	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	CC(=O)Nc1nccc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1		CHEMBL503074	=	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	2227933	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	C(=C/c1c(-c2ccccc2)nc2sccn12)\c1ccnc(Nc2ccccc2)n1		CHEMBL526932	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	2227934	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	CC(Nc1nccc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1)c1ccccc1		CHEMBL502803	=	IC50	nM	84000.0	CHEMBL1868	Homo sapiens	IC50	uM	84.0
	2227935	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	CNc1nccc(/C=C/c2c(-c3ccccc3)nc3sccn23)n1		CHEMBL497290	=	IC50	nM	77000.0	CHEMBL1868	Homo sapiens	IC50	uM	77.0
	2227936	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(Cl)nc3sccn23)n1		CHEMBL507202	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	2227937	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Cc1nc2sccn2c1/C=C/c1ccnc(N)n1		CHEMBL444654	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
Not Determined	2227938	CHEMBL995226	Inhibition of recombinant Flt1 expressed in baculovirus-Sf21 system	B	Nc1nccc(/C=C/c2c(-c3ccc(F)cc3)nc3sccn23)n1		CHEMBL524799		IC50			CHEMBL1868	Homo sapiens	IC50		
	2238318	CHEMBL976285	Inhibition of Flt1	B	Cc1cccc(C)c1/C=C/n1cnc2c(Nc3ccc(P(C)(C)=O)cc3)ncnc21		CHEMBL488840	=	IC50	nM	591.0	CHEMBL1868	Homo sapiens	IC50	nM	591.0
	2248203	CHEMBL1012686	Inhibition of FLT1 at 5 uM	B	O=C1NC(=O)/C(=C/c2cccc(C(F)(F)F)c2)S1		CHEMBL183906	=	Inhibition	%	18.0	CHEMBL1868	Homo sapiens	INH	%	18.0
Not Determined	2248370	CHEMBL1012686	Inhibition of FLT1 at 5 uM	B	CCCOc1ccc(/C=C2\SC(=O)NC2=O)cc1		CHEMBL84558		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	2250295	CHEMBL1011003	Inhibition of VEGFR1	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	nM	3.0
	2251214	CHEMBL1009912	Inhibition of VEGFR1	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
	2268435	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1nn[nH]c1NCc1ccncc1		CHEMBL463032	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2268437	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nn[nH]c1NCc1ccncc1		CHEMBL461981	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2270710	CHEMBL960956	Inhibition of VEGFR1 at 100 nM	B	CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)N5CCN(c6ccc(F)cc6)C5=O)cc4F)c3s2)c1		CHEMBL464211	=	Inhibition	%	99.0	CHEMBL1868	Homo sapiens	INH	%	99.0
	2279703	CHEMBL960111	Inhibition of VEGFR1	B	CN1CCCN(c2cncc(-c3cccc(/C=C/C(=O)O)c3)n2)CC1		CHEMBL493937	>	Ki	nM	10000.0	CHEMBL1868	Homo sapiens	Ki	uM	10.0
	2288952	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	IC50	nM	140.0	CHEMBL1868	Homo sapiens	IC50	uM	0.14
	2288955	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	IC50	nM	170.0	CHEMBL1868	Homo sapiens	IC50	uM	0.17
	2288958	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL522629	=	IC50	nM	130.0	CHEMBL1868	Homo sapiens	IC50	uM	0.13
	2288961	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	Clc1cccc(-n2cc(-c3ccccc3NCc3cccnc3)nn2)c1		CHEMBL489329	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2288964	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1		CHEMBL523301	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2288967	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL490968	=	IC50	nM	66.0	CHEMBL1868	Homo sapiens	IC50	uM	0.066
	2288970	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3cccnc3)nn2)c1		CHEMBL490969	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2288973	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccccn3)nn2)c1		CHEMBL523133	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2288976	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	FC(F)(F)Oc1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL491502	=	IC50	nM	72.0	CHEMBL1868	Homo sapiens	IC50	uM	0.072
	2288979	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL491680	=	IC50	nM	130.0	CHEMBL1868	Homo sapiens	IC50	uM	0.13
	2288982	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	FC(F)(F)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL522304	=	IC50	nM	660.0	CHEMBL1868	Homo sapiens	IC50	uM	0.66
	2288985	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	FC(F)(F)Oc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL491681	=	IC50	nM	1130.0	CHEMBL1868	Homo sapiens	IC50	uM	1.13
	2288988	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	CC(C)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL518652	=	IC50	nM	130.0	CHEMBL1868	Homo sapiens	IC50	uM	0.13
	2288991	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	CC(C)(C)c1cccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)c1		CHEMBL461391	=	IC50	nM	250.0	CHEMBL1868	Homo sapiens	IC50	uM	0.25
	2288994	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	CC(C)(C)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1		CHEMBL461392	=	IC50	nM	530.0	CHEMBL1868	Homo sapiens	IC50	uM	0.53
	2288997	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	c1ccc(-c2cn(-c3ccc4ccccc4n3)nn2)c(NCc2ccncc2)c1		CHEMBL461605	=	IC50	nM	640.0	CHEMBL1868	Homo sapiens	IC50	uM	0.64
	2289000	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	c1ccc(-c2cn(-c3ccc4[nH]ncc4c3)nn2)c(NCc2ccncc2)c1		CHEMBL516645	=	IC50	nM	650.0	CHEMBL1868	Homo sapiens	IC50	uM	0.65
	2289003	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	FC(F)(F)c1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1Cl		CHEMBL522133	=	IC50	nM	510.0	CHEMBL1868	Homo sapiens	IC50	uM	0.51
	2289006	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	FC(F)(F)c1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1Cl		CHEMBL491871	=	IC50	nM	1130.0	CHEMBL1868	Homo sapiens	IC50	uM	1.13
	2289009	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	Clc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1Cl		CHEMBL491872	=	IC50	nM	650.0	CHEMBL1868	Homo sapiens	IC50	uM	0.65
	2289012	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	Cc1ccc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)cc1C(F)(F)F		CHEMBL523320	=	IC50	nM	110.0	CHEMBL1868	Homo sapiens	IC50	uM	0.11
	2289015	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	Cc1cc(-n2cc(-c3ccccc3NCc3ccncc3)nn2)ccc1C(F)(F)F		CHEMBL454403	=	IC50	nM	860.0	CHEMBL1868	Homo sapiens	IC50	uM	0.86
	2289018	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	Fc1ccc(CNc2ccccc2-c2cn(-c3cccc(Cl)c3)nn2)cc1F		CHEMBL460751	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2289021	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccc4c(c3)OCO4)nn2)c1		CHEMBL460958	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2289024	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccc4c(c3)OCO4)nn2)c1		CHEMBL460959	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2289027	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	Clc1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1		CHEMBL516635	=	IC50	nM	170.0	CHEMBL1868	Homo sapiens	IC50	uM	0.17
	2289030	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	FC(F)(F)c1cccc(-n2cc(-c3ccccc3NCc3ccnc4ccccc34)nn2)c1		CHEMBL517021	=	IC50	nM	210.0	CHEMBL1868	Homo sapiens	IC50	uM	0.21
	2289033	CHEMBL960811	Inhibition of VEGFR1 by HTRF assay	B	Clc1cccc(-n2cc(-c3ccccc3NCc3c[nH]cn3)nn2)c1		CHEMBL464619	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2289036	CHEMBL960812	Inhibition of VEGFR1 by HTRF assay in presence of 8 uM ATP	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	IC50	nM	110.0	CHEMBL1868	Homo sapiens	IC50	uM	0.11
	2289038	CHEMBL960812	Inhibition of VEGFR1 by HTRF assay in presence of 8 uM ATP	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	IC50	nM	130.0	CHEMBL1868	Homo sapiens	IC50	uM	0.13
	2298772	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C(=O)N(C)C)cc1)c1ccccc1		CHEMBL525203	=	IC50	nM	82.0	CHEMBL1868	Homo sapiens	IC50	nM	82.0
	2298773	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	104.0	CHEMBL1868	Homo sapiens	IC50	nM	104.0
	2298774	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCCC2)cc1)c1ccccc1		CHEMBL497049	=	IC50	nM	146.0	CHEMBL1868	Homo sapiens	IC50	nM	146.0
	2298775	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)Cn2ccnc2)cc1)c1ccccc1		CHEMBL524453	=	IC50	nM	55.0	CHEMBL1868	Homo sapiens	IC50	nM	55.0
	2298776	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CC(=O)N(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL498088	=	IC50	nM	61.0	CHEMBL1868	Homo sapiens	IC50	nM	61.0
	2298777	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL525909	=	IC50	nM	28.0	CHEMBL1868	Homo sapiens	IC50	nM	28.0
	2298778	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)C(C)=O)cc1)c1ccccc1		CHEMBL498265	=	IC50	nM	35.0	CHEMBL1868	Homo sapiens	IC50	nM	35.0
	2298779	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(CCN(C)C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL498266	=	IC50	nM	69.0	CHEMBL1868	Homo sapiens	IC50	nM	69.0
	2298780	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(C(=O)N(C)CCN(C)C)cc1)c1ccccc1		CHEMBL525550	=	IC50	nM	325.0	CHEMBL1868	Homo sapiens	IC50	nM	325.0
	2298781	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL498105	=	IC50	nM	173.0	CHEMBL1868	Homo sapiens	IC50	nM	173.0
	2298782	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(NC(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL465015	=	IC50	nM	278.0	CHEMBL1868	Homo sapiens	IC50	nM	278.0
Not Determined	2298783	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(NC(=O)CN(C)C)cc1)c1ccccc1		CHEMBL465016		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	2298784	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)S(C)(=O)=O)cc1)c1ccccc1		CHEMBL518867		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	2298785	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN2CCCC2=O)cc1)c1ccccc1		CHEMBL465217		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	2298786	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1cccc(C(=O)N(C)CCN(C)C)c1)c1ccccc1		CHEMBL485642		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	2298787	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccccc1)c1ccccc1		CHEMBL519213		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	2298788	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCN(C)CC1)c1ccccc1		CHEMBL485643		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	2298789	CHEMBL1017194	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\NC1CCC(NC(=O)CN(C)C)CC1)c1ccccc1		CHEMBL483781		IC50			CHEMBL1868	Homo sapiens	IC50		
	2339009	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccccc3)[nH]c2n1		CHEMBL485320	=	IC50	nM	45100.0	CHEMBL1868	Homo sapiens	IC50	uM	45.1
	2339027	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	Nc1nc(Nc2ccc3[nH]ccc3c2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL499067	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	2339028	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	Nc1nc(Nc2ccc(F)c(C(F)(F)F)c2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL482715	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	2339029	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	Nc1nc(Nc2ccc(Cl)cc2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL519147	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	2339030	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	Nc1nc(Nc2ccc(Cl)cc2F)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL483313	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	2339031	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	C#Cc1cccc(Nc2nc(N)nc3[nH]c(CCc4ccccc4)cc23)c1	Outside typical range	CHEMBL520803	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	2339032	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL483312	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	2339033	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	Nc1nc(Nc2ccc(F)c(Cl)c2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL504416	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	2339034	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	Nc1nc(Nc2ccc(F)c(Br)c2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL483108	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	2339035	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150315	=	IC50	nM	17700.0	CHEMBL1868	Homo sapiens	IC50	uM	17.7
	2339036	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccc4ccccc4c3)[nH]c2n1		CHEMBL484109	=	IC50	nM	7800.0	CHEMBL1868	Homo sapiens	IC50	uM	7.8
	2339037	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3cccc4ccccc34)[nH]c2n1		CHEMBL484108	=	IC50	nM	11200.0	CHEMBL1868	Homo sapiens	IC50	uM	11.2
	2339038	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccccc3Cl)[nH]c2n1		CHEMBL482489	=	IC50	nM	32700.0	CHEMBL1868	Homo sapiens	IC50	uM	32.7
	2339039	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	COc1ccc(CCc2cc3c(Nc4cccc(Br)c4)nc(N)nc3[nH]2)cc1		CHEMBL485321	=	IC50	nM	31800.0	CHEMBL1868	Homo sapiens	IC50	uM	31.8
	2339097	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc4ccccc4c3)[nH]c2n1		CHEMBL502015	=	IC50	nM	15200.0	CHEMBL1868	Homo sapiens	IC50	uM	15.2
	2339098	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3cccc4ccccc34)[nH]c2n1		CHEMBL474538	=	IC50	nM	19200.0	CHEMBL1868	Homo sapiens	IC50	uM	19.2
	2339099	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccccc3Cl)[nH]c2n1		CHEMBL499345	=	IC50	nM	26800.0	CHEMBL1868	Homo sapiens	IC50	uM	26.8
	2339100	CHEMBL957462	Inhibition of VEGFR1 expressed in human tumor cells	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccccc3)[nH]c2n1		CHEMBL499344	>	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	uM	50.0
	2340451	CHEMBL963905	Inhibition of Flt1 expressed in mouse NIH3T3 cells by autoradiography	B	COC[C@@H](Cn1ccnc1[N+](=O)[O-])OC(=O)c1ccc(NC=C2C(=O)C=CC2=O)cc1	Non standard unit for type	CHEMBL484119	=	IC50	/uM	23.4	CHEMBL1868	Homo sapiens	IC50	/uM	23.4
	2340452	CHEMBL963905	Inhibition of Flt1 expressed in mouse NIH3T3 cells by autoradiography	B	CC(C)(C)c1ccc(OC[C@H](Cn2ccnc2[N+](=O)[O-])OC(=O)c2ccc(NC=C3C(=O)C=CC3=O)cc2)cc1	Non standard unit for type	CHEMBL490267	=	IC50	/uM	184.0	CHEMBL1868	Homo sapiens	IC50	/uM	184.0
	2340453	CHEMBL963905	Inhibition of Flt1 expressed in mouse NIH3T3 cells by autoradiography	B	CC(C)(C)c1ccc(OC[C@@H](Cn2ccnc2[N+](=O)[O-])OC(=O)c2ccc(NC=C3C(=O)C=CC3=O)cc2)cc1	Non standard unit for type	CHEMBL490266	=	IC50	/uM	18.4	CHEMBL1868	Homo sapiens	IC50	/uM	18.4
	2340454	CHEMBL963905	Inhibition of Flt1 expressed in mouse NIH3T3 cells by autoradiography	B	CC(C)(C)OC[C@H](Cn1ccnc1[N+](=O)[O-])OC(=O)c1ccc(NC=C2C(=O)C=CC2=O)cc1	Non standard unit for type	CHEMBL484321	=	IC50	/uM	213.0	CHEMBL1868	Homo sapiens	IC50	/uM	213.0
	2340455	CHEMBL963905	Inhibition of Flt1 expressed in mouse NIH3T3 cells by autoradiography	B	CC(C)(C)OC[C@@H](Cn1ccnc1[N+](=O)[O-])OC(=O)c1ccc(NC=C2C(=O)C=CC2=O)cc1	Non standard unit for type	CHEMBL484121	=	IC50	/uM	21.3	CHEMBL1868	Homo sapiens	IC50	/uM	21.3
Not Determined	2340456	CHEMBL963905	Inhibition of Flt1 expressed in mouse NIH3T3 cells by autoradiography	B	COC[C@H](Cn1ccnc1[N+](=O)[O-])OC(=O)c1ccc(NC=C2C(=O)C=CC2=O)cc1		CHEMBL484316		IC50			CHEMBL1868	Homo sapiens	IC50		
	2341409	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(C(=O)Cc4c[nH]c5ccccc45)CC3)ncn2)c1		CHEMBL524898	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2341449	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL501459	=	Inhibition	%	39.0	CHEMBL1868	Homo sapiens	INH	%	39.0
	2341490	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCCc3ccc(O)cc3)CC2)n1		CHEMBL501728	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2341531	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	O=C(NCCc1ccc(O)cc1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL499617	=	Inhibition	%	42.0	CHEMBL1868	Homo sapiens	INH	%	42.0
	2341572	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2cc(Nc3cccc(Br)c3)ncn2)CC1		CHEMBL501200	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2341613	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)N[C@@H](CO)c2ccccc2)n1		CHEMBL525070	=	Inhibition	%	5.0	CHEMBL1868	Homo sapiens	INH	%	5.0
	2341654	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc3ncsc3c2)cc(N2CCC[C@H]2C(=O)NCCc2cccc(I)c2)n1		CHEMBL501463	=	Inhibition	%	1.0	CHEMBL1868	Homo sapiens	INH	%	1.0
	2341695	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	O=C(NC1Cc2ccccc2C1)c1cccc(Nc2ccnc(N3CCN(c4ccccc4)CC3)n2)c1		CHEMBL499624	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2341736	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)ncn2)c1		CHEMBL502826	=	Inhibition	%	21.0	CHEMBL1868	Homo sapiens	INH	%	21.0
	2341777	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3ccc(CC(=O)Nc4ccc5ncsc5c4)cc3)ncn2)c1		CHEMBL502827	=	Inhibition	%	22.0	CHEMBL1868	Homo sapiens	INH	%	22.0
	2341818	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	COc1ccc(NC(=O)Cc2ccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)cc2)cn1		CHEMBL526914	=	Inhibition	%	20.0	CHEMBL1868	Homo sapiens	INH	%	20.0
	2341859	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)NCc4ccc(N(C)C)cc4)c3)n2)c1		CHEMBL501471	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2341900	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	O=C(NCc1cccnc1)c1cccc(-c2ccc(Nc3ccc4ncsc4c3)nn2)c1		CHEMBL501182	=	Inhibition	%	43.0	CHEMBL1868	Homo sapiens	INH	%	43.0
	2341941	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N4CCCC5CCCCC54)c3)ncn2)c1		CHEMBL499606	=	Inhibition	%	8.0	CHEMBL1868	Homo sapiens	INH	%	8.0
	2341982	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)nc(N)n2)c1		CHEMBL499865	=	Inhibition	%	15.0	CHEMBL1868	Homo sapiens	INH	%	15.0
	2342023	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)n2)c1		CHEMBL499866	=	Inhibition	%	34.0	CHEMBL1868	Homo sapiens	INH	%	34.0
	2342064	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	O=C(CN1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1)Nc1cc(F)ccc1F		CHEMBL520451	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2342105	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	O=C(NCc1ccncc1)c1cccc(Nc2cc(Nc3cccc(Br)c3)ncn2)c1		CHEMBL482513	=	Inhibition	%	32.0	CHEMBL1868	Homo sapiens	INH	%	32.0
	2342146	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2cc(Nc3cccc(C(=O)N(CC(C)O)CC(C)O)c3)ncn2)c1		CHEMBL483318	=	Inhibition	%	83.0	CHEMBL1868	Homo sapiens	INH	%	83.0
	2342187	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)ncn2)c1		CHEMBL520971	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2342230	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(C)CCc4ccccn4)c3)ncn2)c1		CHEMBL521469	=	Inhibition	%	3.0	CHEMBL1868	Homo sapiens	INH	%	3.0
	2342269	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	CC(=O)N1CCN(C(=O)c2cccc(Nc3cc(N(C)c4cccc(C)c4)ncn3)c2)CC1		CHEMBL521478	=	Inhibition	%	5.0	CHEMBL1868	Homo sapiens	INH	%	5.0
	2342310	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)NCc4ccncc4)c3)ncn2)c1		CHEMBL483506	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2342351	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL483507	=	Inhibition	%	72.0	CHEMBL1868	Homo sapiens	INH	%	72.0
	2342392	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(Nc3cccc(C(=O)NCCCn4ccnc4)c3)nc(N)n2)c1		CHEMBL520980	=	Inhibition	%	4.0	CHEMBL1868	Homo sapiens	INH	%	4.0
	2342433	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1cc(Nc2cccc(OC)c2)nc(N)n1		CHEMBL519962	=	Inhibition	%	3.0	CHEMBL1868	Homo sapiens	INH	%	3.0
	2342515	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	O=C(COc1ccccc1)N1CCN(c2nccc(Nc3ccc4ncsc4c3)n2)CC1		CHEMBL482488	=	Inhibition	%	3.0	CHEMBL1868	Homo sapiens	INH	%	3.0
	2342790	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	O=C(NC[C@@H]1CCCO1)c1cccc(Nc2nccc(Nc3ccc4ncsc4c3)n2)c1		CHEMBL500661	=	Inhibition	%	87.0	CHEMBL1868	Homo sapiens	INH	%	87.0
	2342821	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Clc1ccc2sc(CN3CCN(c4ncnc5c4CN(Cc4ccccc4)CC5)CC3)cc2c1		CHEMBL483710	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2343096	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccccc2)cc(N2CCC(C(=O)NCCc3ccccn3)CC2)n1		CHEMBL521002	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2343120	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	CC(=O)CCCCC(=O)N1CCN(c2nccc(Oc3cccc(C)c3)n2)CC1		CHEMBL484713	=	Inhibition	%	1.0	CHEMBL1868	Homo sapiens	INH	%	1.0
	2343142	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	COc1ccc(-c2noc(CN3CCN(c4cc(Nc5cccc(O)c5)ncn4)CC3)n2)cc1		CHEMBL483715	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2343166	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(CC(=O)Nc4cccc5c4CCCC5)CC3)n2)c1		CHEMBL520512	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2343190	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(N3CCN(CC(=O)Nc4nc(-c5ccccc5)cs4)CC3)ncn2)c1		CHEMBL519534	=	Inhibition	%	14.0	CHEMBL1868	Homo sapiens	INH	%	14.0
	2343214	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Nc1nc(Nc2ccc(C(=O)NCCc3ccncc3)cc2)cc(N2CCOCC2)n1		CHEMBL485524	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2343238	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2nccc3c2CN(C(=O)c2cc(C)n(C)c2C)CC3)c1		CHEMBL519146	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2343262	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c(C)n1C		CHEMBL482710	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2343620	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCN3CCCCC3)nc(N)n2)c1		CHEMBL526526	=	Inhibition	%	13.0	CHEMBL1868	Homo sapiens	INH	%	13.0
	2343623	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Nc1nc(N2CCOCC2)cc(N2CCC(C(=O)NCc3cccs3)CC2)n1		CHEMBL482910	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2343684	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	COc1cccc(Nc2cc(N3CCC[C@H]3C(=O)NCCc3ccc(O)cc3)nc(N)n2)c1		CHEMBL483518	=	Inhibition	%	2.0	CHEMBL1868	Homo sapiens	INH	%	2.0
	2343705	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCc3cccnc3)n2)c1		CHEMBL482717	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2343727	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	COC(=O)C(CO)NC(=O)[C@@H]1CCCN1c1nccc(Oc2cccc(C)c2)n1		CHEMBL519310	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2343751	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCN(C(=O)c4c(C)noc4C)CC3)n2)c1		CHEMBL482721	=	Inhibition	%	7.0	CHEMBL1868	Homo sapiens	INH	%	7.0
	2343771	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)C1CCN(c2cc(N3CCOCC3)nc(N)n2)CC1		CHEMBL519311	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2343793	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Oc2ccnc(N3CCC[C@H]3C(=O)NCCCn3ccnc3)n2)c1		CHEMBL482722	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2343814	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	O=C(c1nc(SCc2ccc(Cl)cc2)n2ccccc12)N1CCN(c2ncnc3c2CN(Cc2ccccc2)CC3)CC1		CHEMBL446637	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2343836	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	CN(C)c1ccc(C(=O)N2CCN(c3ncnc4c3CN(Cc3ccccc3)CC4)CC2)c2ccccc12		CHEMBL520331	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2343858	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(Nc2ncnc3c2CN(C(=O)c2ccc(N(C)C)c4ccccc24)CC3)c1		CHEMBL484324	=	Inhibition	%	1.0	CHEMBL1868	Homo sapiens	INH	%	1.0
	2343880	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)C1CCCN1c1cc(Nc2cccc(Br)c2)ncn1		CHEMBL484521	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2343902	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	COC[C@@H]1CCCN1C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519349	=	Inhibition	%	1.0	CHEMBL1868	Homo sapiens	INH	%	1.0
	2343924	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	CN(C)CC(C)(C)CNC(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521000	=	Inhibition	%	12.0	CHEMBL1868	Homo sapiens	INH	%	12.0
	2343946	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	O=C(C1CCN(c2nccc(Nc3ccccc3)n2)CC1)N1CC[C@@H](O)C1		CHEMBL484706	=	Inhibition	%	6.0	CHEMBL1868	Homo sapiens	INH	%	6.0
	2343967	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(N(C)c2cc(Nc3cccc(C(=O)N(CC(C)C)CC(C)C)c3)ncn2)c1		CHEMBL484707	=	Inhibition	%	5.0	CHEMBL1868	Homo sapiens	INH	%	5.0
	2343989	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	CN(CCc1ccccn1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL521479	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2344012	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	CN(CCCn1ccnc1)C(=O)[C@@H]1CCCN1c1nccc(Nc2ccccc2)n1		CHEMBL519658	=	Inhibition	%	4.0	CHEMBL1868	Homo sapiens	INH	%	4.0
	2344719	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1cccc(CN2CCN(c3cc(N(C)c4cccc(C)c4)ncn3)CC2)c1		CHEMBL446087	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2344742	CHEMBL953369	Inhibition of FLT1 at 10 uM by HTRF assay relative to control	B	Cc1ccc(CN2CCN(c3nccc(C(C#N)c4ccccn4)n3)CC2)cc1		CHEMBL521145	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
Active	2345281	CHEMBL956462	Binding affinity to human recombinant VEGFR1(1-3) N terminal domain by ELISA like binding assay	B	C=CCN(CC(=O)N(CCc1c[nH]c2ccccc12)CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)CC(C)C)C(=O)CN(CC(C)C)C(=O)CN(CCOC)C(=O)CNCCCCN		CHEMBL446122		Activity			CHEMBL1868	Homo sapiens	Activity		
Active	2345282	CHEMBL956464	Binding affinity to human recombinant VEGFR1 extracellular domain by ELISA like binding assay	B	C=CCN(CC(=O)N(CCc1c[nH]c2ccccc12)CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)CC(C)C)C(=O)CN(CC(C)C)C(=O)CN(CCOC)C(=O)CNCCCCN		CHEMBL446122		Activity			CHEMBL1868	Homo sapiens	Activity		
Active	2345286	CHEMBL956462	Binding affinity to human recombinant VEGFR1(1-3) N terminal domain by ELISA like binding assay	B	C=CCN(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)CC(C)C)C(=O)CN(CC(C)C)C(=O)CN(Cc1ccc2c(c1)OCO2)C(=O)CN(CCc1c[nH]c2ccccc12)C(=O)CN(CCCCN)C(=O)CNCCCCN		CHEMBL503055		Activity			CHEMBL1868	Homo sapiens	Activity		
Active	2345287	CHEMBL956462	Binding affinity to human recombinant VEGFR1(1-3) N terminal domain by ELISA like binding assay	B	CC(C)CN(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)C(=O)CN(CCCCN)C(=O)CN(Cc1ccc2c(c1)OCO2)C(=O)CN(CCCCN)C(=O)CN(CC(C)C)C(=O)CN(Cc1ccc2c(c1)OCO2)C(=O)CNCCCCN		CHEMBL510320		Activity			CHEMBL1868	Homo sapiens	Activity		
Active	2345288	CHEMBL956462	Binding affinity to human recombinant VEGFR1(1-3) N terminal domain by ELISA like binding assay	B	CC(C)CN(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)C(=O)CN(CCCCN)C(=O)CN(CC(C)C)C(=O)CN(CCCCN)C(=O)CN(Cc1ccco1)C(=O)CN(CCCCN)C(=O)CNCCc1c[nH]c2ccccc12		CHEMBL452679		Activity			CHEMBL1868	Homo sapiens	Activity		
Active	2345289	CHEMBL956462	Binding affinity to human recombinant VEGFR1(1-3) N terminal domain by ELISA like binding assay	B	CC(C)CN(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)CC(C)C)Cc1ccc2c(c1)OCO2)C(C)c1ccccc1)C(=O)CNCCCCN		CHEMBL467132		Activity			CHEMBL1868	Homo sapiens	Activity		
Active	2345290	CHEMBL956464	Binding affinity to human recombinant VEGFR1 extracellular domain by ELISA like binding assay	B	C=CCN(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)CC(C)C)C(=O)CN(CC(C)C)C(=O)CN(Cc1ccc2c(c1)OCO2)C(=O)CN(CCc1c[nH]c2ccccc12)C(=O)CN(CCCCN)C(=O)CNCCCCN		CHEMBL503055		Activity			CHEMBL1868	Homo sapiens	Activity		
Active	2345291	CHEMBL956464	Binding affinity to human recombinant VEGFR1 extracellular domain by ELISA like binding assay	B	CC(C)CN(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)C(=O)CN(CCCCN)C(=O)CN(Cc1ccc2c(c1)OCO2)C(=O)CN(CCCCN)C(=O)CN(CC(C)C)C(=O)CN(Cc1ccc2c(c1)OCO2)C(=O)CNCCCCN		CHEMBL510320		Activity			CHEMBL1868	Homo sapiens	Activity		
Active	2345292	CHEMBL956464	Binding affinity to human recombinant VEGFR1 extracellular domain by ELISA like binding assay	B	CC(C)CN(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)C(=O)CN(CCCCN)C(=O)CN(CC(C)C)C(=O)CN(CCCCN)C(=O)CN(Cc1ccco1)C(=O)CN(CCCCN)C(=O)CNCCc1c[nH]c2ccccc12		CHEMBL452679		Activity			CHEMBL1868	Homo sapiens	Activity		
Active	2345293	CHEMBL956464	Binding affinity to human recombinant VEGFR1 extracellular domain by ELISA like binding assay	B	CC(C)CN(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CC(=O)N(CCCCN)CC(=O)N(CCCCN)CC(N)=O)CC(C)C)Cc1ccc2c(c1)OCO2)C(C)c1ccccc1)C(=O)CNCCCCN		CHEMBL467132		Activity			CHEMBL1868	Homo sapiens	Activity		
	2361180	CHEMBL970656	Inhibition of Flt1 kinase	B	COc1cc2c(Oc3ccc(-c4cnc(Cc5ccccc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL505896	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	2361202	CHEMBL970656	Inhibition of Flt1 kinase	B	COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL453737	=	IC50	nM	45.0	CHEMBL1868	Homo sapiens	IC50	nM	45.0
Not Determined	2361225	CHEMBL970656	Inhibition of Flt1 kinase	B	COc1cc2c(Oc3ccc(-c4cnc(Nc5ccc(F)cc5)n(C)c4=O)nc3)ccnc2cc1OCCCN1CCOCC1		CHEMBL447602		IC50			CHEMBL1868	Homo sapiens	IC50		
	2379700	CHEMBL1000443	Inhibition of human VEGFR1 expressed in baculovirus insect cell system	B	CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O		CHEMBL290352	=	IC50	nM	209.0	CHEMBL1868	Homo sapiens	IC50	nM	209.0
	2379750	CHEMBL1000443	Inhibition of human VEGFR1 expressed in baculovirus insect cell system	B	COc1ccc2c(c1)CCc1c-2c2c(c3c4ccccc4n(CCO)c13)CNC2=O		CHEMBL460989	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	nM	10000.0
	2379759	CHEMBL1000443	Inhibition of human VEGFR1 expressed in baculovirus insect cell system	B	CC(C)Oc1ccc2c(c1)CCc1c-2c2c(c3c4ccccc4n(CCO)c13)CNC2=O		CHEMBL460990	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	nM	10000.0
	2386933	CHEMBL1006967	inhibition of VEGFR1 at 10 uM	B	Clc1ccc(Nc2nnc(-c3cccc4cnccc34)c3ccccc23)cc1		CHEMBL380316	=	Inhibition	%	91.0	CHEMBL1868	Homo sapiens	INH	%	91.0
	2396070	CHEMBL1006309	Inhibition of FLT1 at 1 uM relative to control	B	COc1ccc(/C=N/Nc2[nH]nc(C)c2C(=O)Nc2cccc(NC(C)=O)c2)cc1		CHEMBL515560	=	Inhibition	%	27.0	CHEMBL1868	Homo sapiens	INH	%	27.0
	2418042	CHEMBL1019614	Inhibition of FLT1 at 1 uM	B	C[C@H]1O[C@@H]2CC(=O)O[C@@H]2C2=C1C(=O)c1c(ccc([C@H]3C[C@@H](N(C)C)[C@H](O)[C@@H](C)O3)c1O)C2=O		CHEMBL2216825	=	Inhibition	%	29.0	CHEMBL1868	Homo sapiens	INH	%	29.0
	2453568	CHEMBL948365	Inhibition of Flt1 by HTRF assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)ccn4c3N)cc2)c1		CHEMBL453057	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	nM	3.0
	2470225	CHEMBL983627	Inhibition of FLT1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL1868	Homo sapiens	INH	%	10.0
	2476626	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Activity	%	6.4	CHEMBL1868	Homo sapiens	Activity	%	6.4
Not Evaluated	2476829	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	NC(=O)c1ccc(-c2cc(C(N)=O)c(N)c(-c3ccc(S(N)(=O)=O)cc3)c2)cc1		CHEMBL514582		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Evaluated	2478668	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	N#Cc1c(NC(=O)c2ccccc2)sc2c1CCCC2		CHEMBL233000		Activity			CHEMBL1868	Homo sapiens	Activity		
	2478871	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	Activity	%	0.1	CHEMBL1868	Homo sapiens	Activity	%	0.1
Not Evaluated	2479726	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	N#Cc1ccc(-c2cnc3[nH]cc(NC(=O)c4cccnc4)c3c2)cc1		CHEMBL516312		Activity			CHEMBL1868	Homo sapiens	Activity		
	2480725	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	CCS(=O)(=O)Nc1ccc2c(c1)/C(=C(/Nc1ccc(CN3CCCCC3)cc1)c1ccccc1)C(=O)N2		CHEMBL514409	=	Activity	%	0.1	CHEMBL1868	Homo sapiens	Activity	%	0.1
	2511583	CHEMBL972541	Inhibition of FLT1	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	19.0	CHEMBL1868	Homo sapiens	IC50	uM	0.019
	2560137	CHEMBL986504	Inhibition of Flt1 by ELISA	B	Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2		CHEMBL477197	=	IC50	nM	2900.0	CHEMBL1868	Homo sapiens	IC50	uM	2.9
	2560143	CHEMBL986516	Inhibition of Flt1 at 10 uM by ELISA	B	Oc1cc2c(cc1O)[C@@H]1c3ccc(O)c(O)c3OC[C@]1(O)C2		CHEMBL477197	=	Inhibition	%	79.6	CHEMBL1868	Homo sapiens	INH	%	79.6
	2561549	CHEMBL981070	Inhibition of human GST-tagged VEGFR1 by HTRF assay	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
	2564592	CHEMBL976316	Inhibition of VEGFR1	B	O=C(c1ccccc1NCc1ccncc1)c1n[nH]c2ccccc12		CHEMBL467549	=	IC50	nM	1900.0	CHEMBL1868	Homo sapiens	IC50	uM	1.9
	2564634	CHEMBL976316	Inhibition of VEGFR1	B	O=C(c1ccccc1NCc1ccc2ncccc2c1)c1n[nH]c2ccccc12		CHEMBL469172	=	IC50	nM	300.0	CHEMBL1868	Homo sapiens	IC50	uM	0.3
	2564659	CHEMBL976316	Inhibition of VEGFR1	B	O=C(c1ccccc1NCc1ccc2cn[nH]c2c1)c1n[nH]c2ccccc12		CHEMBL512124	=	IC50	nM	270.0	CHEMBL1868	Homo sapiens	IC50	uM	0.27
	2564660	CHEMBL976316	Inhibition of VEGFR1	B	O=C(c1ccccc1NCc1ccc2[nH]ncc2c1)c1n[nH]c2ccccc12		CHEMBL469171	=	IC50	nM	460.0	CHEMBL1868	Homo sapiens	IC50	uM	0.46
	2567243	CHEMBL974575	Inhibition of human Flt1 assessed as residual enzyme activity at 0.1 uM	B	CCN1C(=O)C(C)(C)c2cc3[nH]c4c(c3cc21)CCCc1c(C)n[nH]c1-4		CHEMBL223147	=	Activity	%	13.0	CHEMBL1868	Homo sapiens	Activity	%	13.0
Not Evaluated	2577347	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	CC(=O)c1c(-c2ccncc2)[nH]c(-c2ccncc2)c1C		CHEMBL526901		Activity			CHEMBL1868	Homo sapiens	Activity		
	2577550	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	NC(=O)c1ccc(Nc2cc(-c3ccc(F)cc3)[nH]n2)cc1		CHEMBL511337	=	Activity	%	11.1	CHEMBL1868	Homo sapiens	Activity	%	11.1
	2593552	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	0.2	CHEMBL1868	Homo sapiens	Activity	%	0.2
	2593755	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	Cc1ccc(O)cc1Nc1ccnc(Nc2cccc(C(N)=O)c2)n1		CHEMBL249097	=	Activity	%	1.7	CHEMBL1868	Homo sapiens	Activity	%	1.7
	2594021	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCNCC1		CHEMBL450519	=	Activity	%	0.3	CHEMBL1868	Homo sapiens	Activity	%	0.3
Not Evaluated	2594964	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL478649		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Evaluated	2595167	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	Cc1ccc(NC(=O)c2cccc(N3CCCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL1964275		Activity			CHEMBL1868	Homo sapiens	Activity		
	2595233	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(C)(C)C)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL515466	=	Activity	%	13.5	CHEMBL1868	Homo sapiens	Activity	%	13.5
Not Evaluated	2596364	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	CN(C)c1ccc(-c2cc3ncccc3c(NCCCCN)n2)cc1		CHEMBL282342		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Evaluated	2597633	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	O=C(Nc1n[nH]c2nc(-c3cccc(O)c3)ccc12)C1CC1		CHEMBL408019		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Evaluated	2597836	CHEMBL1035890	Binding affinity to human FLT1 at 10 uM relative to control	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454		Activity			CHEMBL1868	Homo sapiens	Activity		
	2602394	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	IC50	nM	140.0	CHEMBL1868	Homo sapiens	IC50	uM	0.14
	2602395	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	IC50	nM	170.0	CHEMBL1868	Homo sapiens	IC50	uM	0.17
	2602396	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL515880	=	IC50	nM	170.0	CHEMBL1868	Homo sapiens	IC50	uM	0.17
	2602397	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1cccnc1		CHEMBL514986	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2602398	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccccn1		CHEMBL475703	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2602399	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1ccncc1		CHEMBL475704	=	IC50	nM	250.0	CHEMBL1868	Homo sapiens	IC50	uM	0.25
	2602400	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1cccnc1		CHEMBL474293	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2602401	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)cc1)c1nscc1NCc1ccccn1		CHEMBL474494	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2602402	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1cccc(OC(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL475509	=	IC50	nM	260.0	CHEMBL1868	Homo sapiens	IC50	uM	0.26
	2602403	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1nscc1NCc1ccncc1		CHEMBL516243	=	IC50	nM	1230.0	CHEMBL1868	Homo sapiens	IC50	uM	1.23
	2602404	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	CC(C)(C)c1cccc(NC(=O)c2nscc2NCc2ccncc2)c1		CHEMBL475510	=	IC50	nM	310.0	CHEMBL1868	Homo sapiens	IC50	uM	0.31
	2602405	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	CC(C)(C)c1ccc(NC(=O)c2nscc2NCc2ccncc2)cc1		CHEMBL475708	=	IC50	nM	610.0	CHEMBL1868	Homo sapiens	IC50	uM	0.61
	2602406	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cl)cc1)c1nscc1NCc1ccncc1		CHEMBL475709	=	IC50	nM	250.0	CHEMBL1868	Homo sapiens	IC50	uM	0.25
	2602407	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccncc1		CHEMBL473287	=	IC50	nM	55.0	CHEMBL1868	Homo sapiens	IC50	uM	0.055
	2602408	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Br)cc1)c1nscc1NCc1ccncc1		CHEMBL473288	=	IC50	nM	260.0	CHEMBL1868	Homo sapiens	IC50	uM	0.26
	2602410	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1ccc2ccccc2n1)c1nscc1NCc1ccncc1		CHEMBL474709	=	IC50	nM	380.0	CHEMBL1868	Homo sapiens	IC50	uM	0.38
	2602411	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(NC1=CC2C=NNC2C=C1)c1nscc1NCc1ccncc1		CHEMBL443921	=	IC50	nM	1090.0	CHEMBL1868	Homo sapiens	IC50	uM	1.09
	2602412	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cl)c(C(F)(F)F)c1)c1nscc1NCc1ccncc1		CHEMBL473268	=	IC50	nM	980.0	CHEMBL1868	Homo sapiens	IC50	uM	0.98
	2602413	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(C(F)(F)F)c(Cl)c1)c1nscc1NCc1ccncc1		CHEMBL512862	=	IC50	nM	1800.0	CHEMBL1868	Homo sapiens	IC50	uM	1.8
	2602414	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1nscc1NCc1ccncc1		CHEMBL470440	=	IC50	nM	750.0	CHEMBL1868	Homo sapiens	IC50	uM	0.75
	2602415	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	Cc1ccc(NC(=O)c2nscc2NCc2ccncc2)cc1C(F)(F)F		CHEMBL470441	=	IC50	nM	190.0	CHEMBL1868	Homo sapiens	IC50	uM	0.19
	2602416	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	Cc1cc(NC(=O)c2nscc2NCc2ccncc2)ccc1C(F)(F)F		CHEMBL512863	=	IC50	nM	670.0	CHEMBL1868	Homo sapiens	IC50	uM	0.67
	2602417	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	Cc1ccc(NC(=O)c2nscc2NCc2ccncc2)c(F)c1		CHEMBL460191	=	IC50	nM	2510.0	CHEMBL1868	Homo sapiens	IC50	uM	2.51
	2602418	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(NCc1ccc2c(c1)OCO2)c1nscc1NCc1ccncc1		CHEMBL462315	=	IC50	nM	700.0	CHEMBL1868	Homo sapiens	IC50	uM	0.7
	2602419	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccc(F)c(F)c1		CHEMBL518204	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2602420	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCCc1ccc2c(c1)OCO2		CHEMBL462527	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2602421	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCCc1ccc2c(c1)OCO2		CHEMBL462528	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2602422	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccnc2ccccc12		CHEMBL517399	=	IC50	nM	330.0	CHEMBL1868	Homo sapiens	IC50	uM	0.33
	2602423	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1nscc1NCc1ccnc2ccccc12		CHEMBL458531	=	IC50	nM	580.0	CHEMBL1868	Homo sapiens	IC50	uM	0.58
	2602424	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1cnoc1		CHEMBL512380	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2602425	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1cccc(Br)c1)c1nscc1NCc1ccc2ccccc2n1		CHEMBL458532	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2603013	CHEMBL1034025	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 8 uM ATP by HTRF assay	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	IC50	nM	110.0	CHEMBL1868	Homo sapiens	IC50	uM	0.11
	2603016	CHEMBL1034025	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 8 uM ATP by HTRF assay	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	IC50	nM	130.0	CHEMBL1868	Homo sapiens	IC50	uM	0.13
	2603059	CHEMBL1023854	Inhibition of VEGFR1	B	Cc1cccc(C(=O)Nc2cccc([C@H](C)Nc3cncc(Cl)n3)c2)c1		CHEMBL504075	=	Kd	nM	5.7	CHEMBL1868	Homo sapiens	Kd	nM	5.7
	2603534	CHEMBL1034023	Inhibition of VEGFR1 assessed as blockade of pGAT-biotin phosphorylation in presence of 2 uM ATP by HTRF assay	B	O=C(Nc1ccccc1Br)c1nscc1NCc1ccncc1		CHEMBL509737	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	2704634	CHEMBL1054869	Inhibition of FLT1 at 10 uM by HotSpot assay relative to control	B	Cc1cc(O)cc(-c2nn(CC#N)cc2-c2cc(NC[C@H](C)O)nc(-c3cccnc3)n2)c1		CHEMBL560733	=	Inhibition	%	-1.67	CHEMBL1868	Homo sapiens	INH	%	-1.67
	2719528	CHEMBL1059978	Inhibition of Tel fused FLT1 expressed in mouse BA/F3 cells	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(NC(=O)c4cncc(-c5cccs5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL556140	<	EC50	nM	500.0	CHEMBL1868	Homo sapiens	EC50	nM	500.0
	2721611	CHEMBL1057440	Inhibition of Flt1 at 1 uM	B	C[C@@H](Oc1cc(-c2cnc3ccccn23)sc1C(N)=O)c1ccc(CNC(C)(C)C)cc1OC(F)F		CHEMBL551079	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	2897238	CHEMBL1061126	Percent residual Flt-1 activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	80.0	CHEMBL1868	Homo sapiens	Activity	%	80.0
	2907339	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	7.5	CHEMBL1868	Homo sapiens	Kd	nM	7.5
	2907340	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	12.0	CHEMBL1868	Homo sapiens	Kd	nM	12.0
	2907341	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	86.0	CHEMBL1868	Homo sapiens	Kd	nM	86.0
	2907342	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	110.0	CHEMBL1868	Homo sapiens	Kd	nM	110.0
	2907343	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	410.0	CHEMBL1868	Homo sapiens	Kd	nM	410.0
	2907344	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907345	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	69.0	CHEMBL1868	Homo sapiens	Kd	nM	69.0
	2907346	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	800.0	CHEMBL1868	Homo sapiens	Kd	nM	800.0
	2907347	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907348	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907349	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907350	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	5000.0	CHEMBL1868	Homo sapiens	Kd	nM	5000.0
	2907351	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907352	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	4400.0	CHEMBL1868	Homo sapiens	Kd	nM	4400.0
	2907353	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907354	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907355	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907356	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	14.0	CHEMBL1868	Homo sapiens	Kd	nM	14.0
	2907357	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907358	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	2100.0	CHEMBL1868	Homo sapiens	Kd	nM	2100.0
	2907359	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907360	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907361	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	3100.0	CHEMBL1868	Homo sapiens	Kd	nM	3100.0
	2907362	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1000.0	CHEMBL1868	Homo sapiens	Kd	nM	1000.0
	2907363	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907364	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	450.0	CHEMBL1868	Homo sapiens	Kd	nM	450.0
	2907365	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	9.6	CHEMBL1868	Homo sapiens	Kd	nM	9.6
	2907366	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907367	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907368	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907369	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907370	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	31.0	CHEMBL1868	Homo sapiens	Kd	nM	31.0
	2907371	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	150.0	CHEMBL1868	Homo sapiens	Kd	nM	150.0
	2907372	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	4.7	CHEMBL1868	Homo sapiens	Kd	nM	4.7
	2907373	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1.8	CHEMBL1868	Homo sapiens	Kd	nM	1.8
	2907374	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	100.0	CHEMBL1868	Homo sapiens	Kd	nM	100.0
	2907375	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	2907376	CHEMBL1061174	Binding constant for FLT1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	260.0	CHEMBL1868	Homo sapiens	Kd	nM	260.0
	2921332	CHEMBL1053733	Inhibition of FLT1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	2.2	CHEMBL1868	Homo sapiens	Activity	%	2.2
	2929947	CHEMBL1057697	Binding affinity to FLT1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	41.0	CHEMBL1868	Homo sapiens	Kd	nM	41.0
	2938503	CHEMBL1041362	Inhibition of FLT-1 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	2943682	CHEMBL1044061	Inhibition of Flt1	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OCCOC		CHEMBL569880	=	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	microM	10.0
	2943690	CHEMBL1044061	Inhibition of Flt1	B	C=CC(=O)N1CCC[C@H]1C(=O)Nc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1OCCOC		CHEMBL571040	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	microM	10.0
	2948622	CHEMBL1047370	Inhibition of VEGFR1 at 100 uM	B	COc1cc2nccc(Oc3ccc(NC(=O)N4CCN(c5ccccc5)C4=O)cc3F)c2cc1OC		CHEMBL573761	=	Inhibition	%	100.0	CHEMBL1868	Homo sapiens	INH	%	100.0
	2989955	CHEMBL1050676	Inhibition of VEGFR1 at 100 nM by radiometric protein kinase assay	B	CCn1cnc(-c2cc3nccc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccccc6)CC5)cc4F)c3s2)c1		CHEMBL565807	=	Inhibition	%	98.0	CHEMBL1868	Homo sapiens	INH	%	98.0
	3006359	CHEMBL1040182	Inhibition of VEGFR1	B	CCCc1cc(N2CCCC(O)C2)nc2sc(C(N)=O)c(N)c12		CHEMBL576989	>	IC50	nM	7000.0	CHEMBL1868	Homo sapiens	IC50	uM	7.0
	3006360	CHEMBL1040182	Inhibition of VEGFR1	B	CCCc1cc(N2CCC(O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL576887	>	IC50	nM	7000.0	CHEMBL1868	Homo sapiens	IC50	uM	7.0
	3006361	CHEMBL1040182	Inhibition of VEGFR1	B	CCCc1cc(N2CCNCC2)nc2sc(C(N)=O)c(N)c12		CHEMBL568922	>	IC50	nM	7000.0	CHEMBL1868	Homo sapiens	IC50	uM	7.0
	3006362	CHEMBL1040182	Inhibition of VEGFR1	B	CCCc1cc(N2CCC(N)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL578601	>	IC50	nM	7000.0	CHEMBL1868	Homo sapiens	IC50	uM	7.0
	3052507	CHEMBL1073159	Residual activity of VEGFR1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	95.0	CHEMBL1868	Homo sapiens	Residual activity	%	95.0
	3052759	CHEMBL1043838	Residual activity of VEGFR1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	74.0	CHEMBL1868	Homo sapiens	Residual activity	%	74.0
	3054068	CHEMBL1073367	Residual activity of VEGFR1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	14.0	CHEMBL1868	Homo sapiens	Residual activity	%	14.0
	3055355	CHEMBL1073159	Residual activity of VEGFR1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	93.0	CHEMBL1868	Homo sapiens	Residual activity	%	93.0
	3055607	CHEMBL1043838	Residual activity of VEGFR1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	75.0	CHEMBL1868	Homo sapiens	Residual activity	%	75.0
	3056912	CHEMBL1073367	Residual activity of VEGFR1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	35.0	CHEMBL1868	Homo sapiens	Residual activity	%	35.0
	3057164	CHEMBL1073159	Residual activity of VEGFR1 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	96.0	CHEMBL1868	Homo sapiens	Residual activity	%	96.0
	3058484	CHEMBL1043838	Residual activity of VEGFR1 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	74.0	CHEMBL1868	Homo sapiens	Residual activity	%	74.0
	3059768	CHEMBL1073367	Residual activity of VEGFR1 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	28.0	CHEMBL1868	Homo sapiens	Residual activity	%	28.0
	3084423	CHEMBL1073286	Inhibition of FLT1	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	9000.0	CHEMBL1868	Homo sapiens	IC50	uM	9.0
	3098412	CHEMBL1067018	Inhibition of human VEGFR1 at 0.1 uM	B	COc1ccccc1NC(=O)CC(Nc1ccc(Oc2ccnc3cc(-c4cn(C)cn4)sc23)c(F)c1)C(F)(F)F		CHEMBL591924	>	Inhibition	%	95.0	CHEMBL1868	Homo sapiens	INH	%	95.0
Active	3098419	CHEMBL1067044	Inhibition of human VEGFR1	B	O=C(CC(Nc1ccc(Oc2cc(NC(=O)N3CCCC3)ncn2)c(F)c1)C(F)(F)F)Nc1ccccc1		CHEMBL612137		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	3102188	CHEMBL1070753	Inhibition of VEGFR1 after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccc(I)cc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL597492	=	IC50	nM	69.4	CHEMBL1868	Homo sapiens	IC50	nM	69.4
	3102189	CHEMBL1070753	Inhibition of VEGFR1 after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccc(Br)cc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL605957	=	IC50	nM	72.4	CHEMBL1868	Homo sapiens	IC50	nM	72.4
	3102190	CHEMBL1070753	Inhibition of VEGFR1 after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL201511	=	IC50	nM	55.0	CHEMBL1868	Homo sapiens	IC50	nM	55.0
	3102191	CHEMBL1070753	Inhibition of VEGFR1 after 80 mins by radiometric protein kinase assay	B	COc1cc(C2=C(c3c[nH]c4ccc(F)cc34)C(=O)NC2=O)cc(OC)c1OC		CHEMBL606168	=	IC50	nM	150.0	CHEMBL1868	Homo sapiens	IC50	nM	150.0
	3123972	CHEMBL1067543	Inhibition of FLT1	B	CC(C)(C)c1cc(NC(=O)Nc2cccc(Oc3cccc4[nH]c(=O)[nH]c34)c2)n(-c2ccccc2)n1		CHEMBL597592	=	IC50	nM	1530.0	CHEMBL1868	Homo sapiens	IC50	uM	1.53
	3123973	CHEMBL1067543	Inhibition of FLT1	B	CC(C)(C)c1cc(NC(=O)c2cccc(Oc3cccc4[nH]c(=O)[nH]c34)c2)n(-c2ccccc2)n1		CHEMBL598626	=	IC50	nM	4160.0	CHEMBL1868	Homo sapiens	IC50	uM	4.16
	3123974	CHEMBL1067543	Inhibition of FLT1	B	O=C(Nc1cc(Oc2cccc3[nH]c(=O)[nH]c23)c(F)c(F)c1F)c1cccc(OC(F)(F)F)c1		CHEMBL602123	=	IC50	nM	4840.0	CHEMBL1868	Homo sapiens	IC50	uM	4.84
	3131738	CHEMBL1065744	Inhibition of VEGFR1	B	COc1ccc(C(=O)NCc2cccc(C(=O)Nc3ccc4c(c3)CNCC4)c2)cc1OC		CHEMBL604087	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	3186238	CHEMBL1111482	Inhibition of VEGFR1	B	CN1CCN(Cc2ccc3c(c2)-c2n[nH]c(-c4ccc(CN(C)C(=O)Nc5cccc(C(F)(F)F)c5)s4)c2C3)CC1		CHEMBL213910	=	IC50	nM	14.0	CHEMBL1868	Homo sapiens	IC50	nM	14.0
Not Active	3191156	CHEMBL1101250	Displacement of biotinylated-VEGF-A125 from human VEGFR1 expressed in human DU145 cells	B	N=C(N)NCCC[C@H](NC(=O)c1sccc1NS(=O)(=O)c1cccc2nsnc12)C(=O)O		CHEMBL1078974		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	3191158	CHEMBL1101252	Displacement of biotinylated-VEGF-A125 from human VEGFR1 expressed in human A549 cells	B	N=C(N)NCCC[C@H](NC(=O)c1sccc1NS(=O)(=O)c1cccc2nsnc12)C(=O)O		CHEMBL1078974		Activity			CHEMBL1868	Homo sapiens	Activity		
	3210380	CHEMBL1109442	Inhibition of VEGFR1 after 1 hr	B	O=C(Nc1cccc(-c2cn3ccnc3c(NCc3ccncc3)n2)c1)Nc1cccc(C(F)(F)F)c1		CHEMBL1081198	=	IC50	nM	747.0	CHEMBL1868	Homo sapiens	IC50	uM	0.747
	3213817	CHEMBL1108404	Inhibition of FLT1 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	8.0	CHEMBL1868	Homo sapiens	INH	%	8.0
	3219928	CHEMBL1115835	Inhibition of FLt	B	Cn1cnc(-c2ccccc2)c1-c1cc2c(N)ncnc2s1		CHEMBL1079428	=	IC50	nM	22000.0	CHEMBL1868	Homo sapiens	IC50	uM	22.0
	3219938	CHEMBL1115835	Inhibition of FLt	B	Cn1cnc(-c2ccccc2)c1-c1nc2c(N)ncnc2s1		CHEMBL1076330	=	IC50	nM	4400.0	CHEMBL1868	Homo sapiens	IC50	uM	4.4
	3224825	CHEMBL1099662	Inhibition of FLT1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	3225075	CHEMBL1099662	Inhibition of FLT1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	3242699	CHEMBL1115351	Inhibition of VEGFR1 in human A498 cells by phosphotyrosine cell-based ELISA	B	Nc1nc(N)c2c(n1)[nH]c1cccc(Sc3ccccc3)c12	Outside typical range	CHEMBL1093099	=	IC50	nM	118100.0	CHEMBL1868	Homo sapiens	IC50	uM	118.1
	3242706	CHEMBL1115351	Inhibition of VEGFR1 in human A498 cells by phosphotyrosine cell-based ELISA	B	Cc1ccc(Sc2cccc3[nH]c4nc(N)nc(N)c4c23)cc1	Outside typical range	CHEMBL1093100	=	IC50	nM	160100.0	CHEMBL1868	Homo sapiens	IC50	uM	160.1
	3242712	CHEMBL1115351	Inhibition of VEGFR1 in human A498 cells by phosphotyrosine cell-based ELISA	B	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150315	=	IC50	nM	14100.0	CHEMBL1868	Homo sapiens	IC50	uM	14.1
	3294244	CHEMBL1104799	Inhibition of FLT1	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	=	IC50	nM	42.0	CHEMBL1868	Homo sapiens	IC50	nM	42.0
	3295268	CHEMBL1115599	Inhibition of VEGFR1	B	Brc1cccc(Nc2ncnc3[nH]c(CCc4ccccc4)cc23)c1	Outside typical range	CHEMBL1094423	=	IC50	nM	129400.0	CHEMBL1868	Homo sapiens	IC50	uM	129.4
	3295269	CHEMBL1115599	Inhibition of VEGFR1	B	Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccccc3)[nH]c2n1		CHEMBL485320	=	IC50	nM	45100.0	CHEMBL1868	Homo sapiens	IC50	uM	45.1
	3295270	CHEMBL1115599	Inhibition of VEGFR1	B	C#Cc1cccc(Nc2ncnc3[nH]c(CCc4ccccc4)cc23)c1	Outside typical range	CHEMBL1096972	=	IC50	nM	142300.0	CHEMBL1868	Homo sapiens	IC50	uM	142.3
	3295271	CHEMBL1115599	Inhibition of VEGFR1	B	C#Cc1cccc(Nc2nc(N)nc3[nH]c(CCc4ccccc4)cc23)c1	Outside typical range	CHEMBL520803	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	3295272	CHEMBL1115599	Inhibition of VEGFR1	B	FC(F)(F)c1cccc(Nc2ncnc3[nH]c(CCc4ccccc4)cc23)c1	Outside typical range	CHEMBL1097743	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	3295273	CHEMBL1115599	Inhibition of VEGFR1	B	Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL483312	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	3295274	CHEMBL1115599	Inhibition of VEGFR1	B	Fc1ccc(Nc2ncnc3[nH]c(CCc4ccccc4)cc23)cc1Br	Outside typical range	CHEMBL1096737	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	3295275	CHEMBL1115599	Inhibition of VEGFR1	B	Nc1nc(Nc2ccc(F)c(Br)c2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL483108	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	3295276	CHEMBL1115599	Inhibition of VEGFR1	B	Fc1ccc(Nc2ncnc3[nH]c(CCc4ccccc4)cc23)cc1C(F)(F)F	Outside typical range	CHEMBL1096415	=	IC50	nM	164300.0	CHEMBL1868	Homo sapiens	IC50	uM	164.3
	3295277	CHEMBL1115599	Inhibition of VEGFR1	B	Nc1nc(Nc2ccc(F)c(C(F)(F)F)c2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL482715	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	3295278	CHEMBL1115599	Inhibition of VEGFR1	B	Fc1cc(Cl)ccc1Nc1ncnc2[nH]c(CCc3ccccc3)cc12	Outside typical range	CHEMBL1096416	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	3295279	CHEMBL1115599	Inhibition of VEGFR1	B	Nc1nc(Nc2ccc(Cl)cc2F)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL483313	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	3295280	CHEMBL1115599	Inhibition of VEGFR1	B	c1ccc(CCc2cc3c(Nc4ccc5[nH]ccc5c4)ncnc3[nH]2)cc1	Outside typical range	CHEMBL1097368	=	IC50	nM	223800.0	CHEMBL1868	Homo sapiens	IC50	uM	223.8
	3295281	CHEMBL1115599	Inhibition of VEGFR1	B	Nc1nc(Nc2ccc3[nH]ccc3c2)c2cc(CCc3ccccc3)[nH]c2n1	Outside typical range	CHEMBL499067	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	3295282	CHEMBL1115599	Inhibition of VEGFR1	B	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150315	=	IC50	nM	17700.0	CHEMBL1868	Homo sapiens	IC50	uM	17.7
	3299630	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1		CHEMBL1095761	>	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	uM	50.0
	3299631	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	Nc1nc(Nc2ccc(Br)cc2Cl)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1	Outside typical range	CHEMBL1095762	>	IC50	nM	300000.0	CHEMBL1868	Homo sapiens	IC50	uM	300.0
	3299632	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	Nc1nc(Nc2ccc(Cl)cc2F)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1		CHEMBL1095130	=	IC50	nM	70900.0	CHEMBL1868	Homo sapiens	IC50	uM	70.9
	3299633	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	Nc1nc(Nc2cccc(F)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1	Outside typical range	CHEMBL1095131	=	IC50	nM	162900.0	CHEMBL1868	Homo sapiens	IC50	uM	162.9
	3299634	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1	Outside typical range	CHEMBL1095445	=	IC50	nM	156100.0	CHEMBL1868	Homo sapiens	IC50	uM	156.1
	3299635	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	C#Cc1cccc(Nc2nc(N)nc3[nH]c(Cc4ccc(Cl)cc4Cl)cc23)c1	Outside typical range	CHEMBL1094475	>	IC50	nM	300000.0	CHEMBL1868	Homo sapiens	IC50	uM	300.0
	3299636	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	Nc1nc(Nc2ccc(C(F)(F)F)c(F)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1	Outside typical range	CHEMBL1094808	>	IC50	nM	300000.0	CHEMBL1868	Homo sapiens	IC50	uM	300.0
	3299637	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	CC(C)c1ccc(Nc2nc(N)nc3[nH]c(Cc4ccc(Cl)cc4Cl)cc23)cc1	Outside typical range	CHEMBL1095463	=	IC50	nM	157000.0	CHEMBL1868	Homo sapiens	IC50	uM	157.0
	3299638	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	CC(C)c1ccccc1Nc1nc(N)nc2[nH]c(Cc3ccc(Cl)cc3Cl)cc12	Outside typical range	CHEMBL1095776	=	IC50	nM	163100.0	CHEMBL1868	Homo sapiens	IC50	uM	163.1
	3299639	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150315	=	IC50	nM	14100.0	CHEMBL1868	Homo sapiens	IC50	uM	14.1
	3299683	CHEMBL1112823	Ratio of compound IC50 to CB676475 IC50 for VEGFR1 phosphorylation in human A498 cells	B	Nc1nc(Nc2ccc(Cl)cc2F)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1		CHEMBL1095130	=	Ratio IC50		5.0	CHEMBL1868	Homo sapiens	Ratio IC50		5.0
	3299685	CHEMBL1112823	Ratio of compound IC50 to CB676475 IC50 for VEGFR1 phosphorylation in human A498 cells	B	COc1ccc(OC)c(Cc2cc3c(Nc4cccc(Br)c4)ncnc3[nH]2)c1		CHEMBL1094782	>	Ratio IC50		14.0	CHEMBL1868	Homo sapiens	Ratio IC50		14.0
	3299699	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	Cc1ccccc1Cc1cc2c(Nc3cccc(Br)c3)nc(N)nc2[nH]1		CHEMBL1095464	>	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	uM	50.0
	3299700	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	COc1ccc(OC)c(Cc2cc3c(Nc4cccc(Br)c4)nc(N)nc3[nH]2)c1		CHEMBL1095465	=	IC50	nM	31100.0	CHEMBL1868	Homo sapiens	IC50	uM	31.1
	3299701	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	Cc1ccccc1Cc1cc2c(Nc3cccc(Br)c3)ncnc2[nH]1	Outside typical range	CHEMBL1095466	>	IC50	nM	300000.0	CHEMBL1868	Homo sapiens	IC50	uM	300.0
	3299702	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	COc1ccc(OC)c(Cc2cc3c(Nc4cccc(Br)c4)ncnc3[nH]2)c1	Outside typical range	CHEMBL1094782	>	IC50	nM	300000.0	CHEMBL1868	Homo sapiens	IC50	uM	300.0
	3299703	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	Clc1ccc(Cc2cc3c(Nc4cccc(Br)c4)ncnc3[nH]2)c(Cl)c1	Outside typical range	CHEMBL1094783	=	IC50	nM	150900.0	CHEMBL1868	Homo sapiens	IC50	uM	150.9
	3299704	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	FC(F)(F)c1cccc(Nc2ncnc3[nH]c(Cc4ccc(Cl)cc4Cl)cc23)c1	Outside typical range	CHEMBL1094784	>	IC50	nM	300000.0	CHEMBL1868	Homo sapiens	IC50	uM	300.0
	3299705	CHEMBL1112817	Inhibition of VEGFR1 phosphorylation in human A498 cells after 10 mins by FLISA	B	C#Cc1cccc(Nc2ncnc3[nH]c(Cc4ccc(Cl)cc4Cl)cc23)c1	Outside typical range	CHEMBL1098440	>	IC50	nM	300000.0	CHEMBL1868	Homo sapiens	IC50	uM	300.0
	3301991	CHEMBL1119045	Inhibition of FLT1 at 1 uM	B	Clc1ccc(CN2CCN(c3c(Br)cnc4[nH]c(-c5ccc(CN6CCOCC6)cc5)nc34)CC2)cc1		CHEMBL1083772	=	Inhibition	%	35.0	CHEMBL1868	Homo sapiens	INH	%	35.0
Not Active	3303771	CHEMBL1118041	Inhibition of VEGFR1 phosphorylation in VEGF165-stimulated HUVEC at 100 uM treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082612		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	3303773	CHEMBL1118041	Inhibition of VEGFR1 phosphorylation in VEGF165-stimulated HUVEC at 100 uM treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](C)NC1=O		CHEMBL1082943		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	3303774	CHEMBL1118041	Inhibition of VEGFR1 phosphorylation in VEGF165-stimulated HUVEC at 100 uM treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis	B	C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082942		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	3303775	CHEMBL1118041	Inhibition of VEGFR1 phosphorylation in VEGF165-stimulated HUVEC at 100 uM treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082941		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	3303776	CHEMBL1118041	Inhibition of VEGFR1 phosphorylation in VEGF165-stimulated HUVEC at 100 uM treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082614		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	3303781	CHEMBL1118168	Binding affinity to human recombinant VEGFR1 extracellular domain immobilized in CNBr-activated sepharose at 25 nmol after 5 mins by pull-down assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082945		Activity			CHEMBL1868	Homo sapiens	Activity		
Not Active	3303783	CHEMBL1118170	Binding affinity to human recombinant VEGFR1 domain 2 immobilized in CNBr-activated sepharose at 25 nmol after 5 mins by pull-down assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082945		Activity			CHEMBL1868	Homo sapiens	Activity		
Active	3303784	CHEMBL1118041	Inhibition of VEGFR1 phosphorylation in VEGF165-stimulated HUVEC at 100 uM treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082945		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Active	3303786	CHEMBL1118041	Inhibition of VEGFR1 phosphorylation in VEGF165-stimulated HUVEC at 100 uM treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis	B	CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082946		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Active	3303788	CHEMBL1118041	Inhibition of VEGFR1 phosphorylation in VEGF165-stimulated HUVEC at 100 uM treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082949		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Determined	3303790	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC1=O		CHEMBL1082952		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303791	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC1=O		CHEMBL1082952		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303792	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC1=O		CHEMBL1082951		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303793	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC1=O		CHEMBL1082951		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303794	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC1=O		CHEMBL1082950		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303795	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC1=O		CHEMBL1082950		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303796	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082949		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303797	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082949		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303798	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082948		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303799	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082948		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303800	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082947		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303801	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082947		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303802	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082946		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303803	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082946		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303804	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082944		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303805	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082944		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303806	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082945		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303807	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082945		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303808	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](C)NC1=O		CHEMBL1082943		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303809	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](C)NC1=O		CHEMBL1082943		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303810	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082942		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303811	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082942		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303812	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082941		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303813	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082941		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303814	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082614		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303815	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082614		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303816	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082612		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303817	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082612		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303818	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(N)=O		CHEMBL1082613		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	3303819	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(N)=O		CHEMBL1082613		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Determined	3303820	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(N)=O		CHEMBL1082613		IC50			CHEMBL1868	Homo sapiens	IC50		
	3303821	CHEMBL1118047	Inhibition of VEGFR1 phosphorylation in VEGF165-stimulated HUVEC at 100 uM treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis relative to control	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082940	=	FC		3.0	CHEMBL1868	Homo sapiens	FC		3.0
	3303823	CHEMBL1118171	Binding affinity to human recombinant VEGFR1 extracellular domain immobilized in CNBr-activated sepharose at 25 nmol after 5 mins by pull-down assay relative to control	B	CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082946	=	FC		3.0	CHEMBL1868	Homo sapiens	FC		3.0
	3303825	CHEMBL1118173	Binding affinity to human recombinant VEGFR1 domain 2 immobilized in CNBr-activated sepharose at 25 nmol after 5 mins by pull-down assay relative to control	B	CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082946	=	FC		3.0	CHEMBL1868	Homo sapiens	FC		3.0
	3303826	CHEMBL1118171	Binding affinity to human recombinant VEGFR1 extracellular domain immobilized in CNBr-activated sepharose at 25 nmol after 5 mins by pull-down assay relative to control	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082949	=	FC		3.0	CHEMBL1868	Homo sapiens	FC		3.0
Active	3303828	CHEMBL1118174	Inhibition of VEGFR1 phosphorylation in VEGF165-stimulated HUVEC at 33 uM treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL389147		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Dose-dependent effect	3303829	CHEMBL1118039	Inhibition of VEGFR1 phosphorylation in VEGF165-stimulated HUVEC treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL389147		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Active	3303831	CHEMBL1118041	Inhibition of VEGFR1 phosphorylation in VEGF165-stimulated HUVEC at 100 uM treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL389147		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	3303833	CHEMBL1118045	Inhibition of VEGFR1 phosphorylation in VEGF165-stimulated HUVEC at 3 uM treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL389147		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Active	3303835	CHEMBL1118043	Inhibition of VEGFR1 phosphorylation in VEGF165-stimulated HUVEC at 10 uM treated for 1 hr before VEGF165 challenge measured after 5 mins by Western blot analysis	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL389147		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	3303839	CHEMBL1118173	Binding affinity to human recombinant VEGFR1 domain 2 immobilized in CNBr-activated sepharose at 25 nmol after 5 mins by pull-down assay relative to control	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082949	=	FC		3.0	CHEMBL1868	Homo sapiens	FC		3.0
	3303840	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O	Outside typical range	CHEMBL1086296	=	IC50	nM	101000.0	CHEMBL1868	Homo sapiens	IC50	uM	101.0
	3303841	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O	Outside typical range	CHEMBL1086296	=	IC50	nM	105000.0	CHEMBL1868	Homo sapiens	IC50	uM	105.0
	3303842	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082940	=	IC50	nM	25000.0	CHEMBL1868	Homo sapiens	IC50	uM	25.0
	3303843	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082940	=	IC50	nM	35000.0	CHEMBL1868	Homo sapiens	IC50	uM	35.0
	3303844	CHEMBL1118038	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL389147	=	IC50	nM	23000.0	CHEMBL1868	Homo sapiens	IC50	uM	23.0
	3303845	CHEMBL1118036	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL389147	=	IC50	nM	32000.0	CHEMBL1868	Homo sapiens	IC50	uM	32.0
	3303846	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC1=O		CHEMBL1082952	=	Inhibition	%	6.0	CHEMBL1868	Homo sapiens	INH	%	6.0
	3303847	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC1=O		CHEMBL1082951	=	Inhibition	%	1.0	CHEMBL1868	Homo sapiens	INH	%	1.0
	3303848	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC1=O		CHEMBL1082952	=	Inhibition	%	14.0	CHEMBL1868	Homo sapiens	INH	%	14.0
	3303849	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC1=O		CHEMBL1082951	=	Inhibition	%	24.0	CHEMBL1868	Homo sapiens	INH	%	24.0
	3303850	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC1=O		CHEMBL1082950	=	Inhibition	%	3.0	CHEMBL1868	Homo sapiens	INH	%	3.0
	3303851	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC1=O		CHEMBL1082950	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	3303852	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082949	=	Inhibition	%	47.0	CHEMBL1868	Homo sapiens	INH	%	47.0
	3303853	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082949	=	Inhibition	%	45.0	CHEMBL1868	Homo sapiens	INH	%	45.0
	3303854	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082948	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	3303855	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082948	=	Inhibition	%	3.0	CHEMBL1868	Homo sapiens	INH	%	3.0
	3303856	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082947	=	Inhibition	%	3.0	CHEMBL1868	Homo sapiens	INH	%	3.0
	3303857	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082947	=	Inhibition	%	7.0	CHEMBL1868	Homo sapiens	INH	%	7.0
	3303858	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082946	=	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	3303859	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082946	=	Inhibition	%	41.0	CHEMBL1868	Homo sapiens	INH	%	41.0
	3303860	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082944	=	Inhibition	%	5.0	CHEMBL1868	Homo sapiens	INH	%	5.0
	3303861	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082944	=	Inhibition	%	10.0	CHEMBL1868	Homo sapiens	INH	%	10.0
	3303862	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082945	=	Inhibition	%	45.0	CHEMBL1868	Homo sapiens	INH	%	45.0
	3303863	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082945	=	Inhibition	%	42.0	CHEMBL1868	Homo sapiens	INH	%	42.0
	3303864	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](C)NC1=O		CHEMBL1082943	=	Inhibition	%	3.0	CHEMBL1868	Homo sapiens	INH	%	3.0
	3303865	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](C)NC1=O		CHEMBL1082943	=	Inhibition	%	3.0	CHEMBL1868	Homo sapiens	INH	%	3.0
	3303866	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082942	=	Inhibition	%	9.0	CHEMBL1868	Homo sapiens	INH	%	9.0
	3303867	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082942	=	Inhibition	%	9.0	CHEMBL1868	Homo sapiens	INH	%	9.0
	3303868	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1086296	=	Inhibition	%	46.0	CHEMBL1868	Homo sapiens	INH	%	46.0
	3303869	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1086296	=	Inhibition	%	49.0	CHEMBL1868	Homo sapiens	INH	%	49.0
	3303870	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082941	=	Inhibition	%	1.0	CHEMBL1868	Homo sapiens	INH	%	1.0
	3303871	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082941	=	Inhibition	%	1.0	CHEMBL1868	Homo sapiens	INH	%	1.0
	3303872	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082940	=	Inhibition	%	77.0	CHEMBL1868	Homo sapiens	INH	%	77.0
	3303873	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082940	=	Inhibition	%	63.0	CHEMBL1868	Homo sapiens	INH	%	63.0
	3303874	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082614	=	Inhibition	%	3.0	CHEMBL1868	Homo sapiens	INH	%	3.0
	3303875	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082614	=	Inhibition	%	4.0	CHEMBL1868	Homo sapiens	INH	%	4.0
	3303876	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082612	=	Inhibition	%	4.0	CHEMBL1868	Homo sapiens	INH	%	4.0
	3303877	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082612	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	3303878	CHEMBL1118037	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 3 at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL389147	=	Inhibition	%	84.0	CHEMBL1868	Homo sapiens	INH	%	84.0
	3303879	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(N)=O		CHEMBL1082613	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	3303880	CHEMBL1118035	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domain at 100 uM by competitive binding assay	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL389147	=	Inhibition	%	73.0	CHEMBL1868	Homo sapiens	INH	%	73.0
	3308385	CHEMBL1119652	Inhibition of VEGFR1 at 3 uM	B	CCCCn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1082829	=	IC50	nM	28.0	CHEMBL1868	Homo sapiens	IC50	nM	28.0
	3308386	CHEMBL1119652	Inhibition of VEGFR1 at 3 uM	B	CC(C)Cn1c2ccc(C3CCCCO3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL1084337	=	IC50	nM	16.0	CHEMBL1868	Homo sapiens	IC50	nM	16.0
	3329241	CHEMBL1166748	Inhibition of VEGFR1	B	Cc1cccc(-c2[nH]c(Cc3cccc(C(N)=O)c3)nc2-c2ccc3ncccc3c2)n1		CHEMBL1164957	=	IC50	nM	2100.0	CHEMBL1868	Homo sapiens	IC50	uM	2.1
	3331947	CHEMBL1169237	Inhibition of FLT1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	3333362	CHEMBL1169237	Inhibition of FLT1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	3334767	CHEMBL1169237	Inhibition of FLT1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	3336187	CHEMBL1169237	Inhibition of FLT1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	3337534	CHEMBL1169237	Inhibition of FLT1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	3337784	CHEMBL1169237	Inhibition of FLT1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	3339118	CHEMBL1169237	Inhibition of FLT1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	3340420	CHEMBL1169237	Inhibition of FLT1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	3340715	CHEMBL1169237	Inhibition of FLT1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	3342131	CHEMBL1169237	Inhibition of FLT1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	3358582	CHEMBL1174427	Inhibition of FLT1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	0.5	CHEMBL1868	Homo sapiens	INH	%	0.5
	3359024	CHEMBL1174427	Inhibition of FLT1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.8	CHEMBL1868	Homo sapiens	INH	%	0.8
	3359785	CHEMBL1177362	Inhibition VEGFR1 at 10 uM	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	3359786	CHEMBL1177361	Inhibition VEGFR1	B	NS(=O)(=O)c1ccc(Nc2nc(N3CCOCC3)nc3[nH]cnc23)cc1		CHEMBL1172957	=	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	3368329	CHEMBL1176563	Inhibition of FLT1 at 1 M	B	Cc1c[nH]c2ncnc(N3CC[C@@H](N)C3)c12		CHEMBL1173273	=	Inhibition	%	10.0	CHEMBL1868	Homo sapiens	INH	%	10.0
	3368330	CHEMBL1176563	Inhibition of FLT1 at 1 M	B	N#Cc1c[nH]c2ncnc(N3CC4(CCNCC4)c4ccccc43)c12		CHEMBL258837	=	Inhibition	%	70.0	CHEMBL1868	Homo sapiens	INH	%	70.0
	3441495	CHEMBL1244078	Inhibition of human VEGFR1	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	34.0	CHEMBL1868	Homo sapiens	IC50	nmol/L	34.0
	3443402	CHEMBL1244435	Inhibition of FLT1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	83.0	CHEMBL1868	Homo sapiens	INH	%	83.0
	3443619	CHEMBL1244435	Inhibition of FLT1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	75.0	CHEMBL1868	Homo sapiens	INH	%	75.0
	3444774	CHEMBL1244435	Inhibition of FLT1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	17.0	CHEMBL1868	Homo sapiens	INH	%	17.0
	3444980	CHEMBL1244844	Binding affinity to FLT1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	41.0	CHEMBL1868	Homo sapiens	Kd	nM	41.0
	3445122	CHEMBL1244844	Binding affinity to FLT1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	120.0	CHEMBL1868	Homo sapiens	Kd	nM	120.0
	3445398	CHEMBL1244435	Inhibition of FLT1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	3445615	CHEMBL1244435	Inhibition of FLT1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	15.0	CHEMBL1868	Homo sapiens	INH	%	15.0
	3445823	CHEMBL1244435	Inhibition of FLT1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	68.0	CHEMBL1868	Homo sapiens	INH	%	68.0
	3446013	CHEMBL1244435	Inhibition of FLT1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	13.0	CHEMBL1868	Homo sapiens	INH	%	13.0
	3447167	CHEMBL1249723	Inhibition of VEGFR-1 kinase	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	IC50	nM	130.0	CHEMBL1868	Homo sapiens	IC50	uM	0.13
	3448009	CHEMBL1249716	Inhibition of human Flt-1 activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	12.0	CHEMBL1868	Homo sapiens	INH	%	12.0
	3448085	CHEMBL1249716	Inhibition of human Flt-1 activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	3448850	CHEMBL1244844	Binding affinity to FLT1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	3100.0	CHEMBL1868	Homo sapiens	Kd	nM	3100.0
	3448930	CHEMBL1244844	Binding affinity to FLT1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	450.0	CHEMBL1868	Homo sapiens	Kd	nM	450.0
	3449177	CHEMBL1244844	Binding affinity to FLT1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1.8	CHEMBL1868	Homo sapiens	Kd	nM	1.8
	3449178	CHEMBL1244844	Binding affinity to FLT1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	31.0	CHEMBL1868	Homo sapiens	Kd	nM	31.0
	3451007	CHEMBL1244844	Binding affinity to FLT1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	uM	10.0
	3463235	CHEMBL1252423	Inhibition of FLT1 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	-2.0	CHEMBL1868	Homo sapiens	INH	%	-2.0
	3463454	CHEMBL1252423	Inhibition of FLT1 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	20.0	CHEMBL1868	Homo sapiens	INH	%	20.0
	3463998	CHEMBL1252423	Inhibition of FLT1 at 1 uM in presence of 100 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	52.0	CHEMBL1868	Homo sapiens	INH	%	52.0
	3471603	CHEMBL1250644	Inhibition of VEGFR1	B	Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c21		CHEMBL1254007	=	IC50	nM	15.0	CHEMBL1868	Homo sapiens	IC50	nM	15.0
	3526789	CHEMBL1272381	Inhibition of FLT1 by Hot Spot filtration binding assay	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	IC50	nM	11.0	CHEMBL1868	Homo sapiens	IC50	uM	0.011
	3526797	CHEMBL1272381	Inhibition of FLT1 by Hot Spot filtration binding assay	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)ccn1		CHEMBL324153	=	IC50	nM	210.0	CHEMBL1868	Homo sapiens	IC50	uM	0.21
	3526805	CHEMBL1272381	Inhibition of FLT1 by Hot Spot filtration binding assay	B	O=c1ccc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)c[nH]1		CHEMBL1271480	=	IC50	nM	470.0	CHEMBL1868	Homo sapiens	IC50	uM	0.47
	3526813	CHEMBL1272381	Inhibition of FLT1 by Hot Spot filtration binding assay	B	c1cc(-c2cnc3c(-c4cn[nH]c4)cnn3c2)ccc1OCCN1CCOCC1		CHEMBL1271532	=	IC50	nM	4.0	CHEMBL1868	Homo sapiens	IC50	uM	0.004
	3526821	CHEMBL1272381	Inhibition of FLT1 by Hot Spot filtration binding assay	B	Nc1cc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)ccn1		CHEMBL1271533	=	IC50	nM	40.0	CHEMBL1868	Homo sapiens	IC50	uM	0.04
	3526829	CHEMBL1272381	Inhibition of FLT1 by Hot Spot filtration binding assay	B	Oc1ccc(-c2cnn3cc(-c4ccc(OCCN5CCOCC5)cc4)cnc23)cc1O		CHEMBL1271641	=	IC50	nM	2.0	CHEMBL1868	Homo sapiens	IC50	uM	0.002
	3526837	CHEMBL1272381	Inhibition of FLT1 by Hot Spot filtration binding assay	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccc(O)c(O)c3)o2)cc1		CHEMBL1271642	=	IC50	nM	74.0	CHEMBL1868	Homo sapiens	IC50	uM	0.074
	3526845	CHEMBL1272381	Inhibition of FLT1 by Hot Spot filtration binding assay	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccc(=O)[nH]c3)o2)cc1		CHEMBL1271692	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	3556525	CHEMBL1285585	Inhibition of FLT1 at 1 uM	B	CN1C[C@@H]2C[C@H]1CN2c1cc(F)c(-c2ccnc3c(-c4cccc5[nH]ncc45)c(-c4ccncc4)nn23)c(F)c1		CHEMBL1276179	=	Inhibition	%	14.0	CHEMBL1868	Homo sapiens	INH	%	14.0
	5120385	CHEMBL1645969	Inhibition of human Flt1 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	107.0	CHEMBL1868	Homo sapiens	INH	%	107.0
	5203003	CHEMBL1670771	Inhibition of human recombinant VEGFR1 expressed in Sf9 cells after 10 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)C[C@H](Br)C[C@H](C)OC2=O		CHEMBL1668415	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	5203008	CHEMBL1670771	Inhibition of human recombinant VEGFR1 expressed in Sf9 cells after 10 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1651523	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	5203009	CHEMBL1670771	Inhibition of human recombinant VEGFR1 expressed in Sf9 cells after 10 mins	B	COc1cc(O)c2c(c1)/C=C/C[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1668411	=	IC50	nM	12.0	CHEMBL1868	Homo sapiens	IC50	uM	0.012
	5203012	CHEMBL1670771	Inhibition of human recombinant VEGFR1 expressed in Sf9 cells after 10 mins	B	COc1cc(O)c2c(c1)/C=C\CCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668420	=	IC50	nM	15000.0	CHEMBL1868	Homo sapiens	IC50	uM	15.0
	5203016	CHEMBL1670771	Inhibition of human recombinant VEGFR1 expressed in Sf9 cells after 10 mins	B	COc1cc(O)c2c(c1)CCCCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668419	=	IC50	nM	33000.0	CHEMBL1868	Homo sapiens	IC50	uM	33.0
	5203019	CHEMBL1670771	Inhibition of human recombinant VEGFR1 expressed in Sf9 cells after 10 mins	B	COc1cc(O)c2c(c1)/C=C/CCCC(=O)/C=C/C[C@H](C)OC2=O		CHEMBL1668418	=	IC50	nM	51000.0	CHEMBL1868	Homo sapiens	IC50	uM	51.0
Not Determined	5247544	CHEMBL1686893	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 7 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CC=CC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684374		IC50			CHEMBL1868	Homo sapiens	IC50		
	5247545	CHEMBL1686893	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 7 after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC=C)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684373	=	IC50	nM	42300.0	CHEMBL1868	Homo sapiens	IC50	uM	42.3
	5247546	CHEMBL1686893	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 7 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O	Outside typical range	CHEMBL1684372	=	IC50	nM	105500.0	CHEMBL1868	Homo sapiens	IC50	uM	105.5
Not Determined	5247547	CHEMBL1686893	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 7 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1C/C=C/C[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684371		IC50			CHEMBL1868	Homo sapiens	IC50		
	5247548	CHEMBL1686893	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 7 after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC=C)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684370	=	IC50	nM	90300.0	CHEMBL1868	Homo sapiens	IC50	uM	90.3
Not Determined	5247549	CHEMBL1686893	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 7 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684369		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	5247550	CHEMBL1686893	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 7 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1C/C=C\C[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684368		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	5247551	CHEMBL1686893	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 7 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1C/C=C/C[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684367		IC50			CHEMBL1868	Homo sapiens	IC50		
	5247552	CHEMBL1686893	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 7 after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC=C)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684366	=	IC50	nM	61200.0	CHEMBL1868	Homo sapiens	IC50	uM	61.2
	5247553	CHEMBL1686893	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 7 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(N)=O	Outside typical range	CHEMBL1684365	=	IC50	nM	102700.0	CHEMBL1868	Homo sapiens	IC50	uM	102.7
	5247554	CHEMBL1686892	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domian at 100 uM after 3 hrs by chemiluminescent competition assay	B	CCC[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684379	=	Inhibition	%	4.7	CHEMBL1868	Homo sapiens	INH	%	4.7
	5247555	CHEMBL1686892	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domian at 100 uM after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC=C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684378	=	Inhibition	%	2.2	CHEMBL1868	Homo sapiens	INH	%	2.2
	5247556	CHEMBL1686892	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domian at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(C)=O)CCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC1=O		CHEMBL1684377	=	Inhibition	%	8.8	CHEMBL1868	Homo sapiens	INH	%	8.8
	5247557	CHEMBL1686892	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domian at 100 uM after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC=C)NC(C)=O)[C@@H](C)CC)C(N)=O		CHEMBL1684376	=	Inhibition	%	54.2	CHEMBL1868	Homo sapiens	INH	%	54.2
	5247558	CHEMBL1686892	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domian at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684375	=	Inhibition	%	23.6	CHEMBL1868	Homo sapiens	INH	%	23.6
	5247559	CHEMBL1686892	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domian at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CC=CC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684374	=	Inhibition	%	33.6	CHEMBL1868	Homo sapiens	INH	%	33.6
	5247560	CHEMBL1686892	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domian at 100 uM after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC=C)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684373	=	Inhibition	%	71.8	CHEMBL1868	Homo sapiens	INH	%	71.8
	5247561	CHEMBL1686892	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domian at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684372	=	Inhibition	%	44.3	CHEMBL1868	Homo sapiens	INH	%	44.3
	5247562	CHEMBL1686892	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domian at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1C/C=C/C[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684371	=	Inhibition	%	32.0	CHEMBL1868	Homo sapiens	INH	%	32.0
	5247563	CHEMBL1686892	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domian at 100 uM after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC=C)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684370	=	Inhibition	%	47.4	CHEMBL1868	Homo sapiens	INH	%	47.4
	5247564	CHEMBL1686892	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domian at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684369	=	Inhibition	%	10.9	CHEMBL1868	Homo sapiens	INH	%	10.9
	5247565	CHEMBL1686892	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domian at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1C/C=C\C[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684368	=	Inhibition	%	24.0	CHEMBL1868	Homo sapiens	INH	%	24.0
	5247566	CHEMBL1686892	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domian at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1C/C=C/C[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684367	=	Inhibition	%	23.0	CHEMBL1868	Homo sapiens	INH	%	23.0
	5247567	CHEMBL1686892	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domian at 100 uM after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC=C)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684366	=	Inhibition	%	66.0	CHEMBL1868	Homo sapiens	INH	%	66.0
	5247568	CHEMBL1686892	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 extracellular domian at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(N)=O		CHEMBL1684365	=	Inhibition	%	45.1	CHEMBL1868	Homo sapiens	INH	%	45.1
	5247569	CHEMBL1686891	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 7 at 100 uM after 3 hrs by chemiluminescent competition assay	B	CCC[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684379	=	Inhibition	%	4.7	CHEMBL1868	Homo sapiens	INH	%	4.7
	5247570	CHEMBL1686891	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 7 at 100 uM after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC=C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684378	=	Inhibition	%	2.2	CHEMBL1868	Homo sapiens	INH	%	2.2
	5247571	CHEMBL1686891	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 7 at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(C)=O)CCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC1=O		CHEMBL1684377	=	Inhibition	%	8.8	CHEMBL1868	Homo sapiens	INH	%	8.8
	5247572	CHEMBL1686891	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 7 at 100 uM after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC=C)NC(C)=O)[C@@H](C)CC)C(N)=O		CHEMBL1684376	=	Inhibition	%	54.2	CHEMBL1868	Homo sapiens	INH	%	54.2
	5247573	CHEMBL1686891	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 7 at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684375	=	Inhibition	%	23.6	CHEMBL1868	Homo sapiens	INH	%	23.6
	5247574	CHEMBL1686891	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 7 at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CC=CC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684374	=	Inhibition	%	33.6	CHEMBL1868	Homo sapiens	INH	%	33.6
	5247575	CHEMBL1686891	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 7 at 100 uM after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC=C)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684373	=	Inhibition	%	71.8	CHEMBL1868	Homo sapiens	INH	%	71.8
	5247576	CHEMBL1686891	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 7 at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684372	=	Inhibition	%	44.3	CHEMBL1868	Homo sapiens	INH	%	44.3
	5247577	CHEMBL1686891	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 7 at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1C/C=C/C[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684371	=	Inhibition	%	32.0	CHEMBL1868	Homo sapiens	INH	%	32.0
	5247578	CHEMBL1686891	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 7 at 100 uM after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC=C)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684370	=	Inhibition	%	47.4	CHEMBL1868	Homo sapiens	INH	%	47.4
	5247579	CHEMBL1686891	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 7 at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684369	=	Inhibition	%	10.9	CHEMBL1868	Homo sapiens	INH	%	10.9
	5247580	CHEMBL1686891	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 7 at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1C/C=C\C[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684368	=	Inhibition	%	24.0	CHEMBL1868	Homo sapiens	INH	%	24.0
	5247581	CHEMBL1686891	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 7 at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1C/C=C/C[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684367	=	Inhibition	%	23.0	CHEMBL1868	Homo sapiens	INH	%	23.0
	5247582	CHEMBL1686891	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 7 at 100 uM after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC=C)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684366	=	Inhibition	%	66.0	CHEMBL1868	Homo sapiens	INH	%	66.0
	5247583	CHEMBL1686891	Inhibition of biotinylated VEGF165 binding to human recombinant VEGFR1 domain 1 to 7 at 100 uM after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(N)=O		CHEMBL1684365	=	Inhibition	%	45.1	CHEMBL1868	Homo sapiens	INH	%	45.1
Not Determined	5247584	CHEMBL1686893	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 7 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684375		IC50			CHEMBL1868	Homo sapiens	IC50		
	5247585	CHEMBL1686893	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 7 after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC=C)NC(C)=O)[C@@H](C)CC)C(N)=O		CHEMBL1684376	=	IC50	nM	98800.0	CHEMBL1868	Homo sapiens	IC50	uM	98.8
Not Determined	5247586	CHEMBL1686893	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 7 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(C)=O)CCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC1=O		CHEMBL1684377		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	5247587	CHEMBL1686893	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 7 after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC=C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684378		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	5247588	CHEMBL1686893	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 7 after 3 hrs by chemiluminescent competition assay	B	CCC[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684379		IC50			CHEMBL1868	Homo sapiens	IC50		
	5247589	CHEMBL1686958	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 3 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(N)=O	Outside typical range	CHEMBL1684365	=	IC50	nM	160000.0	CHEMBL1868	Homo sapiens	IC50	uM	160.0
	5247590	CHEMBL1686958	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 3 after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC=C)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684366	=	IC50	nM	61800.0	CHEMBL1868	Homo sapiens	IC50	uM	61.8
Not Determined	5247591	CHEMBL1686958	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 3 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1C/C=C/C[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684367		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	5247592	CHEMBL1686958	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 3 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1C/C=C\C[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684368		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	5247593	CHEMBL1686958	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 3 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684369		IC50			CHEMBL1868	Homo sapiens	IC50		
	5247594	CHEMBL1686958	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 3 after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC=C)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(=O)N[C@H](C(N)=O)[C@@H](C)CC	Outside typical range	CHEMBL1684370	=	IC50	nM	109500.0	CHEMBL1868	Homo sapiens	IC50	uM	109.5
Not Determined	5247595	CHEMBL1686958	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 3 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1C/C=C/C[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684371		IC50			CHEMBL1868	Homo sapiens	IC50		
	5247596	CHEMBL1686958	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 3 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684372	=	IC50	nM	91600.0	CHEMBL1868	Homo sapiens	IC50	uM	91.6
	5247597	CHEMBL1686958	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 3 after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC=C)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684373	=	IC50	nM	36500.0	CHEMBL1868	Homo sapiens	IC50	uM	36.5
Not Determined	5247598	CHEMBL1686958	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 3 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CC=CC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684374		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	5247599	CHEMBL1686958	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 3 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CCCC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL1684375		IC50			CHEMBL1868	Homo sapiens	IC50		
	5247600	CHEMBL1686958	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 3 after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC=C)NC(C)=O)[C@@H](C)CC)C(N)=O		CHEMBL1684376	=	IC50	nM	76800.0	CHEMBL1868	Homo sapiens	IC50	uM	76.8
Not Determined	5247601	CHEMBL1686958	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 3 after 3 hrs by chemiluminescent competition assay	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(C)=O)CCCC[C@@H](C(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC1=O		CHEMBL1684377		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	5247602	CHEMBL1686958	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 3 after 3 hrs by chemiluminescent competition assay	B	C=CC[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CC=C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684378		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Determined	5247603	CHEMBL1686958	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 domain 1 to 3 after 3 hrs by chemiluminescent competition assay	B	CCC[C@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](C(N)=O)[C@@H](C)CC		CHEMBL1684379		IC50			CHEMBL1868	Homo sapiens	IC50		
	5248422	CHEMBL1686635	Inhibition of FLT1	B	CCNC(=O)Nc1ccc(Oc2ncnc(N)c2/C=N/OC)cc1Cl		CHEMBL1681932	=	IC50	nM	4420.0	CHEMBL1868	Homo sapiens	IC50	nM	4420.0
	6167565	CHEMBL1769038	Binding affinity to human Flt1 assessed as residual binding at 1 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CNC(=O)CCl)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1765717	=	Activity	%	86.0	CHEMBL1868	Homo sapiens	Activity	%	86.0
	6167581	CHEMBL1769055	Binding affinity to human Flt1 assessed as residual binding at 10 uM by site dependent competitive binding assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	78.0	CHEMBL1868	Homo sapiens	Activity	%	78.0
	6171338	CHEMBL1768687	Inhibition of Flt-1	B	CC(=O)N1CCN(c2cnc3cc(C(F)(F)F)cc(NCc4cccc([N+](=O)[O-])c4)c3c2)CC1		CHEMBL1766529	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	nM	10000.0
	6193888	CHEMBL1777646	Inhibition of Flt1 at 10 uM by ELISA based method	B	Cc1c(N)ccc2[nH]c(-c3ccc(N)cc3)nc12		CHEMBL529177	=	Inhibition	%	12.5	CHEMBL1868	Homo sapiens	INH	%	12.5
	6193898	CHEMBL1777646	Inhibition of Flt1 at 10 uM by ELISA based method	B	Oc1ccc(NCn2nnc3ccccc32)cc1		CHEMBL1775067	=	Inhibition	%	2.4	CHEMBL1868	Homo sapiens	INH	%	2.4
	6193909	CHEMBL1777646	Inhibition of Flt1 at 10 uM by ELISA based method	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Inhibition	%	73.2	CHEMBL1868	Homo sapiens	INH	%	73.2
	6212362	CHEMBL1786061	Inhibition of VEGFR1 using poly(Glu-Tyr)4:1 as substrate measured after 60 mins by ELISA	B	CCOC(=O)C1=C2C(=NC1=O)c1cccc3cccc2c13		CHEMBL1784725	=	IC50	nM	3200.0	CHEMBL1868	Homo sapiens	IC50	uM	3.2
	6219896	CHEMBL1785584	Inhibition of human VEGFR1 using poly[Glu:Tyr] by Hotspot assay	B	CNC(=O)c1ncc(C#Cc2cc(C(=O)Nc3ccc(CN4CCN(CCO)CC4)c(C(F)(F)F)c3)ccc2C)n1C		CHEMBL1784637	=	IC50	nM	5.2	CHEMBL1868	Homo sapiens	IC50	nM	5.2
	6267499	CHEMBL1799022	Inhibition of FLT1 at 10 uM	B	O=c1c(Cl)c(OCc2ccc(F)cc2F)cc(CO)n1-c1c(F)cccc1F		CHEMBL1797211	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	6267500	CHEMBL1799022	Inhibition of FLT1 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(C(N)=O)c1		CHEMBL1797224	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	6281538	CHEMBL1804191	Inhibition of human Flt1	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
	6286546	CHEMBL1810166	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells at 1 uM after 120 mins by Kinase-Glo assay	B	O=C(Nc1cc(-c2cccc(NS(=O)(=O)c3ccccc3)c2)n[nH]1)c1ccc(CN2CCOCC2)cc1		CHEMBL1807480	=	Inhibition	%	52.0	CHEMBL1868	Homo sapiens	INH	%	52.0
	6302193	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	18.0	CHEMBL1868	Homo sapiens	IC50	uM	0.018
	6302194	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	37.0	CHEMBL1868	Homo sapiens	IC50	uM	0.037
	6302195	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4cccc(NS(=O)(=O)c5ccccc5)c4)n[nH]3)cc2)CC1		CHEMBL1807392	=	IC50	nM	210.0	CHEMBL1868	Homo sapiens	IC50	uM	0.21
	6302196	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4cccc(NS(=O)(=O)c5cccc(Cl)c5)c4)n[nH]3)cc2)CC1		CHEMBL1807467	=	IC50	nM	40.0	CHEMBL1868	Homo sapiens	IC50	uM	0.04
	6302197	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4cccc(NS(=O)(=O)c5ccc(Cl)cc5)c4)n[nH]3)cc2)CC1		CHEMBL1807468	=	IC50	nM	570.0	CHEMBL1868	Homo sapiens	IC50	uM	0.57
	6302198	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	Cc1cccc(S(=O)(=O)Nc2cccc(-c3cc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)[nH]n3)c2)c1		CHEMBL1807469	=	IC50	nM	140.0	CHEMBL1868	Homo sapiens	IC50	uM	0.14
	6302199	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	Cc1ccc(S(=O)(=O)Nc2cccc(-c3cc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)[nH]n3)c2)cc1		CHEMBL1807470	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	6302200	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	COc1ccc(S(=O)(=O)Nc2cccc(-c3cc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)[nH]n3)c2)cc1		CHEMBL1807471	=	IC50	nM	420.0	CHEMBL1868	Homo sapiens	IC50	uM	0.42
	6302201	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	CCS(=O)(=O)Nc1cccc(-c2cc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)[nH]n2)c1		CHEMBL1807472	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	6302202	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	CCCS(=O)(=O)Nc1cccc(-c2cc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)[nH]n2)c1		CHEMBL1807473	=	IC50	nM	2610.0	CHEMBL1868	Homo sapiens	IC50	uM	2.61
	6302203	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	CC(C)S(=O)(=O)Nc1cccc(-c2cc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)[nH]n2)c1		CHEMBL1807474	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	6302204	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	CN1CCN(c2cccc(C(=O)Nc3cc(-c4cccc(NS(=O)(=O)c5ccccc5)c4)n[nH]3)c2)CC1		CHEMBL1807475	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	6302205	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	O=C(Nc1cc(-c2cccc(NS(=O)(=O)c3ccccc3)c2)n[nH]1)c1cccc(N2CCOCC2)c1		CHEMBL1807476	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	6302206	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	O=C(Nc1cc(-c2cccc(NS(=O)(=O)c3ccccc3)c2)n[nH]1)c1ccc(N2CCOCC2)cc1		CHEMBL1807477	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	6302207	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	O=C(Nc1cc(-c2cccc(NS(=O)(=O)c3ccccc3)c2)n[nH]1)c1ccc(OCCN2CCCC2)cc1		CHEMBL1807478	=	IC50	nM	270.0	CHEMBL1868	Homo sapiens	IC50	uM	0.27
	6302208	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	O=C(Nc1cc(-c2cccc(NS(=O)(=O)c3ccccc3)c2)n[nH]1)c1ccc(OCCN2CCOCC2)cc1		CHEMBL1807479	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	6302209	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	Cc1nc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL1807483	=	IC50	nM	310.0	CHEMBL1868	Homo sapiens	IC50	uM	0.31
	6302210	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	Cc1cccc(S(=O)(=O)Nc2cccc(-c3cc(Nc4cc(N5CCN(C)CC5)nc(C)n4)[nH]n3)c2)c1	Outside typical range	CHEMBL1807484	>	IC50	nM	1000000.0	CHEMBL1868	Homo sapiens	IC50	uM	1000.0
	6302211	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	CCCCS(=O)(=O)Nc1cccc(-c2cc(Nc3cc(N4CCN(C)CC4)nc(C)n3)[nH]n2)c1	Outside typical range	CHEMBL1807485	>	IC50	nM	1000000.0	CHEMBL1868	Homo sapiens	IC50	uM	1000.0
	6302212	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	Cc1nc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)cc(N2CCC(O)CC2)n1	Outside typical range	CHEMBL1807785	>	IC50	nM	1000000.0	CHEMBL1868	Homo sapiens	IC50	uM	1000.0
	6302213	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	Cc1nc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)cc(N2CCN(CCO)CC2)n1	Outside typical range	CHEMBL1807786	>	IC50	nM	1000000.0	CHEMBL1868	Homo sapiens	IC50	uM	1000.0
	6302214	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	Cc1nc(NCCN(C)C)cc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)n1	Outside typical range	CHEMBL1807787	>	IC50	nM	1000000.0	CHEMBL1868	Homo sapiens	IC50	uM	1000.0
	6302215	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	Cc1nc(NCCN2CCOCC2)cc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)n1	Outside typical range	CHEMBL1807788	>	IC50	nM	1000000.0	CHEMBL1868	Homo sapiens	IC50	uM	1000.0
	6302216	CHEMBL1810162	Inhibition of recombinant GST-tagged VEGFR1 expressed in Sf9 insect cells after 120 mins by Kinase-Glo assay	B	Cc1nc(NCCCN2CCOCC2)cc(Nc2cc(-c3cccc(NS(=O)(=O)c4ccccc4)c3)n[nH]2)n1	Outside typical range	CHEMBL1807789	>	IC50	nM	1000000.0	CHEMBL1868	Homo sapiens	IC50	uM	1000.0
	6304896	CHEMBL1816287	Inhibition of FLT1	B	O=C(Nc1ccc(Oc2ncnc3scc(-c4ccccc4)c23)c(F)c1)c1cccn(-c2ccc(F)cc2)c1=O		CHEMBL1813632	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	nM	10000.0
Not Active	6315883	CHEMBL1817208	Inhibition of VEGFR-1 at 50 uM after 1 hrs by luminescence assay	B	Cn1cccc1-c1nc2cc(NC(=O)CCl)ccc2[nH]1		CHEMBL1812491		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	6315884	CHEMBL1817208	Inhibition of VEGFR-1 at 50 uM after 1 hrs by luminescence assay	B	Cc1ccc(-c2nc3cc(NC(=O)CCl)ccc3[nH]2)cc1		CHEMBL1812374	=	Inhibition	%	7.3	CHEMBL1868	Homo sapiens	INH	%	7.3
	6315885	CHEMBL1817208	Inhibition of VEGFR-1 at 50 uM after 1 hrs by luminescence assay	B	Cc1ccc(-c2nc3cc(NC(=O)CCCl)ccc3[nH]2)cc1		CHEMBL1812379	=	Inhibition	%	3.3	CHEMBL1868	Homo sapiens	INH	%	3.3
	6315886	CHEMBL1817208	Inhibition of VEGFR-1 at 50 uM after 1 hrs by luminescence assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	93.4	CHEMBL1868	Homo sapiens	INH	%	93.4
	6341063	CHEMBL1828232	Activity of FLT1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL1868	Homo sapiens	Activity	%	100.0
	6386450	CHEMBL1837858	Inhibition of VEGFR1 juxtamembrane domain-mediated proliferation of mouse BAF3 cells transformed with TEL-Kinase construct	B	CCN1CCN(c2ccc(Nc3cc(N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)ncn3)cc2)CC1.O=P(O)(O)O		CHEMBL1834657	=	IC50	nM	1510.0	CHEMBL1868	Homo sapiens	IC50	nM	1510.0
	7567248	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Kd	nM	0.74	CHEMBL1868	Homo sapiens	Kd	nM	0.74
	7567707	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7568178	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7568636	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	4.7	CHEMBL1868	Homo sapiens	Kd	nM	4.7
	7569221	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7569681	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	=	Kd	nM	2300.0	CHEMBL1868	Homo sapiens	Kd	nM	2300.0
	7570174	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7570601	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	1.8	CHEMBL1868	Homo sapiens	Kd	nM	1.8
	7571197	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7571654	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	5000.0	CHEMBL1868	Homo sapiens	Kd	nM	5000.0
	7571688	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7572151	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7572567	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	550.0	CHEMBL1868	Homo sapiens	Kd	nM	550.0
	7573178	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	63.0	CHEMBL1868	Homo sapiens	Kd	nM	63.0
	7573669	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	53.0	CHEMBL1868	Homo sapiens	Kd	nM	53.0
	7574138	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	450.0	CHEMBL1868	Homo sapiens	Kd	nM	450.0
	7574546	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7575175	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Kd	nM	4400.0	CHEMBL1868	Homo sapiens	Kd	nM	4400.0
	7575646	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	=	Kd	nM	130.0	CHEMBL1868	Homo sapiens	Kd	nM	130.0
	7576111	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	=	Kd	nM	1900.0	CHEMBL1868	Homo sapiens	Kd	nM	1900.0
	7576519	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	4300.0	CHEMBL1868	Homo sapiens	Kd	nM	4300.0
	7576688	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7577147	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	3.8	CHEMBL1868	Homo sapiens	Kd	nM	3.8
	7577625	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	73.0	CHEMBL1868	Homo sapiens	Kd	nM	73.0
	7578095	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	1200.0	CHEMBL1868	Homo sapiens	Kd	nM	1200.0
	7578500	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	260.0	CHEMBL1868	Homo sapiens	Kd	nM	260.0
	7578696	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7579070	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Kd	nM	410.0	CHEMBL1868	Homo sapiens	Kd	nM	410.0
	7579520	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7579994	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7580463	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Kd	nM	9.6	CHEMBL1868	Homo sapiens	Kd	nM	9.6
	7580866	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	100.0	CHEMBL1868	Homo sapiens	Kd	nM	100.0
	7581054	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7581439	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7581884	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7582355	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7582819	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	16.0	CHEMBL1868	Homo sapiens	Kd	nM	16.0
	7583400	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Kd	nM	7.5	CHEMBL1868	Homo sapiens	Kd	nM	7.5
	7583797	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	=	Kd	nM	9900.0	CHEMBL1868	Homo sapiens	Kd	nM	9900.0
	7584242	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7584713	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7585137	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7585730	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	41.0	CHEMBL1868	Homo sapiens	Kd	nM	41.0
	7586138	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	=	Kd	nM	10.0	CHEMBL1868	Homo sapiens	Kd	nM	10.0
	7586584	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7587067	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7587691	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	Kd	nM	5.8	CHEMBL1868	Homo sapiens	Kd	nM	5.8
	7588110	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	120.0	CHEMBL1868	Homo sapiens	Kd	nM	120.0
	7588592	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7589043	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7589656	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	Kd	nM	12.0	CHEMBL1868	Homo sapiens	Kd	nM	12.0
	7590080	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	69.0	CHEMBL1868	Homo sapiens	Kd	nM	69.0
	7590105	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7590579	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	=	Kd	nM	3100.0	CHEMBL1868	Homo sapiens	Kd	nM	3100.0
	7591030	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7592081	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7592554	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1000.0	CHEMBL1868	Homo sapiens	Kd	nM	1000.0
	7593007	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7593154	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	86.0	CHEMBL1868	Homo sapiens	Kd	nM	86.0
	7593589	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	=	Kd	nM	800.0	CHEMBL1868	Homo sapiens	Kd	nM	800.0
	7594061	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7594534	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7594986	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	31.0	CHEMBL1868	Homo sapiens	Kd	nM	31.0
	7595122	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7595566	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	7500.0	CHEMBL1868	Homo sapiens	Kd	nM	7500.0
	7596040	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7596511	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Kd	nM	14.0	CHEMBL1868	Homo sapiens	Kd	nM	14.0
	7596958	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	150.0	CHEMBL1868	Homo sapiens	Kd	nM	150.0
	7597094	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Kd	nM	110.0	CHEMBL1868	Homo sapiens	Kd	nM	110.0
	7597547	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7598020	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL1868	Homo sapiens	Kd	nM	10000.0
	7598490	CHEMBL1908550	Binding constant for FLT1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	23.0	CHEMBL1868	Homo sapiens	Kd	nM	23.0
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599040	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL515914		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599041	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)OC[C@H]1O[C@@H](n2ncc(=O)[nH]c2=O)[C@H](OC(C)=O)[C@@H]1OC(C)=O		CHEMBL515914		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599186	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1		CHEMBL1200558		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599187	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H](C)[C@H](N)C1=N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@H]2CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@H](Cc3cnc[nH]3)NC(=O)[C@@H](Cc3ccccc3)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](CCCN)NC2=O)[C@@H](C)CC)CS1		CHEMBL1200558		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599323	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1		CHEMBL388590		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599324	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCc1oc2ccccc2c1C(=O)c1cc(Br)c(O)c(Br)c1		CHEMBL388590		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599383	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OCc1ccccc1		CHEMBL720		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599384	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OCc1ccccc1		CHEMBL720		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599489	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O		CHEMBL1201207		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7599490	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O		CHEMBL1201207		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601177	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Brc1c(NC2=NCCN2)ccc2nccnc12		CHEMBL844		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601178	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Brc1c(NC2=NCCN2)ccc2nccnc12		CHEMBL844		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601285	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl		CHEMBL1200396		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601286	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCN1CCCCC1C(=O)Nc1c(C)cccc1C.Cl		CHEMBL1200396		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601384	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1458880		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601385	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1458880		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601511	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)n1ccn(C)c1=S		CHEMBL508102		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601512	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)n1ccn(C)c1=S		CHEMBL508102		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601655	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C		CHEMBL211501		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601656	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCCC[C@H]1C(=O)O[C@H](C)[C@H](NC(=O)c2cccc(NC=O)c2O)C(=O)O[C@@H](C)[C@@H]1OC(=O)CC(C)C		CHEMBL211501		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601854	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN		CHEMBL3084803		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601855	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1[C@@H](O)[C@H](N)[C@@H](O[C@H]2O[C@H]([C@H](C)N)CC[C@H]2N)[C@H](O)[C@@H]1N(C)C(=O)CN		CHEMBL3084803		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601974	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O		CHEMBL1095699		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7601975	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	[N-]=[N+]=CC(=O)OC[C@H](N)C(=O)O		CHEMBL1095699		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602117	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCC(CC(=O)O)c1ccc(Cl)cc1		CHEMBL701		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602118	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCC(CC(=O)O)c1ccc(Cl)cc1		CHEMBL701		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602233	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]		CHEMBL221753		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602234	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1.[Cl-]		CHEMBL221753		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602314	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL12089		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602315	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2cc3[n+](cc2c1OC)CCc1cc2c(cc1-3)OCO2.[Cl-]		CHEMBL12089		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602428	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CCNC(=O)c1ccccc1		CHEMBL1231530		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602429	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CCNC(=O)c1ccccc1		CHEMBL1231530		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602980	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[N+](C)(C)CCOC(N)=O.[Cl-]		CHEMBL14		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7602981	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[N+](C)(C)CCOC(N)=O.[Cl-]		CHEMBL14		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604105	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1		CHEMBL1077		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604106	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1c(CC(=O)O)cccc1C(=O)c1ccc(Br)cc1		CHEMBL1077		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604212	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1		CHEMBL894		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604213	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1		CHEMBL894		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604306	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1		CHEMBL319244		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604307	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(/C=C/c1ccc(O)c(O)c1)OCCc1ccccc1		CHEMBL319244		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604581	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc(=O)n(-c2ccccc2)n1C		CHEMBL277474		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604582	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc(=O)n(-c2ccccc2)n1C		CHEMBL277474		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604777	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NCC(O)COc1ccc(CC(N)=O)cc1		CHEMBL24		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604778	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NCC(O)COc1ccc(CC(N)=O)cc1		CHEMBL24		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604902	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21		CHEMBL1598608		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7604903	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C(=O)COc2c(C(=O)NC3CN4CCC3CC4)cc(Cl)cc21		CHEMBL1598608		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605046	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1		CHEMBL1201346		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605047	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CCNC(=O)c1ccc(/N=N/c2ccc(O)c(C(=O)O)c2)cc1		CHEMBL1201346		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605147	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34		CHEMBL31184		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605148	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc2c(c1)cc1ccc3cccc4ccc2c1c34		CHEMBL31184		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605228	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL415690		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605229	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL415690		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605342	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O		CHEMBL264374		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605343	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O		CHEMBL264374		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605888	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)N1c2ccccc2C=Cc2ccccc21		CHEMBL108		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7605889	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)N1c2ccccc2C=Cc2ccccc21		CHEMBL108		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607016	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1		CHEMBL253376		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607017	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(Cc1cc(Br)cc(Br)c1N)C1CCCCC1		CHEMBL253376		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607121	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1		CHEMBL49		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607122	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(c2ncccn2)CC1		CHEMBL49		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607222	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cn1c(=O)c2c(ncn2C)n(C)c1=O		CHEMBL113		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607223	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cn1c(=O)c2c(ncn2C)n(C)c1=O		CHEMBL113		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607495	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O		CHEMBL1256017		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607496	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N=C(N)NCCCCNC(=N)N.O=S(=O)(O)O		CHEMBL1256017		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607689	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O		CHEMBL1487		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607690	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@@H](O)C[C@@H](O)CC(=O)O		CHEMBL1487		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607817	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12		CHEMBL1542		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607818	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cn1cnc([N+](=O)[O-])c1Sc1ncnc2nc[nH]c12		CHEMBL1542		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607960	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1		CHEMBL521589		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7607961	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)C(=O)Oc1cc(OC(=O)N(C)C)cc(C(O)CNC(C)(C)C)c1		CHEMBL521589		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608059	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc2c(c1)c1cccc3ccc4cccc2c4c31		CHEMBL1371125		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608060	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc2c(c1)c1cccc3ccc4cccc2c4c31		CHEMBL1371125		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608135	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL135		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608136	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL135		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608262	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCC[C@H](CC)COC(=O)c1ccccc1C(=O)OC[C@H](CC)CCCC		CHEMBL402794		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7608263	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCC[C@H](CC)COC(=O)c1ccccc1C(=O)OC[C@H](CC)CCCC		CHEMBL402794		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609799	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)C(Br)C(=O)NC(N)=O		CHEMBL1515611		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609800	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)C(Br)C(=O)NC(N)=O		CHEMBL1515611		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609898	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CS(=O)(=O)OCCCCOS(C)(=O)=O		CHEMBL820		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7609899	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CS(=O)(=O)OCCCCOS(C)(=O)=O		CHEMBL820		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610000	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1		CHEMBL65		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610001	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3ccccc3nc2-1		CHEMBL65		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610148	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3		CHEMBL566534		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610149	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1O[C@@H]2O[C@@]3(C)CC[C@H]4[C@H](C)CC[C@@H]([C@H]1C)[C@]42OO3		CHEMBL566534		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610344	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C1[C@@H]2CCC3[C@]4(C)C[C@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@H](C(=O)O)[C@H]4CC[C@]3(C2)[C@@H]1O.[K+].[K+]		CHEMBL499815		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610345	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C1[C@@H]2CCC3[C@]4(C)C[C@H](O[C@@H]5O[C@H](CO)[C@@H](OS(=O)(=O)[O-])[C@H](OS(=O)(=O)[O-])[C@H]5OC(=O)CC(C)C)C[C@@H](C(=O)O)[C@H]4CC[C@]3(C2)[C@@H]1O.[K+].[K+]		CHEMBL499815		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610472	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL564201		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610473	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1cnn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1		CHEMBL564201		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610611	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL270299		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610612	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)c1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL270299		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610714	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)c1ccc(N)cc1		CHEMBL278172		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610715	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)c1ccc(N)cc1		CHEMBL278172		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610777	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL282575		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610778	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@@H]3c4ccc(OC(=O)c5ccccc5)cc4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL282575		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610909	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1		CHEMBL942		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7610910	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)Oc1ccc(C(c2ccc(OC(C)=O)cc2)c2ccccn2)cc1		CHEMBL942		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612458	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Brc1ccccc1		CHEMBL16068		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612459	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Brc1ccccc1		CHEMBL16068		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612565	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCOC(=O)c1ccc(N)cc1		CHEMBL127516		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612566	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCOC(=O)c1ccc(N)cc1		CHEMBL127516		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612659	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1		CHEMBL1016		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612660	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOc1nc2cccc(C(=O)O)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1		CHEMBL1016		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612811	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]1CCC2=O		CHEMBL87285		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612812	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@H]3[C@@H](CC[C@H]4C[C@H](O)CC[C@@]43C)[C@@H]1CCC2=O		CHEMBL87285		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612940	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4		CHEMBL567597		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7612941	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@]32OO4		CHEMBL567597		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613136	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2		CHEMBL517712		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613137	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(CO)c1ccccc1)C2		CHEMBL517712		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613277	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL529		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613278	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL529		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613414	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL1586		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613415	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL1586		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613519	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1ccccc1		CHEMBL541		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613520	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1ccccc1		CHEMBL541		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613581	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12		CHEMBL26260		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613582	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1cc(-c2ccccc2)oc2ccc3ccccc3c12		CHEMBL26260		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613708	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(c1ccc(O)cc1)c1ccc(O)cc1		CHEMBL418971		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7613709	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(c1ccc(O)cc1)c1ccc(O)cc1		CHEMBL418971		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615307	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O		CHEMBL290106		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615308	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1c(Cl)cc(Cl)cc1Sc1cc(Cl)cc(Cl)c1O		CHEMBL290106		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615409	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL493		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615410	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]c(Br)c(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL493		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615528	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12		CHEMBL990		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615529	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(Cc1ccc(C(C)(C)C)cc1)Cc1cccc2ccccc12		CHEMBL990		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615631	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12C(=O)OC(=O)[C@@]1(C)[C@@H]1CC[C@H]2O1		CHEMBL48449		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615632	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12C(=O)OC(=O)[C@@]1(C)[C@@H]1CC[C@H]2O1		CHEMBL48449		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615783	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(C(=O)N2CCCC2=O)cc1		CHEMBL36994		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615784	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(C(=O)N2CCCC2=O)cc1		CHEMBL36994		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615912	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1O[C@H]([C@@H](O)CO)C(O)=C1O		CHEMBL196		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7615913	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1O[C@H]([C@@H](O)CO)C(O)=C1O		CHEMBL196		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616096	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1366		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616097	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1366		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616242	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL1537		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616243	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL1537		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616379	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O		CHEMBL838		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616380	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O		CHEMBL838		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616467	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc2sc(SSc3nc4ccccc4s3)nc2c1		CHEMBL508112		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616468	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc2sc(SSc3nc4ccccc4s3)nc2c1		CHEMBL508112		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616555	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNCCc1ccccn1		CHEMBL24441		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7616556	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNCCc1ccccn1		CHEMBL24441		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618251	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.[Br-]		CHEMBL4649901		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618252	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(N)nc([C@H](CC(N)=O)NC[C@H](N)C(N)=O)nc1C(=O)N[C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@H](C(=O)NCCc1nc(-c2nc(C(=O)NCCC[S+](C)C)cs2)cs1)[C@@H](C)O)[C@@H](O[C@@H]1O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](OC(N)=O)[C@@H]1O)c1c[nH]cn1.[Br-]		CHEMBL4649901		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618343	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1370		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618344	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCC1O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1370		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618455	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12		CHEMBL1255834		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618456	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(N)Cc1c[nH]c2ccc(OCc3cccs3)cc12		CHEMBL1255834		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618569	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O		CHEMBL294199		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618570	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O		CHEMBL294199		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618719	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(C2C(=O)c3ccccc3C2=O)cc1		CHEMBL712		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618720	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(C2C(=O)c3ccccc3C2=O)cc1		CHEMBL712		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618847	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)Oc1ccccc1C(=O)O		CHEMBL25		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7618848	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)Oc1ccccc1C(=O)O		CHEMBL25		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619056	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1		CHEMBL1489		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619057	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1		CHEMBL1489		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619202	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O		CHEMBL158		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619203	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1[C@H](NC(=O)/C(=N\OC(C)(C)C(=O)O)c2csc(N)n2)C(=O)N1S(=O)(=O)O		CHEMBL158		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619339	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1		CHEMBL340978		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619340	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C(=O)O)c1ccc2oc(-c3ccc(Cl)cc3)nc2c1		CHEMBL340978		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619400	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2		CHEMBL1201203		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619401	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(c1ccccc1)c1ccccc1)C2		CHEMBL1201203		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619509	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL632		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7619510	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL632		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620440	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1		CHEMBL296419		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7620441	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(CCN2CCC(Nc3nc4ccccc4n3Cc3ccc(F)cc3)CC2)cc1		CHEMBL296419		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621234	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1		CHEMBL357995		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621235	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc2c(OCC(CNC(C)(C)C)OC(=O)c3ccccc3)cccc2[nH]1		CHEMBL357995		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621341	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1		CHEMBL188921		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621342	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1		CHEMBL188921		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621444	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1476898		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621445	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1476898		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621562	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL1560		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621563	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL1560		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621711	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1		CHEMBL423192		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7621712	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(C)=O)cc1		CHEMBL423192		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622052	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2cc(CC(=O)O)ccc2c1		CHEMBL1105		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622053	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2cc(CC(=O)O)ccc2c1		CHEMBL1105		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622166	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)Nc1nnc(S(N)(=O)=O)s1		CHEMBL20		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622167	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)Nc1nnc(S(N)(=O)=O)s1		CHEMBL20		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622286	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O		CHEMBL1601669		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622287	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C1/C(=C\C=C2/CCC[C@@]3(C)[C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C[C@@H](O)C[C@@H]1O		CHEMBL1601669		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622375	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2		CHEMBL661		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622376	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1nnc2n1-c1ccc(Cl)cc1C(c1ccccc1)=NC2		CHEMBL661		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622500	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1(c2ccc(N)cc2)CCC(=O)NC1=O		CHEMBL488		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622501	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1(c2ccc(N)cc2)CCC(=O)NC1=O		CHEMBL488		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622686	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1(CCC(C)C)C(=O)N=C(O)NC1=O		CHEMBL267894		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622687	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1(CCC(C)C)C(=O)N=C(O)NC1=O		CHEMBL267894		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622785	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1		CHEMBL461727		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622786	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N#C[C@H](O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)c1ccccc1		CHEMBL461727		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622886	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL558551		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7622887	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CC[C@@H](N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL558551		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7623301	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc2c3c(cccc13)C(=O)NC2=O		CHEMBL338790		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7623302	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc2c3c(cccc13)C(=O)NC2=O		CHEMBL338790		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624582	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc(Cn2ccnc2)cc1		CHEMBL14192		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624583	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc(Cn2ccnc2)cc1		CHEMBL14192		Ki			CHEMBL1868	Homo sapiens	Ki		
	7624670	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2		CHEMBL30327	=	IC50	nM	2.69	CHEMBL1868	Homo sapiens	IC50	uM	0.00269
	7624671	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1cc2c(cc1Cl)Oc1cc(Cl)c(Cl)cc1O2		CHEMBL30327	=	Ki	nM	0.697	CHEMBL1868	Homo sapiens	Ki	uM	0.000697
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624998	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]c2ccccc2c2ccccc12		CHEMBL45245		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7624999	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]c2ccccc2c2ccccc12		CHEMBL45245		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625113	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC		CHEMBL502620		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625114	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@@]1(O)C[C@H](O[C@H]2C[C@H](N(C)C)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)c2c(cc3c(c2O)C(=O)c2c(O)cccc2C3=O)[C@H]1C(=O)OC		CHEMBL502620		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625234	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1ncnc2[nH][nH]cc1-2		CHEMBL1467		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625235	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1ncnc2[nH][nH]cc1-2		CHEMBL1467		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625323	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)c1nc(N(C)C)nc(N(C)C)n1		CHEMBL1455		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625324	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)c1nc(N(C)C)nc(N(C)C)n1		CHEMBL1455		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625448	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN		CHEMBL1370561		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625449	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cn1c(=O)c2[nH]cnc2n(C)c1=O.Cn1c(=O)c2[nH]cnc2n(C)c1=O.NCCN		CHEMBL1370561		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625609	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2		CHEMBL1113		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625610	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccc2c(c1)C(N1CCNCC1)=Nc1ccccc1O2		CHEMBL1113		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625830	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1		CHEMBL63560		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7625831	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@](O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc1ccc(C#N)c(C(F)(F)F)c1		CHEMBL63560		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7626255	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@@H](Cc1ccc(F)cc1)C(=O)O		CHEMBL1235242		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7626256	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@@H](Cc1ccc(F)cc1)C(=O)O		CHEMBL1235242		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627207	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1		CHEMBL1399		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627208	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C#N)c1cc(Cn2cncn2)cc(C(C)(C)C#N)c1		CHEMBL1399		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627515	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	S=C=Nc1cccc2ccccc12		CHEMBL1381098		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627516	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	S=C=Nc1cccc2ccccc12		CHEMBL1381098		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627612	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)Nc1cccc(O)c1		CHEMBL9419		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627613	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)Nc1cccc(O)c1		CHEMBL9419		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627937	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O		CHEMBL3215298		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7627938	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H](C)[C@H]1O[C@]2(C=C[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(C=C[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O		CHEMBL3215298		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628055	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN1C[C@@]2(COC)[C@H]3[C@@H](OC)[C@H]4[C@H]1[C@]3([C@H](OC)C[C@H]2O)[C@@H]1C[C@]2(O)[C@@H](OC)[C@H](O)[C@@]4(OC(C)=O)[C@H]1[C@H]2OC(=O)c1ccccc1		CHEMBL2103747		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628056	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN1C[C@@]2(COC)[C@H]3[C@@H](OC)[C@H]4[C@H]1[C@]3([C@H](OC)C[C@H]2O)[C@@H]1C[C@]2(O)[C@@H](OC)[C@H](O)[C@@]4(OC(C)=O)[C@H]1[C@H]2OC(=O)c1ccccc1		CHEMBL2103747		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628177	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=CCO		CHEMBL234926		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628178	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=CCO		CHEMBL234926		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628265	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC12CC3CC(CC(C3)C1)C2		CHEMBL660		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628266	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC12CC3CC(CC(C3)C1)C2		CHEMBL660		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628392	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1		CHEMBL376180		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628393	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(N)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2n1		CHEMBL376180		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628544	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O		CHEMBL1082		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628545	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O		CHEMBL1082		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628627	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1onc(O)c1CC(N)C(=O)O		CHEMBL13378		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7628628	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1onc(O)c1CC(N)C(=O)O		CHEMBL13378		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7629052	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cn[nH]c1		CHEMBL1308		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7629053	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cn[nH]c1		CHEMBL1308		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630176	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C(Cl)Cl		CHEMBL156455		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630177	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C(Cl)Cl		CHEMBL156455		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630274	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)c1cccc(N)c1		CHEMBL81977		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630275	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)c1cccc(N)c1		CHEMBL81977		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630607	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL1566		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630608	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O		CHEMBL1566		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630724	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(O)c2ncn(COCCO)c2n1		CHEMBL184		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630725	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(O)c2ncn(COCCO)c2n1		CHEMBL184		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630845	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O		CHEMBL1110		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630846	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1[nH]cnc1CN1CCc2c(c3ccccc3n2C)C1=O		CHEMBL1110		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630937	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1		CHEMBL153479		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7630938	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1c(Br)cc(Br)cc1CN[C@H]1CC[C@H](O)CC1		CHEMBL153479		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7631085	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2		CHEMBL267345		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7631086	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2		CHEMBL267345		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7631161	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NC[C@H](O)COc1cccc2[nH]ccc12		CHEMBL117405		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7631162	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NC[C@H](O)COc1cccc2[nH]ccc12		CHEMBL117405		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7631586	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCCCCCCc1ccc(O)cc1		CHEMBL153062		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7631587	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCCCCCCc1ccc(O)cc1		CHEMBL153062		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632284	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc(C(=O)O)c(O)c1		CHEMBL1169		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632285	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc(C(=O)O)c(O)c1		CHEMBL1169		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632717	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N=C(Nc1ccccc1)Nc1ccccc1		CHEMBL77675		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632718	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N=C(Nc1ccccc1)Nc1ccccc1		CHEMBL77675		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632815	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3		CHEMBL40583		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7632816	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc2cc3c(ccc4ccccc43)c3c2c1CC3		CHEMBL40583		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633160	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1		CHEMBL642		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633161	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(C(C)=O)c1		CHEMBL642		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633278	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2		CHEMBL1697694		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633279	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc2c(c3oc(=O)c4c(c13)CCC4=O)[C@@H]1C=CO[C@@H]1O2		CHEMBL1697694		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633396	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL1230813		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633397	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL1230813		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633495	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCCCNCCSP(=O)(O)O		CHEMBL1006		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633496	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCCCNCCSP(=O)(O)O		CHEMBL1006		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633802	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL174		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633803	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL174		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633871	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(c1ccccc1Cl)N1CCC(Cc2ccccc2)CC1		CHEMBL1909048		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7633872	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(c1ccccc1Cl)N1CCC(Cc2ccccc2)CC1		CHEMBL1909048		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7634275	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCCCCCc1ccc(O)cc1		CHEMBL195437		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7634276	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCCCCCc1ccc(O)cc1		CHEMBL195437		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7634979	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1		CHEMBL633		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7634980	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1		CHEMBL633		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635357	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(c1ccccc1F)N1CCC(Cc2ccccc2)CC1		CHEMBL437002		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635358	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(c1ccccc1F)N1CCC(Cc2ccccc2)CC1		CHEMBL437002		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635447	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)N1c2ccccc2CCc2ccccc21		CHEMBL41543		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635448	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)N1c2ccccc2CCc2ccccc21		CHEMBL41543		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635540	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O		CHEMBL291338		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635541	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(Nc1ccc(Cl)c(Cl)c1)c1cc(Cl)cc(Cl)c1O		CHEMBL291338		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635875	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl		CHEMBL93645		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635876	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)COC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl		CHEMBL93645		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635994	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O		CHEMBL2105617		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7635995	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1C2CC3C4N(C)c5ccccc5C45CC(C2[C@H]5O)N3C1O		CHEMBL2105617		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636096	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL1403281		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636097	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL1403281		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636213	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O		CHEMBL177		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636214	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCC[C@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]1O[C@H](CO)[C@@H](O)[C@H](N)[C@H]1O		CHEMBL177		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636494	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21		CHEMBL1566249		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7636495	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)OC(C)OC1=C(C(=O)Nc2ccccn2)N(C)S(=O)(=O)c2ccccc21		CHEMBL1566249		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7637013	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc(Cc2ccc(N)cc2)cc1		CHEMBL85728		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7637014	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc(Cc2ccc(N)cc2)cc1		CHEMBL85728		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7637694	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1		CHEMBL1365675		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7637695	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(/N=C/N(C)/C=N/c2ccc(C)cc2C)c(C)c1		CHEMBL1365675		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638200	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1		CHEMBL1909049		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638201	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1		CHEMBL1909049		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638294	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1395		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638295	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1395		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638392	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O		CHEMBL1544		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638393	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O		CHEMBL1544		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638725	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1		CHEMBL189171		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638726	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2c(c1)c(CC(=O)OCC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1		CHEMBL189171		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638844	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1		CHEMBL1483		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638845	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1		CHEMBL1483		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638935	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12		CHEMBL283196		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7638936	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1cc(-c2ccccc2)oc2c1ccc1ccccc12		CHEMBL283196		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639056	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N=C(N)NC(=O)c1nc(Cl)c(N)nc1N		CHEMBL945		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639057	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N=C(N)NC(=O)c1nc(Cl)c(N)nc1N		CHEMBL945		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639270	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCC=C1c2ccccc2CCc2ccccc21		CHEMBL629		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639271	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCC=C1c2ccccc2CCc2ccccc21		CHEMBL629		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639355	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1		CHEMBL116		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639356	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]1CCOC1)S(=O)(=O)c1ccc(N)cc1		CHEMBL116		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639829	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F		CHEMBL917		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7639830	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1F		CHEMBL917		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640950	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1		CHEMBL1909050		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7640951	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccccc1C(=O)N1CCC(Cc2ccccc2)CC1		CHEMBL1909050		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641044	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2		CHEMBL311469		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641045	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)Nc1ccc2c(c1)Cc1ccccc1-2		CHEMBL311469		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641149	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CCCc1cccs1		CHEMBL1230333		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641150	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CCCc1cccs1		CHEMBL1230333		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641369	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Sc1ncnc2nc[nH]c12		CHEMBL1425		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641482	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)Nc1ccc(O)cc1		CHEMBL112		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641483	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)Nc1ccc(O)cc1		CHEMBL112		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641602	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCCCC(O)(P(=O)(O)O)P(=O)(O)O		CHEMBL870		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641603	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCCCC(O)(P(=O)(O)O)P(=O)(O)O		CHEMBL870		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641691	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2		CHEMBL47		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641692	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(C)c2c(c(C)c1O)CC[C@@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)O2		CHEMBL47		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641813	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCCCCCC(=O)O		CHEMBL1046		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7641814	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCCCCCC(=O)O		CHEMBL1046		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7642001	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl		CHEMBL1491		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7642002	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1c1ccccc1Cl		CHEMBL1491		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7642091	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7642092	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1cc(-c2ccncc2)c[nH]c1=O		CHEMBL12856		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7642194	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL426123		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7642195	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CC[C@H](N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL426123		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7642698	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Sc1ncnc2nc[nH]c12		CHEMBL1425		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643879	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nn1nnc2ccccc21		CHEMBL101168		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643880	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nn1nnc2ccccc21		CHEMBL101168		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643966	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](COCC(C)O)O[C@H](O[C@@H]4[C@@H](COCC(C)O)O[C@H](O[C@@H]5[C@@H](COCC(C)O)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](COCC(C)O)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL577294		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7643967	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(O)COC[C@H]1O[C@@H]2O[C@@H]3[C@@H](COCC(C)O)O[C@H](O[C@@H]4[C@@H](COCC(C)O)O[C@H](O[C@@H]5[C@@H](COCC(C)O)O[C@H](O[C@@H]6[C@@H](COCC(C)O)O[C@H](O[C@@H]7[C@@H](COCC(C)O)O[C@H](O[C@@H]8[C@@H](COCC(C)O)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL577294		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644076	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(c1ccccc1C(F)(F)F)N1CCC(Cc2ccccc2)CC1		CHEMBL1909051		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644077	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(c1ccccc1C(F)(F)F)N1CCC(Cc2ccccc2)CC1		CHEMBL1909051		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644531	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1		CHEMBL563		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644532	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C(=O)O)c1ccc(-c2ccccc2)c(F)c1		CHEMBL563		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644671	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2		CHEMBL659		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644672	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2c3c1O[C@H]1C[C@@H](O)C=C[C@@]31CCN(C)C2		CHEMBL659		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644807	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644808	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644914	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1		CHEMBL472		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7644915	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(Cl)cc1C(=O)NCCc1ccc(S(=O)(=O)NC(=O)NC2CCCCC2)cc1		CHEMBL472		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7645048	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL583		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7645049	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(F)c(N2CCNC(C)C2)cc2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL583		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7645120	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1		CHEMBL54		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7645121	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)c1ccc(F)cc1		CHEMBL54		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7645663	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1		CHEMBL56337		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7645664	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(/C=C1\SC(=S)N(CC(=O)O)C1=O)=C\c1ccccc1		CHEMBL56337		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7646228	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1		CHEMBL672		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7646229	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)OC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1		CHEMBL672		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7646369	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F		CHEMBL106		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7646370	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OC(Cn1cncn1)(Cn1cncn1)c1ccc(F)cc1F		CHEMBL106		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7646467	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL989		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7646468	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL989		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647473	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL389621		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647474	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL389621		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647597	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)Cn1cnc2c(N)nc3ccccc3c21		CHEMBL1282		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647598	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)Cn1cnc2c(N)nc3ccccc3c21		CHEMBL1282		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647620	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O		CHEMBL1752		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7647621	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cn1c(=O)c2c(ncn2CC(O)CO)n(C)c1=O		CHEMBL1752		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648005	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C		CHEMBL2220427		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648006	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC(=O)O[C@H]1[C@H](O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)O[C@H](C)C[C@@H]1N(C)C		CHEMBL2220427		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648116	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL241694		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648117	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL241694		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648247	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC12CCC(CC1)C(C)(C)O2		CHEMBL485259		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648248	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC12CCC(CC1)C(C)(C)O2		CHEMBL485259		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648806	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1		CHEMBL806		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648807	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1		CHEMBL806		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648948	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]		CHEMBL1200993		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7648949	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC.[I-].[I-].[I-]		CHEMBL1200993		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649081	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O		CHEMBL3039597		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649082	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O		CHEMBL3039597		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649197	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCC(=O)O		CHEMBL773		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649198	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCC(=O)O		CHEMBL773		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649331	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O		CHEMBL562		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649332	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC1=CC(=O)C[C@@H](C)[C@]12Oc1c(Cl)c(OC)cc(OC)c1C2=O		CHEMBL562		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649379	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1cc(Cl)c(OCC#CI)cc1Cl		CHEMBL1289		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649380	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1cc(Cl)c(OCC#CI)cc1Cl		CHEMBL1289		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649755	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=P1(NCCCl)OCCCN1CCCl		CHEMBL1024		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649756	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=P1(NCCCl)OCCCN1CCCl		CHEMBL1024		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649874	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL305660		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649875	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)c1ccc(C(=O)CCCN2CCC(OC(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL305660		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649961	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1		CHEMBL1902981		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7649962	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCc1ccc(C(=O)C(C)CN2CCCCC2)cc1		CHEMBL1902981		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7650532	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C(=O)O)c1cccc(Oc2ccccc2)c1		CHEMBL1297		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7650533	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C(=O)O)c1cccc(Oc2ccccc2)c1		CHEMBL1297		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7650674	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1[nH]c(=O)ncc1F		CHEMBL1463		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7650675	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1[nH]c(=O)ncc1F		CHEMBL1463		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7650769	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C		CHEMBL1501		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7650770	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)OCC(=O)[C@@]12OC(C)(C)O[C@@H]1C[C@H]1[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]12C		CHEMBL1501		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7651789	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12		CHEMBL1535		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7651790	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12		CHEMBL1535		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652327	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1		CHEMBL768		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652328	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1		CHEMBL768		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652436	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1(C)CC(=O)NC1=O		CHEMBL696		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652437	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1(C)CC(=O)NC1=O		CHEMBL696		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652567	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=CCc1ccc(O)c(OC)c1		CHEMBL42710		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7652568	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=CCc1ccc(O)c(OC)c1		CHEMBL42710		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653117	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21		CHEMBL2220442		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653118	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)n1c(/C=C/C(O)CC(O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21		CHEMBL2220442		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653261	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OC[C@H]1OC2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)OC(OC9[C@@H](CO)OC(C1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL407030		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653262	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OC[C@H]1OC2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)OC(OC9[C@@H](CO)OC(C1[C@H](O)[C@H]2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O		CHEMBL407030		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653364	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]		CHEMBL64894		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653365	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)c1ccc(C(=C2C=CC(=[N+](C)C)C=C2)c2ccc(N(C)C)cc2)cc1.[Cl-]		CHEMBL64894		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653507	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CO		CHEMBL252557		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653508	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CO		CHEMBL252557		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653641	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccccc1OCC(O)CO		CHEMBL980		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653642	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccccc1OCC(O)CO		CHEMBL980		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653697	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4		CHEMBL433257		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7653698	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)C[C@](O)(CCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCc2cc4c(cc2[C@H]13)OCO4		CHEMBL433257		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654081	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654082	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654144	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1		CHEMBL808		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654145	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1		CHEMBL808		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654265	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNC[C@H](O)c1ccc(O)c(O)c1		CHEMBL679		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654266	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNC[C@H](O)c1ccc(O)c(O)c1		CHEMBL679		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654841	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(/C=C/C(=O)O)ccc1O		CHEMBL32749		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654842	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(/C=C/C(=O)O)ccc1O		CHEMBL32749		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654984	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O		CHEMBL1568		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7654985	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(F)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O		CHEMBL1568		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7655078	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12		CHEMBL177756		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7655079	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1ccccc1-c1c2ccc(=O)cc-2oc2cc(O)ccc12		CHEMBL177756		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7655960	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl		CHEMBL496		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7655961	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1c(Cl)cc(Cl)c(Cl)c1Cc1c(O)c(Cl)cc(Cl)c1Cl		CHEMBL496		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656089	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1062		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656090	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1062		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656599	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O		CHEMBL193482		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656600	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1C[C@@H](O)[C@@H]2O		CHEMBL193482		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656713	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OCCO		CHEMBL457299		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656714	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OCCO		CHEMBL457299		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656846	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O		CHEMBL880		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7656847	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)OCC(CCn1cnc2cnc(N)nc21)COC(C)=O		CHEMBL880		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657400	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)P(=O)(O)O		CHEMBL666		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657401	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)P(=O)(O)O		CHEMBL666		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657544	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(O)c2ncn(COC(CO)CO)c2n1		CHEMBL182		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657545	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(O)c2ncn(COC(CO)CO)c2n1		CHEMBL182		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657640	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)=CCC/C(C)=C/CO		CHEMBL25719		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657641	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)=CCC/C(C)=C/CO		CHEMBL25719		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657783	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C		CHEMBL441687		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657784	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)[C@@H](O[C@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@H](C(=O)O)[C@@H](O)[C@H](O)[C@H]2O)CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@@](C)(C(=O)O)CC[C@]3(C)CC[C@]21C		CHEMBL441687		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657906	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N=C(N)N/N=C/c1c(Cl)cccc1Cl		CHEMBL420		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7657907	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N=C(N)N/N=C/c1c(Cl)cccc1Cl		CHEMBL420		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7658381	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=NN(c2ccccc2)C(=O)C1		CHEMBL290916		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7658382	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=NN(c2ccccc2)C(=O)C1		CHEMBL290916		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7658507	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1		CHEMBL417		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7658508	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@@H](O)[C@H](C)O1		CHEMBL417		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7659091	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL914		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7659092	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C(=O)O)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL914		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7659232	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1201010		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7659233	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1201010		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7659325	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1200600		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7659326	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1200600		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660193	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Br.CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2		CHEMBL1319362		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660194	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Br.CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)C(O)c1ccccc1)C2		CHEMBL1319362		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660326	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)NO		CHEMBL467		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660327	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)NO		CHEMBL467		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660375	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O		CHEMBL1130		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660376	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1O[C@@H](n2cc(F)c(=O)[nH]c2=O)[C@H](O)[C@@H]1O		CHEMBL1130		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660828	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O		CHEMBL1405		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660829	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CCC2=O		CHEMBL1405		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660944	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1200623		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7660945	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1200623		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661082	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1		CHEMBL902		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661083	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(N)=Nc1nc(CSCC/C(N)=N/S(N)(=O)=O)cs1		CHEMBL902		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661637	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1		CHEMBL1103		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661638	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1OCCN1/N=C/c1ccc([N+](=O)[O-])o1		CHEMBL1103		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661781	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12		CHEMBL31		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661782	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1c(N2CCNC(C)C2)c(F)cc2c(=O)c(C(=O)O)cn(C3CC3)c12		CHEMBL31		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661877	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1		CHEMBL427216		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7661878	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)cc1		CHEMBL427216		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662020	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CNCP(=O)(O)O		CHEMBL95764		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662021	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CNCP(=O)(O)O		CHEMBL95764		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662138	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(N)=NCCN1CCCCCCC1		CHEMBL765		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662139	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(N)=NCCN1CCCCCCC1		CHEMBL765		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662613	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21		CHEMBL50588		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662614	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H]1CN2CCc3cc(OC)c(OC)cc3[C@@H]2C[C@@H]1C[C@H]1NCCc2cc(OC)c(OC)cc21		CHEMBL50588		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662739	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C		CHEMBL1536		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7662740	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)/C=C/[C@H](C)C(C)C		CHEMBL1536		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7663327	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C		CHEMBL710		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7663328	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C		CHEMBL710		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7663468	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2		CHEMBL407		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7663469	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)c1ncn2c1CN(C)C(=O)c1cc(F)ccc1-2		CHEMBL407		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7663577	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]cc(F)c(=O)[nH]1		CHEMBL185		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7663578	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]cc(F)c(=O)[nH]1		CHEMBL185		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664446	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2		CHEMBL1255901		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664447	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C/C=C1\[C@H]2C=C(C)C[C@@]1(N)c1ccc(=O)[nH]c1C2		CHEMBL1255901		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664577	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)Cc1ccc(C(C)C(=O)O)cc1		CHEMBL521		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664578	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)Cc1ccc(C(C)C(=O)O)cc1		CHEMBL521		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664628	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O		CHEMBL1527608		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664629	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cn1c(=O)c2c(ncn2CC2OCCO2)n(C)c1=O		CHEMBL1527608		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664996	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL1385840		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7664997	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@](NC(=O)[C@@H]3C=C4c5cccc6[nH]cc(c56)C[C@H]4N(C)C3)(C(C)C)C(=O)N12		CHEMBL1385840		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665085	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl		CHEMBL456		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665086	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C(CC)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl		CHEMBL456		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665196	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1200624		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665197	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=C[C@@H](OC(C)=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1200624		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665337	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)Cc1ccc(-c2ccccc2)cc1		CHEMBL413965		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665338	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)Cc1ccc(-c2ccccc2)cc1		CHEMBL413965		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665917	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl		CHEMBL35		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7665918	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl		CHEMBL35		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666061	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1		CHEMBL888		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666062	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1		CHEMBL888		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666157	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O		CHEMBL1481		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666158	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1=C(C)CN(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)N[C@H]3CC[C@H](C)CC3)cc2)C1=O		CHEMBL1481		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666300	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL306043		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666301	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL306043		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666414	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N=C(N)NC(=O)Cc1c(Cl)cccc1Cl		CHEMBL862		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666415	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N=C(N)NC(=O)Cc1c(Cl)cccc1Cl		CHEMBL862		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666907	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL578		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7666908	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL578		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7667613	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O		CHEMBL1493		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7667614	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(-c2ccccc2)oc2c(C(=O)OCCN3CCCCC3)cccc2c1=O		CHEMBL1493		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7667727	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1		CHEMBL30008		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7667728	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Fc1ccc(C(c2ccc(F)cc2)N2CCN(C/C=C/c3ccccc3)CC2)cc1		CHEMBL30008		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7667846	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL41		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7667847	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNCCC(Oc1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL41		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668762	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NNc1nncc2ccccc12		CHEMBL276832		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668763	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NNc1nncc2ccccc12		CHEMBL276832		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668894	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O		CHEMBL1117		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668895	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)[C@]1(O)Cc2c(O)c3c(c(O)c2[C@@H](O[C@H]2C[C@H](N)[C@H](O)[C@H](C)O2)C1)C(=O)c1ccccc1C3=O		CHEMBL1117		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668938	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL53463		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7668939	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL53463		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669298	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL119443		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669299	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL119443		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669405	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@@H](CO)NCCN[C@@H](CC)CO		CHEMBL44884		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669406	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@@H](CO)NCCN[C@@H](CC)CO		CHEMBL44884		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669515	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(O)(P(=O)(O)O)P(=O)(O)O		CHEMBL871		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669516	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(O)(P(=O)(O)O)P(=O)(O)O		CHEMBL871		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669651	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl		CHEMBL1480		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7669652	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc(Cl)c1Cl		CHEMBL1480		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670104	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1		CHEMBL726		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670105	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1		CHEMBL726		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670240	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCC1(CC(=O)O)CCCCC1		CHEMBL940		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670241	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCC1(CC(=O)O)CCCCC1		CHEMBL940		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670384	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1		CHEMBL457		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670385	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1		CHEMBL457		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670479	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1		CHEMBL1073		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670480	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cnc(C(=O)NCCc2ccc(S(=O)(=O)NC(=O)NC3CCCCC3)cc2)cn1		CHEMBL1073		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670616	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1201469		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670617	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1201469		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670719	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1		CHEMBL434063		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7670720	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1)c1ccccn1		CHEMBL434063		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7671219	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21		CHEMBL826		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7671220	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)nc21		CHEMBL826		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7671932	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1		CHEMBL6273		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7671933	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCN(c2c(F)cc3c(=O)c(C(=O)O)cn(CCF)c3c2F)CC1		CHEMBL6273		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7672033	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1512		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7672034	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1512		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673034	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NN		CHEMBL1237174		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673035	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NN		CHEMBL1237174		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673162	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O		CHEMBL252556		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673163	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC1=C(OC)C(=O)C(CCCCCCCCCCO)=C(C)C1=O		CHEMBL252556		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673207	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21		CHEMBL1433		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673208	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1c2cccc(O)c2C(=O)C2=C(O)[C@]3(O)C(=O)C(C(N)=O)=C(O)[C@@H](N(C)C)[C@@H]3[C@@H](O)[C@@H]21		CHEMBL1433		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673556	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL442		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673557	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C=C2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL442		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673688	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCO		CHEMBL545		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673689	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCO		CHEMBL545		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673800	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3		CHEMBL622		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673801	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCc1cccc2c3c([nH]c12)C(CC)(CC(=O)O)OCC3		CHEMBL622		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673937	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1		CHEMBL37161		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7673938	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1		CHEMBL37161		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674365	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1201012		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674366	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)CC[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1201012		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674504	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1200431		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674505	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1200431		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674649	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]([C@](O)(Cn1cncn1)c1ccc(F)cc1F)S(C)(=O)=O		CHEMBL34139		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674650	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]([C@](O)(Cn1cncn1)c1ccc(F)cc1F)S(C)(=O)=O		CHEMBL34139		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674745	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O		CHEMBL1372		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674746	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@@H](CCC(=O)N[C@@H](CSSC[C@H](NC(=O)CC[C@H](N)C(=O)O)C(=O)NCC(=O)O)C(=O)NCC(=O)O)C(=O)O		CHEMBL1372		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674878	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2		CHEMBL289469		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674879	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C2CCCC1CC(NC(=O)c1nn(C)c3ccccc13)C2		CHEMBL289469		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674976	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1		CHEMBL1200845		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7674977	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CCl)O1		CHEMBL1200845		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7675482	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1		CHEMBL1108		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7675508	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1		CHEMBL15511		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7675509	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1		CHEMBL15511		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7676220	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1		CHEMBL1454946		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7676221	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)Nc1nc2cc(C(=O)c3ccc(F)cc3)ccc2[nH]1		CHEMBL1454946		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7676321	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1		CHEMBL1614641		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7676322	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H](C(=O)O)c1ccc2oc(-c3ccc(F)cc3)nc2c1		CHEMBL1614641		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677335	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O		CHEMBL435		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677336	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NS(=O)(=O)c1cc2c(cc1Cl)NCNS2(=O)=O		CHEMBL435		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677463	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I		CHEMBL788		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677464	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]c(=O)n([C@H]2C[C@H](O)[C@@H](CO)O2)cc1I		CHEMBL788		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677481	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(CCCN1CC=C(n2c(=O)[nH]c3ccccc32)CC1)c1ccc(F)cc1		CHEMBL1108		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677833	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL532		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677834	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL532		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677951	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C		CHEMBL691		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7677952	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@@]21C		CHEMBL691		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678078	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O		CHEMBL44657		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678079	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc([C@@H]2c3cc4c(cc3[C@@H](O[C@@H]3O[C@@H]5CO[C@@H](C)O[C@H]5[C@H](O)[C@H]3O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1O		CHEMBL44657		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678295	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909055		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678296	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909055		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678431	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1ccc2ccccc2o1		CHEMBL6466		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7678432	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1ccc2ccccc2o1		CHEMBL6466		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679173	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O		CHEMBL898		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679174	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1cc(-c2ccc(F)cc2F)ccc1O		CHEMBL898		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679240	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[S+](C)[O-]		CHEMBL504		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679241	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[S+](C)[O-]		CHEMBL504		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679740	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]		CHEMBL334255		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679741	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCCCCCCCCCCCCC[n+]1ccccc1.[Br-]		CHEMBL334255		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679819	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1		CHEMBL498		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679820	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1		CHEMBL498		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679964	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1200528		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7679965	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1200528		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680050	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O		CHEMBL557555		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680051	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(Oc1ccc(C2CC2(Cl)Cl)cc1)C(=O)O		CHEMBL557555		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680315	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1		CHEMBL452		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680316	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CN=C(c2ccccc2Cl)c2cc([N+](=O)[O-])ccc2N1		CHEMBL452		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680820	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL139835		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680821	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL139835		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680934	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1		CHEMBL157548		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7680935	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C[C@@H]2C[C@H]1CN2c1cc2c(cc1F)c(=O)c(C(=O)O)cn2C1CC1		CHEMBL157548		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7681023	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1		CHEMBL1201353		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7681024	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CC[C@@H](c1ccc(Cl)cc1)c1ccccn1		CHEMBL1201353		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7681161	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COP(=O)(OC)OC=C(Cl)Cl		CHEMBL167911		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7681162	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COP(=O)(OC)OC=C(Cl)Cl		CHEMBL167911		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7681569	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCC=C1c2ccccc2COc2ccccc21		CHEMBL1628227		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7681570	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCC=C1c2ccccc2COc2ccccc21		CHEMBL1628227		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7681687	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12		CHEMBL723		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7681688	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccccc1OCCNCC(O)COc1cccc2[nH]c3ccccc3c12		CHEMBL723		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682419	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1		CHEMBL1626		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682420	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCC[C@@H]1CCO[C@](C)(c1ccccc1)c1ccc(Cl)cc1		CHEMBL1626		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682631	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909056		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682632	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909056		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682768	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1		CHEMBL428880		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7682769	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1cc(=O)c2c(OCC(O)COc3cccc4oc(C(=O)O)cc(=O)c34)cccc2o1		CHEMBL428880		Ki			CHEMBL1868	Homo sapiens	Ki		
	7683495	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1[C@H]2[C@@H](O[C@]13CC[C@@H](C)CO3)[C@@H](O)[C@H]1[C@@H]3CC[C@H]4C[C@@H](O[C@@H]5O[C@H](CO)[C@H](O[C@@H]6O[C@H](CO)C(O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)C[C@]4(C)[C@H]3CC[C@@]12C		CHEMBL404811	=	IC50	nM	3859.0	CHEMBL1868	Homo sapiens	IC50	uM	3.859
	7683496	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1[C@H]2[C@@H](O[C@]13CC[C@@H](C)CO3)[C@@H](O)[C@H]1[C@@H]3CC[C@H]4C[C@@H](O[C@@H]5O[C@H](CO)[C@H](O[C@@H]6O[C@H](CO)C(O)[C@H](O[C@@H]7OC[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)C[C@]4(C)[C@H]3CC[C@@]12C		CHEMBL404811	=	Ki	nM	1001.0	CHEMBL1868	Homo sapiens	Ki	uM	1.001
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683549	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCOC(c1ccccc1)c1ccccc1		CHEMBL657		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683550	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCOC(c1ccccc1)c1ccccc1		CHEMBL657		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683736	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O		CHEMBL1754		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7683737	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN1CC(CCN2CCOCC2)C(c2ccccc2)(c2ccccc2)C1=O		CHEMBL1754		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684041	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1		CHEMBL515		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684042	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CCCc1ccc(N(CCCl)CCCl)cc1		CHEMBL515		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684121	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12		CHEMBL404520		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684122	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)ccc(Cl)c4[C@@](C)(O)[C@H]3C[C@@H]12		CHEMBL404520		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684265	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc(C2CCCCC2)n(O)c(=O)c1		CHEMBL1413		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684266	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc(C2CCCCC2)n(O)c(=O)c1		CHEMBL1413		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684359	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O		CHEMBL8		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684360	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1cn(C2CC2)c2cc(N3CCNCC3)c(F)cc2c1=O		CHEMBL8		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684613	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1cccc(Cl)c1N=C1NCCN1		CHEMBL134		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7684614	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1cccc(Cl)c1N=C1NCCN1		CHEMBL134		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685115	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(N)nc(NC2CC2)n1		CHEMBL1231107		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685116	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(N)nc(NC2CC2)n1		CHEMBL1231107		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685224	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1		CHEMBL1201216		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685225	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccccc1N1CCN(CCc2nnc3n2CCCC3)CC1		CHEMBL1201216		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685310	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1		CHEMBL248702		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685311	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN[C@@H](C)Cc1cccc(C(F)(F)F)c1		CHEMBL248702		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685450	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl		CHEMBL139		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685451	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)Cc1ccccc1Nc1c(Cl)cccc1Cl		CHEMBL139		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685959	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1ccccc1O		CHEMBL280998		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7685960	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1ccccc1O		CHEMBL280998		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686625	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC		CHEMBL1729		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686626	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC		CHEMBL1729		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686704	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1		CHEMBL49080		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686705	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1		CHEMBL49080		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686916	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C(C)[C@H]1[C@@H]2C(=O)O[C@H]1[C@H]1OC(=O)[C@@]34O[C@@H]3C[C@]2(O)[C@@]14C		CHEMBL47244		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7686917	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C(C)[C@H]1[C@@H]2C(=O)O[C@H]1[C@H]1OC(=O)[C@@]34O[C@@H]3C[C@]2(O)[C@@]14C		CHEMBL47244		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687054	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C/C=C/C(=O)N(CC)c1ccccc1C		CHEMBL1200709		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687055	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C/C=C/C(=O)N(CC)c1ccccc1C		CHEMBL1200709		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687780	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O		CHEMBL254219		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687781	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6CC[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O		CHEMBL254219		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687820	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1		CHEMBL936		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7687821	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OC(CCCN1CCCCC1)(c1ccccc1)c1ccccc1		CHEMBL936		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688011	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC		CHEMBL707		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688012	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc2nc(N3CCN(C(=O)C4COc5ccccc5O4)CC3)nc(N)c2cc1OC		CHEMBL707		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688332	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl		CHEMBL130		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688333	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(N[C@H](CO)[C@H](O)c1ccc([N+](=O)[O-])cc1)C(Cl)Cl		CHEMBL130		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688411	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl		CHEMBL1055		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688412	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NS(=O)(=O)c1cc(C2(O)NC(=O)c3ccccc32)ccc1Cl		CHEMBL1055		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688536	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1		CHEMBL7002		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688537	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1		CHEMBL7002		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688887	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1		CHEMBL1771		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7688888	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)[C@H](c1ccccc1Cl)N1CCc2sccc2C1		CHEMBL1771		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689392	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1		CHEMBL803		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689393	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1		CHEMBL803		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689496	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL178		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689497	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1		CHEMBL178		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689578	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)Cc1ccc([C@H](C)C(=O)O)cc1		CHEMBL175		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689579	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)Cc1ccc([C@H](C)C(=O)O)cc1		CHEMBL175		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689716	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O		CHEMBL1466		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7689717	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1oc2ccccc2c(O)c1Cc1c(O)c2ccccc2oc1=O		CHEMBL1466		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690234	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21		CHEMBL1201195		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690235	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@@]1(NC(=O)CSCC#N)C(=O)N2C(C(=O)O)=C(CSc3nnnn3C)CS[C@@H]21		CHEMBL1201195		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690877	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL11359		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690878	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL11359		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690967	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1		CHEMBL1753		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7690968	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@H](C)Cl)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1		CHEMBL1753		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691178	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2		CHEMBL107		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691179	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc2c(c(OC)c1OC)-c1ccc(OC)c(=O)cc1[C@@H](NC(C)=O)CC2		CHEMBL107		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691316	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1		CHEMBL1480987		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7691317	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1CC(OC(=O)C(O)c2ccccc2)CC(C)(C)C1		CHEMBL1480987		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692062	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O		CHEMBL1751		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692063	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1O[C@@H](O[C@H]2[C@@H](O)C[C@H](O[C@H]3[C@@H](O)C[C@H](O[C@H]4CC[C@]5(C)[C@H]6C[C@@H](O)[C@]7(C)[C@@H](C8=CC(=O)OC8)CC[C@]7(O)[C@@H]6CC[C@@H]5C4)O[C@@H]3C)O[C@@H]2C)C[C@H](O)[C@@H]1O		CHEMBL1751		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692105	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1		CHEMBL932		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692106	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OCCN(CCO)c1nc(N2CCCCC2)c2nc(N(CCO)CCO)nc(N3CCCCC3)c2n1		CHEMBL932		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692600	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1		CHEMBL451		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692601	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNC1=Nc2ccc(Cl)cc2C(c2ccccc2)=[N+]([O-])C1		CHEMBL451		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692681	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]c2cc(Cl)ccc2o1		CHEMBL1371		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692682	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]c2cc(Cl)ccc2o1		CHEMBL1371		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692802	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C(=O)CCCOc1ccc2nc(O)ccc2c1)C1CCCCC1		CHEMBL34431		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7692803	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C(=O)CCCOc1ccc2nc(O)ccc2c1)C1CCCCC1		CHEMBL34431		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693159	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NCC(O)c1ccccc1Cl		CHEMBL1902627		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693160	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NCC(O)c1ccccc1Cl		CHEMBL1902627		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693694	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2		CHEMBL504760		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693695	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)[C@@H]2CC[C@@]1(C)C(=O)C2		CHEMBL504760		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693798	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(O)c(=O)ccn1C		CHEMBL70927		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693799	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(O)c(=O)ccn1C		CHEMBL70927		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693878	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1		CHEMBL75435		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7693879	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H](C(=O)O)c1cccc(C(=O)c2ccccc2)c1		CHEMBL75435		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7694000	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1		CHEMBL1123		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7694001	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCOC(=O)C1(C2CCCCC2)CCCCC1		CHEMBL1123		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7694423	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	ClC(Cl)(Cl)Cl		CHEMBL44814		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7694424	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	ClC(Cl)(Cl)Cl		CHEMBL44814		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7694528	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1		CHEMBL1730		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7694529	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO/N=C(\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(COC(C)=O)CS[C@H]12)c1csc(N)n1		CHEMBL1730		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695167	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21		CHEMBL549		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695168	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCCC1(c2ccc(F)cc2)OCc2cc(C#N)ccc21		CHEMBL549		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695271	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1159650		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695272	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC(=O)O[C@]1(C(=O)CCl)[C@@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1159650		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695450	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O		CHEMBL12131		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695451	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c1cc(I)cc(I)c1O		CHEMBL12131		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695493	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O		CHEMBL2221249		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695494	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O.CCC(C)CCCCC(=O)N[C@@H](CCN)C(=O)N[C@@H](CN[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O		CHEMBL2221249		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695615	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCN(C(c2ccccc2)c2ccccc2)CC1		CHEMBL648		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7695616	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCN(C(c2ccccc2)c2ccccc2)CC1		CHEMBL648		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696348	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O		CHEMBL1255837		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696349	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O.CS(=O)(=O)O		CHEMBL1255837		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696418	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+]		CHEMBL487894		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696419	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(N(C)CS(=O)(=O)[O-])c(=O)n(-c2ccccc2)n1C.[Na+]		CHEMBL487894		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696827	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1		CHEMBL118		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696828	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1		CHEMBL118		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696935	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL110691		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7696936	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(Cl)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL110691		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697022	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C		CHEMBL1042		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697023	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@@]2(C)[C@H]1CC[C@@H]2[C@H](C)CCCC(C)C		CHEMBL1042		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697141	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1		CHEMBL799		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7697142	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CCc2cc(OCCCCc3nnnn3C3CCCCC3)ccc2N1		CHEMBL799		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698032	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.[Cl-]		CHEMBL1687		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698033	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C.[Cl-]		CHEMBL1687		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698136	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNCCCN1c2ccccc2CCc2ccccc21		CHEMBL72		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698137	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNCCCN1c2ccccc2CCc2ccccc21		CHEMBL72		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698220	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3		CHEMBL52440		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698221	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3		CHEMBL52440		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698338	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1		CHEMBL1460		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698339	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]cnc2c1ncn2[C@H]1CC[C@@H](CO)O1		CHEMBL1460		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698707	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)C(=S)SSC(=S)N(CC)CC		CHEMBL964		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698708	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)C(=S)SSC(=S)N(CC)CC		CHEMBL964		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698775	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1351		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7698776	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1351		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699496	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CC(O)(CC(=O)O)C(=O)O		CHEMBL1261		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699497	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CC(O)(CC(=O)O)C(=O)O		CHEMBL1261		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699598	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1		CHEMBL565		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699599	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1		CHEMBL565		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699724	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1		CHEMBL104		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699725	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccccc1C(c1ccccc1)(c1ccccc1)n1ccnc1		CHEMBL104		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699825	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909057		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699826	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909057		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699945	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL123292		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7699946	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1C[C@H](C)C(=O)[C@H]([C@H](O)CC2CC(=O)NC(=O)C2)C1		CHEMBL123292		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7700669	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL1732		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7700670	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL1732		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701255	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	ClC(Cl)Cl		CHEMBL44618		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701256	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	ClC(Cl)Cl		CHEMBL44618		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701342	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O		CHEMBL205596		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701343	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H](CCC(=O)O)[C@H]1CC[C@H]2[C@H]3[C@H](C[C@H](O)[C@@]21C)[C@@]1(C)CC[C@@H](O)C[C@H]1C[C@H]3O		CHEMBL205596		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701459	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN/C(=N/CCSCc1nc[nH]c1C)NC#N		CHEMBL30		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7701460	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN/C(=N/CCSCc1nc[nH]c1C)NC#N		CHEMBL30		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702314	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)/N=N/c1[nH]cnc1C(N)=O		CHEMBL476		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702315	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)/N=N/c1[nH]cnc1C(N)=O		CHEMBL476		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702399	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1		CHEMBL1172		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702400	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccc2c(c1)CCc1cccnc1C2=C1CCNCC1		CHEMBL1172		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702503	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I		CHEMBL1201220		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702504	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)Nc1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I		CHEMBL1201220		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702618	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@H]([C@@H]3[C@@]1(Cl)C2(Cl)Cl)[C@H]1O[C@@H]41		CHEMBL1873703		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702619	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	ClC1=C(Cl)[C@]2(Cl)[C@@H]3[C@@H]4C[C@H]([C@@H]3[C@@]1(Cl)C2(Cl)Cl)[C@H]1O[C@@H]41		CHEMBL1873703		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702992	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1		CHEMBL926		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7702993	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1		CHEMBL926		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703074	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909054		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703075	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909054		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703163	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1		CHEMBL1727		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703164	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=C(C(=O)O)N2C(=O)[C@@H](NC(=O)[C@H](N)c3ccccc3)[C@H]2SC1		CHEMBL1727		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703797	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=C2C(=CO[C@H](C)[C@H]2C)C(O)=C(C(=O)O)C1=O		CHEMBL510139		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703798	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=C2C(=CO[C@H](C)[C@H]2C)C(O)=C(C(=O)O)C1=O		CHEMBL510139		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703899	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(Oc1ccc(Cl)cc1)C(=O)O		CHEMBL683		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7703900	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(Oc1ccc(Cl)cc1)C(=O)O		CHEMBL683		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704019	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12		CHEMBL891		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704020	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1onc(-c2ccccc2Cl)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12		CHEMBL891		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704130	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL1499		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704131	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL1499		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704251	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=P1(N(CCCl)CCCl)NCCCO1		CHEMBL88		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704252	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=P1(N(CCCl)CCCl)NCCCO1		CHEMBL88		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704888	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1		CHEMBL411		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704889	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC/C(=C(/CC)c1ccc(O)cc1)c1ccc(O)cc1		CHEMBL411		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704973	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1		CHEMBL23		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7704974	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc([C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(C)=O)cc1		CHEMBL23		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705558	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc(O)cc(C)c1Cl		CHEMBL398440		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705559	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc(O)cc(C)c1Cl		CHEMBL398440		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705655	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO		CHEMBL1567463		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705656	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[N+](C)(C)CCOP(=O)([O-])OC[C@H](O)CO		CHEMBL1567463		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705772	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C/C=C/c1ccccc1		CHEMBL293492		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7705773	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C/C=C/c1ccccc1		CHEMBL293492		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706674	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O		CHEMBL1554		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706675	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c2oc3c(C)ccc(C(=O)N[C@@H]4C(=O)N[C@H](C(C)C)C(=O)N5CCC[C@H]5C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]4C)c3nc-2c(C(=O)N[C@@H]2C(=O)N[C@H](C(C)C)C(=O)N3CCC[C@H]3C(=O)N(C)CC(=O)N(C)[C@@H](C(C)C)C(=O)O[C@@H]2C)c(N)c1=O		CHEMBL1554		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706751	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO		CHEMBL1766		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706752	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@H]1C(=O)CO		CHEMBL1766		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706857	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21		CHEMBL12		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7706858	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C(=O)CN=C(c2ccccc2)c2cc(Cl)ccc21		CHEMBL12		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7707318	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C.O.O.O		CHEMBL3545252		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7707319	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@@H]12)C3(C)C.O.O.O		CHEMBL3545252		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7707409	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O		CHEMBL460499		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7707410	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCCCNC(=O)n1cc(F)c(=O)[nH]c1=O		CHEMBL460499		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7707498	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1		CHEMBL1477		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7707499	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COCc1c(C(C)C)nc(C(C)C)c(/C=C/[C@@H](O)C[C@@H](O)CC(=O)O)c1-c1ccc(F)cc1		CHEMBL1477		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708174	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL1619		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708175	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(Cl)nc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1		CHEMBL1619		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708252	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1		CHEMBL954		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708253	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCOc1ccc(/C(=C(/Cl)c2ccccc2)c2ccccc2)cc1		CHEMBL954		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708384	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1		CHEMBL42		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708385	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1		CHEMBL42		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708520	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C		CHEMBL1650		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708521	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3C(=O)C[C@@]21C		CHEMBL1650		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708640	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C		CHEMBL160		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7708641	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C/C=C/C[C@@H](C)[C@@H](O)[C@H]1C(=O)N[C@@H](CC)C(=O)N(C)CC(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](CC(C)C)C(=O)N(C)[C@@H](C(C)C)C(=O)N1C		CHEMBL160		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709294	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1200545		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709295	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)OCC(=O)[C@@]1(OC(C)=O)[C@@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C		CHEMBL1200545		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709366	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O		CHEMBL1200406		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709367	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCOC(c1ccccc1)c1ccccc1.Cn1c(=O)c2[nH]c(Cl)nc2n(C)c1=O		CHEMBL1200406		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709932	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21		CHEMBL71		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7709933	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21		CHEMBL71		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710077	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[N+](C)(C)CCO.[Cl-]		CHEMBL282468		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710078	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[N+](C)(C)CCO.[Cl-]		CHEMBL282468		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710166	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1		CHEMBL43064		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710167	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C(=C/c1ccccc1)\CN1CCN(C(c2ccccc2)c2ccccc2)CC1		CHEMBL43064		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710947	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1		CHEMBL516		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7710948	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCC(=C2c3ccccc3C=Cc3ccccc32)CC1		CHEMBL516		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711066	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1479		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711067	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=Cc5oncc5C[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1479		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711171	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL384467		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711172	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO		CHEMBL384467		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711290	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=NS(=O)(=O)c2cc(Cl)ccc2N1		CHEMBL181		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711291	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=NS(=O)(=O)c2cc(Cl)ccc2N1		CHEMBL181		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711722	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1		CHEMBL219916		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711723	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]c2ccccc2n1CCCN1CCC(n2c(=O)[nH]c3cc(Cl)ccc32)CC1		CHEMBL219916		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711826	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=NN(CCCl)C(=O)NCCCl		CHEMBL513		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711827	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=NN(CCCl)C(=O)NCCCl		CHEMBL513		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711935	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cl.NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1		CHEMBL502896		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7711936	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cl.NC[C@H]1CC[C@H](C(=O)Oc2ccc(CCC(=O)O)cc2)CC1		CHEMBL502896		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712576	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL1741		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712577	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL1741		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712611	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21		CHEMBL415		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712612	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCCN1c2ccccc2CCc2ccc(Cl)cc21		CHEMBL415		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712860	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC		CHEMBL19224		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712861	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC		CHEMBL19224		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712985	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C(C)C1(O)OC(=O)C=C1OC		CHEMBL495778		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7712986	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C(C)C1(O)OC(=O)C=C1OC		CHEMBL495778		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713069	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOc1ccc(NC(C)=O)cc1		CHEMBL16073		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713070	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOc1ccc(NC(C)=O)cc1		CHEMBL16073		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713176	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NNc1ccccc1		CHEMBL456807		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713177	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NNc1ccccc1		CHEMBL456807		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713273	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-]		CHEMBL1909073		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713274	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[N+]1(CCOC(=O)C(O)(c2ccccc2)c2ccccc2)CCCCC1.[Br-]		CHEMBL1909073		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713415	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[n+]1ccccc1/C=N/O.[Cl-]		CHEMBL748		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713416	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[n+]1ccccc1/C=N/O.[Cl-]		CHEMBL748		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713535	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCNC(C)C(=O)Nc1ccccc1C		CHEMBL1194		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7713536	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCNC(C)C(=O)Nc1ccccc1C		CHEMBL1194		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7714002	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12		CHEMBL7568		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7714003	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc2ccc(OC)cc12		CHEMBL7568		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7714082	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O		CHEMBL184618		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7714083	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC[C@@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@H]3O[C@H](CN)[C@@H](O)[C@H](O)[C@H]3N)[C@@H]2O)[C@H](N)[C@@H](O)[C@@H]1O		CHEMBL184618		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7714210	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1		CHEMBL63323		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7714211	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1cccnc1Nc1cccc(C(F)(F)F)c1		CHEMBL63323		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7714330	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1		CHEMBL572		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7714331	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CN(/N=C/c2ccc([N+](=O)[O-])o2)C(=O)N1		CHEMBL572		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7714734	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1		CHEMBL1231		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7714735	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1		CHEMBL1231		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715901	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C		CHEMBL103		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715902	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C		CHEMBL103		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715927	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(O)CO		CHEMBL286398		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7715928	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(O)CO		CHEMBL286398		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716671	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909071		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716672	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909071		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716767	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccccc1C(OCCN(C)C)c1ccccc1		CHEMBL900		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716768	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccccc1C(OCCN(C)C)c1ccccc1		CHEMBL900		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716985	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1		CHEMBL762		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7716986	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1		CHEMBL762		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717118	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-]		CHEMBL458019		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717119	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[n+]1ccc(-c2cc[n+](C)cc2)cc1.[Cl-].[Cl-]		CHEMBL458019		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717244	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL29		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717245	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O		CHEMBL29		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717323	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NNCCc1ccccc1		CHEMBL1089		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717324	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NNCCc1ccccc1		CHEMBL1089		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717435	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1N=C(O)NC1(c1ccccc1)c1ccccc1		CHEMBL16		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717436	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1N=C(O)NC1(c1ccccc1)c1ccccc1		CHEMBL16		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717534	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)CN1CCCC1=O		CHEMBL36715		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717535	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)CN1CCCC1=O		CHEMBL36715		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717677	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCOc1ccc(OCCCN2CCOCC2)cc1		CHEMBL1198		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717678	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCOc1ccc(OCCCN2CCOCC2)cc1		CHEMBL1198		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717798	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(NC(C)CCCN)c2ncccc2c1		CHEMBL506		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7717799	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(NC(C)CCCN)c2ncccc2c1		CHEMBL506		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7718340	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-]		CHEMBL54126		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7718341	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)C(=O)Oc1cccc([N+](C)(C)C)c1.[Br-]		CHEMBL54126		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7718466	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O		CHEMBL485549		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7718467	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(N/N=C/c1ccc([N+](=O)[O-])o1)c1cc([N+](=O)[O-])cc([N+](=O)[O-])c1O		CHEMBL485549		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7718588	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1		CHEMBL3183075		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7718589	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNC(=C[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1		CHEMBL3183075		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720157	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1		CHEMBL316561		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720158	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1		CHEMBL316561		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720190	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCc1cc(=O)[nH]c(=S)[nH]1		CHEMBL1518		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720191	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCc1cc(=O)[nH]c(=S)[nH]1		CHEMBL1518		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720399	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O		CHEMBL1592		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720400	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1Cc2ccccc2C[C@H]1C(=O)O		CHEMBL1592		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720937	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2		CHEMBL450895		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7720938	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@]2(O)C[C@H](O)[C@@H](C(=O)O)[C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)/C=C/C=C/C=C/C=C/CC/C=C/C=C/[C@H](C)[C@@H](O)[C@H]1C)O2		CHEMBL450895		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721025	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O		CHEMBL222863		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721026	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O		CHEMBL222863		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721232	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O		CHEMBL1200585		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721233	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12C/C(=C/O)C(=O)C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O		CHEMBL1200585		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721358	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1		CHEMBL490		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721359	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Fc1ccc([C@@H]2CCNC[C@H]2COc2ccc3c(c2)OCO3)cc1		CHEMBL490		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721485	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1		CHEMBL55		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721486	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N=C(N)c1ccc(OCCCCCOc2ccc(C(=N)N)cc2)cc1		CHEMBL55		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721586	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1c2ccccc2C(=O)C1c1ccccc1		CHEMBL711		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721587	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1c2ccccc2C(=O)C1c1ccccc1		CHEMBL711		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721696	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C		CHEMBL94		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721697	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNC(=O)Oc1ccc2c(c1)[C@]1(C)CCN(C)[C@@H]1N2C		CHEMBL94		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721794	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C		CHEMBL295416		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721795	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C		CHEMBL295416		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721933	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21		CHEMBL1144		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7721934	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H](C)C(=O)O[C@H]1C[C@H](O)C=C2C=C[C@H](C)[C@H](CC[C@@H](O)C[C@@H](O)CC(=O)O)[C@H]21		CHEMBL1144		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7722055	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1(c2ccccc2)C(=O)NCNC1=O		CHEMBL856		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7722056	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1(c2ccccc2)C(=O)NCNC1=O		CHEMBL856		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7722616	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O		CHEMBL1572		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7722617	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN[C@@H]1C[C@H](N)[C@@H](O[C@H]2OC(CN)=CC[C@H]2N)[C@H](O)[C@H]1O[C@H]1OC[C@](C)(O)[C@H](NC)[C@H]1O		CHEMBL1572		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7722738	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1		CHEMBL56367		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7722739	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CS(=O)(=O)Nc1ccc([N+](=O)[O-])cc1Oc1ccccc1		CHEMBL56367		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7722857	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)Nc1nc2ccc(C(=O)c3cccs3)cc2[nH]1		CHEMBL9514		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7722858	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)Nc1nc2ccc(C(=O)c3cccs3)cc2[nH]1		CHEMBL9514		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724382	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCCN1c2ccccc2Sc2ccccc21		CHEMBL564		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724383	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCCN1c2ccccc2Sc2ccccc21		CHEMBL564		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724456	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O		CHEMBL600325		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724457	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1O[C@@H](O[C@@H]2C=C3CC[C@@H]4[C@H](CC[C@]5(C)[C@@H](c6ccc(=O)oc6)CC[C@]45O)[C@@]3(C)CC2)[C@H](O)[C@H](O)[C@H]1O		CHEMBL600325		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724664	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909075		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7724665	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909075		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725203	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccccc1N		CHEMBL1612004		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725204	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccccc1N		CHEMBL1612004		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725293	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL414804		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725294	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL414804		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725499	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1cccc2cccnc12		CHEMBL310555		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725500	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1cccc2cccnc12		CHEMBL310555		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725615	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21		CHEMBL540445		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725616	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C1C(=O)O[C@H]2[C@H]1CC/C(C)=C/CC[C@@]1(C)O[C@@H]21		CHEMBL540445		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725738	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O		CHEMBL628		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725739	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)CCCCn1c(=O)c2c(ncn2C)n(C)c1=O		CHEMBL628		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725847	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1(c2ccccc2)C(=O)NC(=O)NC1=O		CHEMBL40		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725848	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1(c2ccccc2)C(=O)NC(=O)NC1=O		CHEMBL40		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725957	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O		CHEMBL1200656		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7725958	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O		CHEMBL1200656		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726059	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21		CHEMBL311350		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726060	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCn1cc(C(=O)O)c(=O)c2cnc(N3CCCC3)nc21		CHEMBL311350		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726199	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1		CHEMBL976		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726200	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(C1CCCCC1)N1CC(=O)N2CCc3ccccc3C2C1		CHEMBL976		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726329	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1		CHEMBL897		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726330	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCN(CCC)S(=O)(=O)c1ccc(C(=O)O)cc1		CHEMBL897		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726774	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5		CHEMBL19019		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726775	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5c4[C@@]2(CCN3CC2CC2)[C@H]1O5		CHEMBL19019		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726885	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1		CHEMBL57		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7726886	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1		CHEMBL57		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7727005	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21		CHEMBL13341		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7727006	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C(=O)CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc21		CHEMBL13341		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7727122	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1162		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7727123	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1162		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728631	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(CN1c2ccccc2Sc2ccccc21)N(C)C		CHEMBL643		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728632	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(CN1c2ccccc2Sc2ccccc21)N(C)C		CHEMBL643		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728742	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@@H](n3cnc4c(N(C)C)ncnc43)[C@@H]2O)cc1		CHEMBL469912		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7728743	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@@H](n3cnc4c(N(C)C)ncnc43)[C@@H]2O)cc1		CHEMBL469912		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729392	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1201146		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729393	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(OC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C		CHEMBL1201146		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729486	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1		CHEMBL3350037		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729487	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H](O)[C@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)Cc2ccccc2)C(=O)N[C@@H](Cc2ccccc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1		CHEMBL3350037		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729575	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1		CHEMBL1071		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729576	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1		CHEMBL1071		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729780	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12		CHEMBL1517		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729781	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3[C@H](O)[C@@H]12		CHEMBL1517		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729897	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21		CHEMBL267648		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7729898	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCN(C)CC3)cc21		CHEMBL267648		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730003	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL531		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730004	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCN1C[C@H](CSC)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21		CHEMBL531		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730133	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1ccccc1		CHEMBL14060		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730134	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1ccccc1		CHEMBL14060		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730243	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NCC(O)COc1cccc2[nH]ccc12		CHEMBL500		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730244	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NCC(O)COc1cccc2[nH]ccc12		CHEMBL500		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730347	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O		CHEMBL527		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730348	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C(C(=O)Nc2ccccn2)=C(O)c2ccccc2S1(=O)=O		CHEMBL527		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730476	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC		CHEMBL2		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730477	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc2nc(N3CCN(C(=O)c4ccco4)CC3)nc(N)c2cc1OC		CHEMBL2		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730614	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1		CHEMBL608		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7730615	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1)Sc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1		CHEMBL608		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7731048	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL757		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7731049	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@@H]3[C@H]4CCC(=O)C=C4CC[C@H]3[C@@H]1CC[C@@H]2O		CHEMBL757		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7731164	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1cccnc1		CHEMBL573		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7731165	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1cccnc1		CHEMBL573		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7731277	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1		CHEMBL1428		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7731278	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1c1cccc([N+](=O)[O-])c1		CHEMBL1428		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732881	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1		CHEMBL631		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7732882	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCNCC(O)COc1ccccc1C(=O)CCc1ccccc1		CHEMBL631		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733001	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)c1cnccn1		CHEMBL614		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733002	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)c1cnccn1		CHEMBL614		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733652	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21		CHEMBL9		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733653	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNCC3)cc21		CHEMBL9		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733747	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23		CHEMBL4		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733748	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23		CHEMBL4		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733844	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)N1c2ccccc2CC(=O)c2ccccc21		CHEMBL1068		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7733845	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)N1c2ccccc2CC(=O)c2ccccc21		CHEMBL1068		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734048	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C		CHEMBL428647		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734049	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(C)=O)[C@H]2[C@H](OC(=O)c2ccccc2)[C@]2(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c3ccccc3)c3ccccc3)C(C)=C1C2(C)C		CHEMBL428647		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734170	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC1=NC(=O)C(c2ccccc2)O1		CHEMBL1177		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734171	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC1=NC(=O)C(c2ccccc2)O1		CHEMBL1177		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734260	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1		CHEMBL75880		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734261	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1		CHEMBL75880		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734390	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc2c(c1)Nc1ccccc1S2		CHEMBL828		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734391	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc2c(c1)Nc1ccccc1S2		CHEMBL828		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734511	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1		CHEMBL595		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734512	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1		CHEMBL595		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734629	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC		CHEMBL61		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734630	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@H]23)OCO4)cc(OC)c1OC		CHEMBL61		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734756	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL131		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734757	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL131		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734897	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCNC(=O)c1ccc(N)cc1		CHEMBL640		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7734898	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCNC(=O)c1ccc(N)cc1		CHEMBL640		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735278	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(CN(CCN(C)C)c2ccccn2)cc1		CHEMBL511		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735279	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(CN(CCN(C)C)c2ccccn2)cc1		CHEMBL511		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735334	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2cc([C@H](C)C(=O)O)ccc2c1		CHEMBL154		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735335	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2cc([C@H](C)C(=O)O)ccc2c1		CHEMBL154		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735450	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)c1cccnc1		CHEMBL1140		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735451	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)c1cccnc1		CHEMBL1140		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735556	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]		CHEMBL1726		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7735557	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1c1ccccc1[N+](=O)[O-]		CHEMBL1726		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737170	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N		CHEMBL1196		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737171	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCOc1ccc(C(=O)OCCN(CC)CC)cc1N		CHEMBL1196		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737942	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC		CHEMBL2107797		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7737943	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#CC1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21CC		CHEMBL2107797		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738024	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1		CHEMBL715		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738025	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc2c(s1)Nc1ccccc1N=C2N1CCN(C)CC1		CHEMBL715		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738141	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1		CHEMBL42442		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738142	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)Nc1nc2cc([S+]([O-])c3ccccc3)ccc2[nH]1		CHEMBL42442		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738357	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(CO)C(O)C(=O)NCCCO		CHEMBL1371937		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738358	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(CO)C(O)C(=O)NCCCO		CHEMBL1371937		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738479	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(O)c2ncn(CCC(CO)CO)c2n1		CHEMBL1540		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738480	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(O)c2ncn(CCC(CO)CO)c2n1		CHEMBL1540		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738563	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL567		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738564	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OCCN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL567		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738681	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1		CHEMBL597		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738682	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(N(CC2=NCCN2)c2cccc(O)c2)cc1		CHEMBL597		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738784	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL1909072		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738785	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)C1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL1909072		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738919	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL3559671		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7738920	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL3559671		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739043	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL635		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739044	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)CO		CHEMBL635		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739186	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCOC(=O)c1ccc(N)cc1		CHEMBL569		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739187	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCOC(=O)c1ccc(N)cc1		CHEMBL569		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739558	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1cccc(O)c1O		CHEMBL307145		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739559	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1cccc(O)c1O		CHEMBL307145		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739616	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1		CHEMBL783		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739617	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)[C@H]1CC[C@H](C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1		CHEMBL783		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739741	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCC[C@H]1c1cccnc1		CHEMBL3		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739742	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCC[C@H]1c1cccnc1		CHEMBL3		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739856	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1		CHEMBL13209		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7739857	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CN=C(c2ccccc2)c2cc([N+](=O)[O-])ccc2N1		CHEMBL13209		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741472	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)c1cccc(C(C)C)c1O		CHEMBL526		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7741473	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)c1cccc(C(C)C)c1O		CHEMBL526		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742251	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNCCC=C1c2ccccc2CCc2ccccc21		CHEMBL445		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742252	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNCCC=C1c2ccccc2CCc2ccccc21		CHEMBL445		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742361	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1		CHEMBL1503		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742362	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2[nH]c([S+]([O-])Cc3ncc(C)c(OC)c3C)nc2c1		CHEMBL1503		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742455	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1		CHEMBL1262		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742456	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccc(CO/N=C(\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1		CHEMBL1262		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742690	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC		CHEMBL1502		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742691	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccnc(C[S+]([O-])c2nc3cc(OC(F)F)ccc3[nH]2)c1OC		CHEMBL1502		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742812	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(S)[C@@H](N)C(=O)O		CHEMBL1430		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742813	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(S)[C@@H](N)C(=O)O		CHEMBL1430		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742896	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)NC(=O)Cc1ccccc1		CHEMBL918		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7742897	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)NC(=O)Cc1ccccc1		CHEMBL918		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743010	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O		CHEMBL101		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743011	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O		CHEMBL101		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743112	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O		CHEMBL702		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743113	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN1CCN(C(=O)N[C@@H](C(=O)N[C@@H]2C(=O)N3[C@@H](C(=O)O)C(C)(C)S[C@H]23)c2ccccc2)C(=O)C1=O		CHEMBL702		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743248	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL2108139		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743249	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL2108139		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743368	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1400945		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743369	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)[C@H]1[C@H](C#N)C[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1400945		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743513	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNNCc1ccc(C(=O)NC(C)C)cc1		CHEMBL1321		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743514	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNNCc1ccc(C(=O)NC(C)C)cc1		CHEMBL1321		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743782	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NCC(O)COc1cccc2ccccc12		CHEMBL27		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743894	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1		CHEMBL716		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743895	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OCCOCCN1CCN(C2=Nc3ccccc3Sc3ccccc32)CC1		CHEMBL716		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743964	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C		CHEMBL584		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7743965	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C		CHEMBL584		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7744097	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]		CHEMBL193		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7744098	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1ccccc1[N+](=O)[O-]		CHEMBL193		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7744215	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1		CHEMBL475534		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7744216	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1c1cccc([N+](=O)[O-])c1		CHEMBL475534		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745805	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL728		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745806	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCN(CCCN2c3ccccc3Sc3ccc(Cl)cc32)CC1		CHEMBL728		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7745825	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NCC(O)COc1cccc2ccccc12		CHEMBL27		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746582	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C		CHEMBL364713		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746583	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2c(c1OC)C(=O)O[C@@H]2[C@H]1c2c(cc3c(c2OC)OCO3)CCN1C		CHEMBL364713		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746694	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O		CHEMBL46		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746695	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1nccn1CC1CCc2c(c3ccccc3n2C)C1=O		CHEMBL46		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746864	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O		CHEMBL580		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746865	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1Nc2ccc(Cl)cc2C(c2ccccc2Cl)=NC1O		CHEMBL580		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746973	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO		CHEMBL689		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7746974	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO		CHEMBL689		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747077	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL717		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747078	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL717		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747190	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12		CHEMBL127		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747191	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C(S[C@@H]3CN[C@H](C(=O)N(C)C)C3)[C@H](C)[C@H]12		CHEMBL127		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747797	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21		CHEMBL58		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747798	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1c2c(O)ccc(O)c2C(=O)c2c(NCCNCCO)ccc(NCCNCCO)c21		CHEMBL58		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747900	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2		CHEMBL866		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7747901	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)O)C(=O)OC2		CHEMBL866		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748031	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314		CHEMBL895		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7748032	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1ccc2c3c1O[C@H]1[C@@H](O)CC[C@@]4(O)[C@@H](C2)N(CC2CCC2)CC[C@]314		CHEMBL895		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749547	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1c2occc2cc2ccc(=O)oc12		CHEMBL416		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749548	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1c2occc2cc2ccc(=O)oc12		CHEMBL416		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749657	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1		CHEMBL1065		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749658	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1		CHEMBL1065		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749790	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cccc(C)c1OCC(C)N		CHEMBL558		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7749791	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cccc(C)c1OCC(C)N		CHEMBL558		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750354	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1		CHEMBL165790		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750355	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)Oc1ccc2c(=O)c(-c3ccccc3)coc2c1		CHEMBL165790		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750490	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1		CHEMBL547		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750491	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=C(/C=C/C(C)=C/C=C/C(C)=C\C(=O)O)C(C)(C)CCC1		CHEMBL547		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750574	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1		CHEMBL534		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750575	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCC(=C2c3ccccc3CC(=O)c3sccc32)CC1		CHEMBL534		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750675	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1		CHEMBL141		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750676	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccn([C@@H]2CS[C@H](CO)O2)c(=O)n1		CHEMBL141		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750810	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc([C@H]2CN3CCSC3=N2)cc1		CHEMBL1454		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750811	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc([C@H]2CN3CCSC3=N2)cc1		CHEMBL1454		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750945	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1		CHEMBL1447		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7750946	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1		CHEMBL1447		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7751159	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1		CHEMBL191		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7751160	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCc1nc(Cl)c(CO)n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1		CHEMBL191		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7751244	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNCCCC12CCC(c3ccccc31)c1ccccc12		CHEMBL21731		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7751245	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNCCCC12CCC(c3ccccc31)c1ccccc12		CHEMBL21731		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7751366	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cccc(Nc2ccccc2C(=O)O)c1C		CHEMBL686		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7751367	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cccc(Nc2ccccc2C(=O)O)c1C		CHEMBL686		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7751480	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=S(=O)([O-])CCS.[Na+]		CHEMBL975		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7751481	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=S(=O)([O-])CCS.[Na+]		CHEMBL975		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752101	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1		CHEMBL86304		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752102	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(NCCN1CCOCC1)c1ccc(Cl)cc1		CHEMBL86304		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752202	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCOCCC1=CCC2CC1C2(C)C		CHEMBL1630579		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7752203	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCOCCC1=CCC2CC1C2(C)C		CHEMBL1630579		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753840	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@H]1O[C@@H]21.[Br-]		CHEMBL1201024		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753841	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[N+]1(C)[C@H]2C[C@H](OC(=O)[C@H](CO)c3ccccc3)C[C@H]1[C@H]1O[C@@H]21.[Br-]		CHEMBL1201024		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753942	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC		CHEMBL86		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7753943	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC		CHEMBL86		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754063	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCN2c3ccccc3Cc3ccccc3C2C1		CHEMBL6437		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754064	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCN2c3ccccc3Cc3ccccc3C2C1		CHEMBL6437		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754500	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5		CHEMBL1618305		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754501	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2/C(=N/N=C2\CC[C@@]4(O)[C@H]6Cc7ccc(O)c8c7[C@@]4(CCN6CC=C)[C@H]2O8)CC[C@@]3(O)[C@H]1C5		CHEMBL1618305		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754674	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NNC(=O)c1ccncc1		CHEMBL92401		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754675	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NNC(=O)c1ccncc1		CHEMBL92401		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754806	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O		CHEMBL64391		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754807	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC(C)n1ncn(-c2ccc(N3CCN(c4ccc(OCC5COC(Cn6cncn6)(c6ccc(Cl)cc6Cl)O5)cc4)CC3)cc2)c1=O		CHEMBL64391		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754890	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O		CHEMBL2106399		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754891	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@@H]1[C@@H](O[C@@H]2O[C@H](C)[C@@H](O[C@H]3C[C@@](C)(O)[C@@H](OC(=O)CC(C)C)[C@H](C)O3)[C@H](N(C)C)[C@H]2O)[C@@H](CC=O)C[C@@H](C)[C@@H](O)/C=C/C=C/C[C@@H](C)OC(=O)C[C@H]1O		CHEMBL2106399		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754998	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1		CHEMBL741		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7754999	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nnc(-c2cccc(Cl)c2Cl)c(N)n1		CHEMBL741		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755126	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O		CHEMBL1201237		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755127	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NC[C@H](O)COc1cccc2c1CCCC2=O		CHEMBL1201237		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755258	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909064		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755259	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909064		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755473	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL503		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755474	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL503		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755558	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909067		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755559	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909067		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755676	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1201139		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755677	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1201139		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755788	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C		CHEMBL1201151		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7755789	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(O)CC[C@H]2[C@@H]3CCc4cc(OC)ccc4[C@H]3CC[C@@]21C		CHEMBL1201151		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756339	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1		CHEMBL91		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756340	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1		CHEMBL91		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756446	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1		CHEMBL1373		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756447	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)C[S+]([O-])C(c1ccccc1)c1ccccc1		CHEMBL1373		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756550	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)N=O		CHEMBL164290		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7756551	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)N=O		CHEMBL164290		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758076	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21		CHEMBL19215		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758077	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@@H]2c3cccc4c3c(cn4C)C[C@H]21		CHEMBL19215		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758197	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COS(C)(=O)=O		CHEMBL313493		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758198	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COS(C)(=O)=O		CHEMBL313493		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758294	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C		CHEMBL878		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758295	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccccc1N1C(=O)c2cc(S(N)(=O)=O)c(Cl)cc2NC1C		CHEMBL878		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758818	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5		CHEMBL80		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758819	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=CCN1CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5		CHEMBL80		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758997	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1		CHEMBL1513		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7758998	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1		CHEMBL1513		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759115	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O		CHEMBL1200633		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759116	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H](C)[C@H]1O[C@]2(CC[C@@H]1C)C[C@@H]1C[C@@H](C/C=C(\C)[C@@H](O[C@H]3C[C@H](OC)[C@@H](O[C@H]4C[C@H](OC)[C@@H](O)[C@H](C)O4)[C@H](C)O3)[C@@H](C)/C=C/C=C3\CO[C@@H]4[C@H](O)C(C)=C[C@@H](C(=O)O1)[C@]34O)O2.CO[C@H]1C[C@H](O[C@H]2[C@H](C)O[C@@H](O[C@@H]3/C(C)=C/C[C@@H]4C[C@@H](C[C@]5(CC[C@H](C)[C@@H](C(C)C)O5)O4)OC(=O)[C@@H]4C=C(C)[C@@H](O)[C@H]5OC/C(=C\C=C\[C@@H]3C)[C@@]45O)C[C@@H]2OC)O[C@@H](C)[C@@H]1O		CHEMBL1200633		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759193	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS		CHEMBL1221512		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759194	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H](C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(C)(=O)=O)C(=O)OC(C)C)NC[C@@H](N)CS		CHEMBL1221512		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759310	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1		CHEMBL480		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759311	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c1nc2ccccc2[nH]1		CHEMBL480		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759439	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C		CHEMBL1201193		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759440	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCN1CCCC[C@H]1C(=O)Nc1c(C)cccc1C		CHEMBL1201193		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759570	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL1237		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759571	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N1CCC[C@H]1C(=O)O		CHEMBL1237		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759805	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1		CHEMBL19299		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759806	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1		CHEMBL19299		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759890	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909068		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7759891	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909068		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760010	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2[nH]cc(CCNC(C)=O)c2c1		CHEMBL45		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760011	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2[nH]cc(CCNC(C)=O)c2c1		CHEMBL45		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760607	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C		CHEMBL1276308		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760608	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3[C@@H](c3ccc(N(C)C)cc3)C[C@@]21C		CHEMBL1276308		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760727	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1ccc(OCc2ccccc2)cc1		CHEMBL1388		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760728	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1ccc(OCc2ccccc2)cc1		CHEMBL1388		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760842	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)C=O		CHEMBL268291		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7760843	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)C=O		CHEMBL268291		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761826	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL157138		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7761827	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)C(=O)N[C@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL157138		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762352	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)C(=N)NC(=N)N		CHEMBL1431		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762353	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)C(=N)NC(=N)N		CHEMBL1431		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762473	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)c1ccccc1O		CHEMBL108545		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762474	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)c1ccccc1O		CHEMBL108545		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762568	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COCCc1ccc(OCC(O)CNC(C)C)cc1		CHEMBL13		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7762569	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COCCc1ccc(OCC(O)CNC(C)C)cc1		CHEMBL13		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763145	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1		CHEMBL406		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763146	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1Cc2ccccc2N1NC(=O)c1ccc(Cl)c(S(N)(=O)=O)c1		CHEMBL406		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763267	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC		CHEMBL481		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763268	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCc1c2c(nc3ccc(OC(=O)N4CCC(N5CCCCC5)CC4)cc13)-c1cc3c(c(=O)n1C2)COC(=O)[C@]3(O)CC		CHEMBL481		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763388	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O		CHEMBL1384		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763389	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O		CHEMBL1384		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763463	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)[C@H]2CC[C@]1(C)C(=O)C2		CHEMBL2252949		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763464	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)[C@H]2CC[C@]1(C)C(=O)C2		CHEMBL2252949		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763577	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909062		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763578	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909062		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763707	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[N+](C)(C)C[C@H](O)CC(=O)[O-]		CHEMBL1149		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7763708	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[N+](C)(C)C[C@H](O)CC(=O)[O-]		CHEMBL1149		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764049	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764050	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764145	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909069		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764146	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909069		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764268	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1		CHEMBL599		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764269	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cnc(NC(=O)C2=C(O)c3ccccc3S(=O)(=O)N2C)s1		CHEMBL599		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764868	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1		CHEMBL189		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764869	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1[nH]c(=O)c(C#N)cc1-c1ccncc1		CHEMBL189		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764973	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1		CHEMBL787		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7764974	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(O)c1ccccc1CC[C@@H](SCC1(CC(=O)O)CC1)c1cccc(/C=C/c2ccc3ccc(Cl)cc3n2)c1		CHEMBL787		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765101	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1		CHEMBL1333512		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7765102	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc(Nc2ccc(Nc3ccccc3)cc2)cc1		CHEMBL1333512		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766085	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21		CHEMBL561		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766086	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c21		CHEMBL561		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766601	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCN(Cc1cccs1)c1ccccn1		CHEMBL1411979		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766602	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)CCN(Cc1cccs1)c1ccccn1		CHEMBL1411979		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766740	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O		CHEMBL459		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766741	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O		CHEMBL459		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766840	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ncc([N+](=O)[O-])n1CCO		CHEMBL137		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7766841	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ncc([N+](=O)[O-])n1CCO		CHEMBL137		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767411	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O		CHEMBL115		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767412	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc1ccccc1)C(=O)N[C@H]1c2ccccc2C[C@H]1O		CHEMBL115		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767535	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O		CHEMBL1712923		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767536	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(N)nc(-c2cc(Cl)ccc2Cl)n1.O=C(O)/C=C\C(=O)O		CHEMBL1712923		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767654	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNC1(c2ccccc2Cl)CCCCC1=O		CHEMBL742		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767655	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNC1(c2ccccc2Cl)CCCCC1=O		CHEMBL742		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767738	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O		CHEMBL245416		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767739	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@@H](Cn1ccc(=O)c(O)c1)C(=O)O		CHEMBL245416		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767861	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909063		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767862	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909063		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767993	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O		CHEMBL1009		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7767994	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O		CHEMBL1009		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7768320	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC		CHEMBL1909065		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7768321	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC		CHEMBL1909065		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7768426	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1		CHEMBL685		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7768427	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)Nc1nc2ccc(C(=O)c3ccccc3)cc2[nH]1		CHEMBL685		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7768551	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O		CHEMBL852		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7768552	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O		CHEMBL852		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769155	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]		CHEMBL802		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769156	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1cc(N2CCCCC2)nc(N)[n+]1[O-]		CHEMBL802		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769247	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1		CHEMBL60889		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769248	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOc1cc(N)c(Cl)cc1C(=O)NCC1CN(Cc2ccc(F)cc2)CCO1		CHEMBL60889		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769381	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2cc(CCC(C)=O)ccc2c1		CHEMBL1070		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7769382	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2cc(CCC(C)=O)ccc2c1		CHEMBL1070		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770374	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=NN(CCCl)C(=O)NC1CCCCC1		CHEMBL514		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770375	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=NN(CCCl)C(=O)NC1CCCCC1		CHEMBL514		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770890	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cn1cc[nH]c1=S		CHEMBL1515		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7770891	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cn1cc[nH]c1=S		CHEMBL1515		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771019	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL1201356		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771020	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@@H](CO)NC(=O)[C@@H]1C=C2c3cccc4[nH]cc(c34)C[C@H]2N(C)C1		CHEMBL1201356		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771131	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C(=O)c1cccnc1)c1cccnc1		CHEMBL934		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771132	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C(=O)c1cccnc1)c1cccnc1		CHEMBL934		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771694	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1		CHEMBL6		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771695	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1		CHEMBL6		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771821	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C/C=C\c1ccc(O)c(OC)c1		CHEMBL445206		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771822	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C/C=C\c1ccc(O)c(OC)c1		CHEMBL445206		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771925	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1		CHEMBL157101		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7771926	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)N1CCN(c2ccc(OCC3COC(Cn4ccnc4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1		CHEMBL157101		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772011	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1		CHEMBL429		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772012	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(CCc1ccccc1)NCC(O)c1ccc(O)c(C(N)=O)c1		CHEMBL429		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772143	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL960		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772144	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1		CHEMBL960		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772276	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23		CHEMBL33		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772277	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc3c(=O)c(C(=O)O)cn1c23		CHEMBL33		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772609	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC.N		CHEMBL2105807		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772610	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1C[C@@H](O[C@H]2C[C@H]([C@H]3O[C@](C)(O)[C@H](C)C[C@@H]3C)O[C@H]2[C@]2(C)CC[C@H]([C@]3(C)CC[C@]4(C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H]5O[C@](O)(CC(=O)O)[C@@H](C)[C@H](OC)[C@H]5OC)O4)O3)O2)O[C@@H](C)[C@@H]1OC.N		CHEMBL2105807		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772712	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl		CHEMBL509		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772713	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl		CHEMBL509		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772816	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1		CHEMBL395110		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7772817	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCCC(CN2c3ccccc3Sc3ccccc32)C1		CHEMBL395110		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773430	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12		CHEMBL105		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773431	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@@]12[C@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1C[C@@H]1N[C@@H]12		CHEMBL105		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773516	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1nc(C)nc(Cl)c1NC1=NCCN1		CHEMBL19236		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773517	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1nc(C)nc(Cl)c1NC1=NCCN1		CHEMBL19236		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773653	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2		CHEMBL649		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7773654	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NCC(O)COc1cccc2c1C[C@H](O)[C@H](O)C2		CHEMBL649		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774625	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1		CHEMBL841		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7774626	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)C(=O)C(CCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1		CHEMBL841		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775150	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccccc1OCC(O)COC(N)=O		CHEMBL1201117		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775151	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccccc1OCC(O)COC(N)=O		CHEMBL1201117		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775272	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)c1ccc(O)cc1		CHEMBL325372		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775273	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)c1ccc(O)cc1		CHEMBL325372		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775384	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@](N)(Cc1ccc(O)cc1)C(=O)O		CHEMBL1200862		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775385	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@](N)(Cc1ccc(O)cc1)C(=O)O		CHEMBL1200862		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775946	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1201631		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7775947	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1201631		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776077	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NNC(=O)c1ccncc1		CHEMBL64		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776078	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NNC(=O)c1ccncc1		CHEMBL64		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776172	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1		CHEMBL571		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776173	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C(=O)O)c1cccc(C(=O)c2ccccc2)c1		CHEMBL571		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776249	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C		CHEMBL460291		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776250	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1c1ccccc1/C=C/C(=O)OC(C)(C)C		CHEMBL460291		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776384	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1		CHEMBL1444		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776385	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N#Cc1ccc(C(c2ccc(C#N)cc2)n2cncn2)cc1		CHEMBL1444		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776514	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC		CHEMBL267044		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776515	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN1CCC[C@H]1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC		CHEMBL267044		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776840	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1200693		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776841	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1200693		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776939	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1390		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7776940	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C		CHEMBL1390		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777043	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cccc(C)c1NC(=O)C1CCCCN1C		CHEMBL1087		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777044	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cccc(C)c1NC(=O)C1CCCCN1C		CHEMBL1087		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777655	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1		CHEMBL1670		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777656	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccc(C(c2ccccc2Cl)C(Cl)Cl)cc1		CHEMBL1670		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777747	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2		CHEMBL1456		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777748	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1c(C)c2c(c(O)c1C/C=C(\C)CCC(=O)OCCN1CCOCC1)C(=O)OC2		CHEMBL1456		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777884	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O		CHEMBL1909070		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7777885	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(Oc1ccc(C2CCCc3ccccc32)cc1)C(=O)O		CHEMBL1909070		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778847	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1		CHEMBL998		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7778848	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc3cccnc32)CC1		CHEMBL998		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779379	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1		CHEMBL34259		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779380	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1		CHEMBL34259		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779499	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12		CHEMBL650		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779500	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]2(C)C=CC(=O)C=C12		CHEMBL650		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779616	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL54440		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7779617	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL54440		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780184	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1c(I)cc(I)c2cccnc12		CHEMBL86754		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780185	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1c(I)cc(I)c2cccnc12		CHEMBL86754		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780319	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NCC(O)c1ccc(O)c(O)c1		CHEMBL434		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780320	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NCC(O)c1ccc(O)c(O)c1		CHEMBL434		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780417	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O		CHEMBL469		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780418	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(c1ccccc1)c1ccc2n1CCC2C(=O)O		CHEMBL469		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780498	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(O)C(=O)O		CHEMBL1200559		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780499	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(O)C(=O)O		CHEMBL1200559		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780633	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O		CHEMBL1679		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780634	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(=O)c2c([nH]1)NCC(CNc1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1)N2C=O		CHEMBL1679		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780763	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CC(=O)Nc1c(C)cccc1C		CHEMBL79		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7780764	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CC(=O)Nc1c(C)cccc1C		CHEMBL79		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781876	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)OCC(COC(C)=O)OC(C)=O		CHEMBL1489254		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7781877	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)OCC(COC(C)=O)OC(C)=O		CHEMBL1489254		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7782005	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1		CHEMBL422		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7782006	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1		CHEMBL422		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7782118	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)c1c[nH]c3ccccc13)C2		CHEMBL56564		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7782119	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1[C@H]2CC[C@@H]1C[C@H](OC(=O)c1c[nH]c3ccccc13)C2		CHEMBL56564		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7782236	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1		CHEMBL865		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7782237	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1onc(-c2ccccc2)c1-c1ccc(S(N)(=O)=O)cc1		CHEMBL865		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7782352	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL159		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7782353	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL159		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7782597	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12		CHEMBL603		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7782598	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12		CHEMBL603		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783482	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO		CHEMBL1451		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783483	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12C[C@H](O)[C@@]3(F)[C@@H](CCC4=CC(=O)C=C[C@@]43C)[C@@H]1C[C@@H](O)[C@]2(O)C(=O)CO		CHEMBL1451		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783605	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1		CHEMBL1490		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783606	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	OC(CCN1CCCCC1)(c1ccccc1)C1CCCCC1		CHEMBL1490		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783724	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12		CHEMBL428		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783725	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@H]1[C@@H]2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)C[C@H]12		CHEMBL428		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783836	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-]		CHEMBL2107687		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783837	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC(C)C(C(=O)OCC[N+](C)(CC)CC)c1ccccc1.[Br-]		CHEMBL2107687		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783957	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL90555		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7783958	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C=O)[C@H]3[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL90555		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784194	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1		CHEMBL1521		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7784195	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(C(C)=O)c1cccc(-c2ccnc3c(C#N)cnn23)c1		CHEMBL1521		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785063	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1504		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785064	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1		CHEMBL1504		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785185	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(CN2CCNCC2)c(OC)c1OC		CHEMBL203266		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785186	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(CN2CCNCC2)c(OC)c1OC		CHEMBL203266		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785303	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC		CHEMBL1566956		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785304	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(C(=O)NC2CCCNC2)cc(OC)c1OC		CHEMBL1566956		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785414	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCC(CCC)C(=O)O		CHEMBL109		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785415	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCC(CCC)C(=O)O		CHEMBL109		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785535	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL238071		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785536	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(N)=O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1		CHEMBL238071		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785773	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCOc1ccccc1-c1nc2nn[nH]c2c(=O)[nH]1		CHEMBL28079		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7785774	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCOc1ccccc1-c1nc2nn[nH]c2c(=O)[nH]1		CHEMBL28079		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786793	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC[C@H]1CC[C@H](C(=O)O)CC1		CHEMBL877		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786794	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC[C@H]1CC[C@H](C(=O)O)CC1		CHEMBL877		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786903	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1		CHEMBL585		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7786904	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1		CHEMBL585		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7787028	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C(=O)OC(C)(C)C1=O		CHEMBL695		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7787029	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C(=O)OC(C)(C)C1=O		CHEMBL695		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7787146	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7787147	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7787262	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C		CHEMBL1069		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7787263	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCC(=O)N(Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1)[C@H](C(=O)O)C(C)C		CHEMBL1069		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7787382	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2		CHEMBL553025		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7787383	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC1=C[C@@H]2CN(C1)Cc1c([nH]c3ccccc13)[C@@](C(=O)OC)(c1cc3c(cc1OC)N(C)[C@H]1[C@@](O)(C(=O)OC)[C@H](OC(C)=O)[C@]4(CC)C=CCN5CC[C@]31[C@@H]54)C2		CHEMBL553025		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7787630	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O		CHEMBL129		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7787631	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O		CHEMBL129		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788670	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC		CHEMBL415324		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788671	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(/C=C/C(=O)Nc2ccccc2C(=O)O)cc1OC		CHEMBL415324		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788776	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O		CHEMBL24944		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788777	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(Nc1ccc(Br)cc1)c1cc(Br)cc(Br)c1O		CHEMBL24944		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788907	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1		CHEMBL1475		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7788908	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1		CHEMBL1475		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7789011	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2		CHEMBL141343		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7789012	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(C)c2c(c(C)c1O)CCC(C)(CN1CCN(c3cc(N4CCCC4)nc(N4CCCC4)n3)CC1)O2		CHEMBL141343		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7789145	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O		CHEMBL262777		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7789146	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(N)[C@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O		CHEMBL262777		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7789251	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7789252	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7789500	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(c1cc2ccccc2s1)N(O)C(N)=O		CHEMBL93		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7789501	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(c1cc2ccccc2s1)N(O)C(N)=O		CHEMBL93		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790523	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1386		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790524	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1386		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790637	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O		CHEMBL1054		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790638	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NS(=O)(=O)c1cc2c(cc1Cl)NC(C(Cl)Cl)NS2(=O)=O		CHEMBL1054		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790763	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2		CHEMBL408		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790764	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1c(C)c2c(c(C)c1O)CCC(C)(COc1ccc(CC3SC(=O)NC3=O)cc1)O2		CHEMBL408		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790867	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O		CHEMBL29292		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7790868	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O		CHEMBL29292		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7791001	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]		CHEMBL1200629		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7791002	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)O[C@H]1C[C@@H]2CC[C@@H]3[C@H](CC[C@@]4(C)[C@H]3C[C@H]([N+]3(C)CCCCC3)[C@@H]4OC(C)=O)[C@@]2(C)C[C@@H]1N1CCCCC1.[Br-]		CHEMBL1200629		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7791108	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O		CHEMBL1464		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7791109	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)CC(c1ccccc1)c1c(O)c2ccccc2oc1=O		CHEMBL1464		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7791354	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	[Cl-].[Cl-].[Zn+2]		CHEMBL1200679		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7791355	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	[Cl-].[Cl-].[Zn+2]		CHEMBL1200679		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792367	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12		CHEMBL621		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792368	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1n(CCCN2CCN(c3cccc(Cl)c3)CC2)nc2ccccn12		CHEMBL621		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792496	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)C(Cl)(Cl)Cl		CHEMBL14053		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792497	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)C(Cl)(Cl)Cl		CHEMBL14053		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792619	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(CO)(CO)CO		CHEMBL1200391		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792620	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(CO)(CO)CO		CHEMBL1200391		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792723	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(N)=O		CHEMBL462547		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792724	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(N)=O		CHEMBL462547		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792856	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1		CHEMBL637		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792857	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(C(CN(C)C)C2(O)CCCCC2)cc1		CHEMBL637		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792972	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7792973	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793225	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909083		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7793226	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909083		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794034	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21		CHEMBL15245		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794035	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21		CHEMBL15245		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794108	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1		CHEMBL38		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794109	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1		CHEMBL38		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794239	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	ClCC(Cl)Cl		CHEMBL43882		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794240	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	ClCC(Cl)Cl		CHEMBL43882		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794353	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1		CHEMBL1200604		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794354	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(Cc1ccncc1)C(=O)C(CO)c1ccccc1		CHEMBL1200604		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794466	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21		CHEMBL1349		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794467	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)[C@H](N)C(=O)OCCOCn1cnc2c(=O)nc(N)[nH]c21		CHEMBL1349		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794585	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC		CHEMBL6966		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7794586	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ccc(CCN(C)CCCC(C#N)(c2ccc(OC)c(OC)c2)C(C)C)cc1OC		CHEMBL6966		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7795461	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21		CHEMBL1908355		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7795462	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)N1C(=O)/C(=C(\O)c2cccs2)c2cc(Cl)ccc21		CHEMBL1908355		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7795522	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCNc1ccc(C(=O)OCCN(C)C)cc1		CHEMBL698		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7795523	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCNc1ccc(C(=O)OCCN(C)C)cc1		CHEMBL698		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7795652	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CCCC[C@@H]1CCSS1		CHEMBL134342		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7795653	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)CCCC[C@@H]1CCSS1		CHEMBL134342		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796071	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1		CHEMBL1790041		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796072	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNC(=C[N+](=O)[O-])NCCSCc1ccc(CN(C)C)o1		CHEMBL1790041		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796201	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc2ccc(OC(F)(F)F)cc2s1		CHEMBL744		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796202	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc2ccc(OC(F)(F)F)cc2s1		CHEMBL744		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796308	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1		CHEMBL429023		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796309	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=C(C)[C@H]1Cc2c(ccc3c2O[C@@H]2COc4cc(OC)c(OC)cc4[C@@H]2C3=O)O1		CHEMBL429023		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796904	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21		CHEMBL1393		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7796905	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21		CHEMBL1393		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797039	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46		CHEMBL227934		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797040	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1C[C@@H]2OCC=C3CN4CC[C@]56c7ccccc7N1[C@H]5[C@H]2[C@H]3C[C@H]46		CHEMBL227934		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797156	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1		CHEMBL446		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797157	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1		CHEMBL446		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797294	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C		CHEMBL453		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797295	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C		CHEMBL453		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797382	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1c2c(nc3ccccc13)CCCC2		CHEMBL95		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797383	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1c2c(nc3ccccc13)CCCC2		CHEMBL95		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797965	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1		CHEMBL1630578		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7797966	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)C3=CC[C@]2(C)[C@H]1C(=O)CN1CCN(c2cc(N3CCCC3)nc(N3CCCC3)n2)CC1		CHEMBL1630578		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798106	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cccc(C2(O)CCCCC2CN(C)C)c1		CHEMBL1237044		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798107	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cccc(C2(O)CCCCC2CN(C)C)c1		CHEMBL1237044		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798671	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)c1ccccc1O		CHEMBL27577		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798787	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O		CHEMBL447		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798788	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=CCC1(C(C)CCC)C(=O)NC(=O)NC1=O		CHEMBL447		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798885	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=[As][O-].[Na+]		CHEMBL1909078		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7798886	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=[As][O-].[Na+]		CHEMBL1909078		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7799688	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O		CHEMBL302795		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7799689	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN1C(C(=O)Nc2ccccn2)=C(O)c2sccc2S1(=O)=O		CHEMBL302795		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7799753	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12		CHEMBL1440		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7799754	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C)[C@@H]1C(O)=C(C(N)=O)C(=O)[C@@]2(O)C(O)=C3C(=O)c4c(O)cccc4[C@@](C)(O)[C@H]3C[C@@H]12		CHEMBL1440		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7799879	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc2[nH]cnc2c(=S)[nH]1		CHEMBL727		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7799880	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1nc2[nH]cnc2c(=S)[nH]1		CHEMBL727		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7800231	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1		CHEMBL1148		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7800232	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cccc(Nc2ccncc2S(=O)(=O)NC(=O)NC(C)C)c1		CHEMBL1148		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7800316	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7800317	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7800450	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(N)C12CC3CC(CC(C3)C1)C2		CHEMBL959		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7800451	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(N)C12CC3CC(CC(C3)C1)C2		CHEMBL959		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7800557	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O		CHEMBL1321154		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7800558	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=[N+]([O-])c1cc([As](=O)(O)O)ccc1O		CHEMBL1321154		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7800675	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)c1ccccc1O		CHEMBL27577		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801157	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909079		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801158	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL1909079		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801292	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O		CHEMBL403		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801293	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1(C)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O		CHEMBL403		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801415	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1		CHEMBL1191		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801416	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1		CHEMBL1191		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801552	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1		CHEMBL15770		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801553	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc([S+](C)[O-])cc1		CHEMBL15770		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801641	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC		CHEMBL269732		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7801642	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC		CHEMBL269732		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802155	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2		CHEMBL479		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802156	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2		CHEMBL479		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802262	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O		CHEMBL1747		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7802263	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)C[C@@H]1O		CHEMBL1747		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803078	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#CCN(C)[C@H](C)Cc1ccccc1		CHEMBL972		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803079	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#CCN(C)[C@H](C)Cc1ccccc1		CHEMBL972		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803181	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL136478		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803182	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL136478		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803918	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1		CHEMBL83		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7803919	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC/C(=C(\c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1		CHEMBL83		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804035	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC		CHEMBL611		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804036	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc2nc(N3CCN(C(=O)C4CCCO4)CC3)nc(N)c2cc1OC		CHEMBL611		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804104	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL468		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804105	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1		CHEMBL468		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804564	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1		CHEMBL273348		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804565	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC1CCN(c2nc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)C1		CHEMBL273348		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804644	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC		CHEMBL772		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804645	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC		CHEMBL772		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804787	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O		CHEMBL923		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804788	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O		CHEMBL923		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804904	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL1214185		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7804905	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O		CHEMBL1214185		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805028	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1ccccc1O		CHEMBL424		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805029	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1ccccc1O		CHEMBL424		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805509	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O		CHEMBL27769		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805510	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O		CHEMBL27769		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805628	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1		CHEMBL1221		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805629	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccc(CSC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1		CHEMBL1221		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805774	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1		CHEMBL443		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805775	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1		CHEMBL443		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805902	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1		CHEMBL18797		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7805903	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CSc1ccc(/C=C2/C(C)=C(CC(=O)O)c3cc(F)ccc32)cc1		CHEMBL18797		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806469	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC		CHEMBL84158		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806470	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN(CC)CCNC(=O)c1cc(S(C)(=O)=O)ccc1OC		CHEMBL84158		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806579	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cccc(C)c1NC(=O)C(C)N		CHEMBL1762		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7806580	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cccc(C)c1NC(=O)C(C)N		CHEMBL1762		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807404	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1CCC(NC(=O)N(CCCl)N=O)CC1		CHEMBL12948		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807405	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1CCC(NC(=O)N(CCCl)N=O)CC1		CHEMBL12948		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807511	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL179166		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7807512	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL179166		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808190	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1		CHEMBL506247		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808191	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(OC[C@H]1O[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H](OC(=O)c2cc(O)c(O)c(OC(=O)c3cc(O)c(O)c(O)c3)c2)[C@@H]1OC(=O)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1)c1cc(O)c(O)c(OC(=O)c2cc(O)c(O)c(O)c2)c1		CHEMBL506247		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808319	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12		CHEMBL822		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808320	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C/C=C/C#CC(C)(C)C)Cc1cccc2ccccc12		CHEMBL822		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808390	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cn1c(=O)c2nc[nH]c2n(C)c1=O		CHEMBL190		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808391	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cn1c(=O)c2nc[nH]c2n(C)c1=O		CHEMBL190		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808843	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NC[C@@H](O)COc1cccc2ccccc12		CHEMBL275742		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808844	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NC[C@@H](O)COc1cccc2ccccc12		CHEMBL275742		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808929	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1		CHEMBL165		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7808930	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1		CHEMBL165		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809051	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2		CHEMBL85		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809052	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1nc2n(c(=O)c1CCN1CCC(c3noc4cc(F)ccc34)CC1)CCCC2		CHEMBL85		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809173	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2		CHEMBL115769		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809174	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(N)[nH]c2nc(-c3ccc(F)cc3)c(-c3ccncc3)c1-2		CHEMBL115769		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809303	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C		CHEMBL1208572		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809304	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@@H](C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]1O[C@@H]([C@@H](CC)C(=O)O)CC[C@@H]1C)[C@H]1O[C@]2(C=C[C@@H](O)[C@]3(CC[C@@](C)([C@H]4CC[C@](O)(CC)[C@H](C)O4)O3)O2)[C@H](C)C[C@@H]1C		CHEMBL1208572		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809789	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O		CHEMBL2079587		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809790	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12Cc3c[nH]nc3C[C@@H]1CC[C@@H]1[C@@H]2CC[C@@]2(C)[C@H]1CC[C@]2(C)O		CHEMBL2079587		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809905	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1		CHEMBL1243		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7809906	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc(S(=O)(=O)NC(=O)c2ccccc2)cc1		CHEMBL1243		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810051	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc(S(N)(=O)=O)cc1		CHEMBL21		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810052	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc(S(N)(=O)=O)cc1		CHEMBL21		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810174	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1		CHEMBL488025		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810175	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1=C(CC(=O)O)c2cc(F)ccc2/C1=C\c1ccc(S(C)(=O)=O)cc1		CHEMBL488025		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810744	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)C1=C(CC(=O)CC1)C[C@H]3C		CHEMBL2103774		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810745	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C#C[C@]1(O)CC[C@H]2[C@H]3[C@H](CC[C@@]21C)C1=C(CC(=O)CC1)C[C@H]3C		CHEMBL2103774		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810863	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1		CHEMBL817		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7810864	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(S(=O)(=O)NC(=O)NN2CCCCCC2)cc1		CHEMBL817		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811442	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NC[C@H](O)COc1cccc2ccccc12		CHEMBL452861		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811443	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NC[C@H](O)COc1cccc2ccccc12		CHEMBL452861		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811670	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21		CHEMBL809		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811671	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21		CHEMBL809		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811803	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1		CHEMBL471		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7811804	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)NCC(O)c1ccc(NS(C)(=O)=O)cc1		CHEMBL471		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812480	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O		CHEMBL404		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812481	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]1(Cn2ccnn2)[C@H](C(=O)O)N2C(=O)C[C@H]2S1(=O)=O		CHEMBL404		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812606	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NCC(O)c1cc(O)cc(O)c1		CHEMBL1760		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812607	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NCC(O)c1cc(O)cc(O)c1		CHEMBL1760		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812689	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc2[nH]c(-c3cscn3)nc2c1		CHEMBL625		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7812690	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	c1ccc2[nH]c(-c3cscn3)nc2c1		CHEMBL625		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7813136	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1		CHEMBL427526		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7813137	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)Cc1ccc([C@@H](C)C(=O)O)cc1		CHEMBL427526		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7813224	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL1643		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7813225	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL1643		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7813340	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1		CHEMBL163		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7813341	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1		CHEMBL163		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7813596	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(Oc1ccccc1C(=O)O)c1ccccc1O		CHEMBL154111		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7813597	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(Oc1ccccc1C(=O)O)c1ccccc1O		CHEMBL154111		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814073	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O		CHEMBL991		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814074	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cn([C@H]2C=C[C@@H](CO)O2)c(=O)[nH]c1=O		CHEMBL991		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814189	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL439		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814190	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL439		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814334	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1		CHEMBL1109		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814335	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc(S(=O)(=O)Nc2ccnn2-c2ccccc2)cc1		CHEMBL1109		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814436	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1		CHEMBL588119		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7814437	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCCCCCN[C@H](C)[C@@H](O)c1ccc(SC(C)C)cc1		CHEMBL588119		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815035	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccccc1CN1CCc2sccc2C1		CHEMBL833		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815036	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Clc1ccccc1CN1CCc2sccc2C1		CHEMBL833		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815158	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1		CHEMBL1020		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815159	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(C(=O)c2ccc(CC(=O)O)n2C)cc1		CHEMBL1020		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815730	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@H](CSC(=S)NCc1ccccc1)C(=O)O		CHEMBL1909076		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815731	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	N[C@H](CSC(=S)NCc1ccccc1)C(=O)O		CHEMBL1909076		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815865	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1		CHEMBL114		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815866	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(N)=O)NC(=O)c1ccc2ccccc2n1		CHEMBL114		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815953	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1		CHEMBL1419		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7815954	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1		CHEMBL1419		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816095	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1		CHEMBL850		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816096	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1		CHEMBL850		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816760	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]c(=O)n(C2CCCO2)cc1F		CHEMBL20883		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816761	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=c1[nH]c(=O)n(C2CCCO2)cc1F		CHEMBL20883		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816859	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1		CHEMBL1306		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816860	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)N1CCN(c2ccc(OC[C@H]3CO[C@](Cn4cncn4)(c4ccc(Cl)cc4Cl)O3)cc2)CC1		CHEMBL1306		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816976	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1		CHEMBL1236282		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7816977	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1		CHEMBL1236282		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7817424	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C		CHEMBL1219		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7817425	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COCCCOc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C		CHEMBL1219		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7817530	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O		CHEMBL444633		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7817531	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(c3C2=O)C2=NC3(CCN(CC(C)C)CC3)NC2=C(NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C)C4=O		CHEMBL444633		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7817640	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCOc1cc(CC2CNC(=O)N2)ccc1OC		CHEMBL18701		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7817641	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCCOc1cc(CC2CNC(=O)N2)ccc1OC		CHEMBL18701		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818369	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O		CHEMBL372795		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818370	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN[C@@H]1[C@H](O[C@H]2[C@H](O[C@@H]3[C@@H](N=C(N)N)[C@H](O)[C@@H](N=C(N)N)[C@H](O)[C@H]3O)O[C@@H](C)[C@]2(O)C=O)O[C@@H](CO)[C@H](O)[C@H]1O		CHEMBL372795		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818485	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1		CHEMBL62193		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818486	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1		CHEMBL62193		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818630	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O		CHEMBL421		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818631	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O		CHEMBL421		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818723	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC		CHEMBL26		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7818724	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCN1CCCC1CNC(=O)c1cc(S(N)(=O)=O)ccc1OC		CHEMBL26		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819314	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl		CHEMBL267744		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819315	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl		CHEMBL267744		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819440	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1		CHEMBL83668		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7819441	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1		CHEMBL83668		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820024	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O		CHEMBL1200748		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820025	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@@](Cc1ccc(O)c(O)c1)(NN)C(=O)O.O		CHEMBL1200748		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820151	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O		CHEMBL37858		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820152	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(O)c1cn(-c2ccc(F)cc2)c2cc(N3CCNCC3)c(F)cc2c1=O		CHEMBL37858		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820234	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12		CHEMBL192		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820235	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCCc1nn(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCN(C)CC4)ccc3OCC)nc12		CHEMBL192		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820376	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1		CHEMBL412873		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7820377	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1		CHEMBL412873		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7821041	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O		CHEMBL2367892		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7821042	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=O)N[C@@H]1[C@H](Oc2c3cc4cc2Oc2ccc(cc2Cl)[C@@H](O[C@@H]2O[C@@H](CO)[C@@H](O)[C@H](O)[C@@H]2NC(C)=O)[C@@H]2NC(=O)[C@H](NC(=O)[C@@H]4NC(=O)[C@H]4NC(=O)[C@@H](Cc5ccc(c(Cl)c5)O3)NC(=O)[C@H](N)c3ccc(O)c(c3)Oc3cc(O)cc4c3)c3ccc(O)c(c3)-c3c(O[C@H]4O[C@H](CO)[C@@H](O)[C@@H](O)[C@@H]4O)cc(O)cc3[C@@H](C(=O)O)NC2=O)O[C@@H](CO)[C@@H](O)[C@@H]1O		CHEMBL2367892		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7821112	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL17157		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7821113	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)c1ccc(C(O)CCCN2CCC(C(O)(c3ccccc3)c3ccccc3)CC2)cc1		CHEMBL17157		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7821235	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL508338		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7821236	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B			CHEMBL508338		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7821660	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12		CHEMBL81		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7821661	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C(c1ccc(OCCN2CCCCC2)cc1)c1c(-c2ccc(O)cc2)sc2cc(O)ccc12		CHEMBL81		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7821787	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C		CHEMBL374478		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7821788	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C		CHEMBL374478		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7821897	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1		CHEMBL122		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7821898	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CS(=O)(=O)c1ccc(C2=C(c3ccccc3)C(=O)OC2)cc1		CHEMBL122		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822634	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O		CHEMBL1651906		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822635	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(N=O)C(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O		CHEMBL1651906		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822749	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC		CHEMBL1539		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822750	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	COc1ncnc(NS(=O)(=O)c2ccc(N)cc2)c1OC		CHEMBL1539		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822889	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc(S(=O)(=O)Nc2nccs2)cc1		CHEMBL437		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822890	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Nc1ccc(S(=O)(=O)Nc2nccs2)cc1		CHEMBL437		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822982	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1		CHEMBL128		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7822983	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1		CHEMBL128		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823566	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1		CHEMBL499		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823567	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1		CHEMBL499		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823690	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1		CHEMBL1076211		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7823691	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccc(C(=O)C(C)CN2CCCCC2)cc1		CHEMBL1076211		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824260	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=CCc1ccc2c(c1)OCO2		CHEMBL242273		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824261	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C=CCc1ccc2c(c1)OCO2		CHEMBL242273		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824380	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824381	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824477	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL1064		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824478	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@H]21		CHEMBL1064		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824620	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12		CHEMBL1167		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7824621	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12		CHEMBL1167		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825285	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1		CHEMBL277100		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825286	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC1CN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3-c2ccc(F)cc2F)CCN1		CHEMBL277100		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825345	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O		CHEMBL386630		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825346	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2O		CHEMBL386630		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825469	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=N)S		CHEMBL38737		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825470	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(=N)S		CHEMBL38737		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825883	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21		CHEMBL1168		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7825884	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1[C@H](C(=O)O)C[C@@H]2CCC[C@@H]21		CHEMBL1168		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826010	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C		CHEMBL1660		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826011	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c(/C=N/N5CCN(C6CCCC6)CC5)c(O)c4c3C2=O)NC(=O)/C(C)=C\C=C\[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@@H]1C		CHEMBL1660		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826120	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1		CHEMBL121		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826121	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccccn1		CHEMBL121		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826856	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]		CHEMBL1909080		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826857	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O.O.O.O.O.O.[Cl-].[Cl-].[Sr+2]		CHEMBL1909080		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826971	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1		CHEMBL438		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7826972	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1		CHEMBL438		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827111	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1		CHEMBL832		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827112	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	O=C1C(CC[S+]([O-])c2ccccc2)C(=O)N(c2ccccc2)N1c1ccccc1		CHEMBL832		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827201	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]		CHEMBL983		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827202	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C.[Cl-].[Cl-]		CHEMBL983		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827792	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C		CHEMBL1220		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827793	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CCS(=O)(=O)CCn1c([N+](=O)[O-])cnc1C		CHEMBL1220		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827915	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1		CHEMBL84		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7827916	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2cc3c(CN(C)C)c(O)ccc3nc2-1		CHEMBL84		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828485	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1		CHEMBL714		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828486	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CC(C)(C)NCC(O)c1ccc(O)c(CO)c1		CHEMBL714		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828600	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ncc([N+](=O)[O-])n1CC(C)O		CHEMBL498847		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828601	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	Cc1ncc([N+](=O)[O-])n1CC(C)O		CHEMBL498847		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828697	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O		CHEMBL221886		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828698	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3OC(CN)=CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O		CHEMBL221886		Ki			CHEMBL1868	Homo sapiens	Ki		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828835	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1		CHEMBL70586		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active (inhibition < 50% @ 10 uM and thus dose-reponse curve not measured)	7828836	CHEMBL1909118	DRUGMATRIX: Vascular Endothelial Growth Factor (VEGF) radioligand binding (ligand: [125I] VEGF)	B	CN(C(=O)Cc1ccc(Cl)c(Cl)c1)[C@H]1CC[C@@]2(CCCO2)C[C@@H]1N1CCCC1		CHEMBL70586		Ki			CHEMBL1868	Homo sapiens	Ki		
	7922687	CHEMBL1918459	Inhibition of human recombinant FLT1 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	38.0	CHEMBL1868	Homo sapiens	INH	%	38.0
	7925724	CHEMBL1920422	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1[N+](=O)[O-]		CHEMBL1915327	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926614	CHEMBL1920329	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1[N+](=O)[O-]		CHEMBL1915327	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926622	CHEMBL1920422	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc([N+](=O)[O-])c1		CHEMBL1915328	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926630	CHEMBL1920329	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc([N+](=O)[O-])c1		CHEMBL1915328	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926638	CHEMBL1920422	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc([N+](=O)[O-])cc1		CHEMBL1915329	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926646	CHEMBL1920329	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc([N+](=O)[O-])cc1		CHEMBL1915329	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926654	CHEMBL1920422	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915331	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926662	CHEMBL1920329	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915331	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926670	CHEMBL1920422	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	Nc1cccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)c1		CHEMBL1915332	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926678	CHEMBL1920329	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1cccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)c1		CHEMBL1915332	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926686	CHEMBL1920422	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915333	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926694	CHEMBL1920329	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915333	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926702	CHEMBL1920422	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915334	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926710	CHEMBL1920329	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccccc1CNc1ccsc1C(=O)Nc1ccc(OC(F)(F)F)cc1		CHEMBL1915334	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926718	CHEMBL1920422	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915336	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926726	CHEMBL1920329	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	CC(=O)Nc1ccc(CNc2ccsc2C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1		CHEMBL1915336	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926734	CHEMBL1920422	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1N=C=S		CHEMBL1915337	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926742	CHEMBL1920329	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccccc1N=C=S		CHEMBL1915337	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926750	CHEMBL1920422	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc(N=C=S)cc1		CHEMBL1915339	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926758	CHEMBL1920329	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccc(N=C=S)cc1		CHEMBL1915339	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926823	CHEMBL1920422	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 1 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc(N=C=S)c1		CHEMBL1915338	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7926828	CHEMBL1920329	Inhibition of VEGFR1 using Tyr 04 peptide as substrate at 10 uM after 60 mins by Z'-LYTE assay	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1cccc(N=C=S)c1		CHEMBL1915338	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7931086	CHEMBL1919263	Inhibition of FLT1 relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	1.0	CHEMBL1868	Homo sapiens	INH	%	1.0
	7939639	CHEMBL1919599	Inhibition of human Flt1	B	[O-][n+]1ccc2c(-c3ccc(F)cc3Cl)ccnc2c1-c1c(Cl)cccc1Cl		CHEMBL1916359	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	7956218	CHEMBL1924837	Inhibition of N-terminus flag-tagged VEGRF1 expressed in baculovirus infected insect cells using ATP as substrate after 10 mins	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	nM	10000.0
	7959775	CHEMBL1932862	Inhibition of FLT1	B	CN(C)CCN1CCN(C(=O)c2cc(C(C)(C)C)sc2NC(=O)Nc2cccc(Cl)c2Cl)CCC1=O		CHEMBL1929238	>	IC50	nM	30000.0	CHEMBL1868	Homo sapiens	IC50	uM	30.0
	7959776	CHEMBL1932862	Inhibition of FLT1	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	IC50	nM	250.0	CHEMBL1868	Homo sapiens	IC50	uM	0.25
	7968529	CHEMBL1932341	Inhibition of VEGFR1 tyrosine kinase activity in VEGF-stimulated human A498 cells after 60 mins by ELISA	B	Cc1ccccc1Cc1cc2c(Nc3cccc(Br)c3)nc(N)nc2[nH]1		CHEMBL1095464	>	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	uM	50.0
	7968530	CHEMBL1932341	Inhibition of VEGFR1 tyrosine kinase activity in VEGF-stimulated human A498 cells after 60 mins by ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3cccc4ccccc34)[nH]c2n1		CHEMBL474538	=	IC50	nM	16000.0	CHEMBL1868	Homo sapiens	IC50	uM	16.0
	7968531	CHEMBL1932341	Inhibition of VEGFR1 tyrosine kinase activity in VEGF-stimulated human A498 cells after 60 mins by ELISA	B	COc1ccc(OC)c(Cc2cc3c(Nc4cccc(Br)c4)nc(N)nc3[nH]2)c1		CHEMBL1095465	=	IC50	nM	45900.0	CHEMBL1868	Homo sapiens	IC50	uM	45.9
	7968532	CHEMBL1932341	Inhibition of VEGFR1 tyrosine kinase activity in VEGF-stimulated human A498 cells after 60 mins by ELISA	B	Cc1ccccc1Cc1cc2c(Nc3ccc(Cl)cc3F)nc(N)nc2[nH]1		CHEMBL1929552	=	IC50	nM	19200.0	CHEMBL1868	Homo sapiens	IC50	uM	19.2
	7968533	CHEMBL1932341	Inhibition of VEGFR1 tyrosine kinase activity in VEGF-stimulated human A498 cells after 60 mins by ELISA	B	Cc1ccccc1Cc1cc2c(Nc3ccc(Cl)cc3)nc(N)nc2[nH]1	Outside typical range	CHEMBL1929553	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	7968534	CHEMBL1932341	Inhibition of VEGFR1 tyrosine kinase activity in VEGF-stimulated human A498 cells after 60 mins by ELISA	B	Nc1nc(Nc2ccc(Cl)cc2F)c2cc(Cc3cccc4ccccc34)[nH]c2n1	Outside typical range	CHEMBL1929554	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	7968535	CHEMBL1932341	Inhibition of VEGFR1 tyrosine kinase activity in VEGF-stimulated human A498 cells after 60 mins by ELISA	B	Nc1nc(Nc2ccc(Cl)cc2)c2cc(Cc3cccc4ccccc34)[nH]c2n1		CHEMBL1929555	=	IC50	nM	31100.0	CHEMBL1868	Homo sapiens	IC50	uM	31.1
	7968536	CHEMBL1932341	Inhibition of VEGFR1 tyrosine kinase activity in VEGF-stimulated human A498 cells after 60 mins by ELISA	B	COc1ccc(OC)c(Cc2cc3c(Nc4ccc(Cl)cc4F)nc(N)nc3[nH]2)c1	Outside typical range	CHEMBL1929556	=	IC50	nM	185600.0	CHEMBL1868	Homo sapiens	IC50	uM	185.6
	7968537	CHEMBL1932341	Inhibition of VEGFR1 tyrosine kinase activity in VEGF-stimulated human A498 cells after 60 mins by ELISA	B	COc1ccc(OC)c(Cc2cc3c(Nc4ccc(Cl)cc4)nc(N)nc3[nH]2)c1		CHEMBL1929557	=	IC50	nM	15200.0	CHEMBL1868	Homo sapiens	IC50	uM	15.2
	7968538	CHEMBL1932341	Inhibition of VEGFR1 tyrosine kinase activity in VEGF-stimulated human A498 cells after 60 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150315	=	IC50	nM	14100.0	CHEMBL1868	Homo sapiens	IC50	uM	14.1
	7971643	CHEMBL1930754	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 whole extracellular domain at 100 uM after 3 hrs by chemiluminescence assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(N)=O		CHEMBL1684365	=	Inhibition	%	45.1	CHEMBL1868	Homo sapiens	INH	%	45.1
	7971644	CHEMBL1930754	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 whole extracellular domain at 100 uM after 3 hrs by chemiluminescence assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL2367585	=	Inhibition	%	11.2	CHEMBL1868	Homo sapiens	INH	%	11.2
	7971645	CHEMBL1930754	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 whole extracellular domain at 100 uM after 3 hrs by chemiluminescence assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(N)=O		CHEMBL2367586	=	Inhibition	%	24.6	CHEMBL1868	Homo sapiens	INH	%	24.6
	7971646	CHEMBL1930754	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 whole extracellular domain at 100 uM after 3 hrs by chemiluminescence assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CNC(=O)C[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL2367587	=	Inhibition	%	15.8	CHEMBL1868	Homo sapiens	INH	%	15.8
	7971647	CHEMBL1930754	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 whole extracellular domain at 100 uM after 3 hrs by chemiluminescence assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CN)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(N)=O		CHEMBL2367588	=	Inhibition	%	25.3	CHEMBL1868	Homo sapiens	INH	%	25.3
	7971648	CHEMBL1930754	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 whole extracellular domain at 100 uM after 3 hrs by chemiluminescence assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CC(=O)NC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL2367589	=	Inhibition	%	53.0	CHEMBL1868	Homo sapiens	INH	%	53.0
	7971649	CHEMBL1930754	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 whole extracellular domain at 100 uM after 3 hrs by chemiluminescence assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CN)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@]1(C)CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(N)=O		CHEMBL2367590	=	Inhibition	%	11.4	CHEMBL1868	Homo sapiens	INH	%	11.4
	7971650	CHEMBL1930754	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 whole extracellular domain at 100 uM after 3 hrs by chemiluminescence assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CNC(=O)C[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@]2(C)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL2367591	=	Inhibition	%	38.0	CHEMBL1868	Homo sapiens	INH	%	38.0
	7971651	CHEMBL1930754	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 whole extracellular domain at 100 uM after 3 hrs by chemiluminescence assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@]1(C)CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CN)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(N)=O		CHEMBL2367592	=	Inhibition	%	3.1	CHEMBL1868	Homo sapiens	INH	%	3.1
	7971652	CHEMBL1930754	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 whole extracellular domain at 100 uM after 3 hrs by chemiluminescence assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CC(=O)NC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@@]2(C)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL2367584	=	Inhibition	%	2.8	CHEMBL1868	Homo sapiens	INH	%	2.8
	7971653	CHEMBL1930755	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 whole extracellular domain after 3 hrs by chemiluminescence assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(N)=O	Outside typical range	CHEMBL1684365	=	IC50	nM	102700.0	CHEMBL1868	Homo sapiens	IC50	uM	102.7
	7971654	CHEMBL1930755	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 whole extracellular domain after 3 hrs by chemiluminescence assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CC(=O)NC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL2367589	=	IC50	nM	93200.0	CHEMBL1868	Homo sapiens	IC50	uM	93.2
	7971655	CHEMBL1930756	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 D1-D3 domain after 3 hrs by chemiluminescence assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(C)=O)[C@@H](C)CC)C(N)=O	Outside typical range	CHEMBL1684365	=	IC50	nM	160000.0	CHEMBL1868	Homo sapiens	IC50	uM	160.0
	7971656	CHEMBL1930756	Displacement of biotinylated VEGF165 from human recombinant VEGFR1 D1-D3 domain after 3 hrs by chemiluminescence assay	B	CC[C@H](C)[C@H](NC(=O)[C@@H]1CC(=O)NC[C@H](NC(=O)[C@H](CCSC)NC(C)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1)C(N)=O		CHEMBL2367589	=	IC50	nM	87600.0	CHEMBL1868	Homo sapiens	IC50	uM	87.6
	7990924	CHEMBL1937673	Inhibition of Flt-1 at 10 uM	B	Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934300	=	Inhibition	%	45.7	CHEMBL1868	Homo sapiens	INH	%	45.7
	7990925	CHEMBL1937673	Inhibition of Flt-1 at 10 uM	B	CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934301	=	Inhibition	%	28.1	CHEMBL1868	Homo sapiens	INH	%	28.1
	7990926	CHEMBL1937673	Inhibition of Flt-1 at 10 uM	B	CCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934302	=	Inhibition	%	60.6	CHEMBL1868	Homo sapiens	INH	%	60.6
	7990927	CHEMBL1937673	Inhibition of Flt-1 at 10 uM	B	CCCC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934303	=	Inhibition	%	53.4	CHEMBL1868	Homo sapiens	INH	%	53.4
	7990928	CHEMBL1937673	Inhibition of Flt-1 at 10 uM	B	CCCC(CCC)C(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934304	=	Inhibition	%	34.1	CHEMBL1868	Homo sapiens	INH	%	34.1
	7990929	CHEMBL1937673	Inhibition of Flt-1 at 10 uM	B	C=CC(=O)Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1		CHEMBL1934305	=	Inhibition	%	39.3	CHEMBL1868	Homo sapiens	INH	%	39.3
	7990930	CHEMBL1937673	Inhibition of Flt-1 at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccco1		CHEMBL1934306	=	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	7990931	CHEMBL1937673	Inhibition of Flt-1 at 10 uM	B	O=C(Oc1cccc(-c2nc(N3CCOCC3)c3cc4ncccc4n3n2)c1)c1ccncc1		CHEMBL1934307	=	Inhibition	%	49.1	CHEMBL1868	Homo sapiens	INH	%	49.1
	7990932	CHEMBL1937673	Inhibition of Flt-1 at 10 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	88.0	CHEMBL1868	Homo sapiens	INH	%	88.0
Not Determined	7990933	CHEMBL1937673	Inhibition of Flt-1 at 10 uM	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Determined	7990934	CHEMBL1937673	Inhibition of Flt-1 at 10 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Determined	7990935	CHEMBL1937673	Inhibition of Flt-1 at 10 uM	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Determined	7990936	CHEMBL1937673	Inhibition of Flt-1 at 10 uM	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)c1ccc(O)c(O)c1		CHEMBL56393		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Determined	7990937	CHEMBL1937673	Inhibition of Flt-1 at 10 uM	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccccc32)c1CCC(=O)O		CHEMBL89363		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	7991156	CHEMBL1937308	Inhibition of VEGFR1	B	CN1CCC(COc2ccc3c(Nc4ccc(NC(=O)Nc5cccc(F)c5)cc4)ncnc3c2)CC1		CHEMBL1934327	=	IC50	nM	1920.0	CHEMBL1868	Homo sapiens	IC50	nM	1920.0
	7992186	CHEMBL1935892	Inhibition of FLT1 at 1 uM	B	CN(c1ccccc1-c1cc(Cl)c2cnc(Nc3ccc(C4CCN(CC(N)=O)CC4)cc3)nn12)S(C)(=O)=O		CHEMBL1934353	=	Inhibition	%	52.0	CHEMBL1868	Homo sapiens	INH	%	52.0
	8010550	CHEMBL1942505	Inhibition of human VEGFR1	B	CC(C)(C)c1cc(NC(=O)NCc2ccccc2Sc2ccc3nnc(-c4ccccc4SCCO)n3c2)n(-c2ccc(O)c(Cl)c2)n1		CHEMBL1938400	=	IC50	nM	890.0	CHEMBL1868	Homo sapiens	IC50	uM	0.89
	8058287	CHEMBL1959297	Inhibition of VEGFR1	B	COc1cc(Cc2cc3c(Nc4cccc(Br)c4)nc(N)nc3[nH]2)cc(OC)c1OC		CHEMBL514014	>	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	uM	50.0
	8058288	CHEMBL1959297	Inhibition of VEGFR1	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(-c4ccccc4)cc3)[nH]c2n1		CHEMBL1956887	>	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	uM	50.0
	8058289	CHEMBL1959297	Inhibition of VEGFR1	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(Cl)c(Cl)c3)[nH]c2n1		CHEMBL1956886	>	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	uM	50.0
	8058290	CHEMBL1959297	Inhibition of VEGFR1	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(Cl)cc3Cl)[nH]c2n1		CHEMBL1095761	>	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	uM	50.0
	8058291	CHEMBL1959297	Inhibition of VEGFR1	B	Cc1ccccc1Cc1cc2c(Nc3cccc(Br)c3)nc(N)nc2[nH]1		CHEMBL1095464	>	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	uM	50.0
	8058292	CHEMBL1959297	Inhibition of VEGFR1	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccccc3)[nH]c2n1		CHEMBL499344	>	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	uM	50.0
	8058293	CHEMBL1959297	Inhibition of VEGFR1	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc(Cl)cc3)[nH]c2n1		CHEMBL1956885	=	IC50	nM	42700.0	CHEMBL1868	Homo sapiens	IC50	uM	42.7
	8058294	CHEMBL1959297	Inhibition of VEGFR1	B	COc1ccc(OC)c(Cc2cc3c(Nc4cccc(Br)c4)nc(N)nc3[nH]2)c1		CHEMBL1095465	=	IC50	nM	31100.0	CHEMBL1868	Homo sapiens	IC50	uM	31.1
	8058295	CHEMBL1959297	Inhibition of VEGFR1	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccccc3Cl)[nH]c2n1		CHEMBL499345	=	IC50	nM	26800.0	CHEMBL1868	Homo sapiens	IC50	uM	26.8
	8058296	CHEMBL1959297	Inhibition of VEGFR1	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3cccc4ccccc34)[nH]c2n1		CHEMBL474538	=	IC50	nM	19200.0	CHEMBL1868	Homo sapiens	IC50	uM	19.2
	8058297	CHEMBL1959297	Inhibition of VEGFR1	B	Nc1nc(Nc2cccc(Br)c2)c2cc(Cc3ccc4ccccc4c3)[nH]c2n1		CHEMBL502015	=	IC50	nM	15200.0	CHEMBL1868	Homo sapiens	IC50	uM	15.2
	8058353	CHEMBL1959285	Inhibition of VEGF-induced VEGFR1 autophosphorylation in human A498 cells incubated for 60 mins prior to VEGF-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccc(-c4ccccc4)cc3)c2n1	Outside typical range	CHEMBL1956897	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	8058354	CHEMBL1959285	Inhibition of VEGF-induced VEGFR1 autophosphorylation in human A498 cells incubated for 60 mins prior to VEGF-induction measured after 10 mins by phosphotyrosine ELISA	B	COc1ccc(OC)c(Cn2ccc3c(Nc4cccc(Br)c4)nc(N)nc32)c1	Outside typical range	CHEMBL1956892	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	8058355	CHEMBL1959285	Inhibition of VEGF-induced VEGFR1 autophosphorylation in human A498 cells incubated for 60 mins prior to VEGF-induction measured after 10 mins by phosphotyrosine ELISA	B	COc1cc(Cn2ccc3c(Nc4cccc(Br)c4)nc(N)nc32)cc(OC)c1OC	Outside typical range	CHEMBL1956898	=	IC50	nM	156500.0	CHEMBL1868	Homo sapiens	IC50	uM	156.5
	8058356	CHEMBL1959285	Inhibition of VEGF-induced VEGFR1 autophosphorylation in human A498 cells incubated for 60 mins prior to VEGF-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3cccc4ccccc34)c2n1	Outside typical range	CHEMBL1956895	=	IC50	nM	150000.0	CHEMBL1868	Homo sapiens	IC50	uM	150.0
	8058357	CHEMBL1959285	Inhibition of VEGF-induced VEGFR1 autophosphorylation in human A498 cells incubated for 60 mins prior to VEGF-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccc(Cl)cc3Cl)c2n1	Outside typical range	CHEMBL1956893	=	IC50	nM	138100.0	CHEMBL1868	Homo sapiens	IC50	uM	138.1
	8058358	CHEMBL1959285	Inhibition of VEGF-induced VEGFR1 autophosphorylation in human A498 cells incubated for 60 mins prior to VEGF-induction measured after 10 mins by phosphotyrosine ELISA	B	Cc1ccccc1Cn1ccc2c(Nc3cccc(Br)c3)nc(N)nc21	Outside typical range	CHEMBL1956889	=	IC50	nM	129300.0	CHEMBL1868	Homo sapiens	IC50	uM	129.3
	8058359	CHEMBL1959285	Inhibition of VEGF-induced VEGFR1 autophosphorylation in human A498 cells incubated for 60 mins prior to VEGF-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccccc3Cl)c2n1	Outside typical range	CHEMBL1956890	=	IC50	nM	126300.0	CHEMBL1868	Homo sapiens	IC50	uM	126.3
	8058360	CHEMBL1959285	Inhibition of VEGF-induced VEGFR1 autophosphorylation in human A498 cells incubated for 60 mins prior to VEGF-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccc(Cl)c(Cl)c3)c2n1	Outside typical range	CHEMBL1956894	=	IC50	nM	118600.0	CHEMBL1868	Homo sapiens	IC50	uM	118.6
	8058361	CHEMBL1959285	Inhibition of VEGF-induced VEGFR1 autophosphorylation in human A498 cells incubated for 60 mins prior to VEGF-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccccc3)c2n1		CHEMBL1956888	=	IC50	nM	99300.0	CHEMBL1868	Homo sapiens	IC50	uM	99.3
	8058362	CHEMBL1959285	Inhibition of VEGF-induced VEGFR1 autophosphorylation in human A498 cells incubated for 60 mins prior to VEGF-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccc(Cl)cc3)c2n1		CHEMBL1956891	=	IC50	nM	79900.0	CHEMBL1868	Homo sapiens	IC50	uM	79.9
	8058363	CHEMBL1959285	Inhibition of VEGF-induced VEGFR1 autophosphorylation in human A498 cells incubated for 60 mins prior to VEGF-induction measured after 10 mins by phosphotyrosine ELISA	B	Nc1nc(Nc2cccc(Br)c2)c2ccn(Cc3ccc4ccccc4c3)c2n1		CHEMBL1956896	=	IC50	nM	50800.0	CHEMBL1868	Homo sapiens	IC50	uM	50.8
	8058364	CHEMBL1959285	Inhibition of VEGF-induced VEGFR1 autophosphorylation in human A498 cells incubated for 60 mins prior to VEGF-induction measured after 10 mins by phosphotyrosine ELISA	B	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150315	=	IC50	nM	17700.0	CHEMBL1868	Homo sapiens	IC50	uM	17.7
	8061560	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	1.82	CHEMBL1868	Homo sapiens	Inhibition	%	1.82
	8061667	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	0.12	CHEMBL1868	Homo sapiens	Inhibition	%	0.12
	8061891	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.33	CHEMBL1868	Homo sapiens	Inhibition	%	3.33
	8062082	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	1.42	CHEMBL1868	Homo sapiens	Inhibition	%	1.42
	8062422	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.36	CHEMBL1868	Homo sapiens	Inhibition	%	1.36
	8062584	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.75	CHEMBL1868	Homo sapiens	Inhibition	%	1.75
	8062906	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	-0.38	CHEMBL1868	Homo sapiens	Inhibition	%	-0.38
	8063038	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	19.82	CHEMBL1868	Homo sapiens	Inhibition	%	19.82
	8063262	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	70.61	CHEMBL1868	Homo sapiens	Inhibition	%	70.61
	8063429	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	-1.35	CHEMBL1868	Homo sapiens	Inhibition	%	-1.35
	8063761	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-0.48	CHEMBL1868	Homo sapiens	Inhibition	%	-0.48
	8063943	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	13.11	CHEMBL1868	Homo sapiens	Inhibition	%	13.11
	8064282	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	1.68	CHEMBL1868	Homo sapiens	Inhibition	%	1.68
	8064492	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	-0.77	CHEMBL1868	Homo sapiens	Inhibition	%	-0.77
	8064854	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	6.85	CHEMBL1868	Homo sapiens	Inhibition	%	6.85
	8065020	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.63	CHEMBL1868	Homo sapiens	Inhibition	%	1.63
	8065360	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	-1.0	CHEMBL1868	Homo sapiens	Inhibition	%	-1.0
	8065535	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.57	CHEMBL1868	Homo sapiens	Inhibition	%	0.57
	8065759	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	11.99	CHEMBL1868	Homo sapiens	Inhibition	%	11.99
	8065874	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.13	CHEMBL1868	Homo sapiens	Inhibition	%	2.13
	8066084	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.01	CHEMBL1868	Homo sapiens	Inhibition	%	1.01
	8066444	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	23.6	CHEMBL1868	Homo sapiens	Inhibition	%	23.6
	8066610	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-0.58	CHEMBL1868	Homo sapiens	Inhibition	%	-0.58
	8066834	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.09	CHEMBL1868	Homo sapiens	Inhibition	%	0.09
	8066958	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	33.0	CHEMBL1868	Homo sapiens	Inhibition	%	33.0
	8067357	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.68	CHEMBL1868	Homo sapiens	Inhibition	%	0.68
	8067478	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	4.41	CHEMBL1868	Homo sapiens	Inhibition	%	4.41
	8067688	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.82	CHEMBL1868	Homo sapiens	Inhibition	%	-0.82
	8067912	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.6	CHEMBL1868	Homo sapiens	Inhibition	%	1.6
	8068047	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	10.44	CHEMBL1868	Homo sapiens	Inhibition	%	10.44
	8068435	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.46	CHEMBL1868	Homo sapiens	Inhibition	%	2.46
	8068560	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	53.66	CHEMBL1868	Homo sapiens	Inhibition	%	53.66
	8068784	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.3	CHEMBL1868	Homo sapiens	Inhibition	%	0.3
	8068958	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	-0.67	CHEMBL1868	Homo sapiens	Inhibition	%	-0.67
	8069083	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.98	CHEMBL1868	Homo sapiens	Inhibition	%	1.98
	8069307	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.63	CHEMBL1868	Homo sapiens	Inhibition	%	2.63
	8069378	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	30.95	CHEMBL1868	Homo sapiens	Inhibition	%	30.95
	8069602	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	11.45	CHEMBL1868	Homo sapiens	Inhibition	%	11.45
	8069763	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	9.52	CHEMBL1868	Homo sapiens	Inhibition	%	9.52
	8070113	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.63	CHEMBL1868	Homo sapiens	Inhibition	%	1.63
	8070285	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-2.5	CHEMBL1868	Homo sapiens	Inhibition	%	-2.5
	8070634	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.29	CHEMBL1868	Homo sapiens	Inhibition	%	0.29
	8070932	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	28.38	CHEMBL1868	Homo sapiens	Inhibition	%	28.38
	8071089	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.01	CHEMBL1868	Homo sapiens	Inhibition	%	0.01
	8071439	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	3.33	CHEMBL1868	Homo sapiens	Inhibition	%	3.33
	8071612	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	-1.05	CHEMBL1868	Homo sapiens	Inhibition	%	-1.05
	8071961	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	6.12	CHEMBL1868	Homo sapiens	Inhibition	%	6.12
	8072275	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	2.97	CHEMBL1868	Homo sapiens	Inhibition	%	2.97
	8072432	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	-0.12	CHEMBL1868	Homo sapiens	Inhibition	%	-0.12
	8072656	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	16.5	CHEMBL1868	Homo sapiens	Inhibition	%	16.5
	8072781	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	29.23	CHEMBL1868	Homo sapiens	Inhibition	%	29.23
	8072948	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.26	CHEMBL1868	Homo sapiens	Inhibition	%	2.26
	8073172	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.22	CHEMBL1868	Homo sapiens	Inhibition	%	4.22
	8073297	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	35.95	CHEMBL1868	Homo sapiens	Inhibition	%	35.95
	8073640	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.83	CHEMBL1868	Homo sapiens	Inhibition	%	0.83
	8073873	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	25.67	CHEMBL1868	Homo sapiens	Inhibition	%	25.67
	8074249	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	22.05	CHEMBL1868	Homo sapiens	Inhibition	%	22.05
	8074379	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.21	CHEMBL1868	Homo sapiens	Inhibition	%	-0.21
	8074760	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.07	CHEMBL1868	Homo sapiens	Inhibition	%	0.07
	8074887	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	78.1	CHEMBL1868	Homo sapiens	Inhibition	%	78.1
	8075111	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	1.51	CHEMBL1868	Homo sapiens	Inhibition	%	1.51
	8075222	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	7.86	CHEMBL1868	Homo sapiens	Inhibition	%	7.86
	8075459	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-1.48	CHEMBL1868	Homo sapiens	Inhibition	%	-1.48
	8075824	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.61	CHEMBL1868	Homo sapiens	Inhibition	%	2.61
	8075966	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	6.59	CHEMBL1868	Homo sapiens	Inhibition	%	6.59
	8076190	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-2.14	CHEMBL1868	Homo sapiens	Inhibition	%	-2.14
	8076338	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	0.23	CHEMBL1868	Homo sapiens	Inhibition	%	0.23
	8076696	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.56	CHEMBL1868	Homo sapiens	Inhibition	%	0.56
	8076798	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-2.17	CHEMBL1868	Homo sapiens	Inhibition	%	-2.17
	8077022	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.42	CHEMBL1868	Homo sapiens	Inhibition	%	0.42
	8077045	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	3.78	CHEMBL1868	Homo sapiens	Inhibition	%	3.78
	8077269	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	36.15	CHEMBL1868	Homo sapiens	Inhibition	%	36.15
	8077397	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	7.03	CHEMBL1868	Homo sapiens	Inhibition	%	7.03
	8077772	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.15	CHEMBL1868	Homo sapiens	Inhibition	%	1.15
	8077915	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.49	CHEMBL1868	Homo sapiens	Inhibition	%	1.49
	8078278	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	2.34	CHEMBL1868	Homo sapiens	Inhibition	%	2.34
	8078604	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.48	CHEMBL1868	Homo sapiens	Inhibition	%	0.48
	8078854	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	79.76	CHEMBL1868	Homo sapiens	Inhibition	%	79.76
	8078970	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	-0.39	CHEMBL1868	Homo sapiens	Inhibition	%	-0.39
	8079352	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-1.57	CHEMBL1868	Homo sapiens	Inhibition	%	-1.57
	8079494	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	4.71	CHEMBL1868	Homo sapiens	Inhibition	%	4.71
	8079718	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	1.64	CHEMBL1868	Homo sapiens	Inhibition	%	1.64
	8079857	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	14.35	CHEMBL1868	Homo sapiens	Inhibition	%	14.35
	8080186	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.61	CHEMBL1868	Homo sapiens	Inhibition	%	0.61
	8080438	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	4.68	CHEMBL1868	Homo sapiens	Inhibition	%	4.68
	8080553	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.58	CHEMBL1868	Homo sapiens	Inhibition	%	1.58
	8080777	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.14	CHEMBL1868	Homo sapiens	Inhibition	%	0.14
	8080941	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-1.26	CHEMBL1868	Homo sapiens	Inhibition	%	-1.26
	8081300	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	-1.13	CHEMBL1868	Homo sapiens	Inhibition	%	-1.13
	8081444	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	0.21	CHEMBL1868	Homo sapiens	Inhibition	%	0.21
	8081771	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.72	CHEMBL1868	Homo sapiens	Inhibition	%	0.72
	8082023	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	39.39	CHEMBL1868	Homo sapiens	Inhibition	%	39.39
	8082360	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.06	CHEMBL1868	Homo sapiens	Inhibition	%	1.06
	8082533	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.52	CHEMBL1868	Homo sapiens	Inhibition	%	-0.52
	8082880	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.31	CHEMBL1868	Homo sapiens	Inhibition	%	1.31
	8083036	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	0.37	CHEMBL1868	Homo sapiens	Inhibition	%	0.37
	8083260	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	0.63	CHEMBL1868	Homo sapiens	Inhibition	%	0.63
	8083359	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.36	CHEMBL1868	Homo sapiens	Inhibition	%	1.36
	8083613	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-1.0	CHEMBL1868	Homo sapiens	Inhibition	%	-1.0
	8083947	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	-0.81	CHEMBL1868	Homo sapiens	Inhibition	%	-0.81
	8084132	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-0.59	CHEMBL1868	Homo sapiens	Inhibition	%	-0.59
	8084356	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	10.97	CHEMBL1868	Homo sapiens	Inhibition	%	10.97
	8084474	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	-0.61	CHEMBL1868	Homo sapiens	Inhibition	%	-0.61
	8084859	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	5.48	CHEMBL1868	Homo sapiens	Inhibition	%	5.48
	8084957	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-2.92	CHEMBL1868	Homo sapiens	Inhibition	%	-2.92
	8085181	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-1.44	CHEMBL1868	Homo sapiens	Inhibition	%	-1.44
	8085213	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	4.33	CHEMBL1868	Homo sapiens	Inhibition	%	4.33
	8085437	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-1.46	CHEMBL1868	Homo sapiens	Inhibition	%	-1.46
	8085545	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	2.41	CHEMBL1868	Homo sapiens	Inhibition	%	2.41
	8085958	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	59.56	CHEMBL1868	Homo sapiens	Inhibition	%	59.56
	8086073	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.1	CHEMBL1868	Homo sapiens	Inhibition	%	1.1
	8086297	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.36	CHEMBL1868	Homo sapiens	Inhibition	%	1.36
	8086459	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-0.55	CHEMBL1868	Homo sapiens	Inhibition	%	-0.55
	8086782	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	0.15	CHEMBL1868	Homo sapiens	Inhibition	%	0.15
	8086993	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.03	CHEMBL1868	Homo sapiens	Inhibition	%	0.03
	8087151	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	11.65	CHEMBL1868	Homo sapiens	Inhibition	%	11.65
	8087375	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.67	CHEMBL1868	Homo sapiens	Inhibition	%	0.67
	8087489	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	91.15	CHEMBL1868	Homo sapiens	Inhibition	%	91.15
	8087851	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	3.76	CHEMBL1868	Homo sapiens	Inhibition	%	3.76
	8087993	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	0.7	CHEMBL1868	Homo sapiens	Inhibition	%	0.7
	8088217	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.54	CHEMBL1868	Homo sapiens	Inhibition	%	2.54
	8088365	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.22	CHEMBL1868	Homo sapiens	Inhibition	%	1.22
	8088717	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	4.55	CHEMBL1868	Homo sapiens	Inhibition	%	4.55
	8088810	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.69	CHEMBL1868	Homo sapiens	Inhibition	%	2.69
	8089034	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	0.59	CHEMBL1868	Homo sapiens	Inhibition	%	0.59
	8089162	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	-0.02	CHEMBL1868	Homo sapiens	Inhibition	%	-0.02
	8089310	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.32	CHEMBL1868	Homo sapiens	Inhibition	%	1.32
	8089534	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.39	CHEMBL1868	Homo sapiens	Inhibition	%	1.39
	8089654	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	3.12	CHEMBL1868	Homo sapiens	Inhibition	%	3.12
	8090058	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.63	CHEMBL1868	Homo sapiens	Inhibition	%	0.63
	8090223	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-1.2	CHEMBL1868	Homo sapiens	Inhibition	%	-1.2
	8090614	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.94	CHEMBL1868	Homo sapiens	Inhibition	%	2.94
	8090753	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	1.9	CHEMBL1868	Homo sapiens	Inhibition	%	1.9
	8090958	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	10.21	CHEMBL1868	Homo sapiens	Inhibition	%	10.21
	8091182	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.38	CHEMBL1868	Homo sapiens	Inhibition	%	2.38
	8091319	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	4.61	CHEMBL1868	Homo sapiens	Inhibition	%	4.61
	8091698	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	4.22	CHEMBL1868	Homo sapiens	Inhibition	%	4.22
	8091814	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	4.3	CHEMBL1868	Homo sapiens	Inhibition	%	4.3
	8092038	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	16.39	CHEMBL1868	Homo sapiens	Inhibition	%	16.39
	8092175	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	1.35	CHEMBL1868	Homo sapiens	Inhibition	%	1.35
	8092550	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	0.1	CHEMBL1868	Homo sapiens	Inhibition	%	0.1
	8092698	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.42	CHEMBL1868	Homo sapiens	Inhibition	%	1.42
	8093051	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	13.32	CHEMBL1868	Homo sapiens	Inhibition	%	13.32
	8093363	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	1.4	CHEMBL1868	Homo sapiens	Inhibition	%	1.4
	8093503	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	2.7	CHEMBL1868	Homo sapiens	Inhibition	%	2.7
	8093866	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	13.92	CHEMBL1868	Homo sapiens	Inhibition	%	13.92
	8093986	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	3.73	CHEMBL1868	Homo sapiens	Inhibition	%	3.73
	8094210	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	13.76	CHEMBL1868	Homo sapiens	Inhibition	%	13.76
	8094390	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.74	CHEMBL1868	Homo sapiens	Inhibition	%	-0.74
	8094565	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.09	CHEMBL1868	Homo sapiens	Inhibition	%	1.09
	8094945	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	-1.07	CHEMBL1868	Homo sapiens	Inhibition	%	-1.07
	8095085	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	44.37	CHEMBL1868	Homo sapiens	Inhibition	%	44.37
	8095309	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	96.07	CHEMBL1868	Homo sapiens	Inhibition	%	96.07
	8095512	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.68	CHEMBL1868	Homo sapiens	Inhibition	%	2.68
	8095653	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	-0.55	CHEMBL1868	Homo sapiens	Inhibition	%	-0.55
	8095877	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	5.76	CHEMBL1868	Homo sapiens	Inhibition	%	5.76
	8096025	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.61	CHEMBL1868	Homo sapiens	Inhibition	%	0.61
	8096366	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.55	CHEMBL1868	Homo sapiens	Inhibition	%	1.55
	8096505	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	2.72	CHEMBL1868	Homo sapiens	Inhibition	%	2.72
	8096885	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	0.78	CHEMBL1868	Homo sapiens	Inhibition	%	0.78
	8097032	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.58	CHEMBL1868	Homo sapiens	Inhibition	%	-0.58
	8097256	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	3.56	CHEMBL1868	Homo sapiens	Inhibition	%	3.56
	8097343	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.7	CHEMBL1868	Homo sapiens	Inhibition	%	3.7
	8097563	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.41	CHEMBL1868	Homo sapiens	Inhibition	%	3.41
	8097713	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	5.16	CHEMBL1868	Homo sapiens	Inhibition	%	5.16
	8097937	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	33.85	CHEMBL1868	Homo sapiens	Inhibition	%	33.85
	8098070	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	3.38	CHEMBL1868	Homo sapiens	Inhibition	%	3.38
	8098414	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-2.33	CHEMBL1868	Homo sapiens	Inhibition	%	-2.33
	8098594	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	1.77	CHEMBL1868	Homo sapiens	Inhibition	%	1.77
	8098779	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	-0.84	CHEMBL1868	Homo sapiens	Inhibition	%	-0.84
	8099003	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	0.61	CHEMBL1868	Homo sapiens	Inhibition	%	0.61
	8099147	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	3.16	CHEMBL1868	Homo sapiens	Inhibition	%	3.16
	8099513	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.7	CHEMBL1868	Homo sapiens	Inhibition	%	1.7
	8099707	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.23	CHEMBL1868	Homo sapiens	Inhibition	%	1.23
	8100078	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	-0.93	CHEMBL1868	Homo sapiens	Inhibition	%	-0.93
	8100224	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.06	CHEMBL1868	Homo sapiens	Inhibition	%	3.06
	8100564	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.06	CHEMBL1868	Homo sapiens	Inhibition	%	1.06
	8100704	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.09	CHEMBL1868	Homo sapiens	Inhibition	%	-0.09
	8100928	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.05	CHEMBL1868	Homo sapiens	Inhibition	%	1.05
	8101088	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.23	CHEMBL1868	Homo sapiens	Inhibition	%	2.23
	8101454	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	8.63	CHEMBL1868	Homo sapiens	Inhibition	%	8.63
	8101639	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.27	CHEMBL1868	Homo sapiens	Inhibition	%	0.27
	8101892	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	2.08	CHEMBL1868	Homo sapiens	Inhibition	%	2.08
	8102271	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	2.24	CHEMBL1868	Homo sapiens	Inhibition	%	2.24
	8102402	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	8.22	CHEMBL1868	Homo sapiens	Inhibition	%	8.22
	8102746	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.83	CHEMBL1868	Homo sapiens	Inhibition	%	-0.83
	8102924	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-2.31	CHEMBL1868	Homo sapiens	Inhibition	%	-2.31
	8103148	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.13	CHEMBL1868	Homo sapiens	Inhibition	%	-0.13
	8103344	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	6.07	CHEMBL1868	Homo sapiens	Inhibition	%	6.07
	8103482	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.3	CHEMBL1868	Homo sapiens	Inhibition	%	2.3
	8103856	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.67	CHEMBL1868	Homo sapiens	Inhibition	%	1.67
	8104041	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	3.07	CHEMBL1868	Homo sapiens	Inhibition	%	3.07
	8104413	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	0.15	CHEMBL1868	Homo sapiens	Inhibition	%	0.15
	8104559	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-0.89	CHEMBL1868	Homo sapiens	Inhibition	%	-0.89
	8104783	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	7.48	CHEMBL1868	Homo sapiens	Inhibition	%	7.48
	8104897	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-0.44	CHEMBL1868	Homo sapiens	Inhibition	%	-0.44
	8105261	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-2.5	CHEMBL1868	Homo sapiens	Inhibition	%	-2.5
	8105427	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.25	CHEMBL1868	Homo sapiens	Inhibition	%	2.25
	8105789	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%		CHEMBL1868	Homo sapiens	Inhibition	%	
	8106069	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.19	CHEMBL1868	Homo sapiens	Inhibition	%	2.19
	8106234	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	18.41	CHEMBL1868	Homo sapiens	Inhibition	%	18.41
	8106614	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	29.25	CHEMBL1868	Homo sapiens	Inhibition	%	29.25
	8106743	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	7.45	CHEMBL1868	Homo sapiens	Inhibition	%	7.45
	8106967	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	30.57	CHEMBL1868	Homo sapiens	Inhibition	%	30.57
	8107088	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-3.05	CHEMBL1868	Homo sapiens	Inhibition	%	-3.05
	8107484	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-0.46	CHEMBL1868	Homo sapiens	Inhibition	%	-0.46
	8107685	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	30.44	CHEMBL1868	Homo sapiens	Inhibition	%	30.44
	8107820	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.29	CHEMBL1868	Homo sapiens	Inhibition	%	1.29
	8108044	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	16.44	CHEMBL1868	Homo sapiens	Inhibition	%	16.44
	8108202	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.22	CHEMBL1868	Homo sapiens	Inhibition	%	1.22
	8108377	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	28.59	CHEMBL1868	Homo sapiens	Inhibition	%	28.59
	8108601	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	56.84	CHEMBL1868	Homo sapiens	Inhibition	%	56.84
	8108748	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	1.38	CHEMBL1868	Homo sapiens	Inhibition	%	1.38
	8109114	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-2.31	CHEMBL1868	Homo sapiens	Inhibition	%	-2.31
	8109228	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	-0.67	CHEMBL1868	Homo sapiens	Inhibition	%	-0.67
	8109582	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-2.3	CHEMBL1868	Homo sapiens	Inhibition	%	-2.3
	8109753	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	1.54	CHEMBL1868	Homo sapiens	Inhibition	%	1.54
	8109977	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	3.12	CHEMBL1868	Homo sapiens	Inhibition	%	3.12
	8110109	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	4.69	CHEMBL1868	Homo sapiens	Inhibition	%	4.69
	8110388	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	3.25	CHEMBL1868	Homo sapiens	Inhibition	%	3.25
	8110554	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.51	CHEMBL1868	Homo sapiens	Inhibition	%	0.51
	8110778	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.19	CHEMBL1868	Homo sapiens	Inhibition	%	1.19
	8110936	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.25	CHEMBL1868	Homo sapiens	Inhibition	%	0.25
	8111283	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	36.42	CHEMBL1868	Homo sapiens	Inhibition	%	36.42
	8111410	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	2.9	CHEMBL1868	Homo sapiens	Inhibition	%	2.9
	8111634	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.39	CHEMBL1868	Homo sapiens	Inhibition	%	1.39
	8111800	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	-0.01	CHEMBL1868	Homo sapiens	Inhibition	%	-0.01
	8112005	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.05	CHEMBL1868	Homo sapiens	Inhibition	%	1.05
	8112366	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.52	CHEMBL1868	Homo sapiens	Inhibition	%	-0.52
	8112534	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.98	CHEMBL1868	Homo sapiens	Inhibition	%	0.98
	8112930	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	2.35	CHEMBL1868	Homo sapiens	Inhibition	%	2.35
	8113082	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	-0.37	CHEMBL1868	Homo sapiens	Inhibition	%	-0.37
	8113442	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.57	CHEMBL1868	Homo sapiens	Inhibition	%	0.57
	8113566	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-0.2	CHEMBL1868	Homo sapiens	Inhibition	%	-0.2
	8113790	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	2.15	CHEMBL1868	Homo sapiens	Inhibition	%	2.15
	8113906	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.33	CHEMBL1868	Homo sapiens	Inhibition	%	-1.33
	8114306	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.21	CHEMBL1868	Homo sapiens	Inhibition	%	1.21
	8114438	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	18.76	CHEMBL1868	Homo sapiens	Inhibition	%	18.76
	8114714	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.97	CHEMBL1868	Homo sapiens	Inhibition	%	2.97
	8115104	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	37.47	CHEMBL1868	Homo sapiens	Inhibition	%	37.47
	8115269	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	0.93	CHEMBL1868	Homo sapiens	Inhibition	%	0.93
	8115613	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	43.83	CHEMBL1868	Homo sapiens	Inhibition	%	43.83
	8115970	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	17.37	CHEMBL1868	Homo sapiens	Inhibition	%	17.37
	8116129	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	-1.72	CHEMBL1868	Homo sapiens	Inhibition	%	-1.72
	8116332	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	11.04	CHEMBL1868	Homo sapiens	Inhibition	%	11.04
	8116556	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	5.67	CHEMBL1868	Homo sapiens	Inhibition	%	5.67
	8116690	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.07	CHEMBL1868	Homo sapiens	Inhibition	%	-0.07
	8116862	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	4.56	CHEMBL1868	Homo sapiens	Inhibition	%	4.56
	8117086	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	14.95	CHEMBL1868	Homo sapiens	Inhibition	%	14.95
	8117257	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.36	CHEMBL1868	Homo sapiens	Inhibition	%	-0.36
	8117415	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.71	CHEMBL1868	Homo sapiens	Inhibition	%	1.71
	8117639	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	10.19	CHEMBL1868	Homo sapiens	Inhibition	%	10.19
	8117769	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.51	CHEMBL1868	Homo sapiens	Inhibition	%	-0.51
	8118131	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.45	CHEMBL1868	Homo sapiens	Inhibition	%	0.45
	8118247	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.04	CHEMBL1868	Homo sapiens	Inhibition	%	-1.04
	8118471	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	-0.38	CHEMBL1868	Homo sapiens	Inhibition	%	-0.38
	8118643	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	2.94	CHEMBL1868	Homo sapiens	Inhibition	%	2.94
	8118779	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.39	CHEMBL1868	Homo sapiens	Inhibition	%	2.39
	8119003	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	2.46	CHEMBL1868	Homo sapiens	Inhibition	%	2.46
	8119050	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	2.09	CHEMBL1868	Homo sapiens	Inhibition	%	2.09
	8119274	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.27	CHEMBL1868	Homo sapiens	Inhibition	%	2.27
	8119433	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	84.5	CHEMBL1868	Homo sapiens	Inhibition	%	84.5
	8119600	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-1.03	CHEMBL1868	Homo sapiens	Inhibition	%	-1.03
	8119824	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.69	CHEMBL1868	Homo sapiens	Inhibition	%	-0.69
	8119943	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.98	CHEMBL1868	Homo sapiens	Inhibition	%	1.98
	8120306	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-1.27	CHEMBL1868	Homo sapiens	Inhibition	%	-1.27
	8120466	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	11.08	CHEMBL1868	Homo sapiens	Inhibition	%	11.08
	8120891	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	16.38	CHEMBL1868	Homo sapiens	Inhibition	%	16.38
	8121019	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.02	CHEMBL1868	Homo sapiens	Inhibition	%	1.02
	8121415	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.12	CHEMBL1868	Homo sapiens	Inhibition	%	-0.12
	8121582	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	5.3	CHEMBL1868	Homo sapiens	Inhibition	%	5.3
	8121969	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	-0.01	CHEMBL1868	Homo sapiens	Inhibition	%	-0.01
	8122090	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.52	CHEMBL1868	Homo sapiens	Inhibition	%	0.52
	8122314	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	26.87	CHEMBL1868	Homo sapiens	Inhibition	%	26.87
	8122452	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	4.56	CHEMBL1868	Homo sapiens	Inhibition	%	4.56
	8122796	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.07	CHEMBL1868	Homo sapiens	Inhibition	%	2.07
	8122963	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	1.26	CHEMBL1868	Homo sapiens	Inhibition	%	1.26
	8123329	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	1.92	CHEMBL1868	Homo sapiens	Inhibition	%	1.92
	8123607	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	0.42	CHEMBL1868	Homo sapiens	Inhibition	%	0.42
	8123757	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.24	CHEMBL1868	Homo sapiens	Inhibition	%	3.24
	8124148	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-1.12	CHEMBL1868	Homo sapiens	Inhibition	%	-1.12
	8124267	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	-0.42	CHEMBL1868	Homo sapiens	Inhibition	%	-0.42
	8124491	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	9.62	CHEMBL1868	Homo sapiens	Inhibition	%	9.62
	8124630	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.4	CHEMBL1868	Homo sapiens	Inhibition	%	-0.4
	8124795	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-2.71	CHEMBL1868	Homo sapiens	Inhibition	%	-2.71
	8125019	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	0.04	CHEMBL1868	Homo sapiens	Inhibition	%	0.04
	8125220	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	2.69	CHEMBL1868	Homo sapiens	Inhibition	%	2.69
	8125350	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	2.87	CHEMBL1868	Homo sapiens	Inhibition	%	2.87
	8125574	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.7	CHEMBL1868	Homo sapiens	Inhibition	%	0.7
	8125742	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	2.35	CHEMBL1868	Homo sapiens	Inhibition	%	2.35
	8125906	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	11.97	CHEMBL1868	Homo sapiens	Inhibition	%	11.97
	8126130	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.76	CHEMBL1868	Homo sapiens	Inhibition	%	0.76
	8126294	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.57	CHEMBL1868	Homo sapiens	Inhibition	%	4.57
	8126633	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	74.33	CHEMBL1868	Homo sapiens	Inhibition	%	74.33
	8126769	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	7.41	CHEMBL1868	Homo sapiens	Inhibition	%	7.41
	8127115	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	-0.48	CHEMBL1868	Homo sapiens	Inhibition	%	-0.48
	8127282	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	0.92	CHEMBL1868	Homo sapiens	Inhibition	%	0.92
	8127506	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	14.19	CHEMBL1868	Homo sapiens	Inhibition	%	14.19
	8127648	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	9.39	CHEMBL1868	Homo sapiens	Inhibition	%	9.39
	8127936	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	0.68	CHEMBL1868	Homo sapiens	Inhibition	%	0.68
	8128088	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	15.12	CHEMBL1868	Homo sapiens	Inhibition	%	15.12
	8128312	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	2.21	CHEMBL1868	Homo sapiens	Inhibition	%	2.21
	8128479	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	1.4	CHEMBL1868	Homo sapiens	Inhibition	%	1.4
	8128822	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	25.13	CHEMBL1868	Homo sapiens	Inhibition	%	25.13
	8128959	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	-2.65	CHEMBL1868	Homo sapiens	Inhibition	%	-2.65
	8129354	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.18	CHEMBL1868	Homo sapiens	Inhibition	%	-0.18
	8129543	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.25	CHEMBL1868	Homo sapiens	Inhibition	%	3.25
	8129906	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.07	CHEMBL1868	Homo sapiens	Inhibition	%	0.07
	8130067	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-0.04	CHEMBL1868	Homo sapiens	Inhibition	%	-0.04
	8130463	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	1.26	CHEMBL1868	Homo sapiens	Inhibition	%	1.26
	8130623	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	3.62	CHEMBL1868	Homo sapiens	Inhibition	%	3.62
	8130963	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	-0.67	CHEMBL1868	Homo sapiens	Inhibition	%	-0.67
	8131102	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	50.58	CHEMBL1868	Homo sapiens	Inhibition	%	50.58
	8131326	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	-1.57	CHEMBL1868	Homo sapiens	Inhibition	%	-1.57
	8131446	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.29	CHEMBL1868	Homo sapiens	Inhibition	%	3.29
	8131837	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	55.32	CHEMBL1868	Homo sapiens	Inhibition	%	55.32
	8131978	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	55.95	CHEMBL1868	Homo sapiens	Inhibition	%	55.95
	8132264	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.1	CHEMBL1868	Homo sapiens	Inhibition	%	2.1
	8132635	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.14	CHEMBL1868	Homo sapiens	Inhibition	%	3.14
	8132803	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.53	CHEMBL1868	Homo sapiens	Inhibition	%	0.53
	8133148	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	-1.24	CHEMBL1868	Homo sapiens	Inhibition	%	-1.24
	8133286	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.09	CHEMBL1868	Homo sapiens	Inhibition	%	1.09
	8133510	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.64	CHEMBL1868	Homo sapiens	Inhibition	%	0.64
	8133682	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.16	CHEMBL1868	Homo sapiens	Inhibition	%	-0.16
	8133862	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	21.38	CHEMBL1868	Homo sapiens	Inhibition	%	21.38
	8134234	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.2	CHEMBL1868	Homo sapiens	Inhibition	%	-0.2
	8134394	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.56	CHEMBL1868	Homo sapiens	Inhibition	%	0.56
	8134618	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	1.47	CHEMBL1868	Homo sapiens	Inhibition	%	1.47
	8134802	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	4.31	CHEMBL1868	Homo sapiens	Inhibition	%	4.31
	8134962	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	16.2	CHEMBL1868	Homo sapiens	Inhibition	%	16.2
	8135301	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.64	CHEMBL1868	Homo sapiens	Inhibition	%	0.64
	8135666	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	2.13	CHEMBL1868	Homo sapiens	Inhibition	%	2.13
	8135787	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	1.21	CHEMBL1868	Homo sapiens	Inhibition	%	1.21
	8136179	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	3.79	CHEMBL1868	Homo sapiens	Inhibition	%	3.79
	8136323	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	91.04	CHEMBL1868	Homo sapiens	Inhibition	%	91.04
	8136547	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	0.92	CHEMBL1868	Homo sapiens	Inhibition	%	0.92
	8136613	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.09	CHEMBL1868	Homo sapiens	Inhibition	%	-0.09
	8136972	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.2	CHEMBL1868	Homo sapiens	Inhibition	%	0.2
	8137135	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.73	CHEMBL1868	Homo sapiens	Inhibition	%	2.73
	8137359	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	2.98	CHEMBL1868	Homo sapiens	Inhibition	%	2.98
	8137479	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	6.44	CHEMBL1868	Homo sapiens	Inhibition	%	6.44
	8137851	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	-0.57	CHEMBL1868	Homo sapiens	Inhibition	%	-0.57
	8138017	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.64	CHEMBL1868	Homo sapiens	Inhibition	%	-1.64
	8138196	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	43.49	CHEMBL1868	Homo sapiens	Inhibition	%	43.49
	8138420	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.29	CHEMBL1868	Homo sapiens	Inhibition	%	-0.29
	8138568	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	0.12	CHEMBL1868	Homo sapiens	Inhibition	%	0.12
	8138950	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	8.07	CHEMBL1868	Homo sapiens	Inhibition	%	8.07
	8139135	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	20.81	CHEMBL1868	Homo sapiens	Inhibition	%	20.81
	8139294	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	-0.29	CHEMBL1868	Homo sapiens	Inhibition	%	-0.29
	8139518	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.74	CHEMBL1868	Homo sapiens	Inhibition	%	1.74
	8139632	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	1.28	CHEMBL1868	Homo sapiens	Inhibition	%	1.28
	8139997	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	0.35	CHEMBL1868	Homo sapiens	Inhibition	%	0.35
	8140120	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	4.59	CHEMBL1868	Homo sapiens	Inhibition	%	4.59
	8140344	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.41	CHEMBL1868	Homo sapiens	Inhibition	%	1.41
	8140503	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.71	CHEMBL1868	Homo sapiens	Inhibition	%	0.71
	8140870	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.35	CHEMBL1868	Homo sapiens	Inhibition	%	2.35
	8140948	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.09	CHEMBL1868	Homo sapiens	Inhibition	%	1.09
	8141172	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.49	CHEMBL1868	Homo sapiens	Inhibition	%	1.49
	8141302	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.26	CHEMBL1868	Homo sapiens	Inhibition	%	2.26
	8141686	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	19.7	CHEMBL1868	Homo sapiens	Inhibition	%	19.7
	8141805	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	1.75	CHEMBL1868	Homo sapiens	Inhibition	%	1.75
	8142190	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	4.09	CHEMBL1868	Homo sapiens	Inhibition	%	4.09
	8142358	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.09	CHEMBL1868	Homo sapiens	Inhibition	%	-1.09
	8142758	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	-0.5	CHEMBL1868	Homo sapiens	Inhibition	%	-0.5
	8142907	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.43	CHEMBL1868	Homo sapiens	Inhibition	%	0.43
	8143286	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.39	CHEMBL1868	Homo sapiens	Inhibition	%	0.39
	8143473	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-0.02	CHEMBL1868	Homo sapiens	Inhibition	%	-0.02
	8143856	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.37	CHEMBL1868	Homo sapiens	Inhibition	%	2.37
	8143970	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.39	CHEMBL1868	Homo sapiens	Inhibition	%	0.39
	8144194	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.47	CHEMBL1868	Homo sapiens	Inhibition	%	-0.47
	8144333	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	-0.47	CHEMBL1868	Homo sapiens	Inhibition	%	-0.47
	8144687	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.14	CHEMBL1868	Homo sapiens	Inhibition	%	1.14
	8144840	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.17	CHEMBL1868	Homo sapiens	Inhibition	%	2.17
	8145201	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	2.06	CHEMBL1868	Homo sapiens	Inhibition	%	2.06
	8145514	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.02	CHEMBL1868	Homo sapiens	Inhibition	%	2.02
	8145638	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.05	CHEMBL1868	Homo sapiens	Inhibition	%	1.05
	8145862	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	7.88	CHEMBL1868	Homo sapiens	Inhibition	%	7.88
	8146023	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	38.49	CHEMBL1868	Homo sapiens	Inhibition	%	38.49
	8146143	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	1.51	CHEMBL1868	Homo sapiens	Inhibition	%	1.51
	8146367	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	4.5	CHEMBL1868	Homo sapiens	Inhibition	%	4.5
	8146527	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	26.84	CHEMBL1868	Homo sapiens	Inhibition	%	26.84
	8146694	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.83	CHEMBL1868	Homo sapiens	Inhibition	%	-0.83
	8146918	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.16	CHEMBL1868	Homo sapiens	Inhibition	%	-0.16
	8147087	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.25	CHEMBL1868	Homo sapiens	Inhibition	%	2.25
	8147229	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-1.81	CHEMBL1868	Homo sapiens	Inhibition	%	-1.81
	8147453	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	2.04	CHEMBL1868	Homo sapiens	Inhibition	%	2.04
	8147606	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	1.35	CHEMBL1868	Homo sapiens	Inhibition	%	1.35
	8147793	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	-1.49	CHEMBL1868	Homo sapiens	Inhibition	%	-1.49
	8148017	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.43	CHEMBL1868	Homo sapiens	Inhibition	%	2.43
	8148175	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	21.19	CHEMBL1868	Homo sapiens	Inhibition	%	21.19
	8148513	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.16	CHEMBL1868	Homo sapiens	Inhibition	%	2.16
	8148652	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.36	CHEMBL1868	Homo sapiens	Inhibition	%	0.36
	8148876	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	2.47	CHEMBL1868	Homo sapiens	Inhibition	%	2.47
	8149014	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	0.89	CHEMBL1868	Homo sapiens	Inhibition	%	0.89
	8149173	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	-0.47	CHEMBL1868	Homo sapiens	Inhibition	%	-0.47
	8149397	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	3.08	CHEMBL1868	Homo sapiens	Inhibition	%	3.08
	8149531	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	4.7	CHEMBL1868	Homo sapiens	Inhibition	%	4.7
	8149853	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	0.98	CHEMBL1868	Homo sapiens	Inhibition	%	0.98
	8150202	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	23.59	CHEMBL1868	Homo sapiens	Inhibition	%	23.59
	8150362	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	51.01	CHEMBL1868	Homo sapiens	Inhibition	%	51.01
	8150706	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	37.67	CHEMBL1868	Homo sapiens	Inhibition	%	37.67
	8150871	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-1.61	CHEMBL1868	Homo sapiens	Inhibition	%	-1.61
	8151258	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-2.04	CHEMBL1868	Homo sapiens	Inhibition	%	-2.04
	8151435	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.84	CHEMBL1868	Homo sapiens	Inhibition	%	2.84
	8151797	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.17	CHEMBL1868	Homo sapiens	Inhibition	%	1.17
	8151951	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	4.29	CHEMBL1868	Homo sapiens	Inhibition	%	4.29
	8152363	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.64	CHEMBL1868	Homo sapiens	Inhibition	%	2.64
	8152521	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	1.21	CHEMBL1868	Homo sapiens	Inhibition	%	1.21
	8152859	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	60.79	CHEMBL1868	Homo sapiens	Inhibition	%	60.79
	8153222	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.35	CHEMBL1868	Homo sapiens	Inhibition	%	0.35
	8153359	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	-0.43	CHEMBL1868	Homo sapiens	Inhibition	%	-0.43
	8153740	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	6.33	CHEMBL1868	Homo sapiens	Inhibition	%	6.33
	8153873	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	2.02	CHEMBL1868	Homo sapiens	Inhibition	%	2.02
	8154097	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	3.5	CHEMBL1868	Homo sapiens	Inhibition	%	3.5
	8154194	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	4.03	CHEMBL1868	Homo sapiens	Inhibition	%	4.03
	8154544	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	78.75	CHEMBL1868	Homo sapiens	Inhibition	%	78.75
	8154703	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.95	CHEMBL1868	Homo sapiens	Inhibition	%	1.95
	8155047	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.4	CHEMBL1868	Homo sapiens	Inhibition	%	0.4
	8155223	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	1.49	CHEMBL1868	Homo sapiens	Inhibition	%	1.49
	8155447	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-2.26	CHEMBL1868	Homo sapiens	Inhibition	%	-2.26
	8155608	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-1.81	CHEMBL1868	Homo sapiens	Inhibition	%	-1.81
	8155786	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	0.02	CHEMBL1868	Homo sapiens	Inhibition	%	0.02
	8156010	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	2.1	CHEMBL1868	Homo sapiens	Inhibition	%	2.1
	8156148	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.98	CHEMBL1868	Homo sapiens	Inhibition	%	-0.98
	8156360	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	3.36	CHEMBL1868	Homo sapiens	Inhibition	%	3.36
	8156734	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	17.21	CHEMBL1868	Homo sapiens	Inhibition	%	17.21
	8156877	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.95	CHEMBL1868	Homo sapiens	Inhibition	%	4.95
	8157101	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	13.1	CHEMBL1868	Homo sapiens	Inhibition	%	13.1
	8157221	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.04	CHEMBL1868	Homo sapiens	Inhibition	%	1.04
	8157586	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	2.19	CHEMBL1868	Homo sapiens	Inhibition	%	2.19
	8157716	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	39.3	CHEMBL1868	Homo sapiens	Inhibition	%	39.3
	8157940	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	1.88	CHEMBL1868	Homo sapiens	Inhibition	%	1.88
	8158101	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.11	CHEMBL1868	Homo sapiens	Inhibition	%	2.11
	8158351	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.09	CHEMBL1868	Homo sapiens	Inhibition	%	2.09
	8158509	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	-0.77	CHEMBL1868	Homo sapiens	Inhibition	%	-0.77
	8158733	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	0.49	CHEMBL1868	Homo sapiens	Inhibition	%	0.49
	8158902	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	0.6	CHEMBL1868	Homo sapiens	Inhibition	%	0.6
	8159261	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.9	CHEMBL1868	Homo sapiens	Inhibition	%	1.9
	8159381	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	-1.53	CHEMBL1868	Homo sapiens	Inhibition	%	-1.53
	8159736	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	11.92	CHEMBL1868	Homo sapiens	Inhibition	%	11.92
	8159877	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.18	CHEMBL1868	Homo sapiens	Inhibition	%	1.18
	8160101	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.86	CHEMBL1868	Homo sapiens	Inhibition	%	0.86
	8160238	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	0.23	CHEMBL1868	Homo sapiens	Inhibition	%	0.23
	8160612	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.09	CHEMBL1868	Homo sapiens	Inhibition	%	0.09
	8160682	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.75	CHEMBL1868	Homo sapiens	Inhibition	%	2.75
	8160906	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	3.26	CHEMBL1868	Homo sapiens	Inhibition	%	3.26
	8161056	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	13.61	CHEMBL1868	Homo sapiens	Inhibition	%	13.61
	8161423	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	8.17	CHEMBL1868	Homo sapiens	Inhibition	%	8.17
	8161548	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	5.46	CHEMBL1868	Homo sapiens	Inhibition	%	5.46
	8161772	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.36	CHEMBL1868	Homo sapiens	Inhibition	%	0.36
	8161910	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	5.18	CHEMBL1868	Homo sapiens	Inhibition	%	5.18
	8162264	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.09	CHEMBL1868	Homo sapiens	Inhibition	%	3.09
	8162424	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	12.65	CHEMBL1868	Homo sapiens	Inhibition	%	12.65
	8162677	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	-0.71	CHEMBL1868	Homo sapiens	Inhibition	%	-0.71
	8163049	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	19.31	CHEMBL1868	Homo sapiens	Inhibition	%	19.31
	8163218	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	1.91	CHEMBL1868	Homo sapiens	Inhibition	%	1.91
	8163576	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	-0.14	CHEMBL1868	Homo sapiens	Inhibition	%	-0.14
	8163699	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	0.25	CHEMBL1868	Homo sapiens	Inhibition	%	0.25
	8163923	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.28	CHEMBL1868	Homo sapiens	Inhibition	%	1.28
	8164057	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.54	CHEMBL1868	Homo sapiens	Inhibition	%	2.54
	8164421	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.16	CHEMBL1868	Homo sapiens	Inhibition	%	1.16
	8164576	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	4.24	CHEMBL1868	Homo sapiens	Inhibition	%	4.24
	8164944	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	1.16	CHEMBL1868	Homo sapiens	Inhibition	%	1.16
	8165238	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	0.02	CHEMBL1868	Homo sapiens	Inhibition	%	0.02
	8165379	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	30.68	CHEMBL1868	Homo sapiens	Inhibition	%	30.68
	8165746	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	20.47	CHEMBL1868	Homo sapiens	Inhibition	%	20.47
	8166096	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.77	CHEMBL1868	Homo sapiens	Inhibition	%	0.77
	8166234	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	2.62	CHEMBL1868	Homo sapiens	Inhibition	%	2.62
	8166588	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	10.64	CHEMBL1868	Homo sapiens	Inhibition	%	10.64
	8166913	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	87.99	CHEMBL1868	Homo sapiens	Inhibition	%	87.99
	8167001	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.67	CHEMBL1868	Homo sapiens	Inhibition	%	4.67
	8167225	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	0.64	CHEMBL1868	Homo sapiens	Inhibition	%	0.64
	8167366	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	67.57	CHEMBL1868	Homo sapiens	Inhibition	%	67.57
	8167530	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	-0.49	CHEMBL1868	Homo sapiens	Inhibition	%	-0.49
	8167754	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	0.41	CHEMBL1868	Homo sapiens	Inhibition	%	0.41
	8167887	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.79	CHEMBL1868	Homo sapiens	Inhibition	%	3.79
	8168235	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	-0.38	CHEMBL1868	Homo sapiens	Inhibition	%	-0.38
	8168376	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	0.66	CHEMBL1868	Homo sapiens	Inhibition	%	0.66
	8168600	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	3.74	CHEMBL1868	Homo sapiens	Inhibition	%	3.74
	8168736	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.59	CHEMBL1868	Homo sapiens	Inhibition	%	1.59
	8168900	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	8.37	CHEMBL1868	Homo sapiens	Inhibition	%	8.37
	8169124	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	28.26	CHEMBL1868	Homo sapiens	Inhibition	%	28.26
	8169266	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.26	CHEMBL1868	Homo sapiens	Inhibition	%	1.26
	8169570	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	-0.67	CHEMBL1868	Homo sapiens	Inhibition	%	-0.67
	8169704	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	1.02	CHEMBL1868	Homo sapiens	Inhibition	%	1.02
	8169928	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.88	CHEMBL1868	Homo sapiens	Inhibition	%	3.88
	8170073	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	23.42	CHEMBL1868	Homo sapiens	Inhibition	%	23.42
	8170422	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	-0.48	CHEMBL1868	Homo sapiens	Inhibition	%	-0.48
	8170562	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	15.91	CHEMBL1868	Homo sapiens	Inhibition	%	15.91
	8170786	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	2.92	CHEMBL1868	Homo sapiens	Inhibition	%	2.92
	8170921	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	43.82	CHEMBL1868	Homo sapiens	Inhibition	%	43.82
	8171118	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	40.7	CHEMBL1868	Homo sapiens	Inhibition	%	40.7
	8171342	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	38.26	CHEMBL1868	Homo sapiens	Inhibition	%	38.26
	8171559	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.14	CHEMBL1868	Homo sapiens	Inhibition	%	2.14
	8171700	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	1.44	CHEMBL1868	Homo sapiens	Inhibition	%	1.44
	8172077	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-0.74	CHEMBL1868	Homo sapiens	Inhibition	%	-0.74
	8172209	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	2.76	CHEMBL1868	Homo sapiens	Inhibition	%	2.76
	8172433	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	10.98	CHEMBL1868	Homo sapiens	Inhibition	%	10.98
	8172561	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.35	CHEMBL1868	Homo sapiens	Inhibition	%	2.35
	8172927	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	3.53	CHEMBL1868	Homo sapiens	Inhibition	%	3.53
	8173063	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.03	CHEMBL1868	Homo sapiens	Inhibition	%	-1.03
	8173452	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	1.64	CHEMBL1868	Homo sapiens	Inhibition	%	1.64
	8173593	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.04	CHEMBL1868	Homo sapiens	Inhibition	%	3.04
	8173904	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	2.21	CHEMBL1868	Homo sapiens	Inhibition	%	2.21
	8174260	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	0.94	CHEMBL1868	Homo sapiens	Inhibition	%	0.94
	8174408	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	73.87	CHEMBL1868	Homo sapiens	Inhibition	%	73.87
	8174632	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.16	CHEMBL1868	Homo sapiens	Inhibition	%	2.16
	8174754	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	-0.65	CHEMBL1868	Homo sapiens	Inhibition	%	-0.65
	8175121	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	23.53	CHEMBL1868	Homo sapiens	Inhibition	%	23.53
	8175257	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	3.33	CHEMBL1868	Homo sapiens	Inhibition	%	3.33
	8175513	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	4.03	CHEMBL1868	Homo sapiens	Inhibition	%	4.03
	8175900	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.5	CHEMBL1868	Homo sapiens	Inhibition	%	2.5
	8176053	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	1.83	CHEMBL1868	Homo sapiens	Inhibition	%	1.83
	8176277	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	1.08	CHEMBL1868	Homo sapiens	Inhibition	%	1.08
	8176426	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.31	CHEMBL1868	Homo sapiens	Inhibition	%	3.31
	8176782	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	30.1	CHEMBL1868	Homo sapiens	Inhibition	%	30.1
	8176912	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	5.66	CHEMBL1868	Homo sapiens	Inhibition	%	5.66
	8177278	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	3.27	CHEMBL1868	Homo sapiens	Inhibition	%	3.27
	8177416	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.85	CHEMBL1868	Homo sapiens	Inhibition	%	-0.85
	8177640	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	2.46	CHEMBL1868	Homo sapiens	Inhibition	%	2.46
	8177804	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	27.61	CHEMBL1868	Homo sapiens	Inhibition	%	27.61
	8177944	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.53	CHEMBL1868	Homo sapiens	Inhibition	%	2.53
	8178168	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	2.06	CHEMBL1868	Homo sapiens	Inhibition	%	2.06
	8178256	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	10.71	CHEMBL1868	Homo sapiens	Inhibition	%	10.71
	8178480	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.8	CHEMBL1868	Homo sapiens	Inhibition	%	1.8
	8178607	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	0.15	CHEMBL1868	Homo sapiens	Inhibition	%	0.15
	8178980	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	3.45	CHEMBL1868	Homo sapiens	Inhibition	%	3.45
	8179103	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.51	CHEMBL1868	Homo sapiens	Inhibition	%	2.51
	8179471	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	2.5	CHEMBL1868	Homo sapiens	Inhibition	%	2.5
	8179608	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	10.95	CHEMBL1868	Homo sapiens	Inhibition	%	10.95
	8179832	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	-1.0	CHEMBL1868	Homo sapiens	Inhibition	%	-1.0
	8179865	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	24.05	CHEMBL1868	Homo sapiens	Inhibition	%	24.05
	8180089	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	0.44	CHEMBL1868	Homo sapiens	Inhibition	%	0.44
	8180243	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	30.01	CHEMBL1868	Homo sapiens	Inhibition	%	30.01
	8180623	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	1.4	CHEMBL1868	Homo sapiens	Inhibition	%	1.4
	8180771	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.02	CHEMBL1868	Homo sapiens	Inhibition	%	1.02
	8181128	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	22.17	CHEMBL1868	Homo sapiens	Inhibition	%	22.17
	8181259	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	29.51	CHEMBL1868	Homo sapiens	Inhibition	%	29.51
	8181483	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	10.77	CHEMBL1868	Homo sapiens	Inhibition	%	10.77
	8181623	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	5.69	CHEMBL1868	Homo sapiens	Inhibition	%	5.69
	8181986	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	19.18	CHEMBL1868	Homo sapiens	Inhibition	%	19.18
	8182149	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	-0.09	CHEMBL1868	Homo sapiens	Inhibition	%	-0.09
	8182513	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.95	CHEMBL1868	Homo sapiens	Inhibition	%	1.95
	8182829	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	2.23	CHEMBL1868	Homo sapiens	Inhibition	%	2.23
	8182951	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	2.07	CHEMBL1868	Homo sapiens	Inhibition	%	2.07
	8183324	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	9.91	CHEMBL1868	Homo sapiens	Inhibition	%	9.91
	8183453	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.26	CHEMBL1868	Homo sapiens	Inhibition	%	1.26
	8183677	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.91	CHEMBL1868	Homo sapiens	Inhibition	%	1.91
	8183819	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	10.34	CHEMBL1868	Homo sapiens	Inhibition	%	10.34
	8184179	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.07	CHEMBL1868	Homo sapiens	Inhibition	%	1.07
	8184445	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	2.94	CHEMBL1868	Homo sapiens	Inhibition	%	2.94
	8184592	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.98	CHEMBL1868	Homo sapiens	Inhibition	%	-0.98
	8184973	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	7.67	CHEMBL1868	Homo sapiens	Inhibition	%	7.67
	8185122	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	12.59	CHEMBL1868	Homo sapiens	Inhibition	%	12.59
	8185346	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	-0.55	CHEMBL1868	Homo sapiens	Inhibition	%	-0.55
	8185477	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	72.6	CHEMBL1868	Homo sapiens	Inhibition	%	72.6
	8185832	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	23.58	CHEMBL1868	Homo sapiens	Inhibition	%	23.58
	8185971	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.64	CHEMBL1868	Homo sapiens	Inhibition	%	3.64
	8186336	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	2.48	CHEMBL1868	Homo sapiens	Inhibition	%	2.48
	8186500	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	6.56	CHEMBL1868	Homo sapiens	Inhibition	%	6.56
	8186724	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	1.27	CHEMBL1868	Homo sapiens	Inhibition	%	1.27
	8186863	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.12	CHEMBL1868	Homo sapiens	Inhibition	%	4.12
	8187185	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.23	CHEMBL1868	Homo sapiens	Inhibition	%	1.23
	8187309	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	3.41	CHEMBL1868	Homo sapiens	Inhibition	%	3.41
	8187533	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.57	CHEMBL1868	Homo sapiens	Inhibition	%	1.57
	8187681	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	55.85	CHEMBL1868	Homo sapiens	Inhibition	%	55.85
	8188034	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	4.89	CHEMBL1868	Homo sapiens	Inhibition	%	4.89
	8188177	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.91	CHEMBL1868	Homo sapiens	Inhibition	%	2.91
	8188536	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	5.44	CHEMBL1868	Homo sapiens	Inhibition	%	5.44
	8188810	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.57	CHEMBL1868	Homo sapiens	Inhibition	%	1.57
	8188958	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.18	CHEMBL1868	Homo sapiens	Inhibition	%	1.18
	8189182	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	-0.74	CHEMBL1868	Homo sapiens	Inhibition	%	-0.74
	8189338	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	30.79	CHEMBL1868	Homo sapiens	Inhibition	%	30.79
	8189711	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.27	CHEMBL1868	Homo sapiens	Inhibition	%	0.27
	8189843	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	2.51	CHEMBL1868	Homo sapiens	Inhibition	%	2.51
	8190199	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	3.32	CHEMBL1868	Homo sapiens	Inhibition	%	3.32
	8190339	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	2.3	CHEMBL1868	Homo sapiens	Inhibition	%	2.3
	8190563	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	1.74	CHEMBL1868	Homo sapiens	Inhibition	%	1.74
	8190700	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	6.3	CHEMBL1868	Homo sapiens	Inhibition	%	6.3
	8191088	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	2.89	CHEMBL1868	Homo sapiens	Inhibition	%	2.89
	8191226	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	4.18	CHEMBL1868	Homo sapiens	Inhibition	%	4.18
	8191546	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	4.11	CHEMBL1868	Homo sapiens	Inhibition	%	4.11
	8191892	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	7.39	CHEMBL1868	Homo sapiens	Inhibition	%	7.39
	8192041	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	4.96	CHEMBL1868	Homo sapiens	Inhibition	%	4.96
	8192394	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-0.52	CHEMBL1868	Homo sapiens	Inhibition	%	-0.52
	8192538	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	8.28	CHEMBL1868	Homo sapiens	Inhibition	%	8.28
	8192762	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	1.31	CHEMBL1868	Homo sapiens	Inhibition	%	1.31
	8192898	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	18.81	CHEMBL1868	Homo sapiens	Inhibition	%	18.81
	8193170	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.58	CHEMBL1868	Homo sapiens	Inhibition	%	1.58
	8193539	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	3.88	CHEMBL1868	Homo sapiens	Inhibition	%	3.88
	8193696	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	7.92	CHEMBL1868	Homo sapiens	Inhibition	%	7.92
	8194069	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.79	CHEMBL1868	Homo sapiens	Inhibition	%	-0.79
	8194200	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	4.95	CHEMBL1868	Homo sapiens	Inhibition	%	4.95
	8194424	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	74.57	CHEMBL1868	Homo sapiens	Inhibition	%	74.57
	8194555	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.73	CHEMBL1868	Homo sapiens	Inhibition	%	4.73
	8194922	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	5.65	CHEMBL1868	Homo sapiens	Inhibition	%	5.65
	8195055	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.32	CHEMBL1868	Homo sapiens	Inhibition	%	1.32
	8195279	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	3.27	CHEMBL1868	Homo sapiens	Inhibition	%	3.27
	8195443	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.07	CHEMBL1868	Homo sapiens	Inhibition	%	1.07
	8195582	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	8.87	CHEMBL1868	Homo sapiens	Inhibition	%	8.87
	8195806	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	0.94	CHEMBL1868	Homo sapiens	Inhibition	%	0.94
	8195904	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.08	CHEMBL1868	Homo sapiens	Inhibition	%	2.08
	8196245	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.86	CHEMBL1868	Homo sapiens	Inhibition	%	0.86
	8196395	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	2.13	CHEMBL1868	Homo sapiens	Inhibition	%	2.13
	8196619	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.49	CHEMBL1868	Homo sapiens	Inhibition	%	2.49
	8196747	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	-0.47	CHEMBL1868	Homo sapiens	Inhibition	%	-0.47
	8197112	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	0.49	CHEMBL1868	Homo sapiens	Inhibition	%	0.49
	8197249	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.04	CHEMBL1868	Homo sapiens	Inhibition	%	1.04
	8197473	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	5.65	CHEMBL1868	Homo sapiens	Inhibition	%	5.65
	8197524	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.41	CHEMBL1868	Homo sapiens	Inhibition	%	0.41
	8197748	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.85	CHEMBL1868	Homo sapiens	Inhibition	%	0.85
	8197888	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	0.69	CHEMBL1868	Homo sapiens	Inhibition	%	0.69
	8198045	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	15.24	CHEMBL1868	Homo sapiens	Inhibition	%	15.24
	8198269	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.95	CHEMBL1868	Homo sapiens	Inhibition	%	0.95
	8198407	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.61	CHEMBL1868	Homo sapiens	Inhibition	%	-0.61
	8198761	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	93.16	CHEMBL1868	Homo sapiens	Inhibition	%	93.16
	8198892	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.82	CHEMBL1868	Homo sapiens	Inhibition	%	1.82
	8199116	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	5.14	CHEMBL1868	Homo sapiens	Inhibition	%	5.14
	8199264	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.21	CHEMBL1868	Homo sapiens	Inhibition	%	3.21
	8199622	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.51	CHEMBL1868	Homo sapiens	Inhibition	%	1.51
	8199785	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	4.42	CHEMBL1868	Homo sapiens	Inhibition	%	4.42
	8200147	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.09	CHEMBL1868	Homo sapiens	Inhibition	%	2.09
	8200251	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.96	CHEMBL1868	Homo sapiens	Inhibition	%	3.96
	8200475	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	4.39	CHEMBL1868	Homo sapiens	Inhibition	%	4.39
	8200590	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.39	CHEMBL1868	Homo sapiens	Inhibition	%	4.39
	8200964	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	22.09	CHEMBL1868	Homo sapiens	Inhibition	%	22.09
	8201094	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.16	CHEMBL1868	Homo sapiens	Inhibition	%	2.16
	8201318	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	10.29	CHEMBL1868	Homo sapiens	Inhibition	%	10.29
	8201453	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.22	CHEMBL1868	Homo sapiens	Inhibition	%	0.22
	8201810	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.86	CHEMBL1868	Homo sapiens	Inhibition	%	0.86
	8202089	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-0.83	CHEMBL1868	Homo sapiens	Inhibition	%	-0.83
	8202229	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	9.81	CHEMBL1868	Homo sapiens	Inhibition	%	9.81
	8202620	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	4.64	CHEMBL1868	Homo sapiens	Inhibition	%	4.64
	8202745	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.1	CHEMBL1868	Homo sapiens	Inhibition	%	1.1
	8203099	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.69	CHEMBL1868	Homo sapiens	Inhibition	%	3.69
	8203454	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	52.76	CHEMBL1868	Homo sapiens	Inhibition	%	52.76
	8203600	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	11.2	CHEMBL1868	Homo sapiens	Inhibition	%	11.2
	8203958	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.02	CHEMBL1868	Homo sapiens	Inhibition	%	1.02
	8204124	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.02	CHEMBL1868	Homo sapiens	Inhibition	%	2.02
	8204485	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	82.11	CHEMBL1868	Homo sapiens	Inhibition	%	82.11
	8204814	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	14.63	CHEMBL1868	Homo sapiens	Inhibition	%	14.63
	8204929	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.92	CHEMBL1868	Homo sapiens	Inhibition	%	2.92
	8205153	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	10.56	CHEMBL1868	Homo sapiens	Inhibition	%	10.56
	8205302	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	3.82	CHEMBL1868	Homo sapiens	Inhibition	%	3.82
	8205662	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.14	CHEMBL1868	Homo sapiens	Inhibition	%	2.14
	8205801	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.57	CHEMBL1868	Homo sapiens	Inhibition	%	2.57
	8206157	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	5.84	CHEMBL1868	Homo sapiens	Inhibition	%	5.84
	8206433	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	-0.68	CHEMBL1868	Homo sapiens	Inhibition	%	-0.68
	8206576	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.63	CHEMBL1868	Homo sapiens	Inhibition	%	-0.63
	8206800	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	0.2	CHEMBL1868	Homo sapiens	Inhibition	%	0.2
	8206980	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.09	CHEMBL1868	Homo sapiens	Inhibition	%	1.09
	8207106	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	1.96	CHEMBL1868	Homo sapiens	Inhibition	%	1.96
	8207330	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	0.88	CHEMBL1868	Homo sapiens	Inhibition	%	0.88
	8207460	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	3.39	CHEMBL1868	Homo sapiens	Inhibition	%	3.39
	8207816	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	93.97	CHEMBL1868	Homo sapiens	Inhibition	%	93.97
	8207961	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.65	CHEMBL1868	Homo sapiens	Inhibition	%	1.65
	8208185	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.94	CHEMBL1868	Homo sapiens	Inhibition	%	0.94
	8208317	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	3.66	CHEMBL1868	Homo sapiens	Inhibition	%	3.66
	8208483	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	2.37	CHEMBL1868	Homo sapiens	Inhibition	%	2.37
	8208707	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.44	CHEMBL1868	Homo sapiens	Inhibition	%	2.44
	8208840	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	95.65	CHEMBL1868	Homo sapiens	Inhibition	%	95.65
	8209169	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	24.93	CHEMBL1868	Homo sapiens	Inhibition	%	24.93
	8209509	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	0.57	CHEMBL1868	Homo sapiens	Inhibition	%	0.57
	8209659	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	8.82	CHEMBL1868	Homo sapiens	Inhibition	%	8.82
	8210019	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	2.02	CHEMBL1868	Homo sapiens	Inhibition	%	2.02
	8210160	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	-0.36	CHEMBL1868	Homo sapiens	Inhibition	%	-0.36
	8210384	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.74	CHEMBL1868	Homo sapiens	Inhibition	%	1.74
	8210520	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	0.44	CHEMBL1868	Homo sapiens	Inhibition	%	0.44
	8210779	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.48	CHEMBL1868	Homo sapiens	Inhibition	%	2.48
	8211147	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.32	CHEMBL1868	Homo sapiens	Inhibition	%	1.32
	8211317	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	2.77	CHEMBL1868	Homo sapiens	Inhibition	%	2.77
	8211664	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	3.45	CHEMBL1868	Homo sapiens	Inhibition	%	3.45
	8211793	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	2.34	CHEMBL1868	Homo sapiens	Inhibition	%	2.34
	8212017	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	17.73	CHEMBL1868	Homo sapiens	Inhibition	%	17.73
	8212149	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	1.89	CHEMBL1868	Homo sapiens	Inhibition	%	1.89
	8212514	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	-0.63	CHEMBL1868	Homo sapiens	Inhibition	%	-0.63
	8212647	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	8.02	CHEMBL1868	Homo sapiens	Inhibition	%	8.02
	8213041	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	4.08	CHEMBL1868	Homo sapiens	Inhibition	%	4.08
	8213170	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.44	CHEMBL1868	Homo sapiens	Inhibition	%	2.44
	8213394	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	7.3	CHEMBL1868	Homo sapiens	Inhibition	%	7.3
	8213498	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	68.39	CHEMBL1868	Homo sapiens	Inhibition	%	68.39
	8213835	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	5.82	CHEMBL1868	Homo sapiens	Inhibition	%	5.82
	8213982	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	0.3	CHEMBL1868	Homo sapiens	Inhibition	%	0.3
	8214206	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.37	CHEMBL1868	Homo sapiens	Inhibition	%	1.37
	8214343	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	4.8	CHEMBL1868	Homo sapiens	Inhibition	%	4.8
	8214701	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	69.93	CHEMBL1868	Homo sapiens	Inhibition	%	69.93
	8214853	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	3.83	CHEMBL1868	Homo sapiens	Inhibition	%	3.83
	8215104	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.52	CHEMBL1868	Homo sapiens	Inhibition	%	2.52
	8215481	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	9.57	CHEMBL1868	Homo sapiens	Inhibition	%	9.57
	8215645	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	0.98	CHEMBL1868	Homo sapiens	Inhibition	%	0.98
	8215988	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.41	CHEMBL1868	Homo sapiens	Inhibition	%	1.41
	8216331	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	1.4	CHEMBL1868	Homo sapiens	Inhibition	%	1.4
	8216467	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.8	CHEMBL1868	Homo sapiens	Inhibition	%	3.8
	8216829	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	0.79	CHEMBL1868	Homo sapiens	Inhibition	%	0.79
	8216963	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	3.18	CHEMBL1868	Homo sapiens	Inhibition	%	3.18
	8217187	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	1.49	CHEMBL1868	Homo sapiens	Inhibition	%	1.49
	8217361	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	1.53	CHEMBL1868	Homo sapiens	Inhibition	%	1.53
	8217716	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.31	CHEMBL1868	Homo sapiens	Inhibition	%	3.31
	8217817	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.79	CHEMBL1868	Homo sapiens	Inhibition	%	0.79
	8218041	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	2.99	CHEMBL1868	Homo sapiens	Inhibition	%	2.99
	8218156	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.37	CHEMBL1868	Homo sapiens	Inhibition	%	2.37
	8218507	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	8.45	CHEMBL1868	Homo sapiens	Inhibition	%	8.45
	8218650	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	26.18	CHEMBL1868	Homo sapiens	Inhibition	%	26.18
	8219005	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	97.76	CHEMBL1868	Homo sapiens	Inhibition	%	97.76
	8219165	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	3.88	CHEMBL1868	Homo sapiens	Inhibition	%	3.88
	8219389	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	15.62	CHEMBL1868	Homo sapiens	Inhibition	%	15.62
	8219415	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.15	CHEMBL1868	Homo sapiens	Inhibition	%	0.15
	8219639	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	-0.18	CHEMBL1868	Homo sapiens	Inhibition	%	-0.18
	8219800	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	-1.7	CHEMBL1868	Homo sapiens	Inhibition	%	-1.7
	8219969	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	-0.89	CHEMBL1868	Homo sapiens	Inhibition	%	-0.89
	8220193	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	0.12	CHEMBL1868	Homo sapiens	Inhibition	%	0.12
	8220322	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.28	CHEMBL1868	Homo sapiens	Inhibition	%	1.28
	8220660	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	4.1	CHEMBL1868	Homo sapiens	Inhibition	%	4.1
	8220798	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	12.73	CHEMBL1868	Homo sapiens	Inhibition	%	12.73
	8221022	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	25.72	CHEMBL1868	Homo sapiens	Inhibition	%	25.72
	8221158	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.46	CHEMBL1868	Homo sapiens	Inhibition	%	2.46
	8221515	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	1.38	CHEMBL1868	Homo sapiens	Inhibition	%	1.38
	8221680	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	4.46	CHEMBL1868	Homo sapiens	Inhibition	%	4.46
	8222035	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	15.74	CHEMBL1868	Homo sapiens	Inhibition	%	15.74
	8222357	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	3.88	CHEMBL1868	Homo sapiens	Inhibition	%	3.88
	8222491	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.95	CHEMBL1868	Homo sapiens	Inhibition	%	2.95
	8222833	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	37.32	CHEMBL1868	Homo sapiens	Inhibition	%	37.32
	8222977	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	47.84	CHEMBL1868	Homo sapiens	Inhibition	%	47.84
	8223201	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	96.65	CHEMBL1868	Homo sapiens	Inhibition	%	96.65
	8223330	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	5.53	CHEMBL1868	Homo sapiens	Inhibition	%	5.53
	8223715	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.03	CHEMBL1868	Homo sapiens	Inhibition	%	1.03
	8223965	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	0.91	CHEMBL1868	Homo sapiens	Inhibition	%	0.91
	8224127	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.37	CHEMBL1868	Homo sapiens	Inhibition	%	2.37
	8224521	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	1.06	CHEMBL1868	Homo sapiens	Inhibition	%	1.06
	8224656	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	0.16	CHEMBL1868	Homo sapiens	Inhibition	%	0.16
	8224880	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	0.98	CHEMBL1868	Homo sapiens	Inhibition	%	0.98
	8224994	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	-0.55	CHEMBL1868	Homo sapiens	Inhibition	%	-0.55
	8225352	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	2.51	CHEMBL1868	Homo sapiens	Inhibition	%	2.51
	8225490	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	7.59	CHEMBL1868	Homo sapiens	Inhibition	%	7.59
	8225849	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	1.96	CHEMBL1868	Homo sapiens	Inhibition	%	1.96
	8226007	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.63	CHEMBL1868	Homo sapiens	Inhibition	%	1.63
	8226231	CHEMBL1962299	GSK_PKIS: FLT1 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.14	CHEMBL1868	Homo sapiens	Inhibition	%	2.14
	8226356	CHEMBL1962298	GSK_PKIS: FLT1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.06	CHEMBL1868	Homo sapiens	Inhibition	%	2.06
inactive	9657262	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9657263	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	=	Ki	nM	10.0	CHEMBL1868	Homo sapiens	pKi		8.0
inactive	9657264	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc2c(Nc3ccc(NC(=O)c4ccccc4)cc3)ncnc2cc1OCCCN1CCOCC1		CHEMBL202721	<	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
inactive	9657265	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
inactive	9657266	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9657267	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	25.12	CHEMBL1868	Homo sapiens	pKi		7.6
active	9657268	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	=	Ki	nM	0.3981	CHEMBL1868	Homo sapiens	pKi		9.4
inactive	9657269	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9657270	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
inactive	9657271	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9657272	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9657273	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	=	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9657274	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccc[nH]2)C(=O)N3)c1)Cc1ccccc1		CHEMBL1980407	=	Ki	nM	0.631	CHEMBL1868	Homo sapiens	pKi		9.2
active	9657275	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	=	Ki	nM	3.162	CHEMBL1868	Homo sapiens	pKi		8.5
inactive	9657276	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9657277	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9657278	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9657279	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)CCCN(C)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1964948	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9657280	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	=	Ki	nM	158.49	CHEMBL1868	Homo sapiens	pKi		6.8
inactive	9657281	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9657282	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9657283	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9657284	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(OC(F)(F)F)cc3)cc2)c2c(N)noc12		CHEMBL1973178	=	Ki	nM	0.631	CHEMBL1868	Homo sapiens	pKi		9.2
inactive	9657285	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1987430	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9657286	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	100.0	CHEMBL1868	Homo sapiens	pKi		7.0
active	9657287	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)c(F)c2)c1		CHEMBL1988778	=	Ki	nM	1.0	CHEMBL1868	Homo sapiens	pKi		9.0
inactive	9657288	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9657289	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9657290	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1ccccc1		CHEMBL1993413	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9657291	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661299	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	158.49	CHEMBL1868	Homo sapiens	pKi		6.8
inactive	9661300	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1ccc(Nc2ncnc3ccccc23)cc1		CHEMBL289959	<	Ki	nM	50118.72	CHEMBL1868	Homo sapiens	pKi		4.3
inactive	9661301	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661302	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
active	9661303	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	=	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661304	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661305	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(O)C1CN(Cc2ccc(OCc3cccc(C(F)(F)F)c3)cc2Cl)C1		CHEMBL1986265	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661306	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661307	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661308	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN1c2ccc(N)cc2C(c2ccccc2)c2cc(N)ccc21		CHEMBL1991734	=	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661309	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661310	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	=	Ki	nM	0.5012	CHEMBL1868	Homo sapiens	pKi		9.3
inactive	9661311	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
inactive	9661312	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661313	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1NCc2c1cccc2-c1cccs1		CHEMBL1991782	<	Ki	nM	79432.82	CHEMBL1868	Homo sapiens	pKi		4.1
active	9661314	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2ncc(Br)cc12		CHEMBL2002105	=	Ki	nM	39810.72	CHEMBL1868	Homo sapiens	pKi		4.4
active	9661315	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	Ki	nM	630.96	CHEMBL1868	Homo sapiens	pKi		6.2
active	9661316	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCCN(CCC#N)C(=O)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1983348	=	Ki	nM	630.96	CHEMBL1868	Homo sapiens	pKi		6.2
inactive	9661317	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	<	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
active	9661318	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	125.89	CHEMBL1868	Homo sapiens	pKi		6.9
inactive	9661319	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2000934	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9661320	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2c1C(=O)Nc1ccccc1N2		CHEMBL1980671	=	Ki	nM	10000.0	CHEMBL1868	Homo sapiens	pKi		5.0
inactive	9661321	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cccc(Cl)c1)Nc1nc(CCNc2ncnc3ccsc23)cs1		CHEMBL1986177	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661322	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661323	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	316.23	CHEMBL1868	Homo sapiens	pKi		6.5
inactive	9661324	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccnc(Nc2cc(C)nc(-c3ccccc3)n2)c1		CHEMBL1985367	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661325	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	<	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
inactive	9661326	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1nc(N2CCNCC2)nc2ccccc12		CHEMBL1996510	<	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
inactive	9661327	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661328	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1cc(-c2cccc(NC(=O)c3ccc(C(C)(C)C)cc3)c2CO)cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c1=O		CHEMBL2001584	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9661329	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	=	Ki	nM	25.12	CHEMBL1868	Homo sapiens	pKi		7.6
inactive	9661330	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661331	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1967998	=	Ki	nM	100.0	CHEMBL1868	Homo sapiens	pKi		7.0
active	9661332	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	0.7943	CHEMBL1868	Homo sapiens	pKi		9.1
inactive	9661333	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(C#N)ccc21		CHEMBL1978562	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9661334	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
active	9661335	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(O)c1csc2c1NCCNC2=O		CHEMBL1974875	=	Ki	nM	25118.86	CHEMBL1868	Homo sapiens	pKi		4.6
active	9661336	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	=	Ki	nM	7.943	CHEMBL1868	Homo sapiens	pKi		8.1
active	9661337	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccnc2[nH]c3cc(C(C)C)ccc3c(=O)c12		CHEMBL1989471	=	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
inactive	9661338	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661339	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661340	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661341	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661342	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1cc2c(-c3ccc(Br)cc3)cncc2s1		CHEMBL1978195	=	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
inactive	9661343	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661344	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Ki	nM	1584.89	CHEMBL1868	Homo sapiens	pKi		5.8
inactive	9661345	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661346	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1966842	=	Ki	nM	1258.93	CHEMBL1868	Homo sapiens	pKi		5.9
inactive	9661347	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661348	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	0.5012	CHEMBL1868	Homo sapiens	pKi		9.3
active	9661349	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
active	9661350	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	2.512	CHEMBL1868	Homo sapiens	pKi		8.6
inactive	9661351	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661352	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661353	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)c(F)c3)c12		CHEMBL2000652	=	Ki	nM	0.631	CHEMBL1868	Homo sapiens	pKi		9.2
active	9661354	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	25.12	CHEMBL1868	Homo sapiens	pKi		7.6
inactive	9661355	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1ccc2nc(N)n(-c3nc4c(s3)CCCC4)c2c1		CHEMBL1996345	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661356	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661357	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COCOc1cccc(OCOC)c1-c1ccc(NS(C)(=O)=O)cc1C(=O)OC		CHEMBL2004025	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9661358	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(-c2cc3c(NCCN)ccc(C(N)=O)c3[nH]2)cc1		CHEMBL1996048	=	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
inactive	9661359	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL461876	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661360	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)cc1		CHEMBL1965033	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9661361	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	=	Ki	nM	3.981	CHEMBL1868	Homo sapiens	pKi		8.4
active	9661362	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	Ki	nM	7.943	CHEMBL1868	Homo sapiens	pKi		8.1
active	9661363	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2cccc(-c3ccc(F)cc3)c12		CHEMBL1971519	=	Ki	nM	79432.82	CHEMBL1868	Homo sapiens	pKi		4.1
inactive	9661364	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661365	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(C2=NNc3cccc4c(OC)ccc2c34)cc1OC		CHEMBL1997335	=	Ki	nM	316.23	CHEMBL1868	Homo sapiens	pKi		6.5
active	9661366	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	=	Ki	nM	5.012	CHEMBL1868	Homo sapiens	pKi		8.3
active	9661367	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	39.81	CHEMBL1868	Homo sapiens	pKi		7.4
active	9661368	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	=	Ki	nM	5.012	CHEMBL1868	Homo sapiens	pKi		8.3
active	9661369	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	=	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661370	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661371	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661372	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1nnc(-c2ccccc2)c(C#N)n1		CHEMBL1994808	=	Ki	nM	79432.82	CHEMBL1868	Homo sapiens	pKi		4.1
inactive	9661373	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661374	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661375	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661376	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	316.23	CHEMBL1868	Homo sapiens	pKi		6.5
inactive	9661377	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661378	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	0.5012	CHEMBL1868	Homo sapiens	pKi		9.3
inactive	9661379	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Oc1cnc2ccc(-c3ccncc3)cc2c1		CHEMBL1973868	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661380	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCCC#Cc1ccc(CN2CC(C(=O)O)C2)cc1		CHEMBL1972462	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661381	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661382	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	0.3981	CHEMBL1868	Homo sapiens	pKi		9.4
active	9661383	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	=	Ki	nM	5.012	CHEMBL1868	Homo sapiens	pKi		8.3
active	9661384	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Ki	nM	63.1	CHEMBL1868	Homo sapiens	pKi		7.2
active	9661385	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
inactive	9661386	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661387	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661388	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	Ki	nM	15.85	CHEMBL1868	Homo sapiens	pKi		7.8
inactive	9661389	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661390	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	50.12	CHEMBL1868	Homo sapiens	pKi		7.3
inactive	9661391	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
inactive	9661392	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCCNC(=O)c1cn(C(CC)CC)c(=O)c2cc(OC)c(OC)cc12		CHEMBL1982700	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9661393	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	=	Ki	nM	125.89	CHEMBL1868	Homo sapiens	pKi		6.9
inactive	9661394	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661395	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(N)=O)cc2)n1		CHEMBL1977634	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661396	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661397	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(=O)Nc1cc2ccccn2n1		CHEMBL1976872	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9661398	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	0.7943	CHEMBL1868	Homo sapiens	pKi		9.1
inactive	9661399	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661400	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Ki	nM	158.49	CHEMBL1868	Homo sapiens	pKi		6.8
active	9661401	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	=	Ki	nM	100.0	CHEMBL1868	Homo sapiens	pKi		7.0
inactive	9661402	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1ccc(-c2c[nH]c3ncnc(N4CCCCC4)c23)cc1		CHEMBL1998953	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661403	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2)c1		CHEMBL1971606	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661404	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661405	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
active	9661406	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)c1cc(=O)[nH]c2[nH][nH]c(=O)c12		CHEMBL1999120	=	Ki	nM	79432.82	CHEMBL1868	Homo sapiens	pKi		4.1
active	9661407	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	316.23	CHEMBL1868	Homo sapiens	pKi		6.5
inactive	9661408	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661409	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(OC(F)F)ccc12		CHEMBL1981215	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661410	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
active	9661411	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1999414	=	Ki	nM	3.162	CHEMBL1868	Homo sapiens	pKi		8.5
inactive	9661412	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cc(F)cc12		CHEMBL1967336	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661413	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1Cl)c1ccccc1F		CHEMBL2001228	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661414	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661415	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	10000.0	CHEMBL1868	Homo sapiens	pKi		5.0
inactive	9661416	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1ccc(-c2ccncc2)cc1NCc1ccccc1		CHEMBL1967992	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9661417	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Ki	nM	31.62	CHEMBL1868	Homo sapiens	pKi		7.5
inactive	9661418	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL2006450	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661419	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661420	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)ccc(F)c12		CHEMBL2001987	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661421	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661422	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCc1c(-c2ccc(C(C)=O)cc2)[nH]c2nccnc12		CHEMBL1994555	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661423	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9661424	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1983640	=	Ki	nM	50.12	CHEMBL1868	Homo sapiens	pKi		7.3
inactive	9661425	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661426	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccccc1-c1cccc2nccn12		CHEMBL1980003	=	Ki	nM	15848.93	CHEMBL1868	Homo sapiens	pKi		4.8
active	9661427	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	=	Ki	nM	10.0	CHEMBL1868	Homo sapiens	pKi		8.0
inactive	9661428	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	<	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
active	9661429	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	=	Ki	nM	316.23	CHEMBL1868	Homo sapiens	pKi		6.5
active	9661430	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	=	Ki	nM	0.2512	CHEMBL1868	Homo sapiens	pKi		9.6
active	9661431	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1ccc(CNc2nc(Nc3cc(C4CC4)[nH]n3)c3sccc3n2)cc1		CHEMBL1997924	=	Ki	nM	31.62	CHEMBL1868	Homo sapiens	pKi		7.5
inactive	9661432	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661433	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	=	Ki	nM	39.81	CHEMBL1868	Homo sapiens	pKi		7.4
inactive	9661434	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)c1ccccc1		CHEMBL1978267	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661435	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661436	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Ki	nM	316.23	CHEMBL1868	Homo sapiens	pKi		6.5
active	9661437	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	=	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661438	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	=	Ki	nM	50.12	CHEMBL1868	Homo sapiens	pKi		7.3
inactive	9661439	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661440	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661441	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661442	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	=	Ki	nM	0.631	CHEMBL1868	Homo sapiens	pKi		9.2
inactive	9661443	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661444	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661445	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	=	Ki	nM	6.31	CHEMBL1868	Homo sapiens	pKi		8.2
active	9661446	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1[nH]c2cc(Br)cnc2[nH]1		CHEMBL1975921	=	Ki	nM	10000.0	CHEMBL1868	Homo sapiens	pKi		5.0
inactive	9661447	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661448	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(CCC(=O)O)(c1ccc(O)c(N)c1)c1ccc(O)c(N)c1		CHEMBL1975923	=	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
active	9661449	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(Nc2nc(Cl)cc(NCc3ccccc3)n2)n[nH]1		CHEMBL2005449	=	Ki	nM	1584.89	CHEMBL1868	Homo sapiens	pKi		5.8
inactive	9661450	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(O)C1CN(Cc2ccc(OCc3ccccc3)cc2Cl)C1		CHEMBL1987998	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661451	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661452	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1cc2ccncc2s1		CHEMBL1971534	=	Ki	nM	7943.28	CHEMBL1868	Homo sapiens	pKi		5.1
inactive	9661453	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
active	9661454	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc([N+](=O)[O-])cc2)n1		CHEMBL242865	=	Ki	nM	794.33	CHEMBL1868	Homo sapiens	pKi		6.1
active	9661455	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	=	Ki	nM	3.981	CHEMBL1868	Homo sapiens	pKi		8.4
inactive	9661456	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661457	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661458	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661459	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	[2H]C([2H])([2H])Oc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1998110	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661460	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661461	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661462	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	63.1	CHEMBL1868	Homo sapiens	pKi		7.2
inactive	9661463	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661464	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661465	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	=	Ki	nM	0.1995	CHEMBL1868	Homo sapiens	pKi		9.7
inactive	9661466	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(Cl)cc4)c3)c12		CHEMBL1990590	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9661467	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	1258.93	CHEMBL1868	Homo sapiens	pKi		5.9
inactive	9661468	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661469	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	OCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1974617	=	Ki	nM	25118.86	CHEMBL1868	Homo sapiens	pKi		4.6
inactive	9661470	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661471	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(Nc2ncnc(N3CCCc4cc(C)ccc43)n2)cc(OC)c1OC		CHEMBL1992125	=	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
inactive	9661472	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661473	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(NC(=O)Nc2ccc(-c3c(F)ccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1993996	=	Ki	nM	0.1	CHEMBL1868	Homo sapiens	pKi		10.0
active	9661474	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	=	Ki	nM	100.0	CHEMBL1868	Homo sapiens	pKi		7.0
active	9661475	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	79.43	CHEMBL1868	Homo sapiens	pKi		7.1
inactive	9661476	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661477	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	5.012	CHEMBL1868	Homo sapiens	pKi		8.3
inactive	9661478	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661479	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
active	9661480	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	0.3981	CHEMBL1868	Homo sapiens	pKi		9.4
inactive	9661481	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661482	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661483	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661484	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(F)cc12		CHEMBL2007603	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661485	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661486	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Cc1cccs1)Nc1nc2ccccc2s1		CHEMBL1421720	=	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
active	9661487	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1nnc2cncc(Cl)n12		CHEMBL1968130	=	Ki	nM	25118.86	CHEMBL1868	Homo sapiens	pKi		4.6
inactive	9661488	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661489	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661490	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	=	Ki	nM	12.59	CHEMBL1868	Homo sapiens	pKi		7.9
inactive	9661491	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661492	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661493	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	=	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661494	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661495	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661496	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	=	Ki	nM	1.0	CHEMBL1868	Homo sapiens	pKi		9.0
active	9661497	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1[nH]cnc2c(Cl)cccc12		CHEMBL1949855	=	Ki	nM	10000.0	CHEMBL1868	Homo sapiens	pKi		5.0
inactive	9661498	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(OCc2ccc(Cl)c(Cl)c2)ccc1CN1CC(C(=O)O)C1		CHEMBL1990223	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661499	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661500	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(c1cc(Br)c(O)c(I)c1)c1cc(Br)c(O)c(I)c1		CHEMBL1964382	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661501	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)CC(O)COc1ccc(Nc2nccc(Nc3cc(Cl)ccc3Cl)n2)cc1		CHEMBL101311	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661502	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661503	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661504	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	=	Ki	nM	3.162	CHEMBL1868	Homo sapiens	pKi		8.5
active	9661505	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL373798	=	Ki	nM	0.1585	CHEMBL1868	Homo sapiens	pKi		9.8
active	9661506	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Ki	nM	158.49	CHEMBL1868	Homo sapiens	pKi		6.8
active	9661507	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(=O)n2ccc(CN(C)C)c(O)c2n1		CHEMBL1988581	=	Ki	nM	79.43	CHEMBL1868	Homo sapiens	pKi		7.1
inactive	9661508	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCC(=O)O)cc2)n1		CHEMBL2005699	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9661509	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661510	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	=	Ki	nM	125.89	CHEMBL1868	Homo sapiens	pKi		6.9
active	9661511	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	=	Ki	nM	1.585	CHEMBL1868	Homo sapiens	pKi		8.8
active	9661512	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN(C(C)=O)c1ccc(Nc2nc(NC3CC3)c3nc[nH]c3n2)cc1		CHEMBL2006564	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
active	9661513	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	25.12	CHEMBL1868	Homo sapiens	pKi		7.6
active	9661514	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	0.631	CHEMBL1868	Homo sapiens	pKi		9.2
active	9661515	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCCCCCCCCN)cnc(N)c34)cc2)c1		CHEMBL1978166	=	Ki	nM	63.1	CHEMBL1868	Homo sapiens	pKi		7.2
inactive	9661516	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2ccccc21		CHEMBL1978167	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9661517	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	0.3981	CHEMBL1868	Homo sapiens	pKi		9.4
inactive	9661518	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
inactive	9661519	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661520	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661521	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	1584.89	CHEMBL1868	Homo sapiens	pKi		5.8
inactive	9661522	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661523	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661524	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	39.81	CHEMBL1868	Homo sapiens	pKi		7.4
inactive	9661525	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661526	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	1.995	CHEMBL1868	Homo sapiens	pKi		8.7
active	9661527	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	=	Ki	nM	0.7943	CHEMBL1868	Homo sapiens	pKi		9.1
inactive	9661528	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661529	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661530	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCC(=O)Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1		CHEMBL1998470	=	Ki	nM	630.96	CHEMBL1868	Homo sapiens	pKi		6.2
inactive	9661531	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9661532	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	=	Ki	nM	1.585	CHEMBL1868	Homo sapiens	pKi		8.8
active	9661533	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccccc1-c1ccnc(Nc2cccc(S(C)(=O)=O)c2)n1		CHEMBL1975903	=	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
inactive	9661534	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9661535	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	31622.78	CHEMBL1868	Homo sapiens	pKi		4.5
active	9661536	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	100.0	CHEMBL1868	Homo sapiens	pKi		7.0
inactive	9661537	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1ccc2nc(N)n(-c3nccs3)c2c1		CHEMBL1988805	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665508	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	1584.89	CHEMBL1868	Homo sapiens	pKi		5.8
inactive	9665509	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665510	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665511	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665512	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1ccc(-c2ccc3cn[nH]c3c2)cc1)Nc1cccc(F)c1		CHEMBL1969942	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665513	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(C(C)NC(=O)c2sc(-c3ccncc3)nc2C)c1		CHEMBL1978567	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665514	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	125.89	CHEMBL1868	Homo sapiens	pKi		6.9
active	9665515	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	=	Ki	nM	63.1	CHEMBL1868	Homo sapiens	pKi		7.2
active	9665516	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	125.89	CHEMBL1868	Homo sapiens	pKi		6.9
active	9665517	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
active	9665518	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1Nc2ccccc2C1=Cc1ccc[nH]1		CHEMBL1996176	=	Ki	nM	1000.0	CHEMBL1868	Homo sapiens	pKi		6.0
inactive	9665519	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1ccc(CNc2cc(-c3c[nH]c4ncccc34)ncn2)cc1		CHEMBL2002346	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665520	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
active	9665521	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	=	Ki	nM	1.259	CHEMBL1868	Homo sapiens	pKi		8.9
inactive	9665522	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665523	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
inactive	9665524	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665525	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1cc2nc(-c3ccccc3)cn2cn1		CHEMBL1972365	=	Ki	nM	1584.89	CHEMBL1868	Homo sapiens	pKi		5.8
inactive	9665526	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665527	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3c(F)ccc4[nH]nc(N)c34)cc2)c1		CHEMBL1996255	=	Ki	nM	0.2512	CHEMBL1868	Homo sapiens	pKi		9.6
active	9665528	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN(CC)CCOc1ccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)cc1		CHEMBL49120	=	Ki	nM	39.81	CHEMBL1868	Homo sapiens	pKi		7.4
active	9665529	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	10.0	CHEMBL1868	Homo sapiens	pKi		8.0
inactive	9665530	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665531	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665532	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCC(=O)Nc1ccc(C(=O)N2CCNCC2)c(O)c1		CHEMBL1988141	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665533	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)cnc2c(-c3ccc4c(c3)OCO4)cnn12		CHEMBL1977134	=	Ki	nM	251.19	CHEMBL1868	Homo sapiens	pKi		6.6
inactive	9665534	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665535	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COCC#Cc1cccc2c1Cc1c(-c3cccs3)n[nH]c1-2		CHEMBL1985206	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665536	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	=	Ki	nM	5.012	CHEMBL1868	Homo sapiens	pKi		8.3
active	9665537	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
inactive	9665538	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	<	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
inactive	9665539	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665540	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	C=CCc1cccc2c(=NO)cc(-c3ccccc3)oc12		CHEMBL1977749	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665541	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2scc(-c3ccccc3)c12		CHEMBL1975212	=	Ki	nM	15848.93	CHEMBL1868	Homo sapiens	pKi		4.8
inactive	9665542	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665543	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1[nH][nH]c2ccc(Br)cc12		CHEMBL2001613	=	Ki	nM	7943.28	CHEMBL1868	Homo sapiens	pKi		5.1
inactive	9665544	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
inactive	9665545	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc2[nH]cc(C=C3C(=O)Nc4ccccc43)c2c1		CHEMBL1997275	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665546	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1cc2c(-c3ccc(Nc4nc5ccccc5o4)cc3)cnc(N)c2s1		CHEMBL1993904	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665547	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2ccc(Cl)cc12		CHEMBL1967513	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665548	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(O)nc2[nH]nc(-c3cccc(-c4ccc(C#N)cc4)c3)c12		CHEMBL2000724	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665549	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	=	Ki	nM	3.162	CHEMBL1868	Homo sapiens	pKi		8.5
active	9665550	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	=	Ki	nM	125.89	CHEMBL1868	Homo sapiens	pKi		6.9
inactive	9665551	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665552	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(Cc1cc(Cl)c(O)c2ncccc12)C1CCCCC1		CHEMBL1982413	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665553	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	39.81	CHEMBL1868	Homo sapiens	pKi		7.4
inactive	9665554	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665555	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665556	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	=	Ki	nM	0.5012	CHEMBL1868	Homo sapiens	pKi		9.3
inactive	9665557	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665558	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(F)c(F)cc12		CHEMBL1981792	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665559	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(NCCc1cccs1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1987535	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665560	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	=	Ki	nM	158.49	CHEMBL1868	Homo sapiens	pKi		6.8
inactive	9665561	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Clc1cc(Nc2nc(NC3CC3)c3sccc3n2)ccc1N1CCOCC1		CHEMBL2002586	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665562	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665563	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1981133	=	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665564	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)Oc1cc(Nc2nc(NC(C)c3ccc(F)cn3)ncc2Cl)n[nH]1		CHEMBL2007421	=	Ki	nM	1584.89	CHEMBL1868	Homo sapiens	pKi		5.8
inactive	9665565	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665566	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cc(Nc2ccc(C(=O)N3CCOCC3)cn2)c(=O)n(C)c1		CHEMBL1973138	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665567	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665568	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1[nH]c2ccc(Cl)cc2c2ncnn12		CHEMBL1992673	=	Ki	nM	63095.73	CHEMBL1868	Homo sapiens	pKi		4.2
active	9665569	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	=	Ki	nM	794.33	CHEMBL1868	Homo sapiens	pKi		6.1
inactive	9665570	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665571	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)C1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1969151	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665572	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1cc(-c2cc3nc(Br)cnc3[nH]2)c2cc(F)ccc21		CHEMBL1993335	=	Ki	nM	1584.89	CHEMBL1868	Homo sapiens	pKi		5.8
active	9665573	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)NC1=NNC(=O)C1=Cc1cc2ccccc2[nH]1		CHEMBL1988692	=	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
inactive	9665574	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1nc(Cl)cc(-c2c[nH]c3ncccc23)n1		CHEMBL2007574	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665575	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665576	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	=	Ki	nM	158.49	CHEMBL1868	Homo sapiens	pKi		6.8
inactive	9665577	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665578	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665579	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665580	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)NCCO)c2)n1		CHEMBL1998680	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665581	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665582	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	<	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
inactive	9665583	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665584	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665585	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	63.1	CHEMBL1868	Homo sapiens	pKi		7.2
active	9665586	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4c3c(N)nn4C)cc2)c1		CHEMBL1985491	=	Ki	nM	2.512	CHEMBL1868	Homo sapiens	pKi		8.6
inactive	9665587	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665588	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665589	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665590	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCNC(=O)c1ccc(Nc2nc(CC)c3cc[nH]c3n2)cc1		CHEMBL1997007	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665591	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665592	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
active	9665593	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1nc2c(O)cccc2s1)Nc1ccccc1-c1ccccc1		CHEMBL2002690	=	Ki	nM	1258.93	CHEMBL1868	Homo sapiens	pKi		5.9
inactive	9665594	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665595	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665596	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665597	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	0.7943	CHEMBL1868	Homo sapiens	pKi		9.1
active	9665598	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	1.995	CHEMBL1868	Homo sapiens	pKi		8.7
active	9665599	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(CN(C)C)cc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4c(F)cccc4F)c3)nc3sccn23)n1		CHEMBL1997051	=	Ki	nM	1258.93	CHEMBL1868	Homo sapiens	pKi		5.9
active	9665600	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	125.89	CHEMBL1868	Homo sapiens	pKi		6.9
inactive	9665601	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1Nc2ccccc2C1=Cc1c[nH]c2ccccc12		CHEMBL1986590	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665602	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665603	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCC(N)C3)c21		CHEMBL1870106	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665604	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665605	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	12.59	CHEMBL1868	Homo sapiens	pKi		7.9
inactive	9665606	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665607	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	<	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
active	9665608	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	79.43	CHEMBL1868	Homo sapiens	pKi		7.1
active	9665609	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1ccc(-c2ccnc3[nH]ccc23)cc1		CHEMBL482538	=	Ki	nM	50118.72	CHEMBL1868	Homo sapiens	pKi		4.3
inactive	9665610	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665611	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(C)c(NC(=O)c2cc(-c3ccco3)nc3ccccc23)c1		CHEMBL1984296	=	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
inactive	9665612	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1nn(C)c2sc(C(N)=O)c(N)c12		CHEMBL1996837	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665613	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665614	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
active	9665615	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CNCC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL1964441	=	Ki	nM	39.81	CHEMBL1868	Homo sapiens	pKi		7.4
inactive	9665616	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cc(-c2c[nH]c3ncccc23)cc(Cl)n1)c1c(F)cccc1F		CHEMBL1991410	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665617	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	ON=C(c1nc2ccccc2[nH]1)c1nc2ccccc2[nH]1		CHEMBL546797	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665618	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	=	Ki	nM	1.995	CHEMBL1868	Homo sapiens	pKi		8.7
inactive	9665619	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665620	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCOCCO)c2)n1		CHEMBL1978271	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665621	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665622	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc(OCCCn4cccc4)c4[nH]nc(N)c34)cc2)c1		CHEMBL2007266	=	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
inactive	9665623	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
inactive	9665624	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(CCC(=O)Nc1cc(C(F)(F)F)ccc1Cl)NN=Cc1c[nH]c2ccccc12		CHEMBL1994308	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665625	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	0.2512	CHEMBL1868	Homo sapiens	pKi		9.6
active	9665626	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	794.33	CHEMBL1868	Homo sapiens	pKi		6.1
active	9665627	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN1CCN(c2ccc(Nc3ncc(C#N)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1973516	=	Ki	nM	12.59	CHEMBL1868	Homo sapiens	pKi		7.9
active	9665628	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	=	Ki	nM	0.3981	CHEMBL1868	Homo sapiens	pKi		9.4
inactive	9665629	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
active	9665630	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	79.43	CHEMBL1868	Homo sapiens	pKi		7.1
inactive	9665631	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665632	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665633	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665634	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665635	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cnc(Nc2nc(NC(C)C)ncc2Br)s1		CHEMBL1973013	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665636	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665637	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665638	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665639	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	=	Ki	nM	3.981	CHEMBL1868	Homo sapiens	pKi		8.4
active	9665640	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(-n2ccc3cnc(Nc4cc(OC)c(OC)c(OC)c4)nc32)cc1		CHEMBL1975927	=	Ki	nM	251.19	CHEMBL1868	Homo sapiens	pKi		6.6
inactive	9665641	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
inactive	9665642	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665643	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(Nc1cncc(-n2cnc3ccc(C#N)cc32)n1)c1ccccc1F		CHEMBL1977138	=	Ki	nM	251.19	CHEMBL1868	Homo sapiens	pKi		6.6
active	9665644	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)c(F)c3)c12		CHEMBL1980904	=	Ki	nM	0.3162	CHEMBL1868	Homo sapiens	pKi		9.5
inactive	9665645	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665646	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	19.95	CHEMBL1868	Homo sapiens	pKi		7.7
inactive	9665647	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
inactive	9665648	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)c1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL1969483	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665649	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1Nc2cc(-c3ccc(O)cc3)ccc2C1=Cc1ccc[nH]1		CHEMBL1980329	=	Ki	nM	19.95	CHEMBL1868	Homo sapiens	pKi		7.7
active	9665650	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1nc(-c2ccc3c(c2)OCO3)c2cc[nH]c2n1		CHEMBL2004515	=	Ki	nM	5011.87	CHEMBL1868	Homo sapiens	pKi		5.3
active	9665651	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	=	Ki	nM	3.981	CHEMBL1868	Homo sapiens	pKi		8.4
inactive	9665652	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cccc(C2Nc3ccc4ccccc4c3C3C=CCC32)c1)c1ccc(F)cc1		CHEMBL1992042	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665653	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665654	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4[nH]nc(N)c34)cc2)c1		CHEMBL271441	=	Ki	nM	0.1585	CHEMBL1868	Homo sapiens	pKi		9.8
inactive	9665655	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665656	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665657	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)s2)c1		CHEMBL1994724	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665658	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(-c2csc3c(C=CC(=O)NCCN(C)C)cnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1989267	=	Ki	nM	1258.93	CHEMBL1868	Homo sapiens	pKi		5.9
inactive	9665659	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ccc2c(C(=O)O)n(-c3ccccc3)nc2c1		CHEMBL1974574	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665660	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665661	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN(CC)CCNC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1970290	=	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
active	9665662	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	=	Ki	nM	50.12	CHEMBL1868	Homo sapiens	pKi		7.3
inactive	9665663	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665664	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
active	9665665	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3coc4c(-c5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1978601	=	Ki	nM	0.2512	CHEMBL1868	Homo sapiens	pKi		9.6
inactive	9665666	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665667	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	C#Cc1cn(C2CCCC2)c2ncnc(N)c12		CHEMBL1993877	=	Ki	nM	1258.93	CHEMBL1868	Homo sapiens	pKi		5.9
inactive	9665668	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
inactive	9665669	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665670	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(N)c34)cc2)ccc1F	Outside typical range	CHEMBL273187	=	Ki	nM	0.007943	CHEMBL1868	Homo sapiens	pKi		11.1
inactive	9665671	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665672	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	1.259	CHEMBL1868	Homo sapiens	pKi		8.9
inactive	9665673	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665674	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
active	9665675	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)c(F)c2)ccc1F		CHEMBL1986979	=	Ki	nM	0.0631	CHEMBL1868	Homo sapiens	pKi		10.2
inactive	9665676	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)c1ccc(N)c2ccccc12		CHEMBL1998253	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665677	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665678	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(Cl)ccc12		CHEMBL1981744	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665679	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	=	Ki	nM	0.3981	CHEMBL1868	Homo sapiens	pKi		9.4
inactive	9665680	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665681	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccccc1-c1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL2000029	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665682	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(N2CCN(C)CC2)ccc1C(=O)Nc1n[nH]c2ccc(Cc3cc(F)cc(F)c3)cc12		CHEMBL1973961	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665683	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665684	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCO)c2)n1		CHEMBL1994977	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665685	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665686	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Oc1ccc2nc(-c3ccc(Sc4ccc(-c5nc6ccc(O)cc6[nH]5)cc4)cc3)[nH]c2c1		CHEMBL2001149	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665687	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665688	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOc1ccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)cc1NC(=O)Cc1ccccc1		CHEMBL2000078	=	Ki	nM	794.33	CHEMBL1868	Homo sapiens	pKi		6.1
inactive	9665689	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc2c(c1)c(-c1cc3nc(Br)cnc3[nH]1)cn2C		CHEMBL2005478	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665690	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	10.0	CHEMBL1868	Homo sapiens	pKi		8.0
active	9665691	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(OC)c1CNc1nc(NC2CCCCC2)nc2ccc(Cl)cc12		CHEMBL1996646	=	Ki	nM	100.0	CHEMBL1868	Homo sapiens	pKi		7.0
inactive	9665692	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1979773	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665693	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	=	Ki	nM	79.43	CHEMBL1868	Homo sapiens	pKi		7.1
active	9665694	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	=	Ki	nM	79.43	CHEMBL1868	Homo sapiens	pKi		7.1
inactive	9665695	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665696	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Cc1ccccc1)Nc1cc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)ccc1Cl		CHEMBL2005482	=	Ki	nM	39.81	CHEMBL1868	Homo sapiens	pKi		7.4
active	9665697	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCCN(C)C)cc2NC3=O)ccc1O		CHEMBL1996702	=	Ki	nM	1584.89	CHEMBL1868	Homo sapiens	pKi		5.8
active	9665698	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	1258.93	CHEMBL1868	Homo sapiens	pKi		5.9
active	9665699	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)Cc4ccccc4)c3)nc3sccn23)n1		CHEMBL1997909	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
inactive	9665700	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1ccc(-c2ccc(=O)[nH]n2)cc1)Nc1cccc(C(F)(F)F)c1		CHEMBL2007124	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665701	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	=	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665702	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1ccc2c(c1)C(c1ccc3c(n1)CCCC3O)C(=O)N2		CHEMBL1985681	=	Ki	nM	1584.89	CHEMBL1868	Homo sapiens	pKi		5.8
active	9665703	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	=	Ki	nM	15.85	CHEMBL1868	Homo sapiens	pKi		7.8
active	9665704	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	=	Ki	nM	3.162	CHEMBL1868	Homo sapiens	pKi		8.5
active	9665705	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	25.12	CHEMBL1868	Homo sapiens	pKi		7.6
inactive	9665706	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#CCC(C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL2002099	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665707	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	<	Ki	nM	1584.89	CHEMBL1868	Homo sapiens	pKi		5.8
inactive	9665708	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	<	Ki	nM	1000.0	CHEMBL1868	Homo sapiens	pKi		6.0
active	9665709	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2c1N=C(c1ccccc1)CCN2		CHEMBL262623	=	Ki	nM	12589.25	CHEMBL1868	Homo sapiens	pKi		4.9
inactive	9665710	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
active	9665711	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	0.2512	CHEMBL1868	Homo sapiens	pKi		9.6
inactive	9665712	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL2004118	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665713	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665714	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665715	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665716	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665717	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
inactive	9665718	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1995211	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665719	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	79.43	CHEMBL1868	Homo sapiens	pKi		7.1
active	9665720	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	=	Ki	nM	3.162	CHEMBL1868	Homo sapiens	pKi		8.5
inactive	9665721	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1ccc(NC2CCCCC2N)nc1Nc1cccc(Cl)c1		CHEMBL1982753	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665722	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	=	Ki	nM	3.981	CHEMBL1868	Homo sapiens	pKi		8.4
inactive	9665723	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(CNC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2006299	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665724	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Oc1cc(O)cc(C=Cc2ccc(O)c(O)c2)c1		CHEMBL1972346	=	Ki	nM	501.19	CHEMBL1868	Homo sapiens	pKi		6.3
inactive	9665725	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(-c2cc3nc(Br)cnc3[nH]2)cc1		CHEMBL1965169	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665726	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN1c2cc(N)ccc2-c2ccc(N)cc2C1(O)c1ccccc1		CHEMBL1991818	=	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
active	9665727	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Ki	nM	63.1	CHEMBL1868	Homo sapiens	pKi		7.2
active	9665728	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL1965170	=	Ki	nM	6.31	CHEMBL1868	Homo sapiens	pKi		8.2
inactive	9665729	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665730	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
inactive	9665731	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665732	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Clc1ccc2c(c1)nnc1nnnn12		CHEMBL1986503	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665733	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	=	Ki	nM	1.995	CHEMBL1868	Homo sapiens	pKi		8.7
active	9665734	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1c(-c2nc3ccccc3[nH]2)c(O)cc2oc(C)cc(=O)c12		CHEMBL1972355	=	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
inactive	9665735	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(=O)[nH]nc1-c1ccc(NC(=O)Nc2cc(C(F)(F)F)ccc2F)c(Cl)c1		CHEMBL1997892	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9665736	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(O)c1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL2001641	=	Ki	nM	79432.82	CHEMBL1868	Homo sapiens	pKi		4.1
inactive	9665737	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(-c2cc(-c3cc(Br)ccc3O)[nH]c(=O)c2C#N)s1		CHEMBL1997193	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665738	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665739	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2cccc(OCC(=O)O)c2)n1		CHEMBL1964902	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9665740	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665741	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665742	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9665743	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9665744	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3)n2)s1		CHEMBL1983715	=	Ki	nM	79.43	CHEMBL1868	Homo sapiens	pKi		7.1
active	9665745	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	=	Ki	nM	251.19	CHEMBL1868	Homo sapiens	pKi		6.6
inactive	9665746	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669705	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669706	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	316.23	CHEMBL1868	Homo sapiens	pKi		6.5
inactive	9669707	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669708	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	=	Ki	nM	1.995	CHEMBL1868	Homo sapiens	pKi		8.7
active	9669709	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	=	Ki	nM	7.943	CHEMBL1868	Homo sapiens	pKi		8.1
active	9669710	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	=	Ki	nM	0.631	CHEMBL1868	Homo sapiens	pKi		9.2
inactive	9669711	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669712	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669713	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669714	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669715	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)Cc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2[nH]ccc12		CHEMBL1980763	=	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
active	9669716	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669717	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(=O)c1ccccc1-c1ncnc2[nH]ccc12		CHEMBL1977931	=	Ki	nM	39810.72	CHEMBL1868	Homo sapiens	pKi		4.4
active	9669718	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	=	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669719	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669720	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669721	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669722	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCCNc1nc(N)c(C(=O)c2ccccc2)s1		CHEMBL2007479	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669723	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669724	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)C(CO)NC(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1971223	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669725	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	19.95	CHEMBL1868	Homo sapiens	pKi		7.7
active	9669726	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4ccc(OC(F)F)cc4)cc3)c12		CHEMBL1972220	=	Ki	nM	2.512	CHEMBL1868	Homo sapiens	pKi		8.6
inactive	9669727	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669728	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Fc1cccc(CNc2ncnc3[nH]cnc23)c1		CHEMBL2003785	=	Ki	nM	79432.82	CHEMBL1868	Homo sapiens	pKi		4.1
inactive	9669729	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669730	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	25.12	CHEMBL1868	Homo sapiens	pKi		7.6
inactive	9669731	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669732	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
inactive	9669733	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669734	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOc1ccccc1-c1cccc(-c2n[nH]c3nc(O)cc(C)c23)c1		CHEMBL1983070	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669735	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669736	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2003514	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669737	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669738	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4ccc(F)c(C(F)(F)F)c4)cc3)ccnc21		CHEMBL1966836	=	Ki	nM	1.0	CHEMBL1868	Homo sapiens	pKi		9.0
inactive	9669739	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669740	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4c(Cl)cccc4Cl)s3)cc2)CC1		CHEMBL1989043	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669741	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669742	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669743	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669744	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	=	Ki	nM	0.5012	CHEMBL1868	Homo sapiens	pKi		9.3
inactive	9669745	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669746	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	=	Ki	nM	1584.89	CHEMBL1868	Homo sapiens	pKi		5.8
inactive	9669747	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	<	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
inactive	9669748	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669749	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	=	Ki	nM	158.49	CHEMBL1868	Homo sapiens	pKi		6.8
inactive	9669750	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669751	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOC(=O)c1nc2c(=O)[nH]c3cc([N+](=O)[O-])c(NC(C)=O)cc3n2c1C		CHEMBL1997611	=	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
active	9669752	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	=	Ki	nM	10.0	CHEMBL1868	Homo sapiens	pKi		8.0
active	9669753	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	=	Ki	nM	1.0	CHEMBL1868	Homo sapiens	pKi		9.0
inactive	9669754	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669755	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	=	Ki	nM	158.49	CHEMBL1868	Homo sapiens	pKi		6.8
active	9669756	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4[nH]nc(N)c34)cc2)c1		CHEMBL272938	=	Ki	nM	0.05012	CHEMBL1868	Homo sapiens	pKi		10.3
active	9669757	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(=O)Nc1ccc(-n2nc3ccc(N)nc3n2)cc1		CHEMBL2002723	=	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
active	9669758	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1sn(-c2ccc3c(c2)OCO3)c(=O)n1Cc1ccccc1		CHEMBL1984632	=	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
inactive	9669759	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669760	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	=	Ki	nM	0.3981	CHEMBL1868	Homo sapiens	pKi		9.4
active	9669761	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1nnc2ccc(-c3ccccc3)cn12		CHEMBL1987143	=	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
inactive	9669762	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669763	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1973720	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669764	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Brc1ccc2cnc(Nc3ccncn3)cc2c1		CHEMBL1984686	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669765	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	=	Ki	nM	3.981	CHEMBL1868	Homo sapiens	pKi		8.4
inactive	9669766	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669767	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669768	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669769	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=S(=O)(Nc1ccc2c(c1)C(=NO)c1ccccc1-2)c1cccc(Br)c1		CHEMBL1973793	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669770	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
active	9669771	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
active	9669772	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	7.943	CHEMBL1868	Homo sapiens	pKi		8.1
inactive	9669773	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCC1CC(NS(=O)(=O)C2CC2)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1992073	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669774	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
inactive	9669775	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669776	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(NC(CCO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1986143	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669777	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3sccc3n2)cc1		CHEMBL2007559	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669778	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Cc1ccc(-c2cccnc2)cc1)Nc1ccc(SC(F)F)cc1		CHEMBL1992581	=	Ki	nM	316.23	CHEMBL1868	Homo sapiens	pKi		6.5
inactive	9669779	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669780	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	Ki	nM	6.31	CHEMBL1868	Homo sapiens	pKi		8.2
inactive	9669781	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669782	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669783	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669784	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2nccc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL403402	=	Ki	nM	0.1995	CHEMBL1868	Homo sapiens	pKi		9.7
active	9669785	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	=	Ki	nM	79.43	CHEMBL1868	Homo sapiens	pKi		7.1
active	9669786	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	=	Ki	nM	251.19	CHEMBL1868	Homo sapiens	pKi		6.6
active	9669787	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	=	Ki	nM	6.31	CHEMBL1868	Homo sapiens	pKi		8.2
inactive	9669788	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(=O)OCCn1nc(-c2cccc(Br)c2)c2c(C(F)(F)F)cc(=O)[nH]c21		CHEMBL1984847	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669789	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(=O)c1c(-c2ccccc2)nn(C)c(=O)c1N		CHEMBL1984402	=	Ki	nM	100000.0	CHEMBL1868	Homo sapiens	pKi		4.0
active	9669790	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	=	Ki	nM	1.259	CHEMBL1868	Homo sapiens	pKi		8.9
inactive	9669791	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Cc1ccc(OC(F)(F)F)cc1)N1CCC2(CC1)NCCc1c2[nH]c2ccccc12		CHEMBL1996576	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669792	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccccc1Nc1nccc(-c2c(-c3cccc(NC(=O)c4ccccc4)c3)nc3sccn23)n1		CHEMBL1988076	=	Ki	nM	316.23	CHEMBL1868	Homo sapiens	pKi		6.5
inactive	9669793	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
inactive	9669794	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669795	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669796	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669797	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	=	Ki	nM	1.259	CHEMBL1868	Homo sapiens	pKi		8.9
active	9669798	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	Ki	nM	25.12	CHEMBL1868	Homo sapiens	pKi		7.6
inactive	9669799	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669800	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
active	9669801	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	=	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
inactive	9669802	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669803	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669804	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669805	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	=	Ki	nM	25.12	CHEMBL1868	Homo sapiens	pKi		7.6
inactive	9669806	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669807	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669808	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
inactive	9669809	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(CNC(=O)c2cnc(-c3ccncc3)nc2)c1		CHEMBL2004159	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669810	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#CC1=C(c2ccccc2)CC(c2ccc(Cl)cc2)C(C(=O)c2ccccc2)C1=O		CHEMBL1978371	=	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
inactive	9669811	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669812	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669813	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	=	Ki	nM	6.31	CHEMBL1868	Homo sapiens	pKi		8.2
active	9669814	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1cnc2[nH]cc(-c3ccnc(NC4CCCCC4)n3)c2c1		CHEMBL385478	=	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669815	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669816	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669817	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	100.0	CHEMBL1868	Homo sapiens	pKi		7.0
active	9669818	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	=	Ki	nM	5.012	CHEMBL1868	Homo sapiens	pKi		8.3
inactive	9669819	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669820	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669821	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669822	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC1CCN(C(=O)CC#N)CC1c1ncc2cnc3[nH]ccc3n12		CHEMBL1966175	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669823	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669824	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC#Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL2007375	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669825	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669826	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1NC(=O)c2c1c(-c1ccccc1Cl)cc1[nH]c3ccc(O)cc3c21		CHEMBL379975	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669827	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(N)c34)cc2)ccc1F	Outside typical range	CHEMBL273187	=	Ki	nM	0.007943	CHEMBL1868	Homo sapiens	pKi		11.1
active	9669828	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	=	Ki	nM	50.12	CHEMBL1868	Homo sapiens	pKi		7.3
inactive	9669829	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CS(=O)(=O)c1cccc(C(=O)Nc2nc3ccccc3n2CCCO)c1		CHEMBL1973016	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669830	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2c(OCCCn3cccc3)ccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL1965387	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669831	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1cc2c(s1)CCc1cn[nH]c1-2		CHEMBL2001539	<	Ki	nM	19952.62	CHEMBL1868	Homo sapiens	pKi		4.7
active	9669832	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(-c2ncnc3[nH]ccc23)ccc1F		CHEMBL1997041	=	Ki	nM	25118.86	CHEMBL1868	Homo sapiens	pKi		4.6
inactive	9669833	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669834	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(-c2ccc3c(c2)Nc2c(O)cccc2NC3=O)ccc1O		CHEMBL550418	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669835	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	=	Ki	nM	50.12	CHEMBL1868	Homo sapiens	pKi		7.3
inactive	9669836	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
inactive	9669837	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOc1ccc(C=C2SC(=N)NC2=O)c(O)c1		CHEMBL1971289	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669838	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	=	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669839	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	7.943	CHEMBL1868	Homo sapiens	pKi		8.1
inactive	9669840	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669841	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	1.0	CHEMBL1868	Homo sapiens	pKi		9.0
inactive	9669842	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669843	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc2c(c1)c(-c1cc3nccnc3[nH]1)cn2C		CHEMBL1233887	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669844	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2c1C(=O)NCCN2		CHEMBL1992607	=	Ki	nM	25118.86	CHEMBL1868	Homo sapiens	pKi		4.6
inactive	9669845	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669846	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)c1cc(NC(=O)C(=O)c2cccc3ccccc23)n(-c2ccc(OCCC(=O)O)cc2)n1		CHEMBL2003689	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669847	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669848	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669849	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN(CC)CCCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1996649	=	Ki	nM	25.12	CHEMBL1868	Homo sapiens	pKi		7.6
inactive	9669850	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669851	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669852	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1986756	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669853	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)c1		CHEMBL409349	=	Ki	nM	0.2512	CHEMBL1868	Homo sapiens	pKi		9.6
inactive	9669854	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669855	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Ki	nM	794.33	CHEMBL1868	Homo sapiens	pKi		6.1
inactive	9669856	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669857	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	=	Ki	nM	25.12	CHEMBL1868	Homo sapiens	pKi		7.6
inactive	9669858	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	<	Ki	nM	1258.93	CHEMBL1868	Homo sapiens	pKi		5.9
inactive	9669859	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669860	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(CCC#N)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1974998	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669861	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669862	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
active	9669863	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Ki	nM	1000.0	CHEMBL1868	Homo sapiens	pKi		6.0
active	9669864	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	=	Ki	nM	10.0	CHEMBL1868	Homo sapiens	pKi		8.0
inactive	9669865	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669866	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	=	Ki	nM	0.631	CHEMBL1868	Homo sapiens	pKi		9.2
active	9669867	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1ccc2nc(-c3ccc([N+](=O)[O-])o3)cn2c1		CHEMBL1973359	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
active	9669868	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)c(F)c2)c1		CHEMBL1994638	=	Ki	nM	0.1259	CHEMBL1868	Homo sapiens	pKi		9.9
inactive	9669869	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669870	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccnc21		CHEMBL1985888	=	Ki	nM	0.3162	CHEMBL1868	Homo sapiens	pKi		9.5
active	9669871	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	158.49	CHEMBL1868	Homo sapiens	pKi		6.8
active	9669872	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN1CCN(c2ccc(Nc3ncc(Cl)c(Nc4ccc5[nH]ncc5c4)n3)cc2)CC1		CHEMBL1979690	=	Ki	nM	79.43	CHEMBL1868	Homo sapiens	pKi		7.1
inactive	9669873	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669874	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669875	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	=	Ki	nM	251.19	CHEMBL1868	Homo sapiens	pKi		6.6
inactive	9669876	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669877	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669878	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncnc2c1c(-c1ccc(Oc3ccc(CO)cc3)cc1)cn2C1CCOC1		CHEMBL1976376	=	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
active	9669879	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(NN=Cc1cc(Br)c(O)c(Br)c1)Nc1ccccc1		CHEMBL1983575	=	Ki	nM	794.33	CHEMBL1868	Homo sapiens	pKi		6.1
inactive	9669880	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1cccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)n1		CHEMBL1968868	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669881	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	158.49	CHEMBL1868	Homo sapiens	pKi		6.8
active	9669882	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	39.81	CHEMBL1868	Homo sapiens	pKi		7.4
active	9669883	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	=	Ki	nM	39.81	CHEMBL1868	Homo sapiens	pKi		7.4
inactive	9669884	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669885	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1ccc([N+](=O)[O-])cc1)N1CCc2[nH]c3c(Cl)cc(Cl)cc3c2C1		CHEMBL1976196	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669886	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669887	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccccc1CNC(=N)Nc1nccc(-c2cccs2)n1		CHEMBL1997197	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669888	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1Cc2cc(-c3ccccc3)cnc2N1		CHEMBL1983630	=	Ki	nM	79432.82	CHEMBL1868	Homo sapiens	pKi		4.1
active	9669889	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	12.59	CHEMBL1868	Homo sapiens	pKi		7.9
active	9669890	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
inactive	9669891	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669892	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669893	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669894	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669895	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	5.012	CHEMBL1868	Homo sapiens	pKi		8.3
active	9669896	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	3.162	CHEMBL1868	Homo sapiens	pKi		8.5
inactive	9669897	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669898	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	0.3162	CHEMBL1868	Homo sapiens	pKi		9.5
active	9669899	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	=	Ki	nM	5.012	CHEMBL1868	Homo sapiens	pKi		8.3
active	9669900	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	=	Ki	nM	125.89	CHEMBL1868	Homo sapiens	pKi		6.9
inactive	9669901	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669902	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1cc(=O)[nH]n1-c1ccccn1		CHEMBL1995765	=	Ki	nM	19952.62	CHEMBL1868	Homo sapiens	pKi		4.7
inactive	9669903	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669904	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669905	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCNC(=O)c1ccc(Nc2nc(CCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL1984760	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669906	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669907	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)CC1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL360847	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669908	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cc(F)ccc1F		CHEMBL1995811	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669909	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669910	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669911	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	1995.26	CHEMBL1868	Homo sapiens	pKi		5.7
inactive	9669912	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(=O)c1cccc2cn[nH]c12		CHEMBL451401	<	Ki	nM	25118.86	CHEMBL1868	Homo sapiens	pKi		4.6
inactive	9669913	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669914	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669915	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	=	Ki	nM	19.95	CHEMBL1868	Homo sapiens	pKi		7.7
inactive	9669916	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669917	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669918	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	25.12	CHEMBL1868	Homo sapiens	pKi		7.6
inactive	9669919	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669920	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669921	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669922	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669923	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	=	Ki	nM	63.1	CHEMBL1868	Homo sapiens	pKi		7.2
inactive	9669924	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669925	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
inactive	9669926	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669927	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669928	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	=	Ki	nM	158.49	CHEMBL1868	Homo sapiens	pKi		6.8
active	9669929	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	=	Ki	nM	1.585	CHEMBL1868	Homo sapiens	pKi		8.8
inactive	9669930	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669931	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669932	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	=	Ki	nM	15.85	CHEMBL1868	Homo sapiens	pKi		7.8
inactive	9669933	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cccc(F)c1)Nc1cccc(-c2ccc3cn[nH]c3c2)c1		CHEMBL1983393	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9669934	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	316.23	CHEMBL1868	Homo sapiens	pKi		6.5
inactive	9669935	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669936	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCCC3CCO)nc12		CHEMBL2006674	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669937	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)c1ccc(Nc2cc(-c3csc(Br)c3)[nH]n2)cc1		CHEMBL1984236	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669938	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cnccn1)Nc1cccc2c(O)cccc12		CHEMBL1992371	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669939	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669940	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9669941	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(N3CC4COCC4C3)cc12		CHEMBL2002599	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9669942	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9669943	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1n[nH]c2ccc(-c3cccnc3)cc12		CHEMBL1967252	=	Ki	nM	31622.78	CHEMBL1868	Homo sapiens	pKi		4.5
active	9673888	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN(CCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL2004637	=	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
inactive	9673889	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)C(C)Nc1ncc(Cl)c(Nc2nccs2)n1		CHEMBL1993374	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9673890	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9673891	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)N(CCCN)C(=O)c1cccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2cccc3ccccc23)c1		CHEMBL1994318	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9673892	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	=	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9673893	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCCCCC(=O)O)c2)n1		CHEMBL1999506	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9673894	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	1.0	CHEMBL1868	Homo sapiens	pKi		9.0
inactive	9673895	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9673896	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	=	Ki	nM	1.585	CHEMBL1868	Homo sapiens	pKi		8.8
inactive	9673897	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9673898	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	=	Ki	nM	199.53	CHEMBL1868	Homo sapiens	pKi		6.7
active	9673899	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)c(F)c3)c12		CHEMBL2000652	=	Ki	nM	0.631	CHEMBL1868	Homo sapiens	pKi		9.2
active	9673900	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Ki	nM	125.89	CHEMBL1868	Homo sapiens	pKi		6.9
inactive	9673901	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOC(=O)c1c(C)n(-c2ccc(I)cc2)c2c1cc(O)c1ccccc12		CHEMBL1970352	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9673902	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9673903	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9673904	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9673905	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN(C)c1ccc(-c2cc(-c3ccc([N+](=O)[O-])cc3)nc(NS(=O)(=O)c3ccc(N)cc3)n2)cc1		CHEMBL1980167	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
inactive	9673906	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9673907	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc(CNC(=O)c2sc3nc(C)cc(C)c3c2N)cc1		CHEMBL1978713	=	Ki	nM	3162.28	CHEMBL1868	Homo sapiens	pKi		5.5
active	9673908	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	=	Ki	nM	630.96	CHEMBL1868	Homo sapiens	pKi		6.2
active	9673909	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	=	Ki	nM	10.0	CHEMBL1868	Homo sapiens	pKi		8.0
active	9673910	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	=	Ki	nM	1.585	CHEMBL1868	Homo sapiens	pKi		8.8
active	9673911	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
inactive	9673912	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9673913	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	31.62	CHEMBL1868	Homo sapiens	pKi		7.5
active	9673914	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	=	Ki	nM	316.23	CHEMBL1868	Homo sapiens	pKi		6.5
inactive	9673915	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9673916	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9673917	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	NCc1cc(Nc2ncnc(-c3ccccc3)n2)ccc1O		CHEMBL1980246	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9673918	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	=	Ki	nM	251.19	CHEMBL1868	Homo sapiens	pKi		6.6
active	9673919	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL374044	=	Ki	nM	0.07943	CHEMBL1868	Homo sapiens	pKi		10.1
inactive	9673920	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
active	9673921	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(Nc1nc2ccccc2s1)c1cccc2c1CN(c1nc(C(=O)O)c(-c3ccc(CO)cc3)s1)CC2		CHEMBL1983980	=	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
active	9673922	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CNc1nc(C)c(-c2ccnc(Nc3ccc(N4CCNCC4)cc3)n2)s1		CHEMBL1999484	=	Ki	nM	39.81	CHEMBL1868	Homo sapiens	pKi		7.4
active	9673923	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	12.59	CHEMBL1868	Homo sapiens	pKi		7.9
active	9673924	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cncc21		CHEMBL404366	=	Ki	nM	0.7943	CHEMBL1868	Homo sapiens	pKi		9.1
inactive	9673925	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
inactive	9673926	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1ccc(NCc2ccc(-c3ccc(F)cc3)nc2)cc1		CHEMBL1986899	<	Ki	nM	3981.07	CHEMBL1868	Homo sapiens	pKi		5.4
active	9673927	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	=	Ki	nM	1.585	CHEMBL1868	Homo sapiens	pKi		8.8
active	9673928	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	100.0	CHEMBL1868	Homo sapiens	pKi		7.0
inactive	9673929	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	2511.89	CHEMBL1868	Homo sapiens	pKi		5.6
active	9673930	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	25.12	CHEMBL1868	Homo sapiens	pKi		7.6
active	9673931	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	50.12	CHEMBL1868	Homo sapiens	pKi		7.3
active	9673932	CHEMBL1963826	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: FLT1	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	=	Ki	nM	398.11	CHEMBL1868	Homo sapiens	pKi		6.4
	10838589	CHEMBL2014429	Inhibition of FLT1 at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	8.0	CHEMBL1868	Homo sapiens	INH	%	8.0
	10843856	CHEMBL2016112	Inhibition of human VEGFR1 using ATP as substrate	B	CC(C)Cn1c2ccc(Nc3ncccn3)cc2c2c3c(c4c(c21)CCc1nn(C)cc1-4)C(=O)NC3		CHEMBL2010872	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	nM	3.0
	10850677	CHEMBL2019797	Inhibition of human Flt1 at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	>	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	10863743	CHEMBL2024898	Inhibition of Flt1 by TR-FRET assay	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	32.0	CHEMBL1868	Homo sapiens	IC50	nM	32.0
	10896864	CHEMBL2039238	Inhibition of Flt1 at 3 uM	B	C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1		CHEMBL2035810	=	Inhibition	%	15.0	CHEMBL1868	Homo sapiens	INH	%	15.0
	10896882	CHEMBL2039256	Inhibition of Flt1	B	C=CC(=O)NCc1coc(-c2c(N)ncnc2Nc2ccc(OCc3ccccn3)c(Cl)c2)n1		CHEMBL2035810	>	IC50	nM	3000.0	CHEMBL1868	Homo sapiens	IC50	uM	3.0
	10936267	CHEMBL2050060	Inhibition of human FLT1	B	Cc1ccc(NC(=O)Nc2nnc(Sc3ncnc4cc(OCCCN5CCOCC5)ccc34)s2)cc1		CHEMBL2046883	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	10949913	CHEMBL2049405	Inhibition of VEGFR1 using ATP preincubated with compound for 5 mins measured after 5 mins	B	CC(C)(N)C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc5sncc45)c(Cl)c3)c21		CHEMBL2048912	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	nM	10000.0
	10974304	CHEMBL2066304	Inhibition of VEGFR1	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(NC(=O)OCc5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL2063319	=	IC50	nM	200.0	CHEMBL1868	Homo sapiens	IC50	nM	200.0
	10974305	CHEMBL2066304	Inhibition of VEGFR1	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(NC(=O)Oc5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL2063318	=	IC50	nM	320.0	CHEMBL1868	Homo sapiens	IC50	nM	320.0
	10974306	CHEMBL2066304	Inhibition of VEGFR1	B	O=C(Nc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCCC4)cc3)[nH]n2)cc1)Oc1ccccc1		CHEMBL2063320	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	10974307	CHEMBL2066304	Inhibition of VEGFR1	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(NS(=O)(=O)c5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL1807466	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	10974308	CHEMBL2066304	Inhibition of VEGFR1	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(CNC(=O)Oc5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL2063321	=	IC50	nM	54.0	CHEMBL1868	Homo sapiens	IC50	nM	54.0
	10974309	CHEMBL2066304	Inhibition of VEGFR1	B	CCOC(=O)NCc1ccc(-c2cc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)[nH]n2)cc1		CHEMBL2063322	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	10974310	CHEMBL2066304	Inhibition of VEGFR1	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(CNC(=O)OCc5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL2063323	=	IC50	nM	20.0	CHEMBL1868	Homo sapiens	IC50	nM	20.0
	10974311	CHEMBL2066304	Inhibition of VEGFR1	B	O=C(NCc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCCC4)cc3)[nH]n2)cc1)OCc1ccccc1		CHEMBL2063324	=	IC50	nM	70.0	CHEMBL1868	Homo sapiens	IC50	nM	70.0
	10974312	CHEMBL2066304	Inhibition of VEGFR1	B	CN1CCN(Cc2ccc(C(=O)Nc3cc(-c4ccc(CNC(=O)OCc5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL2063325	=	IC50	nM	320.0	CHEMBL1868	Homo sapiens	IC50	nM	320.0
	10974313	CHEMBL2066304	Inhibition of VEGFR1	B	O=C(NCc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCOCC4)cc3)[nH]n2)cc1)OCc1ccccc1		CHEMBL2063326	=	IC50	nM	370.0	CHEMBL1868	Homo sapiens	IC50	nM	370.0
	10974314	CHEMBL2066304	Inhibition of VEGFR1	B	O=C(NCc1ccc(-c2cc(NC(=O)c3ccc(OCCCN4CCCC4)cc3)[nH]n2)cc1)OCc1ccccc1		CHEMBL2063327	=	IC50	nM	180.0	CHEMBL1868	Homo sapiens	IC50	nM	180.0
	10974315	CHEMBL2066304	Inhibition of VEGFR1	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(CNC(=O)OCc5cccnc5)cc4)n[nH]3)cc2)CC1		CHEMBL2063328	=	IC50	nM	250.0	CHEMBL1868	Homo sapiens	IC50	nM	250.0
	10974316	CHEMBL2066304	Inhibition of VEGFR1	B	O=C(NCc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCCC4)cc3)[nH]n2)cc1)OCc1cccnc1		CHEMBL2063329	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	10974317	CHEMBL2066304	Inhibition of VEGFR1	B	O=C(NCc1ccc(-c2cc(NC(=O)c3ccc(OCCN4CCOCC4)cc3)[nH]n2)cc1)OCc1cccnc1		CHEMBL2063330	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	10974318	CHEMBL2066304	Inhibition of VEGFR1	B	Cc1cc(COC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)[nH]n3)cc2)no1		CHEMBL2063331	=	IC50	nM	350.0	CHEMBL1868	Homo sapiens	IC50	nM	350.0
	10974319	CHEMBL2066304	Inhibition of VEGFR1	B	Cc1cc(COC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCCC5)cc4)[nH]n3)cc2)no1		CHEMBL2063332	=	IC50	nM	590.0	CHEMBL1868	Homo sapiens	IC50	nM	590.0
	10974320	CHEMBL2066304	Inhibition of VEGFR1	B	Cc1cc(COC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2063333	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	10974321	CHEMBL2066304	Inhibition of VEGFR1	B	CN1CCN(c2ccc(C(=O)Nc3cc(-c4ccc(CNS(=O)(=O)c5ccccc5)cc4)n[nH]3)cc2)CC1		CHEMBL2063334	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	10974322	CHEMBL2066304	Inhibition of VEGFR1	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)OCc4ccccc4)cc3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL2063335	=	IC50	nM	420.0	CHEMBL1868	Homo sapiens	IC50	nM	420.0
	10974323	CHEMBL2066304	Inhibition of VEGFR1	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)OCc4cccnc4)cc3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL2063336	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	10974324	CHEMBL2066304	Inhibition of VEGFR1	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)OCc4cc(C)on4)cc3)n[nH]2)cc(N2CCN(C)CC2)n1		CHEMBL2063337	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	10974325	CHEMBL2066304	Inhibition of VEGFR1	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)OCc4ccccc4)cc3)n[nH]2)cc(N2CCN(CCO)CC2)n1		CHEMBL2063338	=	IC50	nM	290.0	CHEMBL1868	Homo sapiens	IC50	nM	290.0
	10974326	CHEMBL2066304	Inhibition of VEGFR1	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)OCc4cccnc4)cc3)n[nH]2)cc(N2CCN(CCO)CC2)n1		CHEMBL2063434	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	10974327	CHEMBL2066304	Inhibition of VEGFR1	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)OCc4cc(C)on4)cc3)n[nH]2)cc(N2CCN(CCO)CC2)n1		CHEMBL2063435	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	10974328	CHEMBL2066304	Inhibition of VEGFR1	B	Cc1nc(Nc2cc(-c3ccc(CNC(=O)OCc4ccccc4)cc3)n[nH]2)cc(N2CCNCC2)n1		CHEMBL2063436	=	IC50	nM	82.0	CHEMBL1868	Homo sapiens	IC50	nM	82.0
	10974329	CHEMBL2066304	Inhibition of VEGFR1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	nM	10000.0
	10974330	CHEMBL2066304	Inhibition of VEGFR1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	165.0	CHEMBL1868	Homo sapiens	IC50	nM	165.0
	10974331	CHEMBL2066304	Inhibition of VEGFR1	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	70.0	CHEMBL1868	Homo sapiens	IC50	nM	70.0
	10983100	CHEMBL2072603	Inhibition of FLT1	B	C[C@H](NC(=O)c1cc(-c2cnn(C3CCOCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2071457	=	IC50	nM	8160.0	CHEMBL1868	Homo sapiens	IC50	uM	8.16
	10984743	CHEMBL2072039	Inhibition of human Flt1 at 1 uM	B	Nc1cc(Nc2cnccn2)nc(-c2ccnc(N3CCNCC3)c2)c1		CHEMBL2069349	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	11019132	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	1.0	CHEMBL1868	Homo sapiens	IC50	nM	1.0
	11019133	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	IC50	nM	28.0	CHEMBL1868	Homo sapiens	IC50	nM	28.0
	11019134	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	Cc1ccccc1C(=C1C(=O)Nc2ccccc21)c1nc2ccccc2[nH]1		CHEMBL2086721	=	IC50	nM	618.0	CHEMBL1868	Homo sapiens	IC50	nM	618.0
	11019135	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	Cc1cccc(C(=C2C(=O)Nc3ccccc32)c2nc3ccccc3[nH]2)c1		CHEMBL2086722	=	IC50	nM	681.0	CHEMBL1868	Homo sapiens	IC50	nM	681.0
	11019136	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	Cc1ccc(C(=C2C(=O)Nc3ccccc32)c2nc3ccccc3[nH]2)cc1		CHEMBL2086723	=	IC50	nM	599.0	CHEMBL1868	Homo sapiens	IC50	nM	599.0
	11019137	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	O=C1Nc2ccccc2C1=C(c1ccc(F)cc1)c1nc2ccccc2[nH]1		CHEMBL2086724	=	IC50	nM	2308.0	CHEMBL1868	Homo sapiens	IC50	nM	2308.0
	11019138	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	O=C1Nc2ccccc2C1=C(c1cccc(F)c1)c1nc2ccccc2[nH]1		CHEMBL2086725	=	IC50	nM	522.0	CHEMBL1868	Homo sapiens	IC50	nM	522.0
	11019139	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	O=C1Nc2ccccc2C1=C(c1cc(F)cc(F)c1)c1nc2ccccc2[nH]1		CHEMBL2086726	=	IC50	nM	2551.0	CHEMBL1868	Homo sapiens	IC50	nM	2551.0
	11019140	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	O=C1Nc2ccccc2C1=C(c1nc2ccccc2[nH]1)c1ccc(F)cc1F		CHEMBL2086727	=	IC50	nM	1796.0	CHEMBL1868	Homo sapiens	IC50	nM	1796.0
	11019141	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	O=C1Nc2ccccc2C1=C(c1ccc(C(F)(F)F)cc1)c1nc2ccccc2[nH]1		CHEMBL2086728	=	IC50	nM	24000.0	CHEMBL1868	Homo sapiens	IC50	nM	24000.0
	11019142	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	O=C1Nc2ccccc2C1=C(c1nc2ccccc2[nH]1)c1ccc(Cl)cc1Cl		CHEMBL2086729	=	IC50	nM	24400.0	CHEMBL1868	Homo sapiens	IC50	nM	24400.0
	11019143	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	COc1ccc(C(=C2C(=O)Nc3ccccc32)c2nc3ccccc3[nH]2)cc1		CHEMBL2086730	=	IC50	nM	984.0	CHEMBL1868	Homo sapiens	IC50	nM	984.0
	11019144	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCOc1ccc(C(=C2C(=O)Nc3ccccc32)c2nc3ccccc3[nH]2)cc1		CHEMBL2086731	=	IC50	nM	10543.0	CHEMBL1868	Homo sapiens	IC50	nM	10543.0
	11019145	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	Nc1ccc(C(=C2C(=O)Nc3ccccc32)c2nc3ccccc3[nH]2)cc1		CHEMBL2086732	=	IC50	nM	371.0	CHEMBL1868	Homo sapiens	IC50	nM	371.0
	11019146	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	O=C1Nc2ccc(Br)cc2C1=C(c1ccccc1)c1nc2ccccc2[nH]1		CHEMBL2086733	=	IC50	nM	118.0	CHEMBL1868	Homo sapiens	IC50	nM	118.0
	11019147	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	O=C1Nc2cc(Br)ccc2C1=C(c1ccccc1)c1nc2ccccc2[nH]1		CHEMBL2086734	=	IC50	nM	4544.0	CHEMBL1868	Homo sapiens	IC50	nM	4544.0
	11019148	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	O=C1Nc2c(Br)cccc2C1=C(c1ccccc1)c1nc2ccccc2[nH]1		CHEMBL2086735	=	IC50	nM	4880.0	CHEMBL1868	Homo sapiens	IC50	nM	4880.0
	11019149	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	O=C1Nc2ccc(C(=O)O)cc2C1=C(c1ccccc1)c1nc2ccccc2[nH]1		CHEMBL2086736	=	IC50	nM	39.0	CHEMBL1868	Homo sapiens	IC50	nM	39.0
	11019150	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	O=C1Nc2cc(C(=O)O)ccc2C1=C(c1ccccc1)c1nc2ccccc2[nH]1		CHEMBL2086737	=	IC50	nM	582.0	CHEMBL1868	Homo sapiens	IC50	nM	582.0
	11019151	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	O=C1Nc2c(C(=O)O)cccc2C1=C(c1ccccc1)c1nc2ccccc2[nH]1		CHEMBL2086738	=	IC50	nM	20716.0	CHEMBL1868	Homo sapiens	IC50	nM	20716.0
	11019152	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	Nc1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086739	=	IC50	nM	201.0	CHEMBL1868	Homo sapiens	IC50	nM	201.0
	11019153	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	Cc1ccc(C(=C2C(=O)Nc3ccc(C(=O)O)cc32)c2nc3ccccc3[nH]2)cc1		CHEMBL2086740	=	IC50	nM	45.0	CHEMBL1868	Homo sapiens	IC50	nM	45.0
	11019154	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	Cc1ccc(C(=C2C(=O)Nc3ccc(N)cc32)c2nc3ccccc3[nH]2)cc1		CHEMBL2086741	=	IC50	nM	473.0	CHEMBL1868	Homo sapiens	IC50	nM	473.0
	11019155	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	COc1ccc2[nH]c(C(=C3C(=O)Nc4ccc(C(=O)O)cc43)c3ccccc3)nc2c1		CHEMBL2086742	=	IC50	nM	77.0	CHEMBL1868	Homo sapiens	IC50	nM	77.0
	11019156	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	COc1ccc2[nH]c(C(=C3C(=O)Nc4ccc(N)cc43)c3ccccc3)nc2c1		CHEMBL2086743	=	IC50	nM	377.0	CHEMBL1868	Homo sapiens	IC50	nM	377.0
	11019157	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCCCNC(=O)c1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086744	=	IC50	nM	374.0	CHEMBL1868	Homo sapiens	IC50	nM	374.0
	11019158	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	COCCNC(=O)c1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086397	=	IC50	nM	381.0	CHEMBL1868	Homo sapiens	IC50	nM	381.0
	11019159	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CN1CCN(C(=O)c2ccc3c(c2)C(=C(c2ccccc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086745	=	IC50	nM	4322.0	CHEMBL1868	Homo sapiens	IC50	nM	4322.0
	11019160	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCCCNS(=O)(=O)c1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086746	=	IC50	nM	24400.0	CHEMBL1868	Homo sapiens	IC50	nM	24400.0
	11019161	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	COCCNS(=O)(=O)c1ccc2c(c1)C(=C(c1ccccc1)c1nc3ccccc3[nH]1)C(=O)N2		CHEMBL2086747	=	IC50	nM	1950.0	CHEMBL1868	Homo sapiens	IC50	nM	1950.0
	11019162	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CN1CCN(S(=O)(=O)c2ccc3c(c2)C(=C(c2ccccc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086748	=	IC50	nM	1950.0	CHEMBL1868	Homo sapiens	IC50	nM	1950.0
	11019163	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCN1CCC(Oc2ccc3c(c2)C(=C(c2ccccc2)c2nc4cc(OC)ccc4[nH]2)C(=O)N3)CC1		CHEMBL2086749	=	IC50	nM	691.0	CHEMBL1868	Homo sapiens	IC50	nM	691.0
	11019164	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCN1CCCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4cc(OC)ccc4[nH]2)C(=O)N3)C1		CHEMBL2086750	>	IC50	nM	1950.0	CHEMBL1868	Homo sapiens	IC50	nM	1950.0
	11019165	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4cc(OC)ccc4[nH]2)C(=O)N3)CC1		CHEMBL2086751	=	IC50	nM	163.0	CHEMBL1868	Homo sapiens	IC50	nM	163.0
	11019166	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	COCCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086752	=	IC50	nM	184.0	CHEMBL1868	Homo sapiens	IC50	nM	184.0
	11019167	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086753	=	IC50	nM	161.0	CHEMBL1868	Homo sapiens	IC50	nM	161.0
	11019168	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(C)cc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086754	=	IC50	nM	112.0	CHEMBL1868	Homo sapiens	IC50	nM	112.0
	11019169	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(OC)cc2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086755	=	IC50	nM	96.0	CHEMBL1868	Homo sapiens	IC50	nM	96.0
	11019170	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cccc(F)c2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086756	=	IC50	nM	62.0	CHEMBL1868	Homo sapiens	IC50	nM	62.0
	11019171	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cc(F)cc(F)c2)c2nc4ccccc4[nH]2)C(=O)N3)CC1		CHEMBL2086757	=	IC50	nM	66.0	CHEMBL1868	Homo sapiens	IC50	nM	66.0
	11019172	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccccc2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086758	=	IC50	nM	166.0	CHEMBL1868	Homo sapiens	IC50	nM	166.0
	11019173	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cccc(F)c2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086759	=	IC50	nM	25.0	CHEMBL1868	Homo sapiens	IC50	nM	25.0
	11019174	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2ccc(Cl)cc2)c2ncc[nH]2)C(=O)N3)CC1		CHEMBL2086760	=	IC50	nM	7.0	CHEMBL1868	Homo sapiens	IC50	nM	7.0
	11019175	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cccc(F)c2)c2nc(C)c[nH]2)C(=O)N3)CC1		CHEMBL2087167	=	IC50	nM	20.0	CHEMBL1868	Homo sapiens	IC50	nM	20.0
	11019176	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2cc(F)cc(F)c2)c2nc(C)c[nH]2)C(=O)N3)CC1		CHEMBL2087168	=	IC50	nM	11.0	CHEMBL1868	Homo sapiens	IC50	nM	11.0
	11019177	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	CCN1CCC(Nc2ccc3c(c2)C(=C(c2nc(C)c[nH]2)c2ccccc2F)C(=O)N3)CC1		CHEMBL2087169	=	IC50	nM	29.0	CHEMBL1868	Homo sapiens	IC50	nM	29.0
	11019178	CHEMBL2090041	Inhibition of N-terminal GST-tagged Flt1 using poly(Glu,Tyr) as substrate after 60 mins by alphascreen assay	B	O=C1Nc2ccccc2/C1=C/c1nc2ccccc2[nH]1		CHEMBL2087170	=	IC50	nM	405.0	CHEMBL1868	Homo sapiens	IC50	nM	405.0
	12036421	CHEMBL2150257	Inhibition of VEGFR1 after 5 mins	B	CC(C)(C(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(Cl)c4)c(Cl)c3)c21)S(C)(=O)=O.Cc1ccc(S(=O)(=O)O)cc1		CHEMBL2148053	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	nM	10000.0
	12046309	CHEMBL2156639	Inhibition of Flt1 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	1.6	CHEMBL1868	Homo sapiens	INH	%	1.6
	12081326	CHEMBL2167673	Inhibition of FLT1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	IC50	nM	31.0	CHEMBL1868	Homo sapiens	IC50	nM	31.0
	12138533	CHEMBL2186469	Inhibition of VEGFR1	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	=	IC50	nM	3.2	CHEMBL1868	Homo sapiens	IC50	nM	3.2
	12138534	CHEMBL2186469	Inhibition of VEGFR1	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	=	IC50	nM	59.0	CHEMBL1868	Homo sapiens	IC50	nM	59.0
	12138543	CHEMBL2186469	Inhibition of VEGFR1	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	IC50	nM	2.0	CHEMBL1868	Homo sapiens	IC50	nM	2.0
	12138548	CHEMBL2186469	Inhibition of VEGFR1	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	IC50	nM	110.0	CHEMBL1868	Homo sapiens	IC50	nM	110.0
	12138553	CHEMBL2186469	Inhibition of VEGFR1	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12.Cl		CHEMBL2180605	=	IC50	nM	7.0	CHEMBL1868	Homo sapiens	IC50	nM	7.0
	12138558	CHEMBL2186469	Inhibition of VEGFR1	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	IC50	nM	0.21	CHEMBL1868	Homo sapiens	IC50	nM	0.21
	12138563	CHEMBL2186469	Inhibition of VEGFR1	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	0.8	CHEMBL1868	Homo sapiens	IC50	nM	0.8
	12138566	CHEMBL2186469	Inhibition of VEGFR1	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	IC50	nM	5.0	CHEMBL1868	Homo sapiens	IC50	nM	5.0
	12173608	CHEMBL2213547	Inhibition of FLT1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL1868	Homo sapiens	Activity	%	100.0
	12175365	CHEMBL2211565	Inhibition of FLT1 at 1 uM	B	Cc1nn(C)cc1-c1nc2c(N3CCN(Cc4ccc(Cl)cc4)CC3)c(Cl)cnc2[nH]1		CHEMBL2207503	=	Inhibition	%	0.3	CHEMBL1868	Homo sapiens	INH	%	0.3
	12191218	CHEMBL2215712	Inhibition of VEGFR1 by AlphaScreen analysis	B	O=C(Nc1cccc(Oc2ccc3nccn3n2)c1)c1cccc(C(F)(F)F)c1		CHEMBL2206666	=	IC50	nM	8.4	CHEMBL1868	Homo sapiens	IC50	nM	8.4
	12193501	CHEMBL2215279	Inhibition of Flt1 at 100 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	87.1	CHEMBL1868	Homo sapiens	INH	%	87.1
	12193502	CHEMBL2215279	Inhibition of Flt1 at 100 uM	B	O=C1CC(c2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2207940	=	Inhibition	%	21.8	CHEMBL1868	Homo sapiens	INH	%	21.8
	12193799	CHEMBL2212839	Inhibition of FLT1	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)[C@H]1CCCN1		CHEMBL2208034	=	IC50	nM	910.5	CHEMBL1868	Homo sapiens	IC50	nM	910.5
	12195449	CHEMBL2210918	Inhibition of recombinant FLT1 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	=	Ki	nM	14.0	CHEMBL1868	Homo sapiens	Ki	nM	14.0
	12236760	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	102.0	CHEMBL1868	Homo sapiens	Residual Activity	%	102.0
	12236761	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	4.0	CHEMBL1868	Homo sapiens	Residual Activity	%	4.0
	12236762	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	99.0	CHEMBL1868	Homo sapiens	Residual Activity	%	99.0
	12236763	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	96.0	CHEMBL1868	Homo sapiens	Residual Activity	%	96.0
	12236764	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	87.0	CHEMBL1868	Homo sapiens	Residual Activity	%	87.0
	12236765	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	96.0	CHEMBL1868	Homo sapiens	Residual Activity	%	96.0
	12236766	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	22.0	CHEMBL1868	Homo sapiens	Residual Activity	%	22.0
	12236767	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	60.0	CHEMBL1868	Homo sapiens	Residual Activity	%	60.0
	12236768	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	40.0	CHEMBL1868	Homo sapiens	Residual Activity	%	40.0
	12236769	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	43.0	CHEMBL1868	Homo sapiens	Residual Activity	%	43.0
	12236770	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	94.0	CHEMBL1868	Homo sapiens	Residual Activity	%	94.0
	12236771	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	74.0	CHEMBL1868	Homo sapiens	Residual Activity	%	74.0
	12236772	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	86.0	CHEMBL1868	Homo sapiens	Residual Activity	%	86.0
	12236773	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	62.0	CHEMBL1868	Homo sapiens	Residual Activity	%	62.0
	12236774	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	93.0	CHEMBL1868	Homo sapiens	Residual Activity	%	93.0
	12236775	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	38.0	CHEMBL1868	Homo sapiens	Residual Activity	%	38.0
	12236776	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	105.0	CHEMBL1868	Homo sapiens	Residual Activity	%	105.0
	12236777	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	96.0	CHEMBL1868	Homo sapiens	Residual Activity	%	96.0
	12236778	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	72.0	CHEMBL1868	Homo sapiens	Residual Activity	%	72.0
	12236779	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	52.0	CHEMBL1868	Homo sapiens	Residual Activity	%	52.0
	12236780	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	83.0	CHEMBL1868	Homo sapiens	Residual Activity	%	83.0
	12236781	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	77.0	CHEMBL1868	Homo sapiens	Residual Activity	%	77.0
	12236782	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	97.0	CHEMBL1868	Homo sapiens	Residual Activity	%	97.0
	12236783	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12236784	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	119.0	CHEMBL1868	Homo sapiens	Residual Activity	%	119.0
	12236785	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	54.0	CHEMBL1868	Homo sapiens	Residual Activity	%	54.0
	12236786	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	20.0	CHEMBL1868	Homo sapiens	Residual Activity	%	20.0
	12236787	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	29.0	CHEMBL1868	Homo sapiens	Residual Activity	%	29.0
	12236788	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	56.0	CHEMBL1868	Homo sapiens	Residual Activity	%	56.0
	12236789	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	51.0	CHEMBL1868	Homo sapiens	Residual Activity	%	51.0
	12236790	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	36.0	CHEMBL1868	Homo sapiens	Residual Activity	%	36.0
	12236791	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12236792	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	103.0	CHEMBL1868	Homo sapiens	Residual Activity	%	103.0
	12236793	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	98.0	CHEMBL1868	Homo sapiens	Residual Activity	%	98.0
	12236794	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	94.0	CHEMBL1868	Homo sapiens	Residual Activity	%	94.0
	12236795	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	91.0	CHEMBL1868	Homo sapiens	Residual Activity	%	91.0
	12236796	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	62.0	CHEMBL1868	Homo sapiens	Residual Activity	%	62.0
	12236797	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	88.0	CHEMBL1868	Homo sapiens	Residual Activity	%	88.0
	12236798	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	86.0	CHEMBL1868	Homo sapiens	Residual Activity	%	86.0
	12236799	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	17.0	CHEMBL1868	Homo sapiens	Residual Activity	%	17.0
	12236800	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	115.0	CHEMBL1868	Homo sapiens	Residual Activity	%	115.0
	12236801	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	106.0	CHEMBL1868	Homo sapiens	Residual Activity	%	106.0
	12236802	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	4.0	CHEMBL1868	Homo sapiens	Residual Activity	%	4.0
	12236803	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	2.0	CHEMBL1868	Homo sapiens	Residual Activity	%	2.0
	12236804	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	5.0	CHEMBL1868	Homo sapiens	Residual Activity	%	5.0
	12236805	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	85.0	CHEMBL1868	Homo sapiens	Residual Activity	%	85.0
	12236806	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	97.0	CHEMBL1868	Homo sapiens	Residual Activity	%	97.0
	12236807	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	3.0	CHEMBL1868	Homo sapiens	Residual Activity	%	3.0
	12236808	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	115.0	CHEMBL1868	Homo sapiens	Residual Activity	%	115.0
	12236809	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	91.0	CHEMBL1868	Homo sapiens	Residual Activity	%	91.0
	12236810	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	2.0	CHEMBL1868	Homo sapiens	Residual Activity	%	2.0
	12236811	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	15.0	CHEMBL1868	Homo sapiens	Residual Activity	%	15.0
	12236812	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	1.0
	12236813	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	82.0	CHEMBL1868	Homo sapiens	Residual Activity	%	82.0
	12236814	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	98.0	CHEMBL1868	Homo sapiens	Residual Activity	%	98.0
	12236815	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	33.0	CHEMBL1868	Homo sapiens	Residual Activity	%	33.0
	12236816	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	101.0	CHEMBL1868	Homo sapiens	Residual Activity	%	101.0
	12236817	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	97.0	CHEMBL1868	Homo sapiens	Residual Activity	%	97.0
	12236818	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	13.0	CHEMBL1868	Homo sapiens	Residual Activity	%	13.0
	12236819	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	89.0	CHEMBL1868	Homo sapiens	Residual Activity	%	89.0
	12236820	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	55.0	CHEMBL1868	Homo sapiens	Residual Activity	%	55.0
	12236821	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	4.0	CHEMBL1868	Homo sapiens	Residual Activity	%	4.0
	12236822	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	96.0	CHEMBL1868	Homo sapiens	Residual Activity	%	96.0
	12236823	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	100.0	CHEMBL1868	Homo sapiens	Residual Activity	%	100.0
	12236824	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	103.0	CHEMBL1868	Homo sapiens	Residual Activity	%	103.0
	12236825	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	14.0	CHEMBL1868	Homo sapiens	Residual Activity	%	14.0
	12236826	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	86.0	CHEMBL1868	Homo sapiens	Residual Activity	%	86.0
	12236827	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	88.0	CHEMBL1868	Homo sapiens	Residual Activity	%	88.0
	12236828	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	88.0	CHEMBL1868	Homo sapiens	Residual Activity	%	88.0
	12236829	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	18.0	CHEMBL1868	Homo sapiens	Residual Activity	%	18.0
	12236830	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	85.0	CHEMBL1868	Homo sapiens	Residual Activity	%	85.0
	12236831	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	59.0	CHEMBL1868	Homo sapiens	Residual Activity	%	59.0
	12236832	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	14.0	CHEMBL1868	Homo sapiens	Residual Activity	%	14.0
	12236833	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	57.0	CHEMBL1868	Homo sapiens	Residual Activity	%	57.0
	12236834	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	4.0	CHEMBL1868	Homo sapiens	Residual Activity	%	4.0
	12236835	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	37.0	CHEMBL1868	Homo sapiens	Residual Activity	%	37.0
	12236836	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	92.0	CHEMBL1868	Homo sapiens	Residual Activity	%	92.0
	12236837	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	5.0	CHEMBL1868	Homo sapiens	Residual Activity	%	5.0
	12236838	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	95.0	CHEMBL1868	Homo sapiens	Residual Activity	%	95.0
	12236839	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12236840	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	95.0	CHEMBL1868	Homo sapiens	Residual Activity	%	95.0
	12236841	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	18.0	CHEMBL1868	Homo sapiens	Residual Activity	%	18.0
	12236842	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	30.0	CHEMBL1868	Homo sapiens	Residual Activity	%	30.0
	12236843	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	118.0	CHEMBL1868	Homo sapiens	Residual Activity	%	118.0
	12236844	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	67.0	CHEMBL1868	Homo sapiens	Residual Activity	%	67.0
	12236845	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	109.0	CHEMBL1868	Homo sapiens	Residual Activity	%	109.0
	12236846	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	107.0	CHEMBL1868	Homo sapiens	Residual Activity	%	107.0
	12236847	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	101.0	CHEMBL1868	Homo sapiens	Residual Activity	%	101.0
	12236848	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	95.0	CHEMBL1868	Homo sapiens	Residual Activity	%	95.0
	12236849	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	1.0
	12236850	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	90.0	CHEMBL1868	Homo sapiens	Residual Activity	%	90.0
	12236851	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	71.0	CHEMBL1868	Homo sapiens	Residual Activity	%	71.0
	12236852	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12236853	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	100.0	CHEMBL1868	Homo sapiens	Residual Activity	%	100.0
	12236854	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	100.0	CHEMBL1868	Homo sapiens	Residual Activity	%	100.0
	12236855	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	102.0	CHEMBL1868	Homo sapiens	Residual Activity	%	102.0
	12236856	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	102.0	CHEMBL1868	Homo sapiens	Residual Activity	%	102.0
	12236857	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	96.0	CHEMBL1868	Homo sapiens	Residual Activity	%	96.0
	12236858	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	96.0	CHEMBL1868	Homo sapiens	Residual Activity	%	96.0
	12236859	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	86.0	CHEMBL1868	Homo sapiens	Residual Activity	%	86.0
	12236860	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	16.0	CHEMBL1868	Homo sapiens	Residual Activity	%	16.0
	12236861	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12236862	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	101.0	CHEMBL1868	Homo sapiens	Residual Activity	%	101.0
	12236863	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	7.0	CHEMBL1868	Homo sapiens	Residual Activity	%	7.0
	12236864	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	49.0	CHEMBL1868	Homo sapiens	Residual Activity	%	49.0
	12236865	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	94.0	CHEMBL1868	Homo sapiens	Residual Activity	%	94.0
	12236866	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	97.0	CHEMBL1868	Homo sapiens	Residual Activity	%	97.0
	12236867	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	79.0	CHEMBL1868	Homo sapiens	Residual Activity	%	79.0
	12236868	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	92.0	CHEMBL1868	Homo sapiens	Residual Activity	%	92.0
	12236869	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	77.0	CHEMBL1868	Homo sapiens	Residual Activity	%	77.0
	12236870	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	77.0	CHEMBL1868	Homo sapiens	Residual Activity	%	77.0
	12236871	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	89.0	CHEMBL1868	Homo sapiens	Residual Activity	%	89.0
	12236872	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	24.0	CHEMBL1868	Homo sapiens	Residual Activity	%	24.0
	12236873	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	88.0	CHEMBL1868	Homo sapiens	Residual Activity	%	88.0
	12236874	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	82.0	CHEMBL1868	Homo sapiens	Residual Activity	%	82.0
	12236875	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	85.0	CHEMBL1868	Homo sapiens	Residual Activity	%	85.0
	12236876	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	17.0	CHEMBL1868	Homo sapiens	Residual Activity	%	17.0
	12236877	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	100.0	CHEMBL1868	Homo sapiens	Residual Activity	%	100.0
	12236878	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	94.0	CHEMBL1868	Homo sapiens	Residual Activity	%	94.0
	12236879	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	110.0	CHEMBL1868	Homo sapiens	Residual Activity	%	110.0
	12236880	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	43.0	CHEMBL1868	Homo sapiens	Residual Activity	%	43.0
	12236881	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	63.0	CHEMBL1868	Homo sapiens	Residual Activity	%	63.0
	12236882	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	68.0	CHEMBL1868	Homo sapiens	Residual Activity	%	68.0
	12236883	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	26.0	CHEMBL1868	Homo sapiens	Residual Activity	%	26.0
	12236884	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	1.0
	12236885	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	103.0	CHEMBL1868	Homo sapiens	Residual Activity	%	103.0
	12236886	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	88.0	CHEMBL1868	Homo sapiens	Residual Activity	%	88.0
	12236887	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	99.0	CHEMBL1868	Homo sapiens	Residual Activity	%	99.0
	12236888	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	44.0	CHEMBL1868	Homo sapiens	Residual Activity	%	44.0
	12236889	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12236890	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	88.0	CHEMBL1868	Homo sapiens	Residual Activity	%	88.0
	12236891	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	74.0	CHEMBL1868	Homo sapiens	Residual Activity	%	74.0
	12236892	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	26.0	CHEMBL1868	Homo sapiens	Residual Activity	%	26.0
	12236893	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	96.0	CHEMBL1868	Homo sapiens	Residual Activity	%	96.0
	12236894	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12236895	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	69.0	CHEMBL1868	Homo sapiens	Residual Activity	%	69.0
	12236896	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	89.0	CHEMBL1868	Homo sapiens	Residual Activity	%	89.0
	12236897	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	33.0	CHEMBL1868	Homo sapiens	Residual Activity	%	33.0
	12236898	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	-1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	-1.0
	12236899	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	75.0	CHEMBL1868	Homo sapiens	Residual Activity	%	75.0
	12236900	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	83.0	CHEMBL1868	Homo sapiens	Residual Activity	%	83.0
	12236901	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	86.0	CHEMBL1868	Homo sapiens	Residual Activity	%	86.0
	12236902	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	92.0	CHEMBL1868	Homo sapiens	Residual Activity	%	92.0
	12236903	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12236904	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	82.0	CHEMBL1868	Homo sapiens	Residual Activity	%	82.0
	12236905	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	90.0	CHEMBL1868	Homo sapiens	Residual Activity	%	90.0
	12236906	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	24.0	CHEMBL1868	Homo sapiens	Residual Activity	%	24.0
	12236907	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	78.0	CHEMBL1868	Homo sapiens	Residual Activity	%	78.0
	12236908	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	89.0	CHEMBL1868	Homo sapiens	Residual Activity	%	89.0
	12236909	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	98.0	CHEMBL1868	Homo sapiens	Residual Activity	%	98.0
	12236910	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	22.0	CHEMBL1868	Homo sapiens	Residual Activity	%	22.0
	12236911	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	92.0	CHEMBL1868	Homo sapiens	Residual Activity	%	92.0
	12236912	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	86.0	CHEMBL1868	Homo sapiens	Residual Activity	%	86.0
	12236913	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	41.0	CHEMBL1868	Homo sapiens	Residual Activity	%	41.0
	12236914	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	104.0	CHEMBL1868	Homo sapiens	Residual Activity	%	104.0
	12236915	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	54.0	CHEMBL1868	Homo sapiens	Residual Activity	%	54.0
	12236916	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	83.0	CHEMBL1868	Homo sapiens	Residual Activity	%	83.0
	12236917	CHEMBL2219076	Millipore: Percentage of residual kinase activity of FLT1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	14.0	CHEMBL1868	Homo sapiens	Residual Activity	%	14.0
	12236918	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	82.0	CHEMBL1868	Homo sapiens	Residual Activity	%	82.0
	12236919	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	1.0
	12236920	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	61.0	CHEMBL1868	Homo sapiens	Residual Activity	%	61.0
	12236921	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	91.0	CHEMBL1868	Homo sapiens	Residual Activity	%	91.0
	12239527	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	58.0	CHEMBL1868	Homo sapiens	Residual Activity	%	58.0
	12239528	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	88.0	CHEMBL1868	Homo sapiens	Residual Activity	%	88.0
	12239529	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	9.0	CHEMBL1868	Homo sapiens	Residual Activity	%	9.0
	12239530	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	16.0	CHEMBL1868	Homo sapiens	Residual Activity	%	16.0
	12239531	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	3.0	CHEMBL1868	Homo sapiens	Residual Activity	%	3.0
	12239532	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	18.0	CHEMBL1868	Homo sapiens	Residual Activity	%	18.0
	12239533	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	101.0	CHEMBL1868	Homo sapiens	Residual Activity	%	101.0
	12239534	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	90.0	CHEMBL1868	Homo sapiens	Residual Activity	%	90.0
	12239535	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	83.0	CHEMBL1868	Homo sapiens	Residual Activity	%	83.0
	12239536	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	14.0	CHEMBL1868	Homo sapiens	Residual Activity	%	14.0
	12239537	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	64.0	CHEMBL1868	Homo sapiens	Residual Activity	%	64.0
	12239538	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	15.0	CHEMBL1868	Homo sapiens	Residual Activity	%	15.0
	12239539	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	83.0	CHEMBL1868	Homo sapiens	Residual Activity	%	83.0
	12239540	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	47.0	CHEMBL1868	Homo sapiens	Residual Activity	%	47.0
	12239541	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	81.0	CHEMBL1868	Homo sapiens	Residual Activity	%	81.0
	12239542	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	43.0	CHEMBL1868	Homo sapiens	Residual Activity	%	43.0
	12239543	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	86.0	CHEMBL1868	Homo sapiens	Residual Activity	%	86.0
	12239544	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	66.0	CHEMBL1868	Homo sapiens	Residual Activity	%	66.0
	12239545	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	91.0	CHEMBL1868	Homo sapiens	Residual Activity	%	91.0
	12239546	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	2.0	CHEMBL1868	Homo sapiens	Residual Activity	%	2.0
	12239547	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	94.0	CHEMBL1868	Homo sapiens	Residual Activity	%	94.0
	12239548	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	6.0	CHEMBL1868	Homo sapiens	Residual Activity	%	6.0
	12239549	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	2.0	CHEMBL1868	Homo sapiens	Residual Activity	%	2.0
	12239550	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	4.0	CHEMBL1868	Homo sapiens	Residual Activity	%	4.0
	12239551	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	21.0	CHEMBL1868	Homo sapiens	Residual Activity	%	21.0
	12239552	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	11.0	CHEMBL1868	Homo sapiens	Residual Activity	%	11.0
	12239553	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	7.0	CHEMBL1868	Homo sapiens	Residual Activity	%	7.0
	12239554	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	-1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	-1.0
	12239555	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	86.0	CHEMBL1868	Homo sapiens	Residual Activity	%	86.0
	12239556	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	95.0	CHEMBL1868	Homo sapiens	Residual Activity	%	95.0
	12239557	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	99.0	CHEMBL1868	Homo sapiens	Residual Activity	%	99.0
	12239558	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	82.0	CHEMBL1868	Homo sapiens	Residual Activity	%	82.0
	12239559	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	15.0	CHEMBL1868	Homo sapiens	Residual Activity	%	15.0
	12239560	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	96.0	CHEMBL1868	Homo sapiens	Residual Activity	%	96.0
	12239561	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	84.0	CHEMBL1868	Homo sapiens	Residual Activity	%	84.0
	12239562	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	20.0	CHEMBL1868	Homo sapiens	Residual Activity	%	20.0
	12239563	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	112.0	CHEMBL1868	Homo sapiens	Residual Activity	%	112.0
	12239564	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	97.0	CHEMBL1868	Homo sapiens	Residual Activity	%	97.0
	12239565	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	4.0	CHEMBL1868	Homo sapiens	Residual Activity	%	4.0
	12239566	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12239567	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12239568	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	63.0	CHEMBL1868	Homo sapiens	Residual Activity	%	63.0
	12239569	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	92.0	CHEMBL1868	Homo sapiens	Residual Activity	%	92.0
	12239570	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12239571	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	89.0	CHEMBL1868	Homo sapiens	Residual Activity	%	89.0
	12239572	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	80.0	CHEMBL1868	Homo sapiens	Residual Activity	%	80.0
	12239573	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12239574	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12239575	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12239576	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	63.0	CHEMBL1868	Homo sapiens	Residual Activity	%	63.0
	12239577	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	84.0	CHEMBL1868	Homo sapiens	Residual Activity	%	84.0
	12239578	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	48.0	CHEMBL1868	Homo sapiens	Residual Activity	%	48.0
	12239579	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	72.0	CHEMBL1868	Homo sapiens	Residual Activity	%	72.0
	12239580	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	98.0	CHEMBL1868	Homo sapiens	Residual Activity	%	98.0
	12239581	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	1.0
	12239582	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	85.0	CHEMBL1868	Homo sapiens	Residual Activity	%	85.0
	12239583	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	1.0
	12239584	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	1.0
	12239585	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	90.0	CHEMBL1868	Homo sapiens	Residual Activity	%	90.0
	12239586	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	93.0	CHEMBL1868	Homo sapiens	Residual Activity	%	93.0
	12239587	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	96.0	CHEMBL1868	Homo sapiens	Residual Activity	%	96.0
	12239588	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	2.0	CHEMBL1868	Homo sapiens	Residual Activity	%	2.0
	12239589	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	95.0	CHEMBL1868	Homo sapiens	Residual Activity	%	95.0
	12239590	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	95.0	CHEMBL1868	Homo sapiens	Residual Activity	%	95.0
	12239591	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	78.0	CHEMBL1868	Homo sapiens	Residual Activity	%	78.0
	12239592	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	4.0	CHEMBL1868	Homo sapiens	Residual Activity	%	4.0
	12239593	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	83.0	CHEMBL1868	Homo sapiens	Residual Activity	%	83.0
	12239594	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	6.0	CHEMBL1868	Homo sapiens	Residual Activity	%	6.0
	12239595	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	1.0
	12239596	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	27.0	CHEMBL1868	Homo sapiens	Residual Activity	%	27.0
	12239597	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12239598	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	13.0	CHEMBL1868	Homo sapiens	Residual Activity	%	13.0
	12239599	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	85.0	CHEMBL1868	Homo sapiens	Residual Activity	%	85.0
	12239600	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12239601	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	67.0	CHEMBL1868	Homo sapiens	Residual Activity	%	67.0
	12239602	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	-1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	-1.0
	12239603	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	95.0	CHEMBL1868	Homo sapiens	Residual Activity	%	95.0
	12239604	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	2.0	CHEMBL1868	Homo sapiens	Residual Activity	%	2.0
	12239605	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	17.0	CHEMBL1868	Homo sapiens	Residual Activity	%	17.0
	12239606	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	108.0	CHEMBL1868	Homo sapiens	Residual Activity	%	108.0
	12239607	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	56.0	CHEMBL1868	Homo sapiens	Residual Activity	%	56.0
	12239608	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	100.0	CHEMBL1868	Homo sapiens	Residual Activity	%	100.0
	12239609	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	80.0	CHEMBL1868	Homo sapiens	Residual Activity	%	80.0
	12239610	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	39.0	CHEMBL1868	Homo sapiens	Residual Activity	%	39.0
	12239611	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	85.0	CHEMBL1868	Homo sapiens	Residual Activity	%	85.0
	12239612	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12239613	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	77.0	CHEMBL1868	Homo sapiens	Residual Activity	%	77.0
	12239614	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	23.0	CHEMBL1868	Homo sapiens	Residual Activity	%	23.0
	12239615	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	1.0
	12239616	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	95.0	CHEMBL1868	Homo sapiens	Residual Activity	%	95.0
	12239617	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	50.0	CHEMBL1868	Homo sapiens	Residual Activity	%	50.0
	12239618	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	75.0	CHEMBL1868	Homo sapiens	Residual Activity	%	75.0
	12239619	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	106.0	CHEMBL1868	Homo sapiens	Residual Activity	%	106.0
	12239620	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	100.0	CHEMBL1868	Homo sapiens	Residual Activity	%	100.0
	12239621	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	91.0	CHEMBL1868	Homo sapiens	Residual Activity	%	91.0
	12239622	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	80.0	CHEMBL1868	Homo sapiens	Residual Activity	%	80.0
	12239623	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	3.0	CHEMBL1868	Homo sapiens	Residual Activity	%	3.0
	12239624	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12239625	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	92.0	CHEMBL1868	Homo sapiens	Residual Activity	%	92.0
	12239626	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	4.0	CHEMBL1868	Homo sapiens	Residual Activity	%	4.0
	12239627	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	24.0	CHEMBL1868	Homo sapiens	Residual Activity	%	24.0
	12239628	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	87.0	CHEMBL1868	Homo sapiens	Residual Activity	%	87.0
	12239629	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	81.0	CHEMBL1868	Homo sapiens	Residual Activity	%	81.0
	12239630	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	67.0	CHEMBL1868	Homo sapiens	Residual Activity	%	67.0
	12239631	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	94.0	CHEMBL1868	Homo sapiens	Residual Activity	%	94.0
	12239632	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	39.0	CHEMBL1868	Homo sapiens	Residual Activity	%	39.0
	12239633	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	46.0	CHEMBL1868	Homo sapiens	Residual Activity	%	46.0
	12239634	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	60.0	CHEMBL1868	Homo sapiens	Residual Activity	%	60.0
	12239635	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	11.0	CHEMBL1868	Homo sapiens	Residual Activity	%	11.0
	12239636	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	38.0	CHEMBL1868	Homo sapiens	Residual Activity	%	38.0
	12239637	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	39.0	CHEMBL1868	Homo sapiens	Residual Activity	%	39.0
	12239638	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	73.0	CHEMBL1868	Homo sapiens	Residual Activity	%	73.0
	12239639	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	2.0	CHEMBL1868	Homo sapiens	Residual Activity	%	2.0
	12239640	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	92.0	CHEMBL1868	Homo sapiens	Residual Activity	%	92.0
	12239641	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	34.0	CHEMBL1868	Homo sapiens	Residual Activity	%	34.0
	12239642	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	75.0	CHEMBL1868	Homo sapiens	Residual Activity	%	75.0
	12239643	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	11.0	CHEMBL1868	Homo sapiens	Residual Activity	%	11.0
	12239644	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	15.0	CHEMBL1868	Homo sapiens	Residual Activity	%	15.0
	12239645	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	30.0	CHEMBL1868	Homo sapiens	Residual Activity	%	30.0
	12239646	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	19.0	CHEMBL1868	Homo sapiens	Residual Activity	%	19.0
	12239647	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12239648	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	85.0	CHEMBL1868	Homo sapiens	Residual Activity	%	85.0
	12239649	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	43.0	CHEMBL1868	Homo sapiens	Residual Activity	%	43.0
	12239650	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	77.0	CHEMBL1868	Homo sapiens	Residual Activity	%	77.0
	12239651	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	32.0	CHEMBL1868	Homo sapiens	Residual Activity	%	32.0
	12239652	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	-1.0
	12239653	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	55.0	CHEMBL1868	Homo sapiens	Residual Activity	%	55.0
	12239654	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	49.0	CHEMBL1868	Homo sapiens	Residual Activity	%	49.0
	12239655	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	2.0	CHEMBL1868	Homo sapiens	Residual Activity	%	2.0
	12239656	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	84.0	CHEMBL1868	Homo sapiens	Residual Activity	%	84.0
	12239657	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12239658	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	10.0	CHEMBL1868	Homo sapiens	Residual Activity	%	10.0
	12239659	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	66.0	CHEMBL1868	Homo sapiens	Residual Activity	%	66.0
	12239660	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	2.0	CHEMBL1868	Homo sapiens	Residual Activity	%	2.0
	12239661	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	1.0
	12239662	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	52.0	CHEMBL1868	Homo sapiens	Residual Activity	%	52.0
	12239663	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	38.0	CHEMBL1868	Homo sapiens	Residual Activity	%	38.0
	12239664	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	35.0	CHEMBL1868	Homo sapiens	Residual Activity	%	35.0
	12239665	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	81.0	CHEMBL1868	Homo sapiens	Residual Activity	%	81.0
	12239666	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	0.0	CHEMBL1868	Homo sapiens	Residual Activity	%	0.0
	12239667	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	70.0	CHEMBL1868	Homo sapiens	Residual Activity	%	70.0
	12239668	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	82.0	CHEMBL1868	Homo sapiens	Residual Activity	%	82.0
	12239669	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	1.0
	12239670	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	33.0	CHEMBL1868	Homo sapiens	Residual Activity	%	33.0
	12239671	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	35.0	CHEMBL1868	Homo sapiens	Residual Activity	%	35.0
	12239672	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	87.0	CHEMBL1868	Homo sapiens	Residual Activity	%	87.0
	12239673	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	1.0	CHEMBL1868	Homo sapiens	Residual Activity	%	1.0
	12239674	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	67.0	CHEMBL1868	Homo sapiens	Residual Activity	%	67.0
	12239675	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	72.0	CHEMBL1868	Homo sapiens	Residual Activity	%	72.0
	12239676	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	46.0	CHEMBL1868	Homo sapiens	Residual Activity	%	46.0
	12239677	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	96.0	CHEMBL1868	Homo sapiens	Residual Activity	%	96.0
	12239678	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	26.0	CHEMBL1868	Homo sapiens	Residual Activity	%	26.0
	12239679	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	26.0	CHEMBL1868	Homo sapiens	Residual Activity	%	26.0
	12239680	CHEMBL2219077	Millipore: Percentage of residual kinase activity of FLT1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	7.0	CHEMBL1868	Homo sapiens	Residual Activity	%	7.0
	12626724	CHEMBL2316997	Inhibition of VEGFR1 (unknown origin) at 1 uM	B	COc1cc(Nc2ncc(Cl)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)CC1		CHEMBL2312140	>	Inhibition	%	95.0	CHEMBL1868	Homo sapiens	INH	%	95.0
	12670834	CHEMBL2346204	Inhibition of FLT1 (unknown origin) at 100 uM after 60 mins by ELISA relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	87.1	CHEMBL1868	Homo sapiens	INH	%	87.1
	12670835	CHEMBL2346204	Inhibition of FLT1 (unknown origin) at 100 uM after 60 mins by ELISA relative to control	B	O=C1CC(Cc2ccccc2)Sc2ccccc2N1Cc1ccccc1[N+](=O)[O-]		CHEMBL2334795	=	Inhibition	%	0.6	CHEMBL1868	Homo sapiens	INH	%	0.6
	12691972	CHEMBL2339395	Inhibition of recombinant PlGF-1/VEGFR-1 (unknown origin) interaction after 1 hr by ELISA	B	Oc1ccc([C@@H]2C[C@@H](c3c(O)cc(O)c4c3O[C@H](c3ccc(O)cc3)[C@@H](O)C4)c3c(O)cc(O)cc3O2)cc1		CHEMBL2335722	=	IC50	nM	15000.0	CHEMBL1868	Homo sapiens	IC50	uM	15.0
	12692003	CHEMBL2339394	Inhibition of recombinant VEGF-A/VEGFR-1 (unknown origin) interaction after 1 hr by ELISA	B	Oc1ccc([C@H]2Oc3c(c(O)cc4c3[C@H]3c5c(O)cc(O)cc5O[C@@](c5ccc(O)c(O)c5)(O4)[C@@H]3O)C[C@@H]2O)cc1		CHEMBL499587	=	IC50	nM	65000.0	CHEMBL1868	Homo sapiens	IC50	uM	65.0
	12692004	CHEMBL2339394	Inhibition of recombinant VEGF-A/VEGFR-1 (unknown origin) interaction after 1 hr by ELISA	B	Oc1ccc([C@@H]2C[C@@H](c3c(O)cc(O)c4c3O[C@H](c3ccc(O)cc3)[C@@H](O)C4)c3c(O)cc(O)cc3O2)cc1		CHEMBL2335722	=	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	uM	50.0
Dose-dependent effect	12692005	CHEMBL2339395	Inhibition of recombinant PlGF-1/VEGFR-1 (unknown origin) interaction after 1 hr by ELISA	B	Oc1ccc([C@@H]2C[C@@H](c3c(O)cc(O)c4c3O[C@H](c3ccc(O)cc3)[C@@H](O)C4)c3c(O)cc(O)cc3O2)cc1		CHEMBL2335722		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	12692736	CHEMBL2343082	Ratio of compound IC50 to CB676475 IC50 for VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 by phosphotyrosine ELISA cytoblot analysis	B	CC(C)(C)C(=O)Nc1nc(Nc2ccc(F)c(C(F)(F)F)c2)c2cc(CCc3ccccn3)[nH]c2n1		CHEMBL2335019	=	Ratio IC50		5.0	CHEMBL1868	Homo sapiens	Ratio IC50		5.0
	12692737	CHEMBL2343082	Ratio of compound IC50 to CB676475 IC50 for VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 by phosphotyrosine ELISA cytoblot analysis	B	CC(C)(C)C(=O)Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(CCc3ccccn3)[nH]c2n1		CHEMBL2335018	=	Ratio IC50		5.0	CHEMBL1868	Homo sapiens	Ratio IC50		5.0
	12692738	CHEMBL2343082	Ratio of compound IC50 to CB676475 IC50 for VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 by phosphotyrosine ELISA cytoblot analysis	B	C#Cc1cccc(Nc2nc(NC(=O)C(C)(C)C)nc3[nH]c(CCc4ccccn4)cc23)c1		CHEMBL2335017	=	Ratio IC50		5.0	CHEMBL1868	Homo sapiens	Ratio IC50		5.0
	12692739	CHEMBL2343082	Ratio of compound IC50 to CB676475 IC50 for VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 by phosphotyrosine ELISA cytoblot analysis	B	C#Cc1cccc(Nc2nc(N)nc3[nH]c(CCc4ccccn4)cc23)c1		CHEMBL2335379	=	Ratio IC50		5.0	CHEMBL1868	Homo sapiens	Ratio IC50		5.0
	12692740	CHEMBL2343082	Ratio of compound IC50 to CB676475 IC50 for VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 by phosphotyrosine ELISA cytoblot analysis	B	Nc1nc(Nc2ccc(F)c(Br)c2)c2cc(CCc3ccccn3)[nH]c2n1		CHEMBL2335377	=	Ratio IC50		5.0	CHEMBL1868	Homo sapiens	Ratio IC50		5.0
	12692748	CHEMBL2343568	Inhibition of VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	Nc1nc(Nc2cccc(Br)c2)c2cc(CCc3ccccn3)[nH]c2n1		CHEMBL2335376	>	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	uM	50.0
	12692751	CHEMBL2343568	Inhibition of VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	CC(C)(C)C(=O)Nc1nc(Nc2ccc(F)c(Cl)c2)c2cc(CCc3ccccn3)[nH]c2n1	Outside typical range	CHEMBL2335016	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	12692752	CHEMBL2343568	Inhibition of VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	CC(C)(C)C(=O)Nc1nc(Nc2ccc(F)c(Br)c2)c2cc(CCc3ccccn3)[nH]c2n1	Outside typical range	CHEMBL2335015	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	12692753	CHEMBL2343568	Inhibition of VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	Nc1nc(Nc2ccc(F)c(C(F)(F)F)c2)c2cc(CCc3ccccn3)[nH]c2n1	Outside typical range	CHEMBL2335014	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	12692754	CHEMBL2343568	Inhibition of VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(CCc3ccccn3)[nH]c2n1	Outside typical range	CHEMBL2335013	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	12692755	CHEMBL2343568	Inhibition of VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	Nc1nc(Nc2ccc(F)c(Cl)c2)c2cc(CCc3ccccn3)[nH]c2n1	Outside typical range	CHEMBL2335378	>	IC50	nM	200000.0	CHEMBL1868	Homo sapiens	IC50	uM	200.0
	12692759	CHEMBL2343568	Inhibition of VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	CC(C)(C)C(=O)Nc1nc(Nc2ccc(F)c(C(F)(F)F)c2)c2cc(CCc3ccccn3)[nH]c2n1	Outside typical range	CHEMBL2335019	=	IC50	nM	189600.0	CHEMBL1868	Homo sapiens	IC50	uM	189.6
	12692761	CHEMBL2343568	Inhibition of VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	C#Cc1cccc(Nc2nc(NC(=O)C(C)(C)C)nc3[nH]c(CCc4ccccn4)cc23)c1	Outside typical range	CHEMBL2335017	=	IC50	nM	156300.0	CHEMBL1868	Homo sapiens	IC50	uM	156.3
	12692763	CHEMBL2343568	Inhibition of VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	CC(C)(C)C(=O)Nc1nc(Nc2cccc(C(F)(F)F)c2)c2cc(CCc3ccccn3)[nH]c2n1	Outside typical range	CHEMBL2335018	=	IC50	nM	129600.0	CHEMBL1868	Homo sapiens	IC50	uM	129.6
	12692768	CHEMBL2343568	Inhibition of VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	C#Cc1cccc(Nc2nc(N)nc3[nH]c(CCc4ccccn4)cc23)c1	Outside typical range	CHEMBL2335379	=	IC50	nM	103100.0	CHEMBL1868	Homo sapiens	IC50	uM	103.1
	12692769	CHEMBL2343568	Inhibition of VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	Nc1nc(Nc2ccc(F)c(Br)c2)c2cc(CCc3ccccn3)[nH]c2n1		CHEMBL2335377	=	IC50	nM	93600.0	CHEMBL1868	Homo sapiens	IC50	uM	93.6
	12692788	CHEMBL2343568	Inhibition of VEGF-induced VEGFR1 phosphorylation in human A498 cells overexpressing Flt-1 pretreated for 60 mins prior to VEGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis	B	COc1cc2ncnc(Nc3ccc(Cl)cc3F)c2cc1OC		CHEMBL150315	=	IC50	nM	14100.0	CHEMBL1868	Homo sapiens	IC50	uM	14.1
	12693290	CHEMBL2341964	Inhibition of FLT1 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	3500.0	CHEMBL1868	Homo sapiens	IC50	nM	3500.0
	12697477	CHEMBL2343631	Inhibition of GST-Flt1 kinase domain (unknown origin) expressed in baculovirus infected Sf9 cells after 20 mins by scintillation counting	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	3000.0	CHEMBL1868	Homo sapiens	IC50	uM	3.0
	12697481	CHEMBL2343156	Ratio of inhibition of ligand-induced phosphorylation of Flt-1 (unknown origin) overexpressed in NIH-3T3 cells to inhibition of GST-Flt1 kinase domain (unknown origin) expressed in baculovirus infected Sf9 cells	B	NC(=O)C1=C(N)C(=O)C=C(Nc2ccccc2O)C1=O		CHEMBL2332119	=	Ratio		100.0	CHEMBL1868	Homo sapiens	Ratio		100.0
Active	12697482	CHEMBL2343157	Inhibition of ligand-induced phosphorylation of Flt-1 (unknown origin) overexpressed in NIH-3T3 cells at 10 uM after 2 hrs by immunoblotting	B	NC(=O)C1=C(N)C(=O)C=C(Nc2ccccc2O)C1=O		CHEMBL2332119		Activity			CHEMBL1868	Homo sapiens	Activity		
	12697489	CHEMBL2343631	Inhibition of GST-Flt1 kinase domain (unknown origin) expressed in baculovirus infected Sf9 cells after 20 mins by scintillation counting	B	NC(=O)C1=C(N)C(=O)C=C(Nc2ccccc2O)C1=O		CHEMBL2332119	=	IC50	nM	18.0	CHEMBL1868	Homo sapiens	IC50	uM	0.018
	12728078	CHEMBL2351293	Inhibition of VEGFR1 (unknown origin) incubated for 5 mins prior to ATP addition measured after 5 mins by Alphascreen assay	B	O=C(NCCO)C1=Cc2c(ncnc2Nc2ccc(Oc3cccc4sccc34)c(Cl)c2)NCC1		CHEMBL2348417	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	nM	10000.0
	12728828	CHEMBL2352901	Inhibition of FLT1 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	99.0	CHEMBL1868	Homo sapiens	Activity	%	99.0
	12729073	CHEMBL2352251	Inhibition of FLT1 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL1868	Homo sapiens	Activity	%	98.0
	12729956	CHEMBL2352192	Inhibition of FLT1 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	89.0	CHEMBL1868	Homo sapiens	Activity	%	89.0
	12730216	CHEMBL2352901	Inhibition of FLT1 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	89.0	CHEMBL1868	Homo sapiens	Activity	%	89.0
	12730629	CHEMBL2353588	Inhibition of VEGFR1 (unknown origin) by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	=	IC50	nM	3.2	CHEMBL1868	Homo sapiens	IC50	nM	3.2
	13293018	CHEMBL2379874	Inhibition of FLT1 (unknown origin)	B	C[C@@H](Oc1c[nH]c(=O)c(C(=O)Nc2ccc(N3CCN(C)CC3)cc2)c1)c1c(Cl)ccc(F)c1Cl		CHEMBL2376650	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
Active	13294869	CHEMBL2379171	Inhibition of VEGFR1 phosphorylation in growth factor-stimulated HUVEC	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Active	13294877	CHEMBL2379179	Inhibition of VEGFR1 phosphorylation in growth factor-stimulated HUVEC at 3 uM after 24 hrs	B	O=C(O)C(O)C(O)C(=O)O.O=c1[nH]c(CN2CCCCC2)nc2cc(-c3cn(Cc4ccccc4)c4ccccc34)sc12		CHEMBL2377454		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	13327680	CHEMBL2389836	Inhibition of FLT1 (unknown origin) at 1 uM	B	CC(C)(C)c1cc(NC(=O)NCc2ccc(-c3cc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)[nH]n3)cc2)no1		CHEMBL2386802	=	Inhibition	%	99.0	CHEMBL1868	Homo sapiens	INH	%	99.0
	13327681	CHEMBL2389836	Inhibition of FLT1 (unknown origin) at 1 uM	B	Cc1cc(-c2cc(NC(=O)c3ccc(CN4CCN(C)CC4)cc3)[nH]n2)ccc1NC(=O)Nc1cc(C(C)(C)C)on1		CHEMBL2386796	=	Inhibition	%	90.0	CHEMBL1868	Homo sapiens	INH	%	90.0
Not Active	13349234	CHEMBL2399728	Inhibition of recombinant FLT-1 (unknown origin) at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1		CHEMBL2397148		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	13349235	CHEMBL2399728	Inhibition of recombinant FLT-1 (unknown origin) at 10 uM	B	O=C(NC12CC3CC(CC(C3)C1)C2)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1		CHEMBL242459		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	13375860	CHEMBL2405124	Inhibition of VEGFR1 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-10.0	CHEMBL1868	Homo sapiens	INH	%	-10.0
Active	13376815	CHEMBL2404400	Inhibition of FLT1 (unknown origin) at 0.5 uM	B	COc1cc(Nc2ncc(Br)c(-c3cccc(CC#N)c3)n2)ccc1N1CCN(C)[C@@H](C)C1		CHEMBL2403079		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	13389893	CHEMBL2410839	Inhibition of VEGFR1 (unknown origin) using biotinylated poly-GluTyr as substrate by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)ccc2F)n(C)n1		CHEMBL2409778	=	IC50	nM	3.6	CHEMBL1868	Homo sapiens	IC50	nM	3.6
	13389961	CHEMBL2410839	Inhibition of VEGFR1 (unknown origin) using biotinylated poly-GluTyr as substrate by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)sc4c3)c2)n(C)n1		CHEMBL2409790	=	IC50	nM	69.0	CHEMBL1868	Homo sapiens	IC50	nM	69.0
	13389962	CHEMBL2410839	Inhibition of VEGFR1 (unknown origin) using biotinylated poly-GluTyr as substrate by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)sc4n3)c2)n(C)n1		CHEMBL2409781	=	IC50	nM	56.0	CHEMBL1868	Homo sapiens	IC50	nM	56.0
	13389963	CHEMBL2410839	Inhibition of VEGFR1 (unknown origin) using biotinylated poly-GluTyr as substrate by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)cn4c3)c2)n(C)n1		CHEMBL2409779	=	IC50	nM	6.4	CHEMBL1868	Homo sapiens	IC50	nM	6.4
	13389964	CHEMBL2410839	Inhibition of VEGFR1 (unknown origin) using biotinylated poly-GluTyr as substrate by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)nn4c3)c2)n(C)n1		CHEMBL2409775	=	IC50	nM	33.0	CHEMBL1868	Homo sapiens	IC50	nM	33.0
	13389965	CHEMBL2410839	Inhibition of VEGFR1 (unknown origin) using biotinylated poly-GluTyr as substrate by AlphaScreen assay	B	Cc1cc(C(=O)Nc2cccc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)c2)n(C)n1		CHEMBL2348996	=	IC50	nM	7.4	CHEMBL1868	Homo sapiens	IC50	nM	7.4
	13439722	CHEMBL2427771	Competitive binding affinity to FLT1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	13442588	CHEMBL2427771	Competitive binding affinity to FLT1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	95.0	CHEMBL1868	Homo sapiens	INH	%	95.0
	13443078	CHEMBL2427506	Inhibition of FLT1 (unknown origin) at 1 uM relative to control	B	COc1ccc(NC(=O)/C=C/CN(C)C)cc1Nc1ncc(Cl)c(-c2cnn3ccccc23)n1		CHEMBL2426288	>	Inhibition	%	75.0	CHEMBL1868	Homo sapiens	INH	%	75.0
	13445555	CHEMBL2427771	Competitive binding affinity to FLT1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	71.0	CHEMBL1868	Homo sapiens	INH	%	71.0
	13451542	CHEMBL2427771	Competitive binding affinity to FLT1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	82.0	CHEMBL1868	Homo sapiens	INH	%	82.0
	13461863	CHEMBL2434170	Inhibition of VEGFR1 (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c2c1CCC/C2=C1/C(=O)Nc2ccc(F)cc21		CHEMBL2180602	=	IC50	nM	1.3	CHEMBL1868	Homo sapiens	IC50	nM	1.3
	13476440	CHEMBL2439764	Inhibition of wild type human FLT1 by high throughput ATP-[33P] radiolabeled assay	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978	=	IC50	nM	39.0	CHEMBL1868	Homo sapiens	IC50	nM	39.0
	13499577	CHEMBL2447143	Inhibition of FLT1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Sc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2442124	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	13835443	CHEMBL3090737	Inhibition of VEGFR1 (unknown origin) at 1 uM	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)NC4CCC4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087823	>	Inhibition	%	80.0	CHEMBL1868	Homo sapiens	INH	%	80.0
	13835444	CHEMBL3090737	Inhibition of VEGFR1 (unknown origin) at 1 uM	B	Cc1nn(C)cc1-c1nc2c(Oc3ccc(C(=O)Nc4ccccc4)cc3)c(Cl)cnc2[nH]1		CHEMBL3087784	>	Inhibition	%	80.0	CHEMBL1868	Homo sapiens	INH	%	80.0
	13851897	CHEMBL3095045	Inhibition of recombinant FLT-1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	CCN(CC)CCCNC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL3092314	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	13851898	CHEMBL3095045	Inhibition of recombinant FLT-1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	O=C(NCCN1CCCC1)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL3092308	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	13866133	CHEMBL3100613	Inhibition of human FLT1 at 10 uM relative to control	B	COc1ccc(CNC(=O)c2cc(-c3cc(Cl)cc(Cl)c3)cnc2-c2cccnc2)cc1OC		CHEMBL3099899	=	Inhibition	%	20.0	CHEMBL1868	Homo sapiens	INH	%	20.0
	13872142	CHEMBL3101767	Inhibition of human Flt1 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	96.0	CHEMBL1868	Homo sapiens	Activity	%	96.0
	13906554	CHEMBL3117697	Inhibition of FLT1 (unknown origin) at 10 uM after 30 mins relative to control	B	COc1ccc(S(=O)(=O)Nc2cc(Sc3ncnc4nc[nH]c34)c(O)c3ccccc23)cc1OC		CHEMBL3113284	=	Inhibition	%	-2.1	CHEMBL1868	Homo sapiens	INH	%	-2.1
	13954795	CHEMBL3132502	Inhibition of human FLT1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125726	=	Activity	%	24.0	CHEMBL1868	Homo sapiens	Activity	%	24.0
	13954799	CHEMBL3132502	Inhibition of human FLT1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125728	=	Activity	%	22.0	CHEMBL1868	Homo sapiens	Activity	%	22.0
	13954807	CHEMBL3132502	Inhibition of human FLT1 assessed as residual activity at 1 uM relative to control	B	COc1ccc(-c2nc3cc(-c4csc(C(=O)NCC(C)C)c4)cnc3[nH]2)cc1		CHEMBL3125727	=	Activity	%	10.0	CHEMBL1868	Homo sapiens	Activity	%	10.0
	14537545	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	CC1(C)OB(c2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)OC1(C)C		CHEMBL3219504	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537546	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	CC1(C)OB(c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)OC1(C)C		CHEMBL3219505	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537547	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1B1OC(C)(C)C(C)(C)O1		CHEMBL3219502	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537548	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1B1OC(C)(C)C(C)(C)O1		CHEMBL3219503	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537549	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	OB(O)c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1		CHEMBL3218424	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537550	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	OB(O)c1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1		CHEMBL3219506	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537551	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1B(O)O		CHEMBL3219507	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537552	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1B(O)O		CHEMBL3219508	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537553	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	COc1cc2ncnc(Nc3cccc(B(O)O)c3)c2cc1OC		CHEMBL3219509	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537554	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	COCCOc1cc2ncnc(Nc3cccc(B(O)O)c3)c2cc1OCCOC		CHEMBL3217774	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537555	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	COCCOc1cc2ncnc(Nc3cccc(B(O)O)c3)c2cc1OC		CHEMBL3219510	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537556	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(B(O)O)cc3)c2cc1OC		CHEMBL3219511	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537557	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	COCCOc1cc2ncnc(Nc3ccc(B(O)O)cc3)c2cc1OCCOC		CHEMBL3219512	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537558	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	COCCOc1cc2ncnc(Nc3ccc(B(O)O)cc3)c2cc1OC		CHEMBL3219513	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537559	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537560	CHEMBL3223150	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	14537671	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	CC1(C)OB(c2ccc3ncnc(Nc4cccc(Cl)c4)c3c2)OC1(C)C		CHEMBL3219504	=	Inhibition	%	12.0	CHEMBL1868	Homo sapiens	INH	%	12.0
	14537672	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	CC1(C)OB(c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)OC1(C)C		CHEMBL3219505	=	Inhibition	%	8.0	CHEMBL1868	Homo sapiens	INH	%	8.0
Not Active	14537673	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1B1OC(C)(C)C(C)(C)O1		CHEMBL3219502		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	14537674	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1B1OC(C)(C)C(C)(C)O1		CHEMBL3219503		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	14537675	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	OB(O)c1ccc2ncnc(Nc3cccc(Cl)c3)c2c1		CHEMBL3218424	=	Inhibition	%	7.0	CHEMBL1868	Homo sapiens	INH	%	7.0
Not Active	14537676	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	OB(O)c1ccc2ncnc(Nc3ccc(F)c(Cl)c3)c2c1		CHEMBL3219506		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	14537677	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1B(O)O		CHEMBL3219507		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	14537678	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1B(O)O		CHEMBL3219508		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	14537679	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COc1cc2ncnc(Nc3cccc(B(O)O)c3)c2cc1OC		CHEMBL3219509		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	14537680	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COCCOc1cc2ncnc(Nc3cccc(B(O)O)c3)c2cc1OCCOC		CHEMBL3217774		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	14537681	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COCCOc1cc2ncnc(Nc3cccc(B(O)O)c3)c2cc1OC		CHEMBL3219510	=	Inhibition	%	19.0	CHEMBL1868	Homo sapiens	INH	%	19.0
	14537682	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(B(O)O)cc3)c2cc1OC		CHEMBL3219511	=	Inhibition	%	49.0	CHEMBL1868	Homo sapiens	INH	%	49.0
	14537683	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COCCOc1cc2ncnc(Nc3ccc(B(O)O)cc3)c2cc1OCCOC		CHEMBL3219512	=	Inhibition	%	41.0	CHEMBL1868	Homo sapiens	INH	%	41.0
Not Active	14537684	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COCCOc1cc2ncnc(Nc3ccc(B(O)O)cc3)c2cc1OC		CHEMBL3219513		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	14537685	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COc1cc2ncnc(Nc3cccc(CO)c3)c2cc1OC		CHEMBL3219514		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	14537686	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COc1cc2ncnc(Nc3cccc(C(=O)O)c3)c2cc1OC		CHEMBL3220397	=	Inhibition	%	32.0	CHEMBL1868	Homo sapiens	INH	%	32.0
Not Active	14537687	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COC(=O)c1cccc(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3220398		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	14537688	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(C(=O)O)cc3)c2cc1OC		CHEMBL3220399		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	14537689	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COC(=O)c1ccc(Nc2ncnc3cc(OC)c(OC)cc23)cc1		CHEMBL3220400		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	14537690	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COc1cc2ncnc(Nc3cccc(C#N)c3)c2cc1OC		CHEMBL2333998		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	14537691	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(C#N)cc3)c2cc1OC		CHEMBL3217783		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	14537692	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COc1cc2ncnc(Nc3cccc(N)c3)c2cc1OC		CHEMBL3220401		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	14537693	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(N)cc3)c2cc1OC		CHEMBL2333989		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	14537694	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Inhibition	%	32.0	CHEMBL1868	Homo sapiens	INH	%	32.0
Not Active	14537695	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	14537696	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	14537697	CHEMBL3223751	Inhibition of Flt-1 catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation at 1 uM after 20 mins by ELISA	B	O=C(Nc1cccc(C(F)(F)F)c1)c1ccccc1NCc1ccncc1		CHEMBL153843	=	Inhibition	%	34.0	CHEMBL1868	Homo sapiens	INH	%	34.0
Not Active	14545556	CHEMBL3225602	Binding affinity to human VEGFR1 (amino acid residues S27 to I328) at 0.125 to 2 uM by surface plasmon resonance assay	B	CCCCCCCCCCCCCCCCCC(=O)OCC(CO[C@@H]1O[C@H](CS(=O)(=O)[O-])[C@@H](O)[C@H](O)[C@H]1O)OC(=O)CCCCCCCCCCCCCCCCC.[Na+]		CHEMBL3219622		Activity			CHEMBL1868	Homo sapiens	Activity		
	14553626	CHEMBL3225767	Inhibition of VEGFR1 (unknown origin) at 10 uM assessed as residual enzyme activity	B	COc1ccc(-c2n[nH]c3ncc(-c4ccc(Cl)cc4N)cc23)cc1		CHEMBL3220823	=	Activity	%	90.0	CHEMBL1868	Homo sapiens	Activity	%	90.0
Active	14577995	CHEMBL3239325	Inhibition of FLT1 (unknown origin) at 10 uM by KinomeScan analysis	B	O=C(Cc1cccc(Cl)c1)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235538		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Active	14577996	CHEMBL3239325	Inhibition of FLT1 (unknown origin) at 10 uM by KinomeScan analysis	B	O=C(Cc1ccccc1Cl)Nc1nc2ccc(C(F)(F)F)cc2s1		CHEMBL3235542		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	14582504	CHEMBL3242356	Inhibition of human Flt1 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	93.5	CHEMBL1868	Homo sapiens	Activity	%	93.5
	14589531	CHEMBL3239034	Inhibition of recombinant Flt-1 (unknown origin) using Poly(Glu:Tyr)4:1 after 60 mins by ELISA	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3233767	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	14589532	CHEMBL3239034	Inhibition of recombinant Flt-1 (unknown origin) using Poly(Glu:Tyr)4:1 after 60 mins by ELISA	B	O=C(/C=C/CN1CC2CCC1C(=O)C2)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3233785	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
Not Active	14652714	CHEMBL3269395	Inhibition of human FLT-1 kinase at 1 uM	B	CCN(Cc1ccc(C)cc1)C(=O)c1nc(-c2ccccc2Cl)c2ccccc2n1		CHEMBL3261905		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	14652715	CHEMBL3269396	Inhibition of human FLT-1 kinase at 10 uM	B	CCN(Cc1ccc(C)cc1)C(=O)c1nc(-c2ccccc2Cl)c2ccccc2n1		CHEMBL3261905		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	14659724	CHEMBL3269197	Inhibition of VEGFR1 (unknown origin) assessed as residual activity at 0.01 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	100.0	CHEMBL1868	Homo sapiens	Activity	%	100.0
	14659725	CHEMBL3269198	Inhibition of VEGFR1 (unknown origin) assessed as residual activity at 0.1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	82.0	CHEMBL1868	Homo sapiens	Activity	%	82.0
	14659726	CHEMBL3269199	Inhibition of VEGFR1 (unknown origin) assessed as residual activity at 1 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	38.0	CHEMBL1868	Homo sapiens	Activity	%	38.0
	14659727	CHEMBL3269200	Inhibition of VEGFR1 (unknown origin) assessed as residual activity at 10 uM by radioisotopic assay	B	Cc1cccc(-c2[nH]c(CNc3ccccc3F)nc2-c2ccc3ncnn3c2)n1		CHEMBL3260567	=	Activity	%	6.0	CHEMBL1868	Homo sapiens	Activity	%	6.0
	14672864	CHEMBL3266376	Inhibition of FLT1 (unknown origin) at 1 uM by Z'-LYTE assay relative to control	B	CN(C)CCN(Cc1ccc(Cl)cc1)c1ccc2ccccc2n1		CHEMBL3265344	=	Inhibition	%	1.0	CHEMBL1868	Homo sapiens	INH	%	1.0
	14713685	CHEMBL3296760	Binding affinity to VEGFR1 (unknown origin)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Ki	nM	2.0	CHEMBL1868	Homo sapiens	Ki	uM	0.002
	14713711	CHEMBL3296760	Binding affinity to VEGFR1 (unknown origin)	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Ki	nM	1100.0	CHEMBL1868	Homo sapiens	Ki	uM	1.1
	14713732	CHEMBL3296849	Inhibition of VEGFR1 (unknown origin) at 1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)CCN1CCN(C)CC1		CHEMBL3288854	=	Inhibition	%	52.0	CHEMBL1868	Homo sapiens	INH	%	52.0
	14746939	CHEMBL3295612	Inhibition of recombinant VEGFR-1 (unknown origin) using poly (4 Glu, Tyr) as substrate after 60 mins by ELISA	B	Nc1ncnc2scc(-c3ccc4c(C(=O)Nc5ccccc5)cccc4c3)c12		CHEMBL3288526	=	IC50	nM	35.1	CHEMBL1868	Homo sapiens	IC50	nM	35.1
	14975686	CHEMBL3371755	Inhibition of VEGFR1 (unknown origin)	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	IC50	nM	380.0	CHEMBL1868	Homo sapiens	IC50	nM	380.0
	14979240	CHEMBL3379609	Inhibition of Flt1 (unknown origin) at 1 uM	B	CNc1cc2ccc(C#CCOc3ccc(CN4CCNCC4)c(C(F)(F)F)c3)cc2cn1		CHEMBL3355065	=	Inhibition	%	98.0	CHEMBL1868	Homo sapiens	INH	%	98.0
	14979241	CHEMBL3379610	Inhibition of Flt1 (unknown origin)	B	CNc1cc2ccc(C#CCOc3ccc(CN4CCNCC4)c(C(F)(F)F)c3)cc2cn1		CHEMBL3355065	=	IC50	nM	20.0	CHEMBL1868	Homo sapiens	IC50	nM	20.0
	14979419	CHEMBL3372979	Inhibition of Flt1 (unknown origin) in presence of 1 mM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355482	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	14992049	CHEMBL3374154	Inhibition of FLT1 (unknown origin) at 1 uM by ELISA method	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	66.6	CHEMBL1868	Homo sapiens	INH	%	66.6
	14992050	CHEMBL3374154	Inhibition of FLT1 (unknown origin) at 1 uM by ELISA method	B	O=C(Nc1ccc(F)cc1)C1(C(=O)Nc2ccc(Oc3ccnc4[nH]c(=O)[nH]c34)c(F)c2)CC1		CHEMBL3360678	=	Inhibition	%	13.3	CHEMBL1868	Homo sapiens	INH	%	13.3
	14992863	CHEMBL3372226	Inhibition of recombinant FLT1 (unknown origin) after 60 mins by z'-lyte kinase assay	B	O=C1/C(=C\c2ccc(O)c(O)c2)Oc2ccccc21		CHEMBL3361128	=	IC50	nM	3700.0	CHEMBL1868	Homo sapiens	IC50	uM	3.7
	15005107	CHEMBL3366515	Inhibition of Flt-1 (unknown origin) after 60 mins by ELISA	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2cccc(NC(=O)CN)c2)ncc1Cl		CHEMBL3357439	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	15008018	CHEMBL3368001	Inhibition of human Flt1 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	79.0	CHEMBL1868	Homo sapiens	INH	%	79.0
	15008019	CHEMBL3368001	Inhibition of human Flt1 at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	62.0	CHEMBL1868	Homo sapiens	INH	%	62.0
	15008020	CHEMBL3368001	Inhibition of human Flt1 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	Inhibition	%	66.0	CHEMBL1868	Homo sapiens	INH	%	66.0
	15018597	CHEMBL3362261	Inhibition of FLT1 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	9.8	CHEMBL1868	Homo sapiens	INH	%	9.8
	15019178	CHEMBL3364371	Inhibition of FLT1 (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	2.0	CHEMBL1868	Homo sapiens	INH	%	2.0
	15030426	CHEMBL3378160	Inhibition of biotinylated VEGFA165 binding to VEGFR1 (unknown origin) at 10 uM by chemiluminescent assay	B	Cc1ccc(-c2nc3ccccc3[nH]2)cc1NC(=S)NC(=O)c1ccc2c(c1)OCCO2		CHEMBL3322197	=	Inhibition	%	18.0	CHEMBL1868	Homo sapiens	INH	%	18.0
	15030427	CHEMBL3378160	Inhibition of biotinylated VEGFA165 binding to VEGFR1 (unknown origin) at 10 uM by chemiluminescent assay	B	O=C(NC(=S)Nc1cccc(-c2nc3ccccc3[nH]2)c1)c1ccc2c(c1)OCCO2		CHEMBL3322198	=	Inhibition	%	7.0	CHEMBL1868	Homo sapiens	INH	%	7.0
	15030428	CHEMBL3378160	Inhibition of biotinylated VEGFA165 binding to VEGFR1 (unknown origin) at 10 uM by chemiluminescent assay	B	N#Cc1ccc2[nH]c(-c3cccc(NC(=S)NC(=O)c4ccc5c(c4)OCCO5)c3)nc2c1		CHEMBL3322199	=	Inhibition	%	11.0	CHEMBL1868	Homo sapiens	INH	%	11.0
	15030429	CHEMBL3378160	Inhibition of biotinylated VEGFA165 binding to VEGFR1 (unknown origin) at 10 uM by chemiluminescent assay	B	O=C(NC(=S)Nc1cccc(-c2nc3ccccc3[nH]2)c1)c1ccc2c(c1)OCO2		CHEMBL3322201	=	Inhibition	%	7.0	CHEMBL1868	Homo sapiens	INH	%	7.0
Not Determined	15030430	CHEMBL3378160	Inhibition of biotinylated VEGFA165 binding to VEGFR1 (unknown origin) at 10 uM by chemiluminescent assay	B	N#Cc1ccc2[nH]c(-c3cccc(NC(=S)NC(=O)c4ccc5c(c4)OCO5)c3)nc2c1		CHEMBL3322202		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	15030431	CHEMBL3378160	Inhibition of biotinylated VEGFA165 binding to VEGFR1 (unknown origin) at 10 uM by chemiluminescent assay	B	CCOc1ccc(C(=O)NC(=S)Nc2cc(-c3nc4ccccc4[nH]3)ccc2C)cc1OCC		CHEMBL3322205	=	Inhibition	%	22.0	CHEMBL1868	Homo sapiens	INH	%	22.0
Not Determined	15030432	CHEMBL3378160	Inhibition of biotinylated VEGFA165 binding to VEGFR1 (unknown origin) at 10 uM by chemiluminescent assay	B	CCOc1ccc(C(=O)NC(=S)Nc2cccc(-c3nc4ccccc4[nH]3)c2)cc1OCC		CHEMBL3322206		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	15030433	CHEMBL3378160	Inhibition of biotinylated VEGFA165 binding to VEGFR1 (unknown origin) at 10 uM by chemiluminescent assay	B	O=C(NC(=S)Nc1cccc(-c2nc3ccccc3s2)c1)c1ccc2c(c1)OCO2		CHEMBL3322210	=	Inhibition	%	13.0	CHEMBL1868	Homo sapiens	INH	%	13.0
	15037223	CHEMBL3368340	Inhibition of FLT1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1OC		CHEMBL3102948	=	Inhibition	%	81.0	CHEMBL1868	Homo sapiens	INH	%	81.0
	15037224	CHEMBL3368340	Inhibition of FLT1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1cc(-c2c[nH]c3ncc(-c4cccc(N)c4)cc23)cc(OC)c1OC		CHEMBL3319457	=	Inhibition	%	36.0	CHEMBL1868	Homo sapiens	INH	%	36.0
	15037225	CHEMBL3368340	Inhibition of FLT1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4ccc(C(=O)N5CCOCC5)c(N)c4)cc23)cc1OC		CHEMBL3319467	=	Inhibition	%	56.0	CHEMBL1868	Homo sapiens	INH	%	56.0
	15037226	CHEMBL3368340	Inhibition of FLT1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4cc(OC)c(OC)c(OC)c4)cc23)cc1OC		CHEMBL3319468	=	Inhibition	%	75.0	CHEMBL1868	Homo sapiens	INH	%	75.0
	15037227	CHEMBL3368340	Inhibition of FLT1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N		CHEMBL3319470	=	Inhibition	%	43.0	CHEMBL1868	Homo sapiens	INH	%	43.0
	15085838	CHEMBL3383516	Inhibition of purified Flt-1 (unknown origin) at 1 uM after 60 mins by ELISA kinase assay	B	CC(C)S(=O)(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCN(C(=O)C2CCOCC2)CC3)ncc1Cl		CHEMBL3330859	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	15085898	CHEMBL3383516	Inhibition of purified Flt-1 (unknown origin) at 1 uM after 60 mins by ELISA kinase assay	B	CNC(=O)c1ccccc1Nc1nc(Nc2nc3c(s2)CCNCC3)ncc1Cl		CHEMBL3330850	=	Inhibition	%	16.3	CHEMBL1868	Homo sapiens	INH	%	16.3
	15116506	CHEMBL3377060	Inhibition of VEGFR1 (unknown origin)	B	CC(=O)c1ccc(N2CCN(C(=O)CN3CC[C@@H](C(=O)Nc4ccc(O)c(Cl)c4)C3)CC2)cc1		CHEMBL3356117	>	IC50	nM	50000.0	CHEMBL1868	Homo sapiens	IC50	uM	50.0
	15143823	CHEMBL3396126	Inhibition of purified Flt1 (unknown origin) at 1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469	=	Inhibition	%	40.8	CHEMBL1868	Homo sapiens	INH	%	40.8
Not Determined	15143838	CHEMBL3396224	Inhibition of purified Flt1 (unknown origin) at 0.1 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Determined	15143853	CHEMBL3396239	Inhibition of purified Flt1 (unknown origin) at 0.01 uM after 60 mins by ELISA	B	Nc1n[nH]c2cccc(-c3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)c12		CHEMBL3394469		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	15193434	CHEMBL3411880	Inhibition of human VEGFR1	B	CCS(=O)(=O)O.COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL3039504	=	IC50	nM	34.0	CHEMBL1868	Homo sapiens	IC50	nM	34.0
	15223349	CHEMBL3420305	Inhibition of FLT1 (unknown origin)	B	O=c1ccc(-n2ccc3ccc(F)cc32)nn1CCOc1ccnc2cc(OCCCN3CCOCC3)ccc12		CHEMBL3417489	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	15249769	CHEMBL3429403	Inhibition of recombinant VEGFR1 (unknown origin) by cell-free assay	B	[2H]C([2H])([2H])Oc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC([2H])([2H])[2H]		CHEMBL3426917	=	IC50	nM	11.2	CHEMBL1868	Homo sapiens	IC50	nM	11.2
	15249770	CHEMBL3429403	Inhibition of recombinant VEGFR1 (unknown origin) by cell-free assay	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	IC50	nM	6.26	CHEMBL1868	Homo sapiens	IC50	nM	6.26
	15616264	CHEMBL3583126	Inhibition of Tel-fused FLT1 (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	OC1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582442	=	IC50	nM	5300.0	CHEMBL1868	Homo sapiens	IC50	uM	5.3
	15616265	CHEMBL3583126	Inhibition of Tel-fused FLT1 (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	O=C(O)CN1CCN(c2cc(-c3cnc4ccc(N5CCC[C@@H]5c5cccc(F)c5)nn34)ccn2)CC1		CHEMBL3582441	=	IC50	nM	2600.0	CHEMBL1868	Homo sapiens	IC50	uM	2.6
	15616266	CHEMBL3583126	Inhibition of Tel-fused FLT1 (unknown origin) expressed in mouse BA/F3 cells after 48 hrs by luciferase reporter gene assay in absence of recombinant mouse IL3	B	N#Cc1ccc(-c2cnc3ccc(NCc4ccccc4)nn23)cc1		CHEMBL3582427	=	IC50	nM	3000.0	CHEMBL1868	Homo sapiens	IC50	uM	3.0
	15650148	CHEMBL3595414	Inhibition of human FLT1 at 0.1 uM relative to control	B	CCc1cc(NC(=O)Nc2ccc(-c3cnc(Nc4cc(N5CCN(CC)CC5)nc(C)n4)s3)cc2)no1		CHEMBL3593290	=	Inhibition	%	44.0	CHEMBL1868	Homo sapiens	INH	%	44.0
	15654979	CHEMBL3599533	Inhibition of VEGFR1 (unknown origin) at 0.5 uM relative to control	B	Nc1nccc(-c2c[nH]c3ccccc23)n1		CHEMBL48082	=	Inhibition	%	8.0	CHEMBL1868	Homo sapiens	INH	%	8.0
	15654980	CHEMBL3599533	Inhibition of VEGFR1 (unknown origin) at 0.5 uM relative to control	B	Nc1nccc(-c2cn(C(=O)N3CCOCC3)c3ccc(Br)cc23)n1		CHEMBL3133762	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	15654981	CHEMBL3599533	Inhibition of VEGFR1 (unknown origin) at 0.5 uM relative to control	B	Cc1noc(C)c1Cn1cc(-c2ccnc(N)n2)c2ccccc21		CHEMBL3133770	=	Inhibition	%	13.5	CHEMBL1868	Homo sapiens	INH	%	13.5
Not Active	15723461	CHEMBL3620314	Inhibition of FLT1 (unknown origin) at 10 uM after 40 mins by scintillation counting analysis	B	Cc1ccccc1C(=O)Nc1cnoc1C		CHEMBL3616990		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	15731027	CHEMBL3626702	Inhibition of VEGFR1 (unknown origin)	B	O=C1Nc2ccc(O)cc2/C1=C/c1ccc[nH]1		CHEMBL393636	=	IC50	nM	115.5	CHEMBL1868	Homo sapiens	IC50	nM	115.5
	15731028	CHEMBL3626702	Inhibition of VEGFR1 (unknown origin)	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	IC50	nM	43.0	CHEMBL1868	Homo sapiens	IC50	nM	43.0
Not Active	15731029	CHEMBL3626702	Inhibition of VEGFR1 (unknown origin)	B	CSCCCNC(=O)c1ccc2c(c1)NC(=O)/C2=C\c1[nH]c(C)cc1C		CHEMBL3621300		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active	15731030	CHEMBL3626702	Inhibition of VEGFR1 (unknown origin)	B	CSCCCNC(=O)c1ccc2c(c1)/C(=C/c1[nH]c(C)cc1C)C(=O)N2		CHEMBL3621299		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active	15731031	CHEMBL3626702	Inhibition of VEGFR1 (unknown origin)	B	Nc1ccccc1NC(=O)CCCCCCC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL3621298		IC50			CHEMBL1868	Homo sapiens	IC50		
Not Active	15731032	CHEMBL3626702	Inhibition of VEGFR1 (unknown origin)	B	Nc1ccccc1NC(=O)CCCCC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL3621297		IC50			CHEMBL1868	Homo sapiens	IC50		
	15731033	CHEMBL3626702	Inhibition of VEGFR1 (unknown origin)	B	O=C(CCCCC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2)NO		CHEMBL3621296	=	IC50	nM	205.0	CHEMBL1868	Homo sapiens	IC50	nM	205.0
Not Active	15731034	CHEMBL3626702	Inhibition of VEGFR1 (unknown origin)	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccc(NC(=O)CCCCCCC(=O)NO)cc32)[nH]1		CHEMBL3621295		IC50			CHEMBL1868	Homo sapiens	IC50		
	15731035	CHEMBL3626702	Inhibition of VEGFR1 (unknown origin)	B	O=C(CCCCCCC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2)NO		CHEMBL3621294	=	IC50	nM	364.5	CHEMBL1868	Homo sapiens	IC50	nM	364.5
	15736634	CHEMBL3625817	Inhibition of human recombinant Flt1	B	CN(C)CCCNC(=O)c1csc2nc(-c3ccc(NC(=O)Nc4cc(C(C)(C)C)on4)cc3)cn12		CHEMBL3623375	=	IC50	nM	2826.0	CHEMBL1868	Homo sapiens	IC50	uM	2.826
	15745903	CHEMBL3624477	Inhibition of recombinant Flt (unknown origin) at 1 uM after 40 mins by scintillation counting analysis in presence of [gamma33P]-ATP	B	COc1cc2ncnc(Nc3cccc(Cl)c3F)c2cc1OC(=O)N1CCN(C)C[C@H]1C		CHEMBL3623290	=	Inhibition	%	57.0	CHEMBL1868	Homo sapiens	INH	%	57.0
	15756982	CHEMBL3630501	Inhibition of FLT1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	97.55	CHEMBL1868	Homo sapiens	INH	%	97.55
	15757741	CHEMBL3630501	Inhibition of FLT1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	98.05	CHEMBL1868	Homo sapiens	INH	%	98.05
	15758720	CHEMBL3630501	Inhibition of FLT1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	0.33	CHEMBL1868	Homo sapiens	INH	%	0.33
Not Determined	15760023	CHEMBL3631060	Inhibition of VEGFR1 (unknown origin) by radiometric protein kinase assay	B	COc1cc2ncnc(Nc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c2cc1OC		CHEMBL3628796		IC50			CHEMBL1868	Homo sapiens	IC50		
	15760024	CHEMBL3631060	Inhibition of VEGFR1 (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Nc2ncnc3ccccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628797	=	IC50	nM	5750.0	CHEMBL1868	Homo sapiens	IC50	nM	5750.0
	15760025	CHEMBL3631060	Inhibition of VEGFR1 (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Nc2ncnc3sccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628798	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	nM	10000.0
	15760026	CHEMBL3631060	Inhibition of VEGFR1 (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Nc2ncnc3sc4c(c23)CCCC4)cc1)Nc1cccc(Br)c1		CHEMBL3628799	=	IC50	nM	7150.0	CHEMBL1868	Homo sapiens	IC50	nM	7150.0
	15760027	CHEMBL3631060	Inhibition of VEGFR1 (unknown origin) by radiometric protein kinase assay	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c2cc1OC		CHEMBL2018882	=	IC50	nM	46.0	CHEMBL1868	Homo sapiens	IC50	nM	46.0
	15760028	CHEMBL3631060	Inhibition of VEGFR1 (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Oc2ncnc3ccccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628807	=	IC50	nM	650.0	CHEMBL1868	Homo sapiens	IC50	nM	650.0
	15760029	CHEMBL3631060	Inhibition of VEGFR1 (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Oc2ncnc3sccc23)cc1)Nc1cccc(Br)c1		CHEMBL3628808	=	IC50	nM	1080.0	CHEMBL1868	Homo sapiens	IC50	nM	1080.0
	15760030	CHEMBL3631060	Inhibition of VEGFR1 (unknown origin) by radiometric protein kinase assay	B	O=C(Nc1ccc(Oc2ncnc3sc4c(c23)CCCC4)cc1)Nc1cccc(Br)c1		CHEMBL3628811	=	IC50	nM	1700.0	CHEMBL1868	Homo sapiens	IC50	nM	1700.0
231568	16258866	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	Cc1cccc(NC(=O)c2cccc(Oc3ccnc(-c4cc(C(=O)O)c[nH]4)c3)c2)c1		CHEMBL3639549	=	IC50	nM	13.0	CHEMBL1868	Homo sapiens	IC50	nM	13.0
254313	16264626	CHEMBL3708019	Kinase Screen Assay: KINOMEscan (Ambit Biosciences, San Diego, Calif.), a high-throughput method for screening small molecular agents against a large panel of human kinases, was utilized for compound 2. The technology is a competition binding assay that profiled the selectivity of compound 2 against 350 kinases, each fused to a proprietary tag. The quantity of each kinase bound to an immobilized, active site-directed ligand was measured in the presence and absence of compound 2.	B	Cc1nc(Nc2nc3ccc(-c4cccc(C(=O)Nc5cccc(C(F)(F)F)c5)c4)nc3s2)cc(N2CCNCC2)n1		CHEMBL2148120	=	Kd	nM	74.0	CHEMBL1868	Homo sapiens	Kd	nM	74.0
231579	16271035	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)NCCCO)c[nH]4)c3)cc2)c1		CHEMBL3660270	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
231566	16271342	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	Cc1ccc(F)c(NC(=O)c2cccc(Oc3ccnc(-c4cc(C(=O)NO)c[nH]4)c3)c2)c1		CHEMBL3656035	=	IC50	nM	34.0	CHEMBL1868	Homo sapiens	IC50	nM	34.0
231581	16271986	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	O=C(Nc1ccc(Oc2ccnc(-c3cc(C(=O)O)c[nH]3)c2)cc1)Nc1ccc(Cl)c(C(F)(F)F)c1		CHEMBL3660281	=	IC50	nM	20.0	CHEMBL1868	Homo sapiens	IC50	nM	20.0
231574	16272347	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)NCCCC(=O)O)c[nH]4)c3)cc2)c1		CHEMBL3656099	=	IC50	nM	4.0	CHEMBL1868	Homo sapiens	IC50	nM	4.0
231570	16279219	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)N5CCC(C(=O)O)C5)c[nH]4)c3)cc2F)c1		CHEMBL3656086	=	IC50	nM	4.0	CHEMBL1868	Homo sapiens	IC50	nM	4.0
231583	16288260	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)O)c[nH]4)c3)cc2)c1		CHEMBL3660294	=	IC50	nM	4.0	CHEMBL1868	Homo sapiens	IC50	nM	4.0
231573	16288843	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	Cc1cccc(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)O)c[nH]4)c3)cc2F)c1		CHEMBL3656096	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	nM	3.0
231576	16289917	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	Cc1cccc(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)N5CCC[C@@H](O)C5)c[nH]4)c3)cc2)c1		CHEMBL3656111	=	IC50	nM	6.0	CHEMBL1868	Homo sapiens	IC50	nM	6.0
280979	16290400	CHEMBL3707528	Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(NC(=O)Nc2ccc(-c3nsc(NC(=O)NCCCN4CCOCC4)c3C(N)=O)cc2)cc1		CHEMBL3696076	=	IC50	nM	7.0	CHEMBL1868	Homo sapiens	IC50	nM	7.0
249756	16291334	CHEMBL3707719	Homogenous Time-Resolved Fluorescence Assay (HTRF): To determine the activity of the various kinases, a homogenous time-resolved fluorescence (HTRF) in vitro kinase assay was used. (Mathis, G., HTRF(R) Technology. J Biomol Screen, 1999. 4(6): p. 309-314; Alfred J. Kolb, Paul V. Kaplita, David J. Hayes, Young-Whan Park, Christine Pernell, John S. Major and Gerard Mathis, Drug Discovery Today, 1998, 3, 333-342.). For example for KDR, cKIT, FLT1, CSF1R and FTL3, purified enzyme was mixed with 0.5 M N-biotinylated substrate (Biotin-Ahx-AEEEYFFLA-amide (SEQ. ID. 1)), various concentrations of inhibitor in reaction buffer (50 mM HEPES, pH 7.1, 10 mM MgCl2, 2 mM MnCl2, 0.1% BSA and 1 mM DTT, 40 L final volume), ATP (1 mM final conc.) in a black 384-well plate. After 60 minutes incubation at room temperature, the reaction was quenched by addition of a buffered EDTA solution.	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C[C@H](C)O)c5)cnc(N)c34)cc2)c1		CHEMBL3646210	=	IC50	nM	2.04	CHEMBL1868	Homo sapiens	IC50	nM	2.04
280980	16292822	CHEMBL3707528	Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	COCCCNC(=O)Nc1snc(-c2ccc(N)cc2)c1C(N)=O		CHEMBL3696077	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
280974	16297583	CHEMBL3707528	Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)c1c(-c2ccc([NH2+][O-])cc2)nsc1NC(=O)NCCCN1CCOCC1		CHEMBL3696070	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	nM	10000.0
249755	16298902	CHEMBL3707719	Homogenous Time-Resolved Fluorescence Assay (HTRF): To determine the activity of the various kinases, a homogenous time-resolved fluorescence (HTRF) in vitro kinase assay was used. (Mathis, G., HTRF(R) Technology. J Biomol Screen, 1999. 4(6): p. 309-314; Alfred J. Kolb, Paul V. Kaplita, David J. Hayes, Young-Whan Park, Christine Pernell, John S. Major and Gerard Mathis, Drug Discovery Today, 1998, 3, 333-342.). For example for KDR, cKIT, FLT1, CSF1R and FTL3, purified enzyme was mixed with 0.5 M N-biotinylated substrate (Biotin-Ahx-AEEEYFFLA-amide (SEQ. ID. 1)), various concentrations of inhibitor in reaction buffer (50 mM HEPES, pH 7.1, 10 mM MgCl2, 2 mM MnCl2, 0.1% BSA and 1 mM DTT, 40 L final volume), ATP (1 mM final conc.) in a black 384-well plate. After 60 minutes incubation at room temperature, the reaction was quenched by addition of a buffered EDTA solution.	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	2.1	CHEMBL1868	Homo sapiens	IC50	nM	2.1
231582	16299070	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)OCC(O)CO)c[nH]4)c3)cc2)c1		CHEMBL3660290	=	IC50	nM	16.0	CHEMBL1868	Homo sapiens	IC50	nM	16.0
231578	16299339	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)NO)c[nH]4)c3)cc2)c1		CHEMBL3660268	=	IC50	nM	13.0	CHEMBL1868	Homo sapiens	IC50	nM	13.0
231569	16299597	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	Cc1ccoc1C(=O)Nc1cccc(Oc2ccnc(-c3cc(C(=O)N4CC[C@H](O)C4)c[nH]3)c2)c1		CHEMBL3656053	=	IC50	nM	20.0	CHEMBL1868	Homo sapiens	IC50	nM	20.0
231577	16300686	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	CCNC(=O)c1c[nH]c(-c2cc(Oc3ccc(NC(=O)Nc4cccc(C)c4)cc3)ccn2)c1		CHEMBL3656114	=	IC50	nM	5.0	CHEMBL1868	Homo sapiens	IC50	nM	5.0
231567	16304071	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	CCNC(=O)c1c[nH]c(-c2cc(Oc3cccc(C(=O)Nc4occc4C)c3)ccn2)c1		CHEMBL3656037	=	IC50	nM	15.0	CHEMBL1868	Homo sapiens	IC50	nM	15.0
280978	16304438	CHEMBL3707528	Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)c1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)nsc1NC(=O)NCCCN1CCOCC1		CHEMBL3696075	=	IC50	nM	13.0	CHEMBL1868	Homo sapiens	IC50	nM	13.0
280976	16304608	CHEMBL3707528	Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc(NC(=O)NCCCN4CCOCC4)c3C(N)=O)cc2)c1		CHEMBL3696073	=	IC50	nM	11.0	CHEMBL1868	Homo sapiens	IC50	nM	11.0
249757	16307612	CHEMBL3707719	Homogenous Time-Resolved Fluorescence Assay (HTRF): To determine the activity of the various kinases, a homogenous time-resolved fluorescence (HTRF) in vitro kinase assay was used. (Mathis, G., HTRF(R) Technology. J Biomol Screen, 1999. 4(6): p. 309-314; Alfred J. Kolb, Paul V. Kaplita, David J. Hayes, Young-Whan Park, Christine Pernell, John S. Major and Gerard Mathis, Drug Discovery Today, 1998, 3, 333-342.). For example for KDR, cKIT, FLT1, CSF1R and FTL3, purified enzyme was mixed with 0.5 M N-biotinylated substrate (Biotin-Ahx-AEEEYFFLA-amide (SEQ. ID. 1)), various concentrations of inhibitor in reaction buffer (50 mM HEPES, pH 7.1, 10 mM MgCl2, 2 mM MnCl2, 0.1% BSA and 1 mM DTT, 40 L final volume), ATP (1 mM final conc.) in a black 384-well plate. After 60 minutes incubation at room temperature, the reaction was quenched by addition of a buffered EDTA solution.	B	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	=	IC50	nM	4.29	CHEMBL1868	Homo sapiens	IC50	nM	4.29
280977	16311646	CHEMBL3707528	Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	Cc1cccc(NC(=O)Nc2ccc(-c3nsc(NC(=O)NCCCN4CCOCC4)c3C(N)=O)cc2)c1		CHEMBL3696074	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	nM	3.0
249754	16312672	CHEMBL3707719	Homogenous Time-Resolved Fluorescence Assay (HTRF): To determine the activity of the various kinases, a homogenous time-resolved fluorescence (HTRF) in vitro kinase assay was used. (Mathis, G., HTRF(R) Technology. J Biomol Screen, 1999. 4(6): p. 309-314; Alfred J. Kolb, Paul V. Kaplita, David J. Hayes, Young-Whan Park, Christine Pernell, John S. Major and Gerard Mathis, Drug Discovery Today, 1998, 3, 333-342.). For example for KDR, cKIT, FLT1, CSF1R and FTL3, purified enzyme was mixed with 0.5 M N-biotinylated substrate (Biotin-Ahx-AEEEYFFLA-amide (SEQ. ID. 1)), various concentrations of inhibitor in reaction buffer (50 mM HEPES, pH 7.1, 10 mM MgCl2, 2 mM MnCl2, 0.1% BSA and 1 mM DTT, 40 L final volume), ATP (1 mM final conc.) in a black 384-well plate. After 60 minutes incubation at room temperature, the reaction was quenched by addition of a buffered EDTA solution.	B	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	IC50	nM	1.25	CHEMBL1868	Homo sapiens	IC50	nM	1.25
231580	16316611	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	Cc1cccc(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)O)c[nH]4)c3)cc2)c1		CHEMBL3660275	=	IC50	nM	2.0	CHEMBL1868	Homo sapiens	IC50	nM	2.0
231571	16320260	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)NCCCC(=O)O)c[nH]4)c3)cc2F)c1		CHEMBL3656087	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	nM	3.0
280981	16320659	CHEMBL3707528	Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)c1c(-c2ccc(NC(=O)c3cccc(C(F)(F)F)c3)cc2)nsc1NC(=O)NCCCN1CCOCC1		CHEMBL3696079	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
231572	16322610	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)NCCC(=O)O)c[nH]4)c3)cc2F)c1		CHEMBL3656090	=	IC50	nM	5.0	CHEMBL1868	Homo sapiens	IC50	nM	5.0
231575	16327693	CHEMBL3707664	Kinase assays: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30.mu.g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120.mu.L reaction volumes containing 3.6.mu.M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl.sub.2, 0.1 mM MnCl.sub.2 and 0.2 mM Na.sub.3 VO.sub.4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25.degree. C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100.mu.l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc(-c4cc(C(=O)N5CCC(C(=O)O)C5)c[nH]4)c3)cc2)c1		CHEMBL3656104	=	IC50	nM	5.0	CHEMBL1868	Homo sapiens	IC50	nM	5.0
280975	16338354	CHEMBL3707528	Kinase Assay: Biochemical KDR kinase assays were performed in 96 well microtiter plates that were coated overnight with 75 ug/well of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.4. The coated plates were washed with 2 mls per well PBS+0.05% Tween-20 (PBS-T), blocked by incubation with PBS containing 1% BSA, then washed with 2 mls per well PBS-T prior to starting the reaction. Reactions were carried out in 100 uL reaction volumes containing 2.7 uM ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 20 ul per well of kinase buffer containing 200-300 ng purified cytoplasmic domain KDR protein (BPS Bioscience, San Diego, Calif.). Following a 15 minute incubation at 30 C., the reactions were washed 2 mls per well PBS-T.	B	NC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)nsc1NC(=O)NCCCN1CCOCC1		CHEMBL3696072	=	IC50	nM	9.0	CHEMBL1868	Homo sapiens	IC50	nM	9.0
249758	16350530	CHEMBL3707719	Homogenous Time-Resolved Fluorescence Assay (HTRF): To determine the activity of the various kinases, a homogenous time-resolved fluorescence (HTRF) in vitro kinase assay was used. (Mathis, G., HTRF(R) Technology. J Biomol Screen, 1999. 4(6): p. 309-314; Alfred J. Kolb, Paul V. Kaplita, David J. Hayes, Young-Whan Park, Christine Pernell, John S. Major and Gerard Mathis, Drug Discovery Today, 1998, 3, 333-342.). For example for KDR, cKIT, FLT1, CSF1R and FTL3, purified enzyme was mixed with 0.5 M N-biotinylated substrate (Biotin-Ahx-AEEEYFFLA-amide (SEQ. ID. 1)), various concentrations of inhibitor in reaction buffer (50 mM HEPES, pH 7.1, 10 mM MgCl2, 2 mM MnCl2, 0.1% BSA and 1 mM DTT, 40 L final volume), ATP (1 mM final conc.) in a black 384-well plate. After 60 minutes incubation at room temperature, the reaction was quenched by addition of a buffered EDTA solution.	B	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C[C@H](O)CO)c5)cnc(N)c34)cc2)cc1		CHEMBL3646211	=	IC50	nM	1.45	CHEMBL1868	Homo sapiens	IC50	nM	1.45
249759	16355753	CHEMBL3707719	Homogenous Time-Resolved Fluorescence Assay (HTRF): To determine the activity of the various kinases, a homogenous time-resolved fluorescence (HTRF) in vitro kinase assay was used. (Mathis, G., HTRF(R) Technology. J Biomol Screen, 1999. 4(6): p. 309-314; Alfred J. Kolb, Paul V. Kaplita, David J. Hayes, Young-Whan Park, Christine Pernell, John S. Major and Gerard Mathis, Drug Discovery Today, 1998, 3, 333-342.). For example for KDR, cKIT, FLT1, CSF1R and FTL3, purified enzyme was mixed with 0.5 M N-biotinylated substrate (Biotin-Ahx-AEEEYFFLA-amide (SEQ. ID. 1)), various concentrations of inhibitor in reaction buffer (50 mM HEPES, pH 7.1, 10 mM MgCl2, 2 mM MnCl2, 0.1% BSA and 1 mM DTT, 40 L final volume), ATP (1 mM final conc.) in a black 384-well plate. After 60 minutes incubation at room temperature, the reaction was quenched by addition of a buffered EDTA solution.	B	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	IC50	nM	1.9	CHEMBL1868	Homo sapiens	IC50	nM	1.9
	16396071	CHEMBL3742725	Inhibition of human recombinant VEGFR1 using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5ccccc5)cccc4c3)n2)c1		CHEMBL3740721	=	IC50	nM	9.3	CHEMBL1868	Homo sapiens	IC50	nM	9.3
	16396072	CHEMBL3742725	Inhibition of human recombinant VEGFR1 using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5cccc(F)c5)cccc4c3)n2)c1		CHEMBL3740487	=	IC50	nM	4.2	CHEMBL1868	Homo sapiens	IC50	nM	4.2
	16396073	CHEMBL3742725	Inhibition of human recombinant VEGFR1 using Poly (Glu,Tyr) as substrate after 60 mins by ELISA	B	CS(=O)(=O)Cc1cccc(Nc2nccc(Oc3ccc4c(C(=O)Nc5cccnc5)cccc4c3)n2)c1		CHEMBL3739732	=	IC50	nM	4.9	CHEMBL1868	Homo sapiens	IC50	nM	4.9
	16413450	CHEMBL3743694	Inhibition of FLT1 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	16425274	CHEMBL3751110	Inhibition of Flt1 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-0.7	CHEMBL1868	Homo sapiens	INH	%	-0.7
	16431837	CHEMBL3748191	Inhibition of human FLT1 using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	16450849	CHEMBL3762705	Inhibition of FLT1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	71.8	CHEMBL1868	Homo sapiens	INH	%	71.8
	16457733	CHEMBL3761573	Inhibition of FLT1 (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccccc3C(N)=O)cc12)c1ccccc1		CHEMBL3759085	=	Inhibition	%	4.0	CHEMBL1868	Homo sapiens	INH	%	4.0
	16457734	CHEMBL3761573	Inhibition of FLT1 (unknown origin) at 500 nM	B	C[C@@H](Nc1ncnc2sc(-c3ccc(C(=O)NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3758800	=	Inhibition	%	1.0	CHEMBL1868	Homo sapiens	INH	%	1.0
	16457735	CHEMBL3761573	Inhibition of FLT1 (unknown origin) at 500 nM	B	CN(C)CCNC(=O)c1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3s2)cc1		CHEMBL3758376	=	Inhibition	%	5.0	CHEMBL1868	Homo sapiens	INH	%	5.0
	16457736	CHEMBL3761573	Inhibition of FLT1 (unknown origin) at 500 nM	B	COc1cc(C(N)=O)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3759480	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	16457737	CHEMBL3761573	Inhibition of FLT1 (unknown origin) at 500 nM	B	COc1ccc(C(=O)NCCN(C)C)cc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3758582	=	Inhibition	%	-8.0	CHEMBL1868	Homo sapiens	INH	%	-8.0
	16457738	CHEMBL3761573	Inhibition of FLT1 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](C)c3ccccc3)ncnc2s1		CHEMBL3759559	=	Inhibition	%	4.0	CHEMBL1868	Homo sapiens	INH	%	4.0
	16457739	CHEMBL3761573	Inhibition of FLT1 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2s1		CHEMBL3758682	=	Inhibition	%	1.0	CHEMBL1868	Homo sapiens	INH	%	1.0
	16457740	CHEMBL3761573	Inhibition of FLT1 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccccc3)ncnc2s1		CHEMBL3758768	=	Inhibition	%	9.0	CHEMBL1868	Homo sapiens	INH	%	9.0
	16457741	CHEMBL3761573	Inhibition of FLT1 (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3sc(-c4ccc(CO)cc4OC)cc23)c1		CHEMBL3758802	=	Inhibition	%	-7.0	CHEMBL1868	Homo sapiens	INH	%	-7.0
	16457742	CHEMBL3761573	Inhibition of FLT1 (unknown origin) at 500 nM	B	COc1cc(CO)ccc1-c1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2s1		CHEMBL3758351	=	Inhibition	%	2.0	CHEMBL1868	Homo sapiens	INH	%	2.0
	16457743	CHEMBL3761573	Inhibition of FLT1 (unknown origin) at 500 nM	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	17.0	CHEMBL1868	Homo sapiens	INH	%	17.0
	16461610	CHEMBL3762061	Inhibition of recombinant human Flt-1 using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	Cn1cc(-c2cnc(Nc3cccc(Cn4nc(-c5cnn(C)c5)ccc4=O)c3)nc2)cn1		CHEMBL3759079	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16461611	CHEMBL3762061	Inhibition of recombinant human Flt-1 using poly (Glu,Tyr)4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16465586	CHEMBL3766494	Inhibition of Flt-1 (unknown origin) using poly(Glu, Tyr) 4:1 as substrate preincubated for 60 mins followed by substrate addition measured after 1 hr by AlphaScreen assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	6.8	CHEMBL1868	Homo sapiens	IC50	nM	6.8
	16466197	CHEMBL3767456	Inhibition of VEGFR-1 (unknown origin) by tumor cell growth inhibition assay	B	Cn1ccnc1-c1cc2c(Oc3ccc(NC(=S)NC(=O)Cc4ccccc4)cc3F)ccnc2s1		CHEMBL3764474	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	nM	3.0
	16466201	CHEMBL3767460	Inhibition of VEGFR-1 (unknown origin) by AlphaScreen assay	B	CC1=[N+](c2ccccc2)C(=O)C(C(=O)Nc2ccc(Oc3ccc4nc(NC(=O)C5CC5)cn4c3)c(F)c2)C=C1.Cl		CHEMBL3765306	=	IC50	nM	7.7	CHEMBL1868	Homo sapiens	IC50	nM	7.7
	16495998	CHEMBL3779693	Inhibition of N-terminal His6-tagged recombinant human FLT1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	4.0	CHEMBL1868	Homo sapiens	Activity	%	4.0
	16508185	CHEMBL3779693	Inhibition of N-terminal His6-tagged recombinant human FLT1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-16.0	CHEMBL1868	Homo sapiens	Activity	%	-16.0
	16509162	CHEMBL3779693	Inhibition of N-terminal His6-tagged recombinant human FLT1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-24.0	CHEMBL1868	Homo sapiens	Activity	%	-24.0
	16563783	CHEMBL3802292	Inhibition of FLT1 (unknown origin) by Z-LYTE assay	B	CC(NC(=O)c1ccc2[nH]nc(-c3ccncc3)c2c1)c1cccc(Cl)c1		CHEMBL3798631	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16563784	CHEMBL3802292	Inhibition of FLT1 (unknown origin) by Z-LYTE assay	B	Cc1cc(-c2n[nH]c3ccc(C(=O)NC(C)c4c(Cl)cncc4Cl)cc23)ccn1		CHEMBL3798257	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16574806	CHEMBL3802402	Inhibition of recombinant FLT1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 1000 nM incubated for 60 mins by ELISA relative to control	B	Fc1ccc(-c2cnc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cc1		CHEMBL3797579	=	Inhibition	%	11.5	CHEMBL1868	Homo sapiens	INH	%	11.5
	16593534	CHEMBL3811537	Inhibition of GST-tagged human recombinant VEGFR1 (781 to 1338 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	16593591	CHEMBL3812141	Inhibition of His-tagged human recombinant FLT3 (564 to 958 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	16610764	CHEMBL3817687	Inhibition of VEGFR1 (unknown origin)	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	IC50	nM	2.0	CHEMBL1868	Homo sapiens	IC50	nM	2.0
	16610766	CHEMBL3817687	Inhibition of VEGFR1 (unknown origin)	B	O=C(Nc1ccc(Cn2cncn2)cc1)c1ccccc1NCc1ccncc1		CHEMBL3813969	=	Ki	nM	2400.0	CHEMBL1868	Homo sapiens	Ki	nM	2400.0
	16614480	CHEMBL3816610	Inhibition of human FLT1 at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-10.0	CHEMBL1868	Homo sapiens	INH	%	-10.0
	16618213	CHEMBL3816341	Inhibition of recombinant human GST-tagged cytoplasmic FLT1 receptor (781 to 1338 residues) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	16621495	CHEMBL3820488	Inhibition of FLT1 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN1C(=O)COc2c1cnc1ccc(Sc3nnc4c(F)cc(-c5cnn(C)c5)cn34)cc21		CHEMBL3818247	>	IC50	nM	30000.0	CHEMBL1868	Homo sapiens	IC50	nM	30000.0
	16622210	CHEMBL3820488	Inhibition of FLT1 (unknown origin) incubated for 1 hr by spectrophotometric analysis	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.4	CHEMBL1868	Homo sapiens	IC50	nM	5.4
	16627516	CHEMBL3820334	Inhibition of recombinant human N-terminal GST-tagged FLT1 (783-end residues) expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	5.0	CHEMBL1868	Homo sapiens	INH	%	5.0
	16627517	CHEMBL3820334	Inhibition of recombinant human N-terminal GST-tagged FLT1 (783-end residues) expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	12.0	CHEMBL1868	Homo sapiens	INH	%	12.0
	16628486	CHEMBL3820298	Inhibition of human recombinant full-length FLT1 at 1 uM after 30 mins	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL1868	Homo sapiens	INH	%	80.0
	16636724	CHEMBL3825317	Inhibition of human Flt1 (784 to 1338 residues) at 1 uM	B	CC(=O)N1CCC(n2nc(C)c(Nc3ncc(Cl)c(-c4cnn5ccccc45)n3)c2C)CC1		CHEMBL3823914	=	Inhibition	%	80.0	CHEMBL1868	Homo sapiens	INH	%	80.0
	16653344	CHEMBL3830180	Inhibition of recombinant human Flt1 using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA	B	C[C@@H](Oc1ccc2[nH]nc(-c3nc4cc(N5CCN(C)CC5)ccc4[nH]3)c2c1)c1c(Cl)cncc1Cl		CHEMBL3827178	>	IC50	nM	100.0	CHEMBL1868	Homo sapiens	IC50	nM	100.0
	16655120	CHEMBL3830421	Inhibition of N-terminal GST-tagged recombinant human FLT1 (783 residues) expressed in insect Sf21 cells using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CC1(C)c2cc(C3CCN(CC4CCOCC4)CC3)ccc2C(=O)c2c1[nH]c1cc(C#N)ccc21		CHEMBL3735648	=	IC50	nM	159.0	CHEMBL1868	Homo sapiens	IC50	nM	159.0
	16737938	CHEMBL3856655	Inhibition of recombinant human FLT1 expressed in insect Sf21 cells assessed as remaining activity at 10 uM preincubated for 15 mins followed by poly(Glu:Tyr) substrate addition for 30 mins in presence of [gamma-32P]ATP by TR-FRET assay	B	CNCCOc1ccc(-c2sc3nc(-c4cccs4)nc(NN4C(=O)C=C(C)C4=O)c3c2C)cc1.Cl		CHEMBL3966536	=	Activity	%	40.0	CHEMBL1868	Homo sapiens	Activity	%	40.0
	16739448	CHEMBL3857050	Inhibition of GST tagged recombinant human FLT1 cytoplasmic domain (781 to 1338 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	17.0	CHEMBL1868	Homo sapiens	INH	%	17.0
	16739449	CHEMBL3857050	Inhibition of GST tagged recombinant human FLT1 cytoplasmic domain (781 to 1338 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN4CCCCC4)cc3)cc12)c1ccccc1		CHEMBL3891846	=	Inhibition	%	1.0	CHEMBL1868	Homo sapiens	INH	%	1.0
	16739450	CHEMBL3857050	Inhibition of GST tagged recombinant human FLT1 cytoplasmic domain (781 to 1338 residues) expressed in baculovirus at 500 nM by Z'-LYTE assay	B	C[C@@H](Nc1ncnc2oc(-c3ccc(NCCN(C)C)cc3)cc12)c1ccccc1		CHEMBL3901622	=	Inhibition	%	-2.0	CHEMBL1868	Homo sapiens	INH	%	-2.0
	16742591	CHEMBL3857919	Inhibition of FLT1 (unknown origin) preincubated for 60 mins followed by biotinylated-poly (Glu, Tyr) 4:1 substrate addition measured after 1 hr by AlphaScreen assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	6.8	CHEMBL1868	Homo sapiens	IC50	nM	6.8
	16742599	CHEMBL3857912	Inhibition of FLT1 (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	12.0	CHEMBL1868	Homo sapiens	IC50	nM	12.0
	16815389	CHEMBL3871601	Inhibition of VEGFR1 (unknown origin)	B	CNC(=O)c1ccccc1Sc1ccc2c(CCc3ccccn3)n[nH]c2c1		CHEMBL3939307	=	IC50	nM	0.1	CHEMBL1868	Homo sapiens	IC50	nM	0.1
	16815455	CHEMBL3871616	Inhibition of human recombinant GST-tagged FLT1 cytoplasmic domain (781 to 1338 residues) expressed in baculovirus expression system at 1 uM	B	O=C(O)/C=C\C(=O)Nc1cccc(-c2n[nH]c3ccc(NS(=O)(=O)c4ccccc4)cc23)c1		CHEMBL3986609	=	Inhibition	%	1.0	CHEMBL1868	Homo sapiens	INH	%	1.0
	16906755	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906756	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OC[C@H]1CN2CCCC[C@H]2CO1		CHEMBL3968192	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906757	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OC[C@H]1CN2CCOC[C@H]2CO1		CHEMBL3977450	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906758	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OC[C@H]1CN2CCOC[C@H]2CO1		CHEMBL3959516	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906759	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OC[C@H]1CN2CCOC[C@H]2CO1		CHEMBL3956820	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906760	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3893890	<	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906761	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3928396	<	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906762	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3946242	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906763	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN2CCOCC2CO1		CHEMBL3943570	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906764	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3908311	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906765	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3905501	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906766	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OC[C@@H]1CN2CCOC[C@H]2CO1		CHEMBL3924147	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906767	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@H]1CN2CCOC[C@H]2CO1		CHEMBL3971781	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906768	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@H]1CN2CCOC[C@H]2CO1		CHEMBL3914441	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906769	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@H]1CN2CCC[C@@H]2CO1		CHEMBL3917220	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906770	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3968522	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906771	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@@H]1CN2CCC[C@@H]2CO1		CHEMBL3977759	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906772	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3928883	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906773	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@H]1CN2CCC[C@H]2CO1		CHEMBL3931623	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906774	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3959774	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906775	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3962487	<	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906776	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3922278	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906777	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3924998	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906778	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2CO1		CHEMBL3896122	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906779	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC[C@@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3893416	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906780	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1OC[C@@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3934134	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906781	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1OC[C@@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3931427	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906782	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCCC[C@H]2C(=O)N1		CHEMBL3940489	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906783	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCCC[C@@H]2C(=O)N1		CHEMBL3900059	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906784	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2C(=O)N1		CHEMBL3947712	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906785	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@@H]2C(=O)N1		CHEMBL3945072	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906786	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2C(=O)N1		CHEMBL3986135	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906787	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1CN2CCC[C@H]2C(=O)N1C		CHEMBL3983466	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906788	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCC1CN2CSC[C@H]2CO1		CHEMBL3917294	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906789	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OC1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3920036	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906790	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Br)cc3F)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3946590	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906791	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3986404	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906792	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3F)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3961005	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906793	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3Cl)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3958481	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906794	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3919145	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906795	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3Cl)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3895424	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906796	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@@H]1C[C@H]2OCC3(OCCO3)[C@H]2O1		CHEMBL3964605	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906797	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(F)c(Cl)c3F)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3955486	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906798	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cc(Cl)c(Cl)cc3F)ncnc2cc1O[C@@H]1C[C@H]2OC[C@H](OC)[C@H]2O1		CHEMBL3924380	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906799	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC(F)F)CO[C@H]12		CHEMBL3921689	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906800	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cccc(Cl)c3F)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3955359	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906801	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3964556	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906802	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3910031	>	IC50	nM	20000.0	CHEMBL1868	Homo sapiens	IC50	nM	20000.0
	16906803	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	CCO[C@H]1CO[C@@H]2[C@@H](Oc3cc4ncnc(Nc5ccc(Br)c(Cl)c5)c4cc3OC)CO[C@H]12		CHEMBL3907230	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906804	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cccc(Br)c3C)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3895458	>	IC50	nM	20000.0	CHEMBL1868	Homo sapiens	IC50	nM	20000.0
	16906805	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3cccc(Cl)c3C)ncnc2cc1O[C@H]1CO[C@@H]2[C@@H](OC)CO[C@H]12		CHEMBL3959160	>	IC50	nM	20000.0	CHEMBL1868	Homo sapiens	IC50	nM	20000.0
	16906806	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2CCO[C@H]12		CHEMBL3932115	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906807	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Br)c(Cl)c3)ncnc2cc1O[C@H]1CO[C@@H]2[C@H](OC)CO[C@H]12		CHEMBL3929354	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	16906808	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1cscn1		CHEMBL3968322	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
	16906809	CHEMBL3883070	Inhibition of recombinant human N-terminal GST-tagged factor 10a cleavage site-fused Flt1 (K784 to I1338 residues) expressed in baculovirus infected insect Sf9 cells using poly-EY as substrate after 120 mins in presence of gamma33P-ATP by liquid scintillation spectrometry	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3)ncnc2cc1OCc1cccnc1		CHEMBL3965901	=	IC50	nM	50.0	CHEMBL1868	Homo sapiens	IC50	nM	50.0
335473	17713691	CHEMBL3887386	In vitro Enzyme Assay: The effects of compound of formula II on inhibiting VEGFR were compared against that of sunitinib in vitro.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)N1CCOCCOCCOCC1		CHEMBL3950152	=	IC50	nM	40.0	CHEMBL1868	Homo sapiens	IC50	nM	40.0
399280	17766117	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)O)sc34)cc2)c1		CHEMBL3986507	=	IC50	nM	16.0	CHEMBL1868	Homo sapiens	IC50	nM	16.0
399374	17766211	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCc5nn[nH]n5)sc34)cc2)c1		CHEMBL3944753	=	IC50	nM	4.0	CHEMBL1868	Homo sapiens	IC50	nM	4.0
399375	17766212	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCc5nn[nH]n5)sc34)cc2)c1		CHEMBL3911718	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
399376	17766213	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CCOC(=O)CN1CCN(CCCNC(=O)c2cc3nccc(Oc4ccc(NC(=O)Nc5cc(C)ccc5F)cc4)c3s2)CC1		CHEMBL3917483	=	IC50	nM	5.0	CHEMBL1868	Homo sapiens	IC50	nM	5.0
399377	17766214	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCN5CCCC(CO)C5)sc34)cc2)c1		CHEMBL3932948	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	nM	3.0
399378	17766215	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCN5CCOC(CO)C5)sc34)cc2)c1		CHEMBL3904954	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
399379	17766216	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)[C@@H]1C[C@@H](O)CN1CCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)c2s1		CHEMBL4107173	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
399380	17766217	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CNCCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)c2s1		CHEMBL3896004	=	IC50	nM	6.0	CHEMBL1868	Homo sapiens	IC50	nM	6.0
399381	17766218	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CN(CCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)c2s1)CC(=O)OC		CHEMBL3918564	=	IC50	nM	9.0	CHEMBL1868	Homo sapiens	IC50	nM	9.0
399382	17766219	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CCOC(=O)N1CCN(CCNC(=O)c2cc3nccc(Oc4ccc(NC(=O)Nc5cc(C)ccc5F)c(F)c4)c3s2)CC1		CHEMBL3890520	=	IC50	nM	13.0	CHEMBL1868	Homo sapiens	IC50	nM	13.0
399383	17766220	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CCOC(=O)N1CCN(CCCNC(=O)c2cc3nccc(Oc4ccc(NC(=O)Nc5cc(C)ccc5F)c(F)c4)c3s2)CC1		CHEMBL3906005	=	IC50	nM	9.0	CHEMBL1868	Homo sapiens	IC50	nM	9.0
399384	17766221	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CNCCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)c(F)c3)c2s1		CHEMBL3979830	=	IC50	nM	8.0	CHEMBL1868	Homo sapiens	IC50	nM	8.0
399385	17766222	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CN(CCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)c(F)c3)c2s1)CC(=O)OC		CHEMBL3972255	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
399386	17766223	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CN(CCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)c(F)c3)c2s1)CC(=O)OC		CHEMBL3975323	=	IC50	nM	11.0	CHEMBL1868	Homo sapiens	IC50	nM	11.0
399387	17766224	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)C1CCN(C(=O)c2cc3nccc(Oc4ccc(NC(=O)Nc5cc(C)ccc5F)c(F)c4)c3s2)C1		CHEMBL3966952	=	IC50	nM	8.0	CHEMBL1868	Homo sapiens	IC50	nM	8.0
399388	17766225	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CCOC(=O)CN1CCN(C(=O)CN2CCN(C(=O)c3cc4nccc(Oc5ccc(NC(=O)Nc6cc(C)ccc6F)c(F)c5)c4s3)CC2)CC1		CHEMBL3895671	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
399389	17766226	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CCOC(=O)CN1CCN(C(=O)c2cc3nccc(Oc4ccc(NC(=O)Nc5cc(C)ccc5F)c(F)c4)c3s2)CC1		CHEMBL3965868	=	IC50	nM	112.0	CHEMBL1868	Homo sapiens	IC50	nM	112.0
399390	17766227	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)CNCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)c(F)c3)c2s1		CHEMBL3890891	=	IC50	nM	9.0	CHEMBL1868	Homo sapiens	IC50	nM	9.0
399391	17766228	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCN)sc34)cc2F)c1		CHEMBL3951242	=	IC50	nM	11.0	CHEMBL1868	Homo sapiens	IC50	nM	11.0
399392	17766229	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCNC(=O)OC(C)(C)C)sc34)cc2F)c1		CHEMBL3980166	=	IC50	nM	60.0	CHEMBL1868	Homo sapiens	IC50	nM	60.0
399393	17766230	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCN5CCN(C)CC5)sc34)cc2F)c1		CHEMBL3934764	=	IC50	nM	6.0	CHEMBL1868	Homo sapiens	IC50	nM	6.0
399394	17766231	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCN5CCCC(CO)C5)sc34)cc2F)c1		CHEMBL3967877	=	IC50	nM	8.0	CHEMBL1868	Homo sapiens	IC50	nM	8.0
399395	17766232	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCN5CCOC(CO)C5)sc34)cc2F)c1		CHEMBL3964131	=	IC50	nM	9.0	CHEMBL1868	Homo sapiens	IC50	nM	9.0
399396	17766233	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCN5CCC(O)CC5)sc34)cc2F)c1		CHEMBL3910242	=	IC50	nM	8.0	CHEMBL1868	Homo sapiens	IC50	nM	8.0
399397	17766234	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	COC(=O)[C@@H]1C[C@@H](O)CN1CCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)c(F)c3)c2s1		CHEMBL4109002	=	IC50	nM	8.0	CHEMBL1868	Homo sapiens	IC50	nM	8.0
399398	17766235	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCN5CCC(C(=O)O)C5)sc34)cc2F)c1		CHEMBL3936588	=	IC50	nM	18.0	CHEMBL1868	Homo sapiens	IC50	nM	18.0
399399	17766236	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCN5CCOCC5)sc34)cc2F)c1		CHEMBL3918251	=	IC50	nM	7.0	CHEMBL1868	Homo sapiens	IC50	nM	7.0
399400	17766237	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CCOC(=O)CCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)c2s1		CHEMBL3942670	=	IC50	nM	16.0	CHEMBL1868	Homo sapiens	IC50	nM	16.0
399401	17766238	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CCOC(=O)CCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)c(F)c3)c2s1		CHEMBL3919480	=	IC50	nM	15.0	CHEMBL1868	Homo sapiens	IC50	nM	15.0
399402	17766239	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCC(=O)O)sc34)cc2F)c1		CHEMBL3927233	=	IC50	nM	7.0	CHEMBL1868	Homo sapiens	IC50	nM	7.0
399403	17766240	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCC(=O)O)sc34)cc2)c1		CHEMBL3897945	=	IC50	nM	7.0	CHEMBL1868	Homo sapiens	IC50	nM	7.0
399404	17766241	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CCN(CC)CCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)c2s1		CHEMBL3961927	=	IC50	nM	5.0	CHEMBL1868	Homo sapiens	IC50	nM	5.0
399405	17766242	CHEMBL3888412	Kinase Assay: Kinase assays were performed in 96 well microtiter plates that were coated overnight with 30 g of poly-Glu-Tyr (4:1) in 10 mM Phosphate Buffered Saline (PBS), pH 7.2-7.4. The plates were incubated with 1% BSA and then washed four times with PBS prior to starting the reaction. Reactions were carried out in 120 L reaction volumes containing 3.6 M ATP in kinase buffer (50 mM Hepes buffer pH 7.4, 20 mM MgCl2, 0.1 mM MnCl2 and 0.2 mM Na3VO4). Test compounds were reconstituted in 100% DMSO and added to the reaction to give a final DMSO concentration of 5%. Reactions were initiated by the addition 0.5 ng of purified protein. Following a ten minute incubation at 25 C., the reactions were washed four times with PBS containing 0.05% Tween-20. 100 l of a monoclonal anti-phosphotyrosine antibody-peroxidase conjugate was diluted 1:10000 in PBS-Tween-20 and added to the wells for 30 minutes. Following four washes with PBS-Tween-20, 100 l of 0-phenylenediamine Dihydrochloride in Phosphate-citrate buffer, containing urea hydrogen peroxide, was added to the wells for 7 minutes as a colorimetric substrate for the peroxidase. The reaction was terminated by the addition of 100 l of 2.5N H2 SO4 to each well and read using a microplate ELISA reader set at 492 nm.	B	CCN(CC)CCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)c2s1		CHEMBL3934424	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	nM	3.0
399406	17766243	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCc5nn[nH]n5)sc34)cc2)c1		CHEMBL3944753	=	IC50	nM	20.0	CHEMBL1868	Homo sapiens	IC50	nM	20.0
399407	17766244	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCc5nn[nH]n5)sc34)cc2)c1		CHEMBL3911718	=	IC50	nM	19.0	CHEMBL1868	Homo sapiens	IC50	nM	19.0
399408	17766245	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	CCOC(=O)CN1CCN(CCCNC(=O)c2cc3nccc(Oc4ccc(NC(=O)Nc5cc(C)ccc5F)cc4)c3s2)CC1		CHEMBL3917483	=	IC50	nM	13.0	CHEMBL1868	Homo sapiens	IC50	nM	13.0
399409	17766246	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCN5CCCC(CO)C5)sc34)cc2)c1		CHEMBL3932948	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
399410	17766247	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCN5CCOC(CO)C5)sc34)cc2)c1		CHEMBL3904954	=	IC50	nM	15.0	CHEMBL1868	Homo sapiens	IC50	nM	15.0
399411	17766248	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	COC(=O)[C@@H]1C[C@@H](O)CN1CCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)c2s1		CHEMBL4107173	=	IC50	nM	15.0	CHEMBL1868	Homo sapiens	IC50	nM	15.0
399412	17766249	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	COC(=O)CNCCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)c2s1		CHEMBL3896004	=	IC50	nM	11.0	CHEMBL1868	Homo sapiens	IC50	nM	11.0
399413	17766250	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	COC(=O)CN(CCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)c2s1)CC(=O)OC		CHEMBL3918564	=	IC50	nM	14.0	CHEMBL1868	Homo sapiens	IC50	nM	14.0
399414	17766251	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	CCOC(=O)N1CCN(CCNC(=O)c2cc3nccc(Oc4ccc(NC(=O)Nc5cc(C)ccc5F)c(F)c4)c3s2)CC1		CHEMBL3890520	=	IC50	nM	14.0	CHEMBL1868	Homo sapiens	IC50	nM	14.0
399415	17766252	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	CCOC(=O)N1CCN(CCCNC(=O)c2cc3nccc(Oc4ccc(NC(=O)Nc5cc(C)ccc5F)c(F)c4)c3s2)CC1		CHEMBL3906005	=	IC50	nM	14.0	CHEMBL1868	Homo sapiens	IC50	nM	14.0
399416	17766253	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	COC(=O)CNCCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)c(F)c3)c2s1		CHEMBL3979830	=	IC50	nM	11.0	CHEMBL1868	Homo sapiens	IC50	nM	11.0
399417	17766254	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	COC(=O)CN(CCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)c(F)c3)c2s1)CC(=O)OC		CHEMBL3972255	=	IC50	nM	12.0	CHEMBL1868	Homo sapiens	IC50	nM	12.0
399418	17766255	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	COC(=O)CN(CCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)c(F)c3)c2s1)CC(=O)OC		CHEMBL3975323	=	IC50	nM	17.0	CHEMBL1868	Homo sapiens	IC50	nM	17.0
399419	17766256	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	COC(=O)C1CCN(C(=O)c2cc3nccc(Oc4ccc(NC(=O)Nc5cc(C)ccc5F)c(F)c4)c3s2)C1		CHEMBL3966952	=	IC50	nM	17.0	CHEMBL1868	Homo sapiens	IC50	nM	17.0
399420	17766257	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	CCOC(=O)CN1CCN(C(=O)CN2CCN(C(=O)c3cc4nccc(Oc5ccc(NC(=O)Nc6cc(C)ccc6F)c(F)c5)c4s3)CC2)CC1		CHEMBL3895671	=	IC50	nM	13.0	CHEMBL1868	Homo sapiens	IC50	nM	13.0
399421	17766258	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	CCOC(=O)CN1CCN(C(=O)c2cc3nccc(Oc4ccc(NC(=O)Nc5cc(C)ccc5F)c(F)c4)c3s2)CC1		CHEMBL3965868	=	IC50	nM	17.0	CHEMBL1868	Homo sapiens	IC50	nM	17.0
399422	17766259	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	COC(=O)CNCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)c(F)c3)c2s1		CHEMBL3890891	=	IC50	nM	13.0	CHEMBL1868	Homo sapiens	IC50	nM	13.0
399423	17766260	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCN)sc34)cc2F)c1		CHEMBL3951242	=	IC50	nM	15.0	CHEMBL1868	Homo sapiens	IC50	nM	15.0
399424	17766261	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCNC(=O)OC(C)(C)C)sc34)cc2F)c1		CHEMBL3980166	=	IC50	nM	69.0	CHEMBL1868	Homo sapiens	IC50	nM	69.0
399425	17766262	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCN5CCN(C)CC5)sc34)cc2F)c1		CHEMBL3934764	=	IC50	nM	11.0	CHEMBL1868	Homo sapiens	IC50	nM	11.0
399426	17766263	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCN5CCCCC5)sc34)cc2)c1		CHEMBL3926026	=	IC50	nM	16.0	CHEMBL1868	Homo sapiens	IC50	nM	16.0
399427	17766264	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCN5CCN(C)CC5)sc34)cc2)c1		CHEMBL3906088	=	IC50	nM	9.0	CHEMBL1868	Homo sapiens	IC50	nM	9.0
399428	17766265	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(Oc3ccnc4cc(C(=O)NCCCN5CCCC5)sc34)cc2)c1		CHEMBL3939959	=	IC50	nM	16.0	CHEMBL1868	Homo sapiens	IC50	nM	16.0
399429	17766266	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	CCN(CC)CCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)c2s1		CHEMBL3961927	=	IC50	nM	13.0	CHEMBL1868	Homo sapiens	IC50	nM	13.0
399430	17766267	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	CCN(CC)CCCNC(=O)c1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)c2s1		CHEMBL3934424	=	IC50	nM	12.0	CHEMBL1868	Homo sapiens	IC50	nM	12.0
399431	17766268	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	COC(=O)c1cc2nccc(Oc3cccc(NC(=O)c4occc4C)c3)c2s1		CHEMBL3916459	=	IC50	nM	169.0	CHEMBL1868	Homo sapiens	IC50	nM	169.0
399432	17766269	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccoc1C(=O)Nc1cccc(Oc2ccnc3cc(C(=O)O)sc23)c1		CHEMBL3891953	=	IC50	nM	920.0	CHEMBL1868	Homo sapiens	IC50	nM	920.0
399433	17766270	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	CCNC(=O)c1cc2nccc(Oc3cccc(NC(=O)c4occc4C)c3)c2s1		CHEMBL3977907	=	IC50	nM	191.0	CHEMBL1868	Homo sapiens	IC50	nM	191.0
399434	17766271	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	CCN(CC)C(=O)c1cc2nccc(Oc3cccc(NC(=O)c4occc4C)c3)c2s1		CHEMBL3948737	=	IC50	nM	424.0	CHEMBL1868	Homo sapiens	IC50	nM	424.0
399435	17766272	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccoc1C(=O)Nc1cccc(Oc2ccnc3cc(C(=O)NO)sc23)c1		CHEMBL3937925	=	IC50	nM	277.0	CHEMBL1868	Homo sapiens	IC50	nM	277.0
399436	17766273	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccoc1C(=O)Nc1cccc(Oc2ccnc3cc(C(=O)NCCCO)sc23)c1		CHEMBL3906367	=	IC50	nM	146.0	CHEMBL1868	Homo sapiens	IC50	nM	146.0
399437	17766274	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccoc1C(=O)Nc1cccc(Oc2ccnc3cc(C(=O)NCCO)sc23)c1		CHEMBL3919076	=	IC50	nM	392.0	CHEMBL1868	Homo sapiens	IC50	nM	392.0
399438	17766275	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccoc1C(=O)Nc1cccc(Oc2ccnc3cc(C(=O)NCCc4nn[nH]n4)sc23)c1		CHEMBL3949914	=	IC50	nM	323.0	CHEMBL1868	Homo sapiens	IC50	nM	323.0
399439	17766276	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccoc1C(=O)Nc1cccc(Oc2ccnc3cc(C(=O)OCCCO)sc23)c1		CHEMBL3943862	=	IC50	nM	146.0	CHEMBL1868	Homo sapiens	IC50	nM	146.0
399440	17766277	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccoc1C(=O)Nc1cccc(Oc2ccnc3cc(C(=O)OCCO)sc23)c1		CHEMBL3896274	=	IC50	nM	212.0	CHEMBL1868	Homo sapiens	IC50	nM	212.0
399441	17766278	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	COCCOC(=O)c1cc2nccc(Oc3cccc(NC(=O)c4occc4C)c3)c2s1		CHEMBL3983962	=	IC50	nM	273.0	CHEMBL1868	Homo sapiens	IC50	nM	273.0
399442	17766279	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	COC(=O)CNCCCNC(=O)c1cc2nccc(Oc3cccc(NC(=O)c4occc4C)c3)c2s1		CHEMBL3968013	=	IC50	nM	238.0	CHEMBL1868	Homo sapiens	IC50	nM	238.0
399443	17766280	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	Cc1ccc(F)c(NC(=O)c2cccc(Oc3ccnc4cc(C(=O)O)sc34)c2)c1		CHEMBL3929416	=	IC50	nM	223.0	CHEMBL1868	Homo sapiens	IC50	nM	223.0
399444	17766281	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	CCNC(=O)c1cc2nccc(Oc3cccc(C(=O)Nc4cc(C)ccc4F)c3)c2s1		CHEMBL3907284	=	IC50	nM	74.0	CHEMBL1868	Homo sapiens	IC50	nM	74.0
399445	17766282	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	CCN(CC)C(=O)c1cc2nccc(Oc3cccc(C(=O)Nc4cc(C)ccc4F)c3)c2s1		CHEMBL3920518	=	IC50	nM	206.0	CHEMBL1868	Homo sapiens	IC50	nM	206.0
399446	17766283	CHEMBL3888413	FLIPR (Fluorometric Imaging Plate Reader) Technology Assay: Automated FLIPR (Fluorometric Imaging Plate Reader) technology was used to screen for inhibitors of PDGF induced increases in intracellular calcium levels in fluorescent dye loaded endothelial cells. NHDF-Ad (Normal human dermal fibroblasts) (Lonza) were seeded in 384-well fibronectin coated black-walled plates overnight at 37 C./5% CO2. Cells were loaded with calcium indicator Fluo-4 for 45 minutes at 37 C. Cells were washed 4 times (ELx405-CW, Bio-Tek) to remove extracellular dye. Test compounds were reconstituted in 100% DMSO and added to the cells to give a final DMSO concentration of 0.1%. For screening, cells were pre-incubated with test agents for 30 minutes, at a single concentration (10 M) or at concentrations ranging from 0.001 nM to 10 M followed by PDGF stimulation (10 ng/mL). Changes in fluorescence at 515 nm were measured simultaneously in all 384 wells using a cooled CCD camera.	B	COC(=O)CNCCCNC(=O)c1cc2nccc(Oc3cccc(C(=O)Nc4cc(C)ccc4F)c3)c2s1		CHEMBL3944929	=	IC50	nM	59.0	CHEMBL1868	Homo sapiens	IC50	nM	59.0
431432	17791540	CHEMBL3889042	In Vitro Inhibition Assay: In Vitro Inhibition of Tyrosine Kinases using a 10-point Titration Curve.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	=	IC50	nM	122.0	CHEMBL1868	Homo sapiens	IC50	nM	122.0
	17957985	CHEMBL3993998	Inhibition of recombinant human GST-tagged VEGFR1 cytoplasmic domain (781 to 1338 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2cccc2CN(C)C)cc1)c1ccccc1		CHEMBL4069394	=	IC50	nM	99.2	CHEMBL1868	Homo sapiens	IC50	nM	99.2
	17957986	CHEMBL3993998	Inhibition of recombinant human GST-tagged VEGFR1 cytoplasmic domain (781 to 1338 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labeled peptide substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	23.4	CHEMBL1868	Homo sapiens	IC50	nM	23.4
	17979936	CHEMBL3998331	Inhibition of VEGFR1 (unknown origin)	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	IC50	nM	7.0	CHEMBL1868	Homo sapiens	IC50	nM	7.0
	17979948	CHEMBL3998342	Inhibition of recombinant VEGFR1 (unknown origin) expressed in baculovirus infected insect cells using biotinylated peptide substrate GGGGQDGKDYIVLPI in presence of ATP incubated for 1 to 4 hrs by time resolved fluorescence assay	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
	18002359	CHEMBL4002770	Inhibition of recombinant VEGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	A	CN1CCN(Cc2ccc(NC(=O)c3ccc(Cl)c(C#Cc4cncc(N5CCOCC5)c4)c3)cc2C(F)(F)F)CC1		CHEMBL4091628	=	IC50	nM	62.7	CHEMBL1868	Homo sapiens	IC50	nM	62.7
	18002377	CHEMBL4002770	Inhibition of recombinant VEGFR1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	A	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	20.9	CHEMBL1868	Homo sapiens	IC50	nM	20.9
	18021243	CHEMBL4005951	Inhibition of recombinant human N-terminal GST-tagged Flt1 (783 to end amino acid residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 10 uM	B	Cc1nc(NC2CCCC2)sc1-c1ccnc(Nc2ccc(N3CCNCC3)cn2)n1		CHEMBL4071812	<	Inhibition	%	10.0	CHEMBL1868	Homo sapiens	INH	%	10.0
	18021244	CHEMBL4005951	Inhibition of recombinant human N-terminal GST-tagged Flt1 (783 to end amino acid residues) expressed in baculovirus infected Sf21 insect cells assessed as residual activity at 10 uM	B	Cc1nc(NC2CCCC2)sc1-c1nc(Nc2ccc(N3CCN(C)CC3)cn2)ncc1F		CHEMBL4072255	<	Inhibition	%	10.0	CHEMBL1868	Homo sapiens	INH	%	10.0
	18031698	CHEMBL4007707	Inhibition of Flt1(unknown origin) after 60 mins by TR-FRET assay	B	CCCNC(=O)c1ccc(Nc2nc(NCC(F)(F)F)c3cc[nH]c3n2)cc1		CHEMBL2006765	=	IC50	nM	4220.0	CHEMBL1868	Homo sapiens	IC50	uM	4.22
	18031699	CHEMBL4007707	Inhibition of Flt1(unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc(N3CCOCC3)c(Cl)c2)nc2ccoc12		CHEMBL4078893	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	18031700	CHEMBL4007707	Inhibition of Flt1(unknown origin) after 60 mins by TR-FRET assay	B	FC(F)(F)CNc1nc(Nc2ccc3cn[nH]c3c2)nc2ccoc12		CHEMBL4066664	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	18031701	CHEMBL4007707	Inhibition of Flt1(unknown origin) after 60 mins by TR-FRET assay	B	CC1(C)OCC(=O)Nc2cc(Nc3nc(NCC(F)(F)F)c4occc4n3)ccc21		CHEMBL4069365	=	IC50	nM	9130.0	CHEMBL1868	Homo sapiens	IC50	uM	9.13
	18031702	CHEMBL4007707	Inhibition of Flt1(unknown origin) after 60 mins by TR-FRET assay	B	Cc1n[nH]c2cc(Nc3nc(NC4CC4)c4occc4n3)ccc12		CHEMBL4062803	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	18033087	CHEMBL4007903	Inhibition of human VEGFR1 at 0.1 uM relative to control	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1NC(=O)[C@H]1CCCN1.Cl		CHEMBL4093614	=	Inhibition	%	30.0	CHEMBL1868	Homo sapiens	INH	%	30.0
	18053017	CHEMBL4011864	Inhibition of FLT1 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-0.2	CHEMBL1868	Homo sapiens	INH	%	-0.2
	18057863	CHEMBL4012625	Inhibition of VEGFR1 (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition in presence of ATP by mobility shift assay	B	Cc1cccc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)c1		CHEMBL4103605	=	IC50	nM	3493.0	CHEMBL1868	Homo sapiens	IC50	nM	3493.0
	18057874	CHEMBL4012662	Inhibition of human GST-tagged FLT1 (781 to 1338 residues) expressed in baculovirus by ELISA	B	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCOCC1		CHEMBL4072731	=	IC50	nM	159.0	CHEMBL1868	Homo sapiens	IC50	nM	159.0
	18057892	CHEMBL4012661	Inhibition of human GST-tagged FLT1 (781 to 1338 residues) expressed in baculovirus assessed as activity remaining at 1 uM by ELISA relative to control	B	Cc1cc(NC(=O)Nc2ccc(-c3ccnc4[nH]nc(C)c34)cc2)ccc1N1CCOCC1		CHEMBL4072731	=	Activity	%	1.4	CHEMBL1868	Homo sapiens	Activity	%	1.4
	18085969	CHEMBL4018637	Inhibition of recombinant VEGFR-1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(Cl)ccc3O)cc12		CHEMBL4105329	>	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
	18085970	CHEMBL4018637	Inhibition of recombinant VEGFR-1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	OC[C@H](Nc1cnc(-c2cc(Cl)ccc2O)c(-c2ccc3cnccc3c2)c1)c1ccccc1		CHEMBL4067871	>	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
	18085971	CHEMBL4018637	Inhibition of recombinant VEGFR-1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3cc(F)ccc3O)cc12		CHEMBL4062877	=	IC50	nM	1.0	CHEMBL1868	Homo sapiens	IC50	nM	1.0
	18085972	CHEMBL4018637	Inhibition of recombinant VEGFR-1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3-c3ccc(F)cc3O)cc12		CHEMBL4075917	>	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
	18096336	CHEMBL4021223	Inhibition of FLT1 (unknown origin) using FAM-labeled peptide as substrate preincubated for 5 to 10 mins followed by substrate/ATP addition measured after 30 to 60 mins by mobility shift assay	B	CC(c1cc2cc(-c3cnn(C)c3)cnc2cc1F)n1nnc2ncc(-c3cnn(CCO)c3)nc21		CHEMBL4074262	>	IC50	nM	30000.0	CHEMBL1868	Homo sapiens	IC50	nM	30000.0
	18105918	CHEMBL4022694	Inhibition of human FLT1 using KDRY1175 [B91616] biotin-GGGGQDGKDYIVLPI-NH2 peptide substrate after 1 hr by scintillation counting method	B	Nc1nc(NCCNc2ncc(-n3ccnc3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-]		CHEMBL3185148	>	IC50	nM	5000.0	CHEMBL1868	Homo sapiens	IC50	uM	5.0
	18105919	CHEMBL4022694	Inhibition of human FLT1 using KDRY1175 [B91616] biotin-GGGGQDGKDYIVLPI-NH2 peptide substrate after 1 hr by scintillation counting method	B	Nc1nc(NCCNc2ncc(-c3ncc[nH]3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-]		CHEMBL1080901	>	IC50	nM	5000.0	CHEMBL1868	Homo sapiens	IC50	uM	5.0
	18105920	CHEMBL4022694	Inhibition of human FLT1 using KDRY1175 [B91616] biotin-GGGGQDGKDYIVLPI-NH2 peptide substrate after 1 hr by scintillation counting method	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	>	IC50	nM	5000.0	CHEMBL1868	Homo sapiens	IC50	uM	5.0
	18114349	CHEMBL4025145	Inhibition of wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	97.0	CHEMBL1868	Homo sapiens	Activity	%	97.0
	18117597	CHEMBL4025910	Inhibition of recombinant human VEGFR-1 expressed in Spodoptera frugiperda insect cells at 3 uM relative to control	B	COc1ccc(-c2nnc(-n3c(-c4ccccc4)nc4cc(Cl)ccc4c3=O)s2)cc1		CHEMBL4103440	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	18141852	CHEMBL4031450	Binding affinity to FLT1 (unknown origin) by KinomeSCan assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	=	Kd	nM	41.0	CHEMBL1868	Homo sapiens	Kd	nM	41.0
	18147074	CHEMBL4032519	Inhibition of VEGFR1 (unknown origin) at 100 nM relative to control	B	Nc1nccc(-c2c[nH]c3ncc(-c4ccc(F)cc4)cc23)n1		CHEMBL4095226	=	Inhibition	%	76.5	CHEMBL1868	Homo sapiens	INH	%	76.5
	18147075	CHEMBL4032519	Inhibition of VEGFR1 (unknown origin) at 100 nM relative to control	B	COc1ccnc2[nH]cc(-c3ccnc(N)n3)c12		CHEMBL270686	=	Inhibition	%	0.9	CHEMBL1868	Homo sapiens	INH	%	0.9
	18147110	CHEMBL4032539	Inhibition of VEGFR1 (unknown origin) at 500 nM relative to control	B	Nc1nccc(-c2c[nH]c3ncc(-c4ccc(F)cc4)cc23)n1		CHEMBL4095226	=	Inhibition	%	86.9	CHEMBL1868	Homo sapiens	INH	%	86.9
	18147111	CHEMBL4032539	Inhibition of VEGFR1 (unknown origin) at 500 nM relative to control	B	COc1ccnc2[nH]cc(-c3ccnc(N)n3)c12		CHEMBL270686	=	Inhibition	%	3.1	CHEMBL1868	Homo sapiens	INH	%	3.1
Active	18149672	CHEMBL4033353	Inhibition of human Flt1 at 0.5 uM relative to control	B	COc1cc2ncnc(Oc3ccc(NC(=O)Nc4ccc(CN5CCOCC5)c(C(F)(F)F)c4)c4ccccc34)c2cc1OC		CHEMBL4075561		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Active	18149673	CHEMBL4033353	Inhibition of human Flt1 at 0.5 uM relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	18183810	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC1=O		CHEMBL4092853	=	Inhibition	%	70.7	CHEMBL1868	Homo sapiens	INH	%	70.7
	18183811	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CSCC[C@@H]1NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CO)C(N)=O)NC1=O		CHEMBL4077087	=	Inhibition	%	72.6	CHEMBL1868	Homo sapiens	INH	%	72.6
Not Active	18183812	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(C)C		CHEMBL4088656		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	18183813	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(C)C		CHEMBL4073956	=	Inhibition	%	25.2	CHEMBL1868	Homo sapiens	INH	%	25.2
	18183814	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@@H](C)O)C(C)C		CHEMBL4100726	=	Inhibition	%	27.5	CHEMBL1868	Homo sapiens	INH	%	27.5
	18183815	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@@H](C)O)C(C)C		CHEMBL4090834	=	Inhibition	%	33.4	CHEMBL1868	Homo sapiens	INH	%	33.4
	18183816	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O		CHEMBL4062901	=	Inhibition	%	18.4	CHEMBL1868	Homo sapiens	INH	%	18.4
Dose-dependent effect	18183817	CHEMBL4040242	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA	B	CSCC[C@@H]1NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CO)C(N)=O)NC1=O		CHEMBL4077087		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Dose-dependent effect	18183818	CHEMBL4040242	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA	B	CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC1=O		CHEMBL4092853		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Dose-dependent effect	18183819	CHEMBL4040242	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(C)=O)CCCCNC(=O)CC[C@@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC1=O		CHEMBL4071072		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Dose-dependent effect	18183820	CHEMBL4040242	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL4090414		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Dose-dependent effect	18183821	CHEMBL4040242	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL4062433		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Dose-dependent effect	18183822	CHEMBL4040242	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA	B	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(C)C		CHEMBL4083044		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Dose-dependent effect	18183823	CHEMBL4040242	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@@H](C)O)C(C)C		CHEMBL4090834		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	18183827	CHEMBL4040242	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA	B	CSCC[C@@H]1NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CO)C(N)=O)NC1=O		CHEMBL4077087	=	IC50	nM	56000.0	CHEMBL1868	Homo sapiens	IC50	uM	56.0
	18183828	CHEMBL4040242	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA	B	CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC1=O		CHEMBL4092853	=	IC50	nM	10400.0	CHEMBL1868	Homo sapiens	IC50	uM	10.4
	18183829	CHEMBL4040242	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(C)=O)CCCCNC(=O)CC[C@@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC1=O		CHEMBL4071072	=	IC50	nM	75100.0	CHEMBL1868	Homo sapiens	IC50	uM	75.1
	18183830	CHEMBL4040242	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC1=O	Outside typical range	CHEMBL4090414	=	IC50	nM	157400.0	CHEMBL1868	Homo sapiens	IC50	uM	157.4
	18183831	CHEMBL4040242	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL4062433	=	IC50	nM	50400.0	CHEMBL1868	Homo sapiens	IC50	uM	50.4
	18183832	CHEMBL4040242	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA	B	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(C)C	Outside typical range	CHEMBL4083044	=	IC50	nM	129500.0	CHEMBL1868	Homo sapiens	IC50	uM	129.5
	18183833	CHEMBL4040242	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@@H](C)O)C(C)C	Outside typical range	CHEMBL4090834	=	IC50	nM	271100.0	CHEMBL1868	Homo sapiens	IC50	uM	271.1
	18183834	CHEMBL4040243	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 3 to 200 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](CCCCN)NC1=O		CHEMBL4098556	=	Inhibition	%	40.0	CHEMBL1868	Homo sapiens	INH	%	40.0
	18183835	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CSCC[C@@H]1NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CO)C(N)=O)NC1=O		CHEMBL4077087	=	Inhibition	%	42.6	CHEMBL1868	Homo sapiens	INH	%	42.6
	18183836	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CSCC[C@@H]1NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)CNC1=O		CHEMBL4092853	=	Inhibition	%	67.4	CHEMBL1868	Homo sapiens	INH	%	67.4
Not Active	18183837	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL4098133		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	18183838	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(C)=O)CCCCNC(=O)CC[C@@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC1=O		CHEMBL4071072	=	Inhibition	%	38.8	CHEMBL1868	Homo sapiens	INH	%	38.8
	18183839	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL4090414	=	Inhibition	%	18.7	CHEMBL1868	Homo sapiens	INH	%	18.7
	18183840	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL4062433	=	Inhibition	%	52.3	CHEMBL1868	Homo sapiens	INH	%	52.3
	18183841	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@@H](C)CC)[C@@H](C)CC		CHEMBL4077694	=	Inhibition	%	14.9	CHEMBL1868	Homo sapiens	INH	%	14.9
Not Active	18183842	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@@H](C)O)C(C)C		CHEMBL4101960		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	18183843	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(N)=O)[C@@H](C)CC		CHEMBL4071519		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	18183844	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](CCCCN)NC1=O		CHEMBL4098556	=	Inhibition	%	42.8	CHEMBL1868	Homo sapiens	INH	%	42.8
Not Active	18183845	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC1=O		CHEMBL4082051		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	18183846	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@@H]1NC(=O)[C@@H](N)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC1=O		CHEMBL4060166		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Not Active	18183847	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(N)=O		CHEMBL4101023		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	18183848	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@@H](N)CC(=O)O)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N2CCC[C@H]2C(=O)N[C@@H](CO)C(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL4098133	=	Inhibition	%	8.6	CHEMBL1868	Homo sapiens	INH	%	8.6
	18183849	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(C)=O)CCCCNC(=O)CC[C@@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC1=O		CHEMBL4071072	=	Inhibition	%	55.0	CHEMBL1868	Homo sapiens	INH	%	55.0
	18183850	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL4090414	=	Inhibition	%	54.9	CHEMBL1868	Homo sapiens	INH	%	54.9
	18183851	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL4062433	=	Inhibition	%	67.2	CHEMBL1868	Homo sapiens	INH	%	67.2
	18183852	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@@H](C)CC)[C@@H](C)CC		CHEMBL4077694	=	Inhibition	%	45.3	CHEMBL1868	Homo sapiens	INH	%	45.3
	18183853	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccccc1)C(N)=O)[C@@H](C)O)C(C)C		CHEMBL4101960	=	Inhibition	%	27.9	CHEMBL1868	Homo sapiens	INH	%	27.9
	18183854	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(N)=O)[C@@H](C)CC		CHEMBL4071519	=	Inhibition	%	26.0	CHEMBL1868	Homo sapiens	INH	%	26.0
	18183855	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@H]2CCCN2C(=O)[C@H](CCCCN)NC1=O		CHEMBL4098556	=	Inhibition	%	43.4	CHEMBL1868	Homo sapiens	INH	%	43.4
	18183856	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@@H]1NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc2ccccc2)C(N)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC1=O		CHEMBL4082051	=	Inhibition	%	8.9	CHEMBL1868	Homo sapiens	INH	%	8.9
	18183857	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@@H]1NC(=O)[C@@H](N)CSSC[C@@H](C(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCCCN)NC1=O		CHEMBL4060166	=	Inhibition	%	2.4	CHEMBL1868	Homo sapiens	INH	%	2.4
	18183858	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCSC)[C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(N)=O		CHEMBL4101023	=	Inhibition	%	14.1	CHEMBL1868	Homo sapiens	INH	%	14.1
	18183859	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(C)C		CHEMBL4083044	=	Inhibition	%	57.9	CHEMBL1868	Homo sapiens	INH	%	57.9
	18183860	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC(C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O		CHEMBL4062901	=	Inhibition	%	42.1	CHEMBL1868	Homo sapiens	INH	%	42.1
	18183861	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CO)NC(C)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@@H](C)O)C(C)C		CHEMBL4090834	=	Inhibition	%	48.8	CHEMBL1868	Homo sapiens	INH	%	48.8
	18183862	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](C)C(=O)N[C@H](C(N)=O)[C@@H](C)O)[C@@H](C)O)C(C)C		CHEMBL4100726	=	Inhibition	%	42.5	CHEMBL1868	Homo sapiens	INH	%	42.5
	18183863	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCCN)NC(C)=O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(C)C		CHEMBL4073956	=	Inhibition	%	33.6	CHEMBL1868	Homo sapiens	INH	%	33.6
	18183864	CHEMBL4040245	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 100 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(C)C		CHEMBL4088656	=	Inhibition	%	14.5	CHEMBL1868	Homo sapiens	INH	%	14.5
	18183865	CHEMBL4040244	Displacement of biotinylated VEGF-A (165 residues) from humanized recombinant C-terminal His-tagged VEGFR-1 extracellular domain expressed in baculovirus infected Sf21 cells at 50 uM preincubated for 1 hr followed by btVEGF-A165 addition measured after 2 hrs by ELISA relative to control	B	CC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccc(O)cc1)C(N)=O)C(C)C		CHEMBL4083044	=	Inhibition	%	32.5	CHEMBL1868	Homo sapiens	INH	%	32.5
	18203669	CHEMBL4043956	Inhibition of wild-type human partial length FLT1 (R781 to F1239 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	5.6	CHEMBL1868	Homo sapiens	Activity	%	5.6
	18218043	CHEMBL4047101	Inhibition of FLT1 (unknown origin) at 10 uM using [33P]-ATP after 20 to 40 mins by scintillation counting method	B	Cc1ccc(NC(=O)c2c(N=Cc3ccc4ccccc4c3)c(C#N)c3n2CCC3)cc1		CHEMBL4079032	=	Inhibition	%	10.0	CHEMBL1868	Homo sapiens	INH	%	10.0
	18218044	CHEMBL4047101	Inhibition of FLT1 (unknown origin) at 10 uM using [33P]-ATP after 20 to 40 mins by scintillation counting method	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	-10.0	CHEMBL1868	Homo sapiens	INH	%	-10.0
	18220909	CHEMBL4047632	Inhibition of wild type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as residual activity by Kinome scan assay relative to control	B	CNC(=O)c1cnc(Nc2ccc3ncsc3c2)cc1N[C@@H](c1ccccc1)[C@H](O)CO		CHEMBL4075955	<	Activity	%	10.0	CHEMBL1868	Homo sapiens	Activity	%	10.0
	18250447	CHEMBL4054264	Inhibition of VEGFR-1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 100 uM after 1 hr by ELISA relative to control	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4081419	=	Inhibition	%	6.8	CHEMBL1868	Homo sapiens	INH	%	6.8
	18250448	CHEMBL4054265	Inhibition of VEGFR-1 (unknown origin) using poly (Glu, Tyr) 4:1 as substrate at 1 uM after 1 hr by ELISA relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	74.2	CHEMBL1868	Homo sapiens	INH	%	74.2
	18253817	CHEMBL4055193	Inhibition of wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	100.0	CHEMBL1868	Homo sapiens	Activity	%	100.0
	18253818	CHEMBL4055193	Inhibition of wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	90.0	CHEMBL1868	Homo sapiens	Activity	%	90.0
	18265863	CHEMBL4057313	Inhibition of FLT1 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	12.7	CHEMBL1868	Homo sapiens	INH	%	12.7
	18266057	CHEMBL4057507	Inhibition of FLT1 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-2.3	CHEMBL1868	Homo sapiens	INH	%	-2.3
	18273763	CHEMBL4059197	Inhibition of human FLT1 using poly[Glu:Tyr] (4:1) as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition measure after 120 mins by filter binding method	B	CN1CCN(Cc2ccc(NC(=O)c3n[nH]cc3Nc3ncnc4sccc34)cc2)CC1		CHEMBL4075720	=	IC50	nM	19.8	CHEMBL1868	Homo sapiens	IC50	nM	19.8
	18274425	CHEMBL4059355	Inhibition of human VEGFR1 assessed as remaining activity at 1 uM after 30 mins by qPCR method	B	CNCc1cc(Oc2ccc3c(ccn3C(=O)Nc3cc(C(F)(F)F)n(C)n3)c2)ncn1		CHEMBL4076112	<=	Activity	%	10.0	CHEMBL1868	Homo sapiens	Activity	%	10.0
	18275374	CHEMBL4118508	Inhibition of human FLT1 (781 to 1239 residues) expressed in bacterial expression system assessed as enzyme activity at 1 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	16.0	CHEMBL1868	Homo sapiens	Activity	%	16.0
	18276146	CHEMBL4119076	Inhibition of human FLT1 (781 to 1239 residues) expressed in bacterial expression system assessed as enzyme activity at 10 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	0.5	CHEMBL1868	Homo sapiens	Activity	%	0.5
	18282093	CHEMBL4120048	Inhibition of recombinant GST-tagged human FLT1 cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	4.8	CHEMBL1868	Homo sapiens	INH	%	4.8
	18282412	CHEMBL4120048	Inhibition of recombinant GST-tagged human FLT1 cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	-0.6	CHEMBL1868	Homo sapiens	INH	%	-0.6
	18282761	CHEMBL4120346	Inhibition of FLT1 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	12.7	CHEMBL1868	Homo sapiens	INH	%	12.7
	18282988	CHEMBL4120573	Inhibition of FLT1 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	14.7	CHEMBL1868	Homo sapiens	INH	%	14.7
	18283212	CHEMBL4120797	Inhibition of FLT1 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	1.3	CHEMBL1868	Homo sapiens	INH	%	1.3
	18290803	CHEMBL4122586	Inhibition of recombinant human VEGFR1 using Ulight-TK peptide as substrate at 10 uM after 15 mins in presence of ATP by LANCE method relative to control	B	COc1ccc2c(N[C@@H](C)Cc3cc(C)[nH]n3)ncnc2c1OC		CHEMBL4128481	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
Dose-dependent effect	18296915	CHEMBL4123876	Inhibition of VEGFR1 in human MCF7 cells assessed as downregulation of protein expression after 48 hrs by Western blot method	B	CCOc1cc(F)ccc1-c1ccc(-n2cc(-c3ccccc3)nn2)cc1		CHEMBL4127222		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Dose-dependent effect	18296916	CHEMBL4123876	Inhibition of VEGFR1 in human MCF7 cells assessed as downregulation of protein expression after 48 hrs by Western blot method	B	c1ccc(-c2cn(-c3ccc(-c4cc5ccccc5s4)cc3)nn2)cc1		CHEMBL4128955		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	18296919	CHEMBL4123879	Inhibition of VEGFR1 in human MCF7 cells assessed as downregulation of protein expression at 0.5 uM after 48 hrs by Western blot method relative to beta-actin	B	CCOc1cc(F)ccc1-c1ccc(-n2cc(-c3ccccc3)nn2)cc1		CHEMBL4127222	=	FC		0.8	CHEMBL1868	Homo sapiens	FC		0.8
	18296920	CHEMBL4123880	Inhibition of VEGFR1 in human MCF7 cells assessed as downregulation of protein expression at 1 uM after 48 hrs by Western blot method relative to beta-actin	B	CCOc1cc(F)ccc1-c1ccc(-n2cc(-c3ccccc3)nn2)cc1		CHEMBL4127222	=	FC		0.29	CHEMBL1868	Homo sapiens	FC		0.29
	18296921	CHEMBL4123881	Inhibition of VEGFR1 in human MCF7 cells assessed as downregulation of protein expression at 2 uM after 48 hrs by Western blot method relative to beta-actin	B	CCOc1cc(F)ccc1-c1ccc(-n2cc(-c3ccccc3)nn2)cc1		CHEMBL4127222	=	FC		0.54	CHEMBL1868	Homo sapiens	FC		0.54
	18296922	CHEMBL4123882	Inhibition of VEGFR1 in human MCF7 cells assessed as downregulation of protein expression at 5 uM after 48 hrs by Western blot method relative to beta-actin	B	c1ccc(-c2cn(-c3ccc(-c4cc5ccccc5s4)cc3)nn2)cc1		CHEMBL4128955	=	FC		0.8	CHEMBL1868	Homo sapiens	FC		0.8
	18296923	CHEMBL4123883	Inhibition of VEGFR1 in human MCF7 cells assessed as downregulation of protein expression at 10 uM after 48 hrs by Western blot method relative to beta-actin	B	c1ccc(-c2cn(-c3ccc(-c4cc5ccccc5s4)cc3)nn2)cc1		CHEMBL4128955	=	FC		0.7	CHEMBL1868	Homo sapiens	FC		0.7
	18296924	CHEMBL4123884	Inhibition of VEGFR1 in human MCF7 cells assessed as downregulation of protein expression at 15 uM after 48 hrs by Western blot method relative to beta-actin	B	c1ccc(-c2cn(-c3ccc(-c4cc5ccccc5s4)cc3)nn2)cc1		CHEMBL4128955	=	FC		0.63	CHEMBL1868	Homo sapiens	FC		0.63
	18316953	CHEMBL4133285	Inhibition of FLT1 (unknown origin) at 10 uM relative to control	B	COc1ccc(Nc2nccc(-c3sc(SCCN4CCOCC4)nc3C)n2)c(OC)c1		CHEMBL4174540	=	Inhibition	%	80.0	CHEMBL1868	Homo sapiens	INH	%	80.0
	18316954	CHEMBL4133285	Inhibition of FLT1 (unknown origin) at 10 uM relative to control	B	COc1ccc(Nc2nccc(-c3c[nH]c4ccccc34)n2)c(OC)c1		CHEMBL4173067	=	Inhibition	%	92.0	CHEMBL1868	Homo sapiens	INH	%	92.0
	18328502	CHEMBL4135862	Inhibition of VEGFR-1 (unknown origin)	B	C=CC(=O)Nc1ccc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2)cn1		CHEMBL4171543	=	IC50	nM	25.0	CHEMBL1868	Homo sapiens	IC50	nM	25.0
	18356032	CHEMBL4140583	Inhibition of VEGFR1 (unknown origin)	B	Nc1n[nH]c2cccc(-c3ccc(NC(=S)Nc4cc(Br)ccc4OC(F)(F)F)cc3)c12		CHEMBL4160854	=	IC50	nM	23.0	CHEMBL1868	Homo sapiens	IC50	nM	23.0
	18379918	CHEMBL4145819	Inhibition of VEGFR1 (unknown origin) at 10 uM relative to control	B	COc1cc(NC(=O)Nc2cnc(Nc3ccc(N4CCOCC4)cc3)nc2Oc2ccc(C)cc2OC)cc(OC)c1		CHEMBL4159506	=	Inhibition	%	-8.17	CHEMBL1868	Homo sapiens	INH	%	-8.17
	18379970	CHEMBL4145871	Inhibition of VEGFR1 (unknown origin)	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	8.19	CHEMBL1868	Homo sapiens	IC50	nM	8.19
	18420721	CHEMBL4153879	Inhibition of FLT1 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1	Outside typical range	CHEMBL941	=	Inhibition	%	-42.0	CHEMBL1868	Homo sapiens	INH	%	-42.0
	18420722	CHEMBL4153879	Inhibition of FLT1 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	COc1ccc(CCN2CCC(Nc3nc4nc5ccc(C)cc5nc4c(=O)[nH]3)CC2)cc1		CHEMBL4167512	=	Inhibition	%	-5.0	CHEMBL1868	Homo sapiens	INH	%	-5.0
	18420723	CHEMBL4153879	Inhibition of FLT1 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	COc1ccc2nc3nc(NCc4ccc(CN5CCN(C)CC5)cc4)[nH]c(=O)c3nc2c1		CHEMBL4171939	=	Inhibition	%	12.0	CHEMBL1868	Homo sapiens	INH	%	12.0
	18420724	CHEMBL4153879	Inhibition of FLT1 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	O=c1[nH]c(NCc2ccc(CN3CCCCC3)cc2)nc2nc3ccccc3cc12	Outside typical range	CHEMBL4160278	=	Inhibition	%	-15.0	CHEMBL1868	Homo sapiens	INH	%	-15.0
	18420725	CHEMBL4153879	Inhibition of FLT1 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	CN1CCN(Cc2ccc(CNc3nc4nc5ccc(Cl)cc5cc4c(=O)[nH]3)cc2)CC1	Outside typical range	CHEMBL4171176	=	Inhibition	%	-22.0	CHEMBL1868	Homo sapiens	INH	%	-22.0
	18420726	CHEMBL4153879	Inhibition of FLT1 (unknown origin) at 10 uM by [33P]-ATP radiometric assay	B	Cc1ccc2nc3nc(NCc4ccc(CN5CCN(C)CC5)cc4)[nH]c(=O)c3cc2c1	Outside typical range	CHEMBL4163273	=	Inhibition	%	-25.0	CHEMBL1868	Homo sapiens	INH	%	-25.0
	18431057	CHEMBL4155738	Inhibition of recombinant GST-tagged human FLT1 cytoplasmic domain expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	O=C1Nc2ccc(C(=O)N[C@H](CO)c3ccccc3)cc2/C1=C(\c1ccccc1)c1ncc[nH]1		CHEMBL4160587	=	Inhibition	%	74.0	CHEMBL1868	Homo sapiens	INH	%	74.0
	18431333	CHEMBL4155785	Inhibition of FLT1 (unknown origin) at 1 uM relative to control	B	Cn1ncc2c(Oc3ccc4c(c3)nc(Nc3ccc(OC(F)(F)F)cc3)n4C)ncnc21		CHEMBL4170025	=	Inhibition	%	54.7	CHEMBL1868	Homo sapiens	INH	%	54.7
	18432389	CHEMBL4155895	Inhibition of human FLT1 by Hotspot assay	B	CN1CCN(Cc2ccc(NC(=O)c3n[nH]cc3Nc3ncnc4sccc34)cc2)CC1		CHEMBL4075720	=	IC50	nM	19.8	CHEMBL1868	Homo sapiens	IC50	nM	19.8
	18432390	CHEMBL4155895	Inhibition of human FLT1 by Hotspot assay	B	Cc1nc2c(c(Nc3c[nH]nc3C(=O)Nc3ccc(N4CCNCC4)cc3)n1)CCC2		CHEMBL4163870	=	IC50	nM	220.19	CHEMBL1868	Homo sapiens	IC50	nM	220.19
	18432391	CHEMBL4155895	Inhibition of human FLT1 by Hotspot assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	15.97	CHEMBL1868	Homo sapiens	IC50	nM	15.97
	18432399	CHEMBL4155899	Inhibition of human FLT1 at 0.123 uM by Hotspot assay relative to control	B	Cc1nc2c(c(Nc3c[nH]nc3C(=O)Nc3ccc(N4CCNCC4)cc3)n1)CCC2		CHEMBL4163870	>	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	18440211	CHEMBL4157035	Binding affinity to wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	97.0	CHEMBL1868	Homo sapiens	Activity	%	97.0
	18443308	CHEMBL4157921	Inhibition of human VEGFR1 assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	87.0	CHEMBL1868	Homo sapiens	Activity	%	87.0
	18449948	CHEMBL4178182	Inhibition of human VEGFR2 (unknown origin) at 500 nM relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Inhibition	%	59.0	CHEMBL1868	Homo sapiens	INH	%	59.0
	18484651	CHEMBL4185814	Binding affinity to wild-type human partial length FLT1 (R781 to F1239 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	91.0	CHEMBL1868	Homo sapiens	Activity	%	91.0
	18484988	CHEMBL4185814	Binding affinity to wild-type human partial length FLT1 (R781 to F1239 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	87.0	CHEMBL1868	Homo sapiens	Activity	%	87.0
	18507785	CHEMBL4190977	Inhibition of recombinant human Flt1 (783 to end residues) at 1 uM using KKKSPGEYVNIEFG as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	59.0	CHEMBL1868	Homo sapiens	INH	%	59.0
	18531078	CHEMBL4195390	Inhibition of VEGFR-1 (unknown origin) after 40 mins by kinase-Glo assay	B	Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)NCCCCCCC(=O)NO)cc4)n3)cc2nn1C		CHEMBL4212117	=	IC50	nM	35.0	CHEMBL1868	Homo sapiens	IC50	uM	0.035
	18531079	CHEMBL4195390	Inhibition of VEGFR-1 (unknown origin) after 40 mins by kinase-Glo assay	B	Cc1c2ccc(N(C)c3ccnc(Nc4ccc(C(=O)Nc5ccccc5N)cc4)n3)cc2nn1C		CHEMBL4213341	=	IC50	nM	22.0	CHEMBL1868	Homo sapiens	IC50	uM	0.022
	18531080	CHEMBL4195390	Inhibition of VEGFR-1 (unknown origin) after 40 mins by kinase-Glo assay	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	98.0	CHEMBL1868	Homo sapiens	IC50	uM	0.098
Active	18568245	CHEMBL4220020	Inhibition of VEGFR1 (unknown origin) at 500 nM	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	18568749	CHEMBL4220255	Inhibition of FLT1 (unknown origin)	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	=	IC50	nM	3.0	CHEMBL1868	Homo sapiens	IC50	nM	3.0
	18653627	CHEMBL4230090	Inhibition of FLT1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	99.0	CHEMBL1868	Homo sapiens	INH	%	99.0
	18653628	CHEMBL4230090	Inhibition of FLT1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	89.0	CHEMBL1868	Homo sapiens	INH	%	89.0
	18655521	CHEMBL4230714	Binding affinity to wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	75.0	CHEMBL1868	Homo sapiens	Activity	%	75.0
	18656504	CHEMBL4231212	Inhibition of recombinant human Flt1 expressed in Sf9 insect cells using Ulight-TK peptide as substrate after 15 mins by LANCE method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	35.0	CHEMBL1868	Homo sapiens	IC50	10'-8M	3.5
	18658983	CHEMBL4231726	Inhibition of GST-tagged human FLT1 at 5 uM preincubated for 20 mins followed by [33P]-ATP addition measured after 2 hrs by Hot-Spot kinase assay	B	COc1ccc2c(OCc3nnc4sc(-c5cnn(C)c5)nn34)ccnc2c1		CHEMBL4249147	=	Inhibition	%	0.28	CHEMBL1868	Homo sapiens	INH	%	0.28
	18665421	CHEMBL4233326	Inhibition of FLT-1 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	18674676	CHEMBL4235359	Inhibition of FLT1 (unknown origin)	B	CS(=O)(=O)Nc1cccc(CC(=O)Nc2nc(-c3c[nH]c4ncccc34)cs2)c1		CHEMBL4249925	>	Ki	nM	2000.0	CHEMBL1868	Homo sapiens	Ki	nM	2000.0
	18674677	CHEMBL4235359	Inhibition of FLT1 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2c[nH]c3ncccc23)cs1		CHEMBL4245242	>	Ki	nM	2000.0	CHEMBL1868	Homo sapiens	Ki	nM	2000.0
Not Determined	18674678	CHEMBL4235359	Inhibition of FLT1 (unknown origin)	B	CN1CCN(CCCOc2cccc(CC(=O)Nc3nc(-c4c[nH]c5ncccc45)cs3)c2)CC1		CHEMBL4248525		Ki			CHEMBL1868	Homo sapiens	Ki		
	18737825	CHEMBL4261414	Inhibition of recombinant human Flt1 (783 to end residues) using KKKSPGEYVNIEF as substrate after 40 mins in presence of [gamma-33P]-ATP by scintillation counting analysis	B	CCn1cc(-c2ccc3c(c2)CCN3C(=O)Cc2cccc(OC(F)(F)F)c2)c2c(N)ncnc21		CHEMBL4281823	=	IC50	nM	76.0	CHEMBL1868	Homo sapiens	IC50	nM	76.0
	18751106	CHEMBL4263808	Inhibition of FLT1 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	19.0	CHEMBL1868	Homo sapiens	INH	%	19.0
	18751600	CHEMBL4264303	Binding affinity to wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	98.0	CHEMBL1868	Homo sapiens	Activity	%	98.0
	18761514	CHEMBL4266567	Inhibition of recombinant human N-terminal GST-tagged FLT1 (783 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	-5.0	CHEMBL1868	Homo sapiens	INH	%	-5.0
	18761785	CHEMBL4266567	Inhibition of recombinant human N-terminal GST-tagged FLT1 (783 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	-10.0	CHEMBL1868	Homo sapiens	INH	%	-10.0
	18761948	CHEMBL4266567	Inhibition of recombinant human N-terminal GST-tagged FLT1 (783 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	2.0	CHEMBL1868	Homo sapiens	INH	%	2.0
	18765633	CHEMBL4267284	Inhibition of recombinant human GST-tagged FLT1 cytoplasmic domain (781 to 1338 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(Nc3cc(OC)ccc3OC)ncn2)c1		CHEMBL4288300	=	Inhibition	%	18.1	CHEMBL1868	Homo sapiens	INH	%	18.1
	18765634	CHEMBL4267284	Inhibition of recombinant human GST-tagged FLT1 cytoplasmic domain (781 to 1338 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1ccc(Nc2cc(NC(=O)c3ccccc3)ncn2)cc1		CHEMBL4283823	=	Inhibition	%	2.3	CHEMBL1868	Homo sapiens	INH	%	2.3
	18765635	CHEMBL4267284	Inhibition of recombinant human GST-tagged FLT1 cytoplasmic domain (781 to 1338 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(Nc2cccc(Cl)c2)ncn1		CHEMBL4282460	=	Inhibition	%	12.3	CHEMBL1868	Homo sapiens	INH	%	12.3
	18765636	CHEMBL4267284	Inhibition of recombinant human GST-tagged FLT1 cytoplasmic domain (781 to 1338 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	CCOC(=O)c1ccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)cc1		CHEMBL4290750	=	Inhibition	%	2.9	CHEMBL1868	Homo sapiens	INH	%	2.9
	18765637	CHEMBL4267284	Inhibition of recombinant human GST-tagged FLT1 cytoplasmic domain (781 to 1338 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	COc1cccc(Nc2cc(NC(=O)CCCC(=O)O)ncn2)c1		CHEMBL4294156	=	Inhibition	%	11.8	CHEMBL1868	Homo sapiens	INH	%	11.8
	18765638	CHEMBL4267284	Inhibition of recombinant human GST-tagged FLT1 cytoplasmic domain (781 to 1338 residues) expressed in baculovirus expression system at 1 uM using FAM-labeled peptide as substrate after 10 mins by mobility shift assay relative to control	B	O=C(O)CCCC(=O)Nc1cc(N2CCOCC2)ncn1		CHEMBL4283970	=	Inhibition	%	-9.5	CHEMBL1868	Homo sapiens	INH	%	-9.5
	18769881	CHEMBL4268025	Inhibition of recombinant human VEGFR1 at 1000 nM after 60 mins by ELISA relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	66.0	CHEMBL1868	Homo sapiens	INH	%	66.0
	18769882	CHEMBL4268025	Inhibition of recombinant human VEGFR1 at 1000 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCOCC4)ncc32)cc1		CHEMBL4282231	=	Inhibition	%	28.1	CHEMBL1868	Homo sapiens	INH	%	28.1
Not Determined	18769883	CHEMBL4268025	Inhibition of recombinant human VEGFR1 at 1000 nM after 60 mins by ELISA relative to control	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	18769884	CHEMBL4268026	Inhibition of recombinant human VEGFR1 at 100 nM after 60 mins by ELISA relative to control	B	Cc1ccc(C2=Nc3c(n[nH]c3C)Nc3nc(N4CCOCC4)ncc32)cc1		CHEMBL4282231	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	18784677	CHEMBL4271231	Inhibition of VEGFR1 (unknown origin) using KKKSPGEYVNIEFG substrate and [33P-g-ATP] incubated for 30 mins	B	O=C(Nc1ccc(F)cc1)c1sccc1Nc1cccc2c1OCCO2		CHEMBL4286029	=	IC50	nM	1900.0	CHEMBL1868	Homo sapiens	IC50	uM	1.9
	18784678	CHEMBL4271231	Inhibition of VEGFR1 (unknown origin) using KKKSPGEYVNIEFG substrate and [33P-g-ATP] incubated for 30 mins	B	O=C(Nc1ccc(F)cc1)c1sccc1Nc1cccc2c1OCO2		CHEMBL4287524	=	IC50	nM	2500.0	CHEMBL1868	Homo sapiens	IC50	uM	2.5
	18784846	CHEMBL4271313	Inhibition of VEGFR1 (unknown origin)	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	IC50	nM	0.1	CHEMBL1868	Homo sapiens	IC50	nM	0.1
	18786384	CHEMBL4271715	Inhibition of recombinant VEGFR1 (unknown origin) at 10 nM using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA based spectrophotometric method relative to control	B	CNC(=O)c1cccc2cc(Oc3ccnc(NC(=O)c4ccc(N5CCN(C)CC5)cc4)c3)ccc12		CHEMBL4290371	=	Inhibition	%	79.3	CHEMBL1868	Homo sapiens	INH	%	79.3
	18786396	CHEMBL4271727	Inhibition of VEGFR1 (unknown origin)	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	IC50	nM	7.0	CHEMBL1868	Homo sapiens	IC50	nM	7.0
	18812043	CHEMBL4276191	Inhibition of human Flt1 at 100 uM	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	74.8	CHEMBL1868	Homo sapiens	INH	%	74.8
	18812044	CHEMBL4276191	Inhibition of human Flt1 at 100 uM	B	O=C(NCc1ccccc1)c1ccc(C2CC(=O)N(Cc3ccccc3[N+](=O)[O-])c3ccccc3S2)cc1		CHEMBL4281295	=	Inhibition	%	6.8	CHEMBL1868	Homo sapiens	INH	%	6.8
	18812045	CHEMBL4276191	Inhibition of human Flt1 at 100 uM	B	O=C1CC(c2ccc(C(=O)NCc3cccc(Cl)c3)cc2)Sc2ccccc2N1		CHEMBL4277682	=	Inhibition	%	8.9	CHEMBL1868	Homo sapiens	INH	%	8.9
	18854170	CHEMBL4307051	Inhibition of VEGFR1 (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	IC50	nM	13.0	CHEMBL1868	Homo sapiens	IC50	nM	13.0
	18854171	CHEMBL4307051	Inhibition of VEGFR1 (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	IC50	nM	22.0	CHEMBL1868	Homo sapiens	IC50	nM	22.0
	18854172	CHEMBL4307051	Inhibition of VEGFR1 (unknown origin)	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
	18854173	CHEMBL4307051	Inhibition of VEGFR1 (unknown origin)	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	13.0	CHEMBL1868	Homo sapiens	IC50	nM	13.0
	18854174	CHEMBL4307051	Inhibition of VEGFR1 (unknown origin)	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	=	IC50	nM	0.1	CHEMBL1868	Homo sapiens	IC50	nM	0.1
	18857972	CHEMBL4307818	Binding affinity to wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	82.0	CHEMBL1868	Homo sapiens	Activity	%	82.0
	18885097	CHEMBL4313072	Inhibition of human VEGFR1 using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA	A	C=CC(=O)Nc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4446835	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	18885116	CHEMBL4313083	Inhibition of human VEGFR1 at 1000 nM using poly (Glu, Tyr)4:1 as substrate measured after 60 mins by ELISA relative to control	A	C=CC(=O)NCc1ccc(-n2nc3c(=O)[nH]nc(N)c3c2-c2oc3ccc(C)cc3c2C)cc1		CHEMBL4541330	=	Inhibition	%	67.6	CHEMBL1868	Homo sapiens	INH	%	67.6
Active	18885183	CHEMBL4313109	Inhibition of recombinant human Flt1 (783 to end residues) at 100 nM using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	A	Cc1c(-c2c3c(N)n[nH]c(=O)c3nn2-c2ccc(NC(=O)/C=C/CN(C)C)cc2)oc2ccc(Cl)cc12		CHEMBL4462946		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	18892622	CHEMBL4314679	Inhibition of recombinant human Flt1 (783 to end residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	97.5	CHEMBL1868	Homo sapiens	Activity	%	97.5
	18895031	CHEMBL4315513	Inhibition of recombinant human N-terminal GST-tagged FLT1 (784 to end residues) expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CC(C)C/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccc(Br)cc1)CCC2		CHEMBL4592358	=	Activity	%	1.0	CHEMBL1868	Homo sapiens	Activity	%	1.0
	18895050	CHEMBL4315513	Inhibition of recombinant human N-terminal GST-tagged FLT1 (784 to end residues) expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CC/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4527978	=	Activity	%	18.0	CHEMBL1868	Homo sapiens	Activity	%	18.0
	18895069	CHEMBL4315513	Inhibition of recombinant human N-terminal GST-tagged FLT1 (784 to end residues) expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CCC1SCC(=O)N1c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4471323	=	Activity	%	32.0	CHEMBL1868	Homo sapiens	Activity	%	32.0
	18895088	CHEMBL4315513	Inhibition of recombinant human N-terminal GST-tagged FLT1 (784 to end residues) expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	-10.0	CHEMBL1868	Homo sapiens	Activity	%	-10.0
	18923169	CHEMBL4323943	Inhibition of recombinant human FLT1 (783 to end residues) using KKKSPGEYVNIEF as substrate incubated for 40 mins in presence of [gamma33P]-ATP by scintillation counting based radiometry assay	B	Cc1cnc(Nc2ccc(N3CCC(N(C)CCO)CC3)c(F)c2)nc1-c1cnn(C(C)C)c1		CHEMBL4447631	=	IC50	nM	22.0	CHEMBL1868	Homo sapiens	IC50	nM	22.0
	18930930	CHEMBL4325588	Inhibition of recombinant human VEGFR1 expressed in Spodoptera frugiperda insect cells at 1000 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	89.8	CHEMBL1868	Homo sapiens	INH	%	89.8
	18930954	CHEMBL4325612	Inhibition of recombinant human VEGFR1 expressed in Spodoptera frugiperda insect cells at 100 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	78.5	CHEMBL1868	Homo sapiens	INH	%	78.5
	18930978	CHEMBL4325636	Inhibition of recombinant human VEGFR1 expressed in Spodoptera frugiperda insect cells at 10 nM using poly (Glu, Tyr)4:1 as substrate measured after 1 hr by ELISA relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4576115	=	Inhibition	%	36.2	CHEMBL1868	Homo sapiens	INH	%	36.2
	18934098	CHEMBL4326630	Inhibition of human FLT1 at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CC(=O)N1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(N4Cc5cccc(N(C)S(C)(=O)=O)c5C4)n3)cc2)CC1		CHEMBL4476226	=	Inhibition	%	49.0	CHEMBL1868	Homo sapiens	INH	%	49.0
	18934331	CHEMBL4326707	Inhibition of FLT (unknown origin)	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	IC50	nM	200.0	CHEMBL1868	Homo sapiens	IC50	uM	0.2
	18937939	CHEMBL4327637	Inhibition of human FLT1 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	94.72	CHEMBL1868	Homo sapiens	Activity	%	94.72
	18937940	CHEMBL4327637	Inhibition of human FLT1 assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	96.11	CHEMBL1868	Homo sapiens	Activity	%	96.11
	18938540	CHEMBL4328060	Inhibition of human FLT1 assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL1868	Homo sapiens	Activity	%	65.0
	18938918	CHEMBL4328424	Inhibition of human FLT1 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	14.7	CHEMBL1868	Homo sapiens	IC50	10'-8M	1.47
	18955298	CHEMBL4332295	Inhibition of VEGFR1 (unknown origin)	B	COc1cccc(NC(=O)N2CCCc3cc(Nc4ncnc5cc(OC)c(OC)cc45)ccc32)c1		CHEMBL4539051	=	IC50	nM	5.5	CHEMBL1868	Homo sapiens	IC50	nM	5.5
	18955299	CHEMBL4332295	Inhibition of VEGFR1 (unknown origin)	B	COc1cc2ncnc(Nc3ccc4c(c3)CCCN4C(=O)Nc3cccc(Cl)c3)c2cc1OC		CHEMBL4589270	=	IC50	nM	7.1	CHEMBL1868	Homo sapiens	IC50	nM	7.1
	18955300	CHEMBL4332295	Inhibition of VEGFR1 (unknown origin)	B	COc1cc2ncnc(Nc3ccc4c(c3)CCCN4C(=O)Nc3ccc(C(C)=O)cc3)c2cc1OC		CHEMBL4548316	=	IC50	nM	9.6	CHEMBL1868	Homo sapiens	IC50	nM	9.6
	18955301	CHEMBL4332295	Inhibition of VEGFR1 (unknown origin)	B	CCOc1cc2ncc(C#N)c(Nc3ccc(Cl)c(F)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL4578561	=	IC50	nM	1255.0	CHEMBL1868	Homo sapiens	IC50	uM	1.255
	18958889	CHEMBL4333408	Binding affinity to wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	76.0	CHEMBL1868	Homo sapiens	Activity	%	76.0
	18964303	CHEMBL4335089	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	97.0	CHEMBL1868	Homo sapiens	Activity	%	97.0
	18964304	CHEMBL4335089	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	96.0	CHEMBL1868	Homo sapiens	Activity	%	96.0
	18971906	CHEMBL4336916	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEF as substrate at 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	49.0	CHEMBL1868	Homo sapiens	Activity	%	49.0
	18974051	CHEMBL4337770	Inhibition of human VEGFR1 using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4453304	=	IC50	nM	845.0	CHEMBL1868	Homo sapiens	IC50	nM	845.0
	18974056	CHEMBL4337775	Inhibition of human VEGFR1 assessed as enzyme residual activity at 10 uM using poly[Glu:Tyr] (4:1) substrate and [gamma-33P]-ATP by radiometric biochemical kinase assay relative to control	B	COc1cc(O)c2c(c1)-c1cccc(c1)[C@@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL4453304	=	Activity	%	36.64	CHEMBL1868	Homo sapiens	Activity	%	36.64
	18985716	CHEMBL4340015	Inhibition of FLT1 (unknown origin)	B	COC[C@@H](C)Nc1cc(NC(=O)N2CCCc3cc(CN4CCCCOC4=O)c(C=O)nc32)ncc1C#N		CHEMBL4475216	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	nM	10000.0
	18989186	CHEMBL4340737	Inhibition of recombinant human N-terminal GST-tagged VEGFR1 C-terminal domain (K784 to I1338 residues) expressed in Sf9 insect cells using Poly(Glu:Tyr)4:1 as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12		CHEMBL4446681	=	IC50	nM	43000.0	CHEMBL1868	Homo sapiens	IC50	uM	43.0
	18994676	CHEMBL4342019	Inhibition of FLT1 (unknown origin) using poly (Glu, Tyr) 4:1 substrate incubated for 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)NS(=O)(=O)Cc4ccc(F)cc4)cc3F)ccnc2cc1OCCCN1CCCC1		CHEMBL4533153	=	IC50	nM	418.0	CHEMBL1868	Homo sapiens	IC50	nM	418.0
	18994677	CHEMBL4342019	Inhibition of FLT1 (unknown origin) using poly (Glu, Tyr) 4:1 substrate incubated for 30 mins by HTRF assay	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	IC50	nM	8.6	CHEMBL1868	Homo sapiens	IC50	nM	8.6
	19021588	CHEMBL4347811	Inhibition of recombinant human FLT1 at 20 nM using Ulight-TK peptide as substrate measured after 15 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO	Outside typical range	CHEMBL4526274	=	Inhibition	%	-12.0	CHEMBL1868	Homo sapiens	INH	%	-12.0
	19021589	CHEMBL4347812	Inhibition of recombinant human FLT1 at 200 nM using Ulight-TK peptide as substrate measured after 15 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	61.0	CHEMBL1868	Homo sapiens	INH	%	61.0
	19035304	CHEMBL4350400	Inhibition of human FLT1 assessed as residual activity at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	O=C1NC2(CCCCC2)n2c1c(Cl)cc(Nc1ccncn1)c2=O		CHEMBL4439094	=	Activity	%	100.0	CHEMBL1868	Homo sapiens	Activity	%	100.0
Not Active	19039775	CHEMBL4351867	Inhibition of recombinant human Flt1 (783 to end residues) at 10 uM using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
Active	19041116	CHEMBL4352377	Inhibition of human FLT1 at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	19052902	CHEMBL4355630	Inhibition of VEGFR1 (unknown origin)	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	IC50	nM	100.0	CHEMBL1868	Homo sapiens	IC50	uM	0.1
	19059591	CHEMBL4357892	Binding affinity to wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	100.0	CHEMBL1868	Homo sapiens	Activity	%	100.0
	19090162	CHEMBL4365736	Inhibition of wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	89.0	CHEMBL1868	Homo sapiens	Activity	%	89.0
	19091933	CHEMBL4366407	Inhibition of human FLT1 at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	3.08	CHEMBL1868	Homo sapiens	INH	%	3.08
	19092272	CHEMBL4366692	Inhibition of FLT1 (unknown origin) at 1 uM relative to control	B	Nc1nccc(Oc2ccc(Nc3nccc4ccn(-c5ccc(F)cc5)c(=O)c34)cc2F)c1Cl		CHEMBL4474232	=	Inhibition	%	95.0	CHEMBL1868	Homo sapiens	INH	%	95.0
	19112647	CHEMBL4370774	Inhibition of VEGFR1 (unknown origin)	B	CCCCNc1ncnc2c1sc1nc3ccccc3cc12		CHEMBL4449599	=	IC50	nM	540.0	CHEMBL1868	Homo sapiens	IC50	umol/L	0.54
	19125166	CHEMBL4373580	Inhibition of recombinant human N-terminal GST-tagged VEGFR1 (K784 to I1338 residues) expressed in sf9 cells assessed as equivalents of test compound required to show 50% inhibition using Poly(Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]-ATP by scintillation counting method	B	O=C(CCCC(=O)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21		CHEMBL4465918	=	Activity	equiv	283.3	CHEMBL1868	Homo sapiens	Activity	equiv	283.3
Dose-dependent effect	19125171	CHEMBL4373575	Inhibition of recombinant human N-terminal GST-tagged VEGFR1 (K784 to I1338 residues) expressed in sf9 cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]-ATP by scintillation counting method	B	O=C(CCCC(=O)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21		CHEMBL4465918		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	19125176	CHEMBL4373575	Inhibition of recombinant human N-terminal GST-tagged VEGFR1 (K784 to I1338 residues) expressed in sf9 cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]-ATP by scintillation counting method	B	O=C(CCCC(=O)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21)N1C[C@@H](CCl)c2c1cc(O)c1ccccc21		CHEMBL4465918	=	IC50	nM	1275.0	CHEMBL1868	Homo sapiens	IC50	nM	1275.0
	19125187	CHEMBL4373575	Inhibition of recombinant human N-terminal GST-tagged VEGFR1 (K784 to I1338 residues) expressed in sf9 cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]-ATP by scintillation counting method	B	C[C@@H]1CN(C(=O)CCCC(=O)N2C[C@@H](C)c3c2cc(O)c2ccccc32)c2cc(O)c3ccccc3c21		CHEMBL4473548	=	IC50	nM	2100.0	CHEMBL1868	Homo sapiens	IC50	nM	2100.0
	19125192	CHEMBL4373580	Inhibition of recombinant human N-terminal GST-tagged VEGFR1 (K784 to I1338 residues) expressed in sf9 cells assessed as equivalents of test compound required to show 50% inhibition using Poly(Glu,Tyr) 4:1 as substrate after 60 mins in presence of [gamma33P]-ATP by scintillation counting method	B	C[C@@H]1CN(C(=O)CCCC(=O)N2C[C@@H](C)c3c2cc(O)c2ccccc32)c2cc(O)c3ccccc3c21		CHEMBL4473548	=	Activity	equiv	511.0	CHEMBL1868	Homo sapiens	Activity	equiv	511.0
	19140817	CHEMBL4376581	Inhibition of recombinant human GST-tagged FLT1 catalytic domain (781 to 1338 residues) expressed in baculovirus expression system at 1 uM using biotin as substrate preincubated for 5 mins followed by substrate addition and measured after 30 to 60 mins in presence of ATP by HTRF assay relative to control	B	Cn1cc(-c2ccc(F)cc2)c(=O)c2c(Nc3ccc(Oc4ccnc(NC(=O)C5CC5)c4)c(F)c3)nccc21		CHEMBL4584949	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	19144848	CHEMBL4377864	Inhibition of recombinant human Flt1 (783 to end residues) at 1 uM using KKKSPGEYVNIEFG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	71.0	CHEMBL1868	Homo sapiens	INH	%	71.0
	19146938	CHEMBL4378854	Inhibition of recombinant human Flt1 (783 to end residues) at 10 uM using KKKSPGEYVNIEFG as substrate after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CS(=O)(=O)Nc1ccc(Cc2ccc3ccccc3c2)cc1	Outside typical range	CHEMBL4459587	=	Inhibition	%	-11.0	CHEMBL1868	Homo sapiens	INH	%	-11.0
	19147857	CHEMBL4379331	Inhibition of recombinant human FLT1 (783 to end residues) using KKKSPGEYVNIEF as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	uM	10.0
	19159419	CHEMBL4382523	Binding affinity to wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	47.0	CHEMBL1868	Homo sapiens	Activity	%	47.0
	19159840	CHEMBL4382852	Inhibition of recombinant FLT1 (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA	B	C=CC(=O)N1CC[C@H](n2cc(-c3cc4cc(C)cc(OC)c4s3)c3c(N)ncnc32)C1		CHEMBL4475243	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	19161569	CHEMBL4383415	Inhibition of wild type C-terminal FLAG-tagged human TEL fused FLT1 (unknown origin) transfected in mouse BAF3 cells assessed as growth inhibition after 72 hrs by CCK8 assay	B	CN1CCN(Cc2ccc(NC(=O)CCSc3ccc4c(/C=C/c5ccccn5)n[nH]c4c3)cc2C(F)(F)F)CC1		CHEMBL4439424	=	GI50	nM	2.0	CHEMBL1868	Homo sapiens	GI50	uM	0.002
	19174143	CHEMBL4385679	Displacement of biotinylated VEGF-A165 from human VEGFR-1 ECD incubated for 1 hr by ELISA	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(=O)NCCc2ccc(O)c(O)c2)NC(=O)[C@H](CCC(=O)O)NC1=O	Outside typical range	CHEMBL4592007	=	IC50	nM	196000.0	CHEMBL1868	Homo sapiens	IC50	uM	196.0
	19174144	CHEMBL4385678	Displacement of biotinylated VEGF-A165 from human VEGFR-1 ECD at 100 uM incubated for 1 hr by ELISA relative to control	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)N[C@@H](CC(=O)O)C(=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(=O)NCCc2ccc(O)c(O)c2)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL4443501	=	Inhibition	%	24.7	CHEMBL1868	Homo sapiens	INH	%	24.7
	19174145	CHEMBL4385678	Displacement of biotinylated VEGF-A165 from human VEGFR-1 ECD at 100 uM incubated for 1 hr by ELISA relative to control	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCc2ccccc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(=O)NCCc2ccc(O)c(O)c2)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL4585303	=	Inhibition	%	15.4	CHEMBL1868	Homo sapiens	INH	%	15.4
	19174146	CHEMBL4385678	Displacement of biotinylated VEGF-A165 from human VEGFR-1 ECD at 100 uM incubated for 1 hr by ELISA relative to control	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(=O)NCCc2ccc(O)c(O)c2)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL4468615	=	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	19174147	CHEMBL4385678	Displacement of biotinylated VEGF-A165 from human VEGFR-1 ECD at 100 uM incubated for 1 hr by ELISA relative to control	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(=O)NCCc2ccc(O)c(O)c2)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL4592007	=	Inhibition	%	48.4	CHEMBL1868	Homo sapiens	INH	%	48.4
	19174148	CHEMBL4385678	Displacement of biotinylated VEGF-A165 from human VEGFR-1 ECD at 100 uM incubated for 1 hr by ELISA relative to control	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL1082949	=	Inhibition	%	14.5	CHEMBL1868	Homo sapiens	INH	%	14.5
	19174149	CHEMBL4385675	Binding affinity to 15N-labeled VEGFR1 domain 2 (unknown origin) at 26 mM by TROSY [1H-15N] spectroscopic analysis	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(=O)NCCc2ccc(O)c(O)c2)NC(=O)[C@H](CCC(=O)O)NC1=O	Outside typical range	CHEMBL4592007	=	Kd	nM	621000.0	CHEMBL1868	Homo sapiens	Kd	uM	621.0
	19174152	CHEMBL4385678	Displacement of biotinylated VEGF-A165 from human VEGFR-1 ECD at 100 uM incubated for 1 hr by ELISA relative to control	B	CC(C)C[C@@H]1NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CC[C@@H](C(N)=O)NC(=O)[C@H](CCC(=O)O)NC1=O		CHEMBL389147	=	Inhibition	%	19.3	CHEMBL1868	Homo sapiens	INH	%	19.3
	19181035	CHEMBL4387246	Inhibition of recombinant human GST-tagged FLT1 catalytic domain (781 to 1338 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	3.0	CHEMBL1868	Homo sapiens	INH	%	3.0
	19181261	CHEMBL4387246	Inhibition of recombinant human GST-tagged FLT1 catalytic domain (781 to 1338 residues) expressed in baculovirus expression system at 0.1 uM using tyrosine-4 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	2.5	CHEMBL1868	Homo sapiens	INH	%	2.5
	19191588	CHEMBL4389242	Inhibition of wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	2.2	CHEMBL1868	Homo sapiens	INH	%	2.2
	19191905	CHEMBL4389719	Inhibition of wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	35.0	CHEMBL1868	Homo sapiens	INH	%	35.0
	19199877	CHEMBL4391345	Binding affinity to wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	1.6	CHEMBL1868	Homo sapiens	Activity	%	1.6
	19236736	CHEMBL4398809	Inhibition of VEGFR1 (unknown origin) at 100 nM relative to control	B	COc1cc2c(Nc3ccc(NC(=O)C(c4cc(F)ccc4F)N4Cc5ccccc5C4=O)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL4443483	<	Inhibition	%	25.0	CHEMBL1868	Homo sapiens	INH	%	25.0
	19237211	CHEMBL4398902	Inhibition of FLT1 (unknown origin) at 1 uM	B	COc1ccc(CC(=O)Nc2ccc3[nH]c(-c4ccc(Cl)cc4)nc3c2)cc1		CHEMBL4557230	=	Inhibition	%	26.1	CHEMBL1868	Homo sapiens	INH	%	26.1
	19239347	CHEMBL4399257	Inhibition of VEGFR1 (unknown origin)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	IC50	nM	1.5	CHEMBL1868	Homo sapiens	IC50	nM	1.5
	19266429	CHEMBL4405379	Inhibition of wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	19295883	CHEMBL4412360	Inhibition of VEGFR1 (unknown origin) at 1000 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	86.6	CHEMBL1868	Homo sapiens	INH	%	86.6
	19295913	CHEMBL4412390	Inhibition of VEGFR1 (unknown origin) at 100 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	46.8	CHEMBL1868	Homo sapiens	INH	%	46.8
	19295943	CHEMBL4412420	Inhibition of VEGFR1 (unknown origin) at 10 nM relative to control	B	Cc1ccc(C(=O)Nc2cccc(C(F)(F)F)c2)cc1-c1ccc2c(-c3cnn(C4CC4)c3)n[nH]c2c1		CHEMBL4534119	=	Inhibition	%	25.8	CHEMBL1868	Homo sapiens	INH	%	25.8
	19312949	CHEMBL4416504	Inhibition of recombinant human N-terminal GST-tagged FLT1 (783 to end residues) expressed in baculovirus infected Sf21 insect cells at 10 uM using KKKSPGEYVNIEFG as substrate relative to control	B	N#CC[C@H]1CC[C@H](n2c(=O)[nH]c3cnc(Nc4ccc[nH]c4=O)nc32)CC1		CHEMBL4463007	=	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	19319998	CHEMBL4417592	Inhibition of N-terminal GST tagged human FLT1 cytoplasmic domain (781 to 1338 AA) expressed in baculovirus at 10 uM using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay relative to control	B	COc1ccc(OC)c(Nc2cc(NC(=O)Nc3c(Cl)cccc3Cl)ncn2)c1		CHEMBL4548481	=	Inhibition	%	27.63	CHEMBL1868	Homo sapiens	INH	%	27.63
	19371127	CHEMBL4424881	Inhibition of human N-terminal GST-tagged Flt1 (783 to end residues) expressed in baculovirus infected Sf21 insect cells using KKKSPGEYVNIEFG as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	19435836	CHEMBL4430394	Inhibition of human FLT1 at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL4516793	=	Inhibition	%	-3.0	CHEMBL1868	Homo sapiens	INH	%	-3.0
	19435837	CHEMBL4430394	Inhibition of human FLT1 at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(-c4ccc(N5CCN(C)CC5)cc4)n[nH]c3c1)C(=O)N2		CHEMBL4448596	=	Inhibition	%	12.0	CHEMBL1868	Homo sapiens	INH	%	12.0
	19435838	CHEMBL4430394	Inhibition of human FLT1 at 0.1 uM	B	COc1ccc2c(c1)[C@]1(C[C@H]1c1ccc3c(/C=C/c4ccc(N5CCN(C)CC5)nc4)n[nH]c3c1)C(=O)N2		CHEMBL3353341	=	Inhibition	%	26.0	CHEMBL1868	Homo sapiens	INH	%	26.0
	19445438	CHEMBL4432485	Inhibition of recombinant VEGFR1 (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	Nc1nccc(Oc2ccc(NC(=O)c3cc4ccccc4n(-c4ccccc4)c3=O)cc2F)c1Cl		CHEMBL4582423	=	Inhibition	%	78.0	CHEMBL1868	Homo sapiens	INH	%	78.0
	19445470	CHEMBL4432485	Inhibition of recombinant VEGFR1 (unknown origin) at 1 uM using poly (Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	=	Inhibition	%	95.5	CHEMBL1868	Homo sapiens	INH	%	95.5
	19475350	CHEMBL4479445	Inhibition of human FLT1	B	C[C@@H](c1cc2cccnc2cc1F)n1cnc2ncc(-c3cnn(C)c3)nc21		CHEMBL4068255	>	IC50	nM	30000.0	CHEMBL1868	Homo sapiens	IC50	nM	30000.0
	20598192	CHEMBL4602921	Inhibition of human FLT1	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	uM	1.0
	20600533	CHEMBL4603485	Inhibition of recombinant human GST-tagged FLT1 catalytic domain (781 to 1338 residues) expressed in baculovirus expression system using tyrosine-4 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL1868	Homo sapiens	IC50	uM	100.0
	20609546	CHEMBL4605801	Inhibition of FLT1 (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4ccccc4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4640601	>	IC50	nM	11000.0	CHEMBL1868	Homo sapiens	IC50	uM	11.0
	20609547	CHEMBL4605801	Inhibition of FLT1 (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COC(=O)Nc1ccc(-c2c(OC3CCN(C)CC3)nc3c(-c4ccc(OC)c(OC)c4)cnn3c2N)cc1		CHEMBL4634073	=	IC50	nM	3000.0	CHEMBL1868	Homo sapiens	IC50	uM	3.0
	20609548	CHEMBL4605801	Inhibition of FLT1 (unknown origin) transfected in mouse Ba/F3 cells assessed as reduction in cell viability incubated for 48 hrs by brightglo-luciferase reporter gene assay	B	COc1ccc(-c2cnn3c(N)c(-c4nccs4)c(OC4CCN(C)CC4)nc23)cc1OC		CHEMBL4636995	>	IC50	nM	11000.0	CHEMBL1868	Homo sapiens	IC50	uM	11.0
	20654890	CHEMBL4616953	Inhibition of VEGFR1 (unknown origin)	B	ClC(Cn1ncc2c(NCc3ccccc3)ncnc21)c1ccccc1		CHEMBL411043	=	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	pIC50		6.0
Active	20657209	CHEMBL4617463	Inhibition of human recombinant Flt1 (783-end) using KKKSPGEYVNIEFG as substrate at 1 uM incubated for 40 mins in presence of [gamma-33P]ATP by radiometric scintillation assay	B	COc1cccc(Cn2cnc3sc(-c4ccnc5[nH]ccc45)cc3c2=O)c1		CHEMBL4638815		Inhibition	%		CHEMBL1868	Homo sapiens	INH		
	20681251	CHEMBL4623161	Inhibition of GST-tagged human recombinant VEGFR1 cytoplasmic domain (781 to 1338 residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(-n2c(C)ccc2CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL4644718	=	IC50	nM	31.0	CHEMBL1868	Homo sapiens	IC50	nM	31.0
	20681252	CHEMBL4623161	Inhibition of GST-tagged human recombinant VEGFR1 cytoplasmic domain (781 to 1338 residues) expressed in baculovirus expression system using FAM-labeled peptide and ATP as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	IC50	nM	23.0	CHEMBL1868	Homo sapiens	IC50	nM	23.0
	20683647	CHEMBL4623626	Inhibition of VEGFR1 (unknown origin) at 10 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl	Outside typical range	CHEMBL4644985	=	Inhibition	%	-12.0	CHEMBL1868	Homo sapiens	INH	%	-12.0
	20683648	CHEMBL4623627	Inhibition of VEGFR1 (unknown origin) at 100 nM relative to control	B	C[C@@H](Oc1cncc(-c2cnn(C3CCNCC3)c2)c1)c1c(Cl)ccc(F)c1Cl.Cl		CHEMBL4644985	=	Inhibition	%	-1.0	CHEMBL1868	Homo sapiens	INH	%	-1.0
	22392059	CHEMBL4667154	Inhibition of recombinant human GST-tagged FLT1 (781 to 1338 residues) expressed in baculovirus expression system using Tyr 04 as substrate at 10 uM incubated for 60 mins by Z'-Lyte assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	3.5	CHEMBL1868	Homo sapiens	INH	%	3.5
	22423605	CHEMBL4674378	Inhibition of human FLT1 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	84.28	CHEMBL1868	Homo sapiens	Activity	%	84.28
	22423606	CHEMBL4674378	Inhibition of human FLT1 using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	17.38	CHEMBL1868	Homo sapiens	Activity	%	17.38
	22809741	CHEMBL4713276	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEF as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis relative to control	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	Activity	%	-1.0	CHEMBL1868	Homo sapiens	Activity	%	-1.0
	22809804	CHEMBL4713339	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity using KKKSPGEYVNIEF as substrate incubated for 40 mins in presence of Km ATP by radiometric scintillation counting analysis	B	CNC(=O)c1cnc2[nH]ccc2c1N[C@@H]1CCN(Cc2ccc(Cl)cc2)[C@H](C)C1		CHEMBL4761365	=	IC50	nM	106.0	CHEMBL1868	Homo sapiens	IC50	nM	106.0
	22809992	CHEMBL4713431	Inhibition of VEGFR1 (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	IC50	nM	22.0	CHEMBL1868	Homo sapiens	IC50	nM	22.0
	22810000	CHEMBL4713437	Inhibition of FLT1 (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	=	IC50	nM	12.0	CHEMBL1868	Homo sapiens	IC50	nM	12.0
	22818106	CHEMBL4715329	Inhibition of recombinant human N-terminal GST-tagged FLT1 (783 to end residues) expressed in baculovirus infected Sf21 insect cells at 2 uM using KKKSPGEYVNIEFG as substrate relative to control	B	C[C@@H](c1ccc2ncccc2c1)c1nnc2sc(-c3cnn(C)c3)nn12		CHEMBL4791034	<	Inhibition	%	50.0	CHEMBL1868	Homo sapiens	INH	%	50.0
	22836222	CHEMBL4718859	Inhibition of recombinant human GST-tagged FLT1 catalytic domain (781 to 1338 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Inhibition	%	17.0	CHEMBL1868	Homo sapiens	INH	%	17.0
	22836223	CHEMBL4718859	Inhibition of recombinant human GST-tagged FLT1 catalytic domain (781 to 1338 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OCC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4786776	=	Inhibition	%	-4.0	CHEMBL1868	Homo sapiens	INH	%	-4.0
	22836224	CHEMBL4718859	Inhibition of recombinant human GST-tagged FLT1 catalytic domain (781 to 1338 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CN(C)CCNCc1ccc(-c2cc3c(N[C@H](CO)c4ccccc4)ncnc3[nH]2)cc1F		CHEMBL4748367	=	Inhibition	%	12.0	CHEMBL1868	Homo sapiens	INH	%	12.0
	22836225	CHEMBL4718859	Inhibition of recombinant human GST-tagged FLT1 catalytic domain (781 to 1338 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	CCOc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4776396	=	Inhibition	%	3.0	CHEMBL1868	Homo sapiens	INH	%	3.0
	22836226	CHEMBL4718859	Inhibition of recombinant human GST-tagged FLT1 catalytic domain (781 to 1338 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	COc1ccccc1-c1cc2c(N[C@H](CO)c3ccccc3)ncnc2[nH]1		CHEMBL4783569	=	Inhibition	%	5.0	CHEMBL1868	Homo sapiens	INH	%	5.0
	22836227	CHEMBL4718859	Inhibition of recombinant human GST-tagged FLT1 catalytic domain (781 to 1338 residues) expressed in baculovirus expression system at 500 nM using Tyr 04 peptide as substrate incubated for 1 hr in presence of ATP at its Km concentration by Z'-LYTE assay relative to control	B	OC[C@@H](Nc1ncnc2[nH]c(-c3ccccc3)cc12)c1ccccc1		CHEMBL4780286	=	Inhibition	%	8.0	CHEMBL1868	Homo sapiens	INH	%	8.0
	22843740	CHEMBL4720726	Inhibition of human FLT1 using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	6.31	CHEMBL1868	Homo sapiens	IC50	10^-9M	6.31
	22844092	CHEMBL4721078	Inhibition of human FLT1 assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	81.21	CHEMBL1868	Homo sapiens	Activity	%	81.21
	22844714	CHEMBL4721389	Inhibition of wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	97.48	CHEMBL1868	Homo sapiens	Activity	%	97.48
	22845487	CHEMBL4721768	Binding affinity to Nluc-tagged FLT1 (unknown origin) expressed in HeLa cells assessed as change in melting temperature incubated for 30 to 60 mins by NaLTSA assay	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	Delta Tm	degrees C	2.35	CHEMBL1868	Homo sapiens	deltaTm	degrees C	2.35
	22845507	CHEMBL4721788	Binding affinity to FLT1 (unknown origin)	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	=	IC50	nM	3.7	CHEMBL1868	Homo sapiens	IC50	nM	3.7
	22853505	CHEMBL4724271	Effect on human recombinant N-terminal GST-tagged FLT1 (784 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	-78.0	CHEMBL1868	Homo sapiens	Activity	%	-78.0
	22853506	CHEMBL4724271	Effect on human recombinant N-terminal GST-tagged FLT1 (784 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	=	Activity	%	86.0	CHEMBL1868	Homo sapiens	Activity	%	86.0
	22853507	CHEMBL4724271	Effect on human recombinant N-terminal GST-tagged FLT1 (784 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	CN1CCN(CCCOc2ccc3ncnc(Nc4ccc(Oc5cccc(C(F)(F)F)c5)c(Cl)c4)c3c2)CC1		CHEMBL4749477	=	Activity	%	29.0	CHEMBL1868	Homo sapiens	Activity	%	29.0
	22853508	CHEMBL4724271	Effect on human recombinant N-terminal GST-tagged FLT1 (784 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(Nc1ccc2ncnc(Nc3ccc(Oc4cccc(F)c4)c(Cl)c3)c2c1)c1ccc(CNCCO)cc1		CHEMBL4782561	=	Activity	%	-25.0	CHEMBL1868	Homo sapiens	Activity	%	-25.0
	22853509	CHEMBL4724271	Effect on human recombinant N-terminal GST-tagged FLT1 (784 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	Cc1cccc(Oc2ccc(Nc3ncnc4ccc(NC(=O)CNCCO)cc34)cc2Cl)c1		CHEMBL4753194	=	Activity	%	5.0	CHEMBL1868	Homo sapiens	Activity	%	5.0
	22853510	CHEMBL4724271	Effect on human recombinant N-terminal GST-tagged FLT1 (784 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c2c1		CHEMBL4777529	=	Activity	%	51.0	CHEMBL1868	Homo sapiens	Activity	%	51.0
	22853511	CHEMBL4724271	Effect on human recombinant N-terminal GST-tagged FLT1 (784 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(Oc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL4757576	=	Activity	%	-9.0	CHEMBL1868	Homo sapiens	Activity	%	-9.0
	22853512	CHEMBL4724271	Effect on human recombinant N-terminal GST-tagged FLT1 (784 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CN1CCOCC1)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL3637894	=	Activity	%	49.0	CHEMBL1868	Homo sapiens	Activity	%	49.0
	22853513	CHEMBL4724271	Effect on human recombinant N-terminal GST-tagged FLT1 (784 to end residues) expressed in baculovirus infected Sf9 insect cells in presence of substrate and [gamma-32ATP] at 10 uM incubated for 30 mins by scintillation counting based radiometry assay relative to control	B	O=C(CNCCO)Nc1ccc2ncnc(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2c1		CHEMBL4783947	=	Activity	%	7.0	CHEMBL1868	Homo sapiens	Activity	%	7.0
	22874811	CHEMBL4725502	Inhibition of human VEGFR1 assessed as remaining enzyme activity at 1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	3.0	CHEMBL1868	Homo sapiens	Activity	%	3.0
	22874846	CHEMBL4725537	Inhibition of human VEGFR1 assessed as remaining enzyme activity at 0.1 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	3.0	CHEMBL1868	Homo sapiens	Activity	%	3.0
	22874872	CHEMBL4725563	Inhibition of human VEGFR1 assessed as remaining enzyme activity at 0.01 uM	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	=	Activity	%	43.0	CHEMBL1868	Homo sapiens	Activity	%	43.0
	22949534	CHEMBL4765816	Inhibition of human VEGFR1 assessed as residual activity at 0.1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	91.0	CHEMBL1868	Homo sapiens	Activity	%	91.0
	22949535	CHEMBL4765816	Inhibition of human VEGFR1 assessed as residual activity at 0.1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	100.0	CHEMBL1868	Homo sapiens	Activity	%	100.0
	22949536	CHEMBL4765816	Inhibition of human VEGFR1 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	96.0	CHEMBL1868	Homo sapiens	Activity	%	96.0
	22949537	CHEMBL4765816	Inhibition of human VEGFR1 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	96.0	CHEMBL1868	Homo sapiens	Activity	%	96.0
	22949538	CHEMBL4765816	Inhibition of human VEGFR1 assessed as residual activity at 0.1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	94.0	CHEMBL1868	Homo sapiens	Activity	%	94.0
	22949539	CHEMBL4765816	Inhibition of human VEGFR1 assessed as residual activity at 0.1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	82.0	CHEMBL1868	Homo sapiens	Activity	%	82.0
	22949540	CHEMBL4765817	Inhibition of human VEGFR1 assessed as residual activity at 1 uM relative to control	B	CNS(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(OC)cc13)C(=O)N2		CHEMBL104519	=	Activity	%	59.0	CHEMBL1868	Homo sapiens	Activity	%	59.0
	22949541	CHEMBL4765817	Inhibition of human VEGFR1 assessed as residual activity at 1 uM relative to control	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cn(C)c3ccc(O)cc13)C(=O)N2		CHEMBL4798255	=	Activity	%	93.0	CHEMBL1868	Homo sapiens	Activity	%	93.0
	22949542	CHEMBL4765817	Inhibition of human VEGFR1 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(=O)(=O)N(C)C)cc31)cn2C		CHEMBL322153	=	Activity	%	93.0	CHEMBL1868	Homo sapiens	Activity	%	93.0
	22949543	CHEMBL4765817	Inhibition of human VEGFR1 assessed as residual activity at 1 uM relative to control	B	COc1ccc2[nH]cc(/C=C3\C(=O)Nc4ccc(S(N)(=O)=O)cc43)c2c1		CHEMBL106226	=	Activity	%	76.0	CHEMBL1868	Homo sapiens	Activity	%	76.0
	22949544	CHEMBL4765817	Inhibition of human VEGFR1 assessed as residual activity at 1 uM relative to control	B	COc1ccc2c(c1)c(/C=C1\C(=O)Nc3ccc(S(N)(=O)=O)cc31)cn2C		CHEMBL104333	=	Activity	%	85.0	CHEMBL1868	Homo sapiens	Activity	%	85.0
	22949545	CHEMBL4765817	Inhibition of human VEGFR1 assessed as residual activity at 1 uM relative to control	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Activity	%	81.0	CHEMBL1868	Homo sapiens	Activity	%	81.0
	22950587	CHEMBL4766154	Inhibition of human recombinant FLT1 (783 to end residues) using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis	B	Cc1ccc(NC(=O)c2ccc(C)c(C(F)(F)F)c2)cc1C#Cc1nn([C@H]2CC[C@H](O)CC2)c2ncnc(N)c12		CHEMBL4798527	=	IC50	nM	15.0	CHEMBL1868	Homo sapiens	IC50	uM	0.015
	22952843	CHEMBL4766780	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 10 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	0.0	CHEMBL1868	Homo sapiens	Activity	%	0.0
	22953068	CHEMBL4767005	Inhibition of recombinant human FLT1 (783 to end residues) using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	IC50	nM	8.0	CHEMBL1868	Homo sapiens	IC50	uM	0.008
	22964398	CHEMBL4769125	Inhibition of wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system at 100 nM by Kinomescan method relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	96.1	CHEMBL1868	Homo sapiens	INH	%	96.1
	22964399	CHEMBL4769125	Inhibition of wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system at 100 nM by Kinomescan method relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCO)cc32)c1C		CHEMBL4800500	=	Inhibition	%	42.0	CHEMBL1868	Homo sapiens	INH	%	42.0
	22964400	CHEMBL4769125	Inhibition of wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system at 100 nM by Kinomescan method relative to control	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(CCC(N)=O)cc32)c1C		CHEMBL4781578	=	Inhibition	%	43.0	CHEMBL1868	Homo sapiens	INH	%	43.0
	22964821	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CCC(=O)Nc1cc(Nc2ncnc3sc4c(c23)CCNC4)ccc1N(C)C		CHEMBL4797762	=	Activity	%	107.0	CHEMBL1868	Homo sapiens	Activity	%	107.0
	22964822	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2cc(Nc3ncnc4sc5c(c34)CCNC5)ccc2N(C)C)cc1		CHEMBL4792957	=	Activity	%	96.0	CHEMBL1868	Homo sapiens	Activity	%	96.0
	22964823	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCNC4)cc1NC(=O)c1ccccn1		CHEMBL4779061	=	Activity	%	96.0	CHEMBL1868	Homo sapiens	Activity	%	96.0
	22964824	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCNC4)cc1NC(=O)c1cccnc1		CHEMBL4791285	=	Activity	%	104.0	CHEMBL1868	Homo sapiens	Activity	%	104.0
	22964825	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCNC4)cc1NC(=O)c1ccncc1		CHEMBL4789876	=	Activity	%	103.0	CHEMBL1868	Homo sapiens	Activity	%	103.0
	22964826	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCNC4)cc1NC(=O)c1cccc2ccccc12		CHEMBL4776313	=	Activity	%	105.0	CHEMBL1868	Homo sapiens	Activity	%	105.0
	22964827	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCNC4)cc1NC(=O)c1ccco1		CHEMBL4792239	=	Activity	%	96.0	CHEMBL1868	Homo sapiens	Activity	%	96.0
	22964828	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCNC4)cc1NC(=O)c1cccs1		CHEMBL4781587	=	Activity	%	101.0	CHEMBL1868	Homo sapiens	Activity	%	101.0
	22964829	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CCC(=O)Nc1cc(Nc2ncnc3sc4c(c23)CCN(C)C4)ccc1N(C)C		CHEMBL4789682	=	Activity	%	95.0	CHEMBL1868	Homo sapiens	Activity	%	95.0
	22964830	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CCC(=O)Nc1cc(Nc2ncnc3sc4c(c23)CCN(CC)C4)ccc1N(C)C		CHEMBL4780364	=	Activity	%	109.0	CHEMBL1868	Homo sapiens	Activity	%	109.0
	22964831	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CCC(=O)Nc1cc(Nc2ncnc3sc4c(c23)CCN(Cc2ccccc2)C4)ccc1N(C)C		CHEMBL4783779	=	Activity	%	106.0	CHEMBL1868	Homo sapiens	Activity	%	106.0
	22964832	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CCC(=O)Nc1cc(Nc2ncnc3sc4c(c23)CCN(c2ncccn2)C4)ccc1N(C)C		CHEMBL4792209	=	Activity	%	106.0	CHEMBL1868	Homo sapiens	Activity	%	106.0
	22964833	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	Cc1ccc(C(=O)Nc2cc(Nc3ncnc4sc5c(c34)CCN(C)C5)ccc2N(C)C)cc1		CHEMBL4792190	=	Activity	%	97.0	CHEMBL1868	Homo sapiens	Activity	%	97.0
	22964834	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN1CCc2c(sc3ncnc(Nc4ccc(N(C)C)c(NC(=O)c5ccccn5)c4)c23)C1		CHEMBL4797790	=	Activity	%	94.0	CHEMBL1868	Homo sapiens	Activity	%	94.0
	22964835	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN1CCc2c(sc3ncnc(Nc4ccc(N(C)C)c(NC(=O)c5cccnc5)c4)c23)C1		CHEMBL4789382	=	Activity	%	103.0	CHEMBL1868	Homo sapiens	Activity	%	103.0
	22964836	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN1CCc2c(sc3ncnc(Nc4ccc(N(C)C)c(NC(=O)c5ccncc5)c4)c23)C1		CHEMBL4776027	=	Activity	%	105.0	CHEMBL1868	Homo sapiens	Activity	%	105.0
	22964837	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN1CCc2c(sc3ncnc(Nc4ccc(N(C)C)c(NC(=O)c5cccc6ccccc56)c4)c23)C1		CHEMBL4788399	=	Activity	%	101.0	CHEMBL1868	Homo sapiens	Activity	%	101.0
	22964838	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN1CCc2c(sc3ncnc(Nc4ccc(N(C)C)c(NC(=O)c5ccco5)c4)c23)C1		CHEMBL4776450	=	Activity	%	105.0	CHEMBL1868	Homo sapiens	Activity	%	105.0
	22964839	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN1CCc2c(sc3ncnc(Nc4ccc(N(C)C)c(NC(=O)c5cccs5)c4)c23)C1		CHEMBL4796101	=	Activity	%	108.0	CHEMBL1868	Homo sapiens	Activity	%	108.0
	22964840	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CCC(=O)Nc1cc(Nc2ncnc3sc4c(c23)CCN(CCCN2CCOCC2)C4)ccc1N(C)C		CHEMBL4786692	=	Activity	%	90.0	CHEMBL1868	Homo sapiens	Activity	%	90.0
	22964841	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN1CCN(CCCN2CCc3c(sc4ncnc(Nc5ccc(N(C)C)c(NC(=O)c6ccco6)c5)c34)C2)CC1		CHEMBL4793408	=	Activity	%	100.0	CHEMBL1868	Homo sapiens	Activity	%	100.0
	22964842	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN1CCN(CCCN2CCc3c(sc4ncnc(Nc5ccc(N(C)C)c(NC(=O)c6cccs6)c5)c34)C2)CC1		CHEMBL4796030	=	Activity	%	98.0	CHEMBL1868	Homo sapiens	Activity	%	98.0
	22964843	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)CCCN1CCc2c(sc3ncnc(Nc4ccc(N(C)C)c(NC(=O)c5ccco5)c4)c23)C1		CHEMBL4797743	=	Activity	%	91.0	CHEMBL1868	Homo sapiens	Activity	%	91.0
	22964844	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)CCCN1CCc2c(sc3ncnc(Nc4ccc(N(C)C)c(NC(=O)c5cccs5)c4)c23)C1		CHEMBL4795178	=	Activity	%	98.0	CHEMBL1868	Homo sapiens	Activity	%	98.0
	22964845	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CCC(=O)Nc1cc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2ccc(C(F)(F)F)cc2)C4)ccc1N(C)C		CHEMBL4793743	=	Activity	%	109.0	CHEMBL1868	Homo sapiens	Activity	%	109.0
	22964846	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2ccccn2)C4)cc1NC(=O)c1ccco1		CHEMBL4792676	=	Activity	%	86.0	CHEMBL1868	Homo sapiens	Activity	%	86.0
	22964847	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2cccnc2)C4)cc1NC(=O)c1ccco1		CHEMBL4776586	=	Activity	%	89.0	CHEMBL1868	Homo sapiens	Activity	%	89.0
	22964848	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2ccncc2)C4)cc1NC(=O)c1ccco1		CHEMBL4785969	=	Activity	%	109.0	CHEMBL1868	Homo sapiens	Activity	%	109.0
	22964849	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2ncccn2)C4)cc1NC(=O)c1ccco1		CHEMBL4783799	=	Activity	%	101.0	CHEMBL1868	Homo sapiens	Activity	%	101.0
	22964850	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2cnccn2)C4)cc1NC(=O)c1ccco1		CHEMBL4792355	=	Activity	%	98.0	CHEMBL1868	Homo sapiens	Activity	%	98.0
	22964851	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2ccccn2)C4)cc1NC(=O)c1cccs1		CHEMBL4793876	=	Activity	%	87.0	CHEMBL1868	Homo sapiens	Activity	%	87.0
	22964852	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2cccnc2)C4)cc1NC(=O)c1cccs1		CHEMBL4798071	=	Activity	%	81.0	CHEMBL1868	Homo sapiens	Activity	%	81.0
	22964853	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2ccncc2)C4)cc1NC(=O)c1cccs1		CHEMBL4782332	=	Activity	%	85.0	CHEMBL1868	Homo sapiens	Activity	%	85.0
	22964854	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2ncccn2)C4)cc1NC(=O)c1cccs1		CHEMBL4779396	=	Activity	%	104.0	CHEMBL1868	Homo sapiens	Activity	%	104.0
	22964855	CHEMBL4769249	Inhibition of recombinant human FLT1 (783 to end residues) assessed as residual activity at 1 uM using KKKSPGEYVNIEFG as substrate incubated for 40 mins by [gamma-33P]-ATP scintillation counting based radiometry assay relative to control	B	CN(C)c1ccc(Nc2ncnc3sc4c(c23)CCN(C(=O)c2cnccn2)C4)cc1NC(=O)c1cccs1		CHEMBL4797847	=	Activity	%	98.0	CHEMBL1868	Homo sapiens	Activity	%	98.0
	22969938	CHEMBL4770454	Binding affinity to human FLT1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	31.0	CHEMBL1868	Homo sapiens	Kd	nM	31.0
	22979769	CHEMBL4772651	Binding affinity to wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	=	Kd	nM	120.0	CHEMBL1868	Homo sapiens	Kd	nM	120.0
	22979803	CHEMBL4772685	Inhibition of wild-type human partial length FLT1 (R781 to F1239 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C[C@@H](Nc1ccc2[nH]nc(/C=C/c3ccccn3)c2c1)c1cc(F)cc(F)c1		CHEMBL4792981	>	Activity	%	90.0	CHEMBL1868	Homo sapiens	Activity	%	90.0
	23122577	CHEMBL4804928	Inhibition of human FLT1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	99.0	CHEMBL1868	Homo sapiens	Activity	%	99.0
	23123272	CHEMBL4805516	Inhibition of human FLT1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	95.0	CHEMBL1868	Homo sapiens	Activity	%	95.0
	23123619	CHEMBL4805863	Inhibition of DNA-tagged human FLT1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	93.0	CHEMBL1868	Homo sapiens	Activity	%	93.0
	23124634	CHEMBL4806533	Inhibition of human FLT1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL1868	Homo sapiens	Activity	%	100.0
	23124635	CHEMBL4806533	Inhibition of human FLT1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL1868	Homo sapiens	Activity	%	100.0
	23127485	CHEMBL4807631	Inhibition of VEGFR1 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	50.0	CHEMBL1868	Homo sapiens	Activity	%	50.0
	23127486	CHEMBL4807631	Inhibition of VEGFR1 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	92.0	CHEMBL1868	Homo sapiens	Activity	%	92.0
	23128692	CHEMBL4808039	Inhibition of VEGFR1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	50.0	CHEMBL1868	Homo sapiens	Activity	%	50.0
	23128693	CHEMBL4808039	Inhibition of VEGFR1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL1868	Homo sapiens	Activity	%	75.0
	23128694	CHEMBL4808039	Inhibition of VEGFR1 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL1868	Homo sapiens	Activity	%	75.0
	23154598	CHEMBL4811102	Inhibition of human VEGFR1 at 1 uM measured after 30 mins by [gamma-33P]-ATP assay	A	CN1CCN(c2ccc(Nc3nccc(Nc4ccc5nc[nH]c5c4)n3)cc2)CC1		CHEMBL4858727	=	Inhibition	%	7.9	CHEMBL1868	Homo sapiens	INH	%	7.9
	23154599	CHEMBL4811102	Inhibition of human VEGFR1 at 1 uM measured after 30 mins by [gamma-33P]-ATP assay	A	Cc1cc(Nc2nccc(Nc3ccc4nc[nH]c4c3)n2)ccc1N1CCN(C)CC1		CHEMBL4850121	=	Inhibition	%	2.9	CHEMBL1868	Homo sapiens	INH	%	2.9
	23154600	CHEMBL4811102	Inhibition of human VEGFR1 at 1 uM measured after 30 mins by [gamma-33P]-ATP assay	A	Cc1cccc(Nc2ncc([N+](=O)[O-])c(Nc3ccc4nc[nH]c4c3)n2)c1		CHEMBL4855763	=	Inhibition	%	27.9	CHEMBL1868	Homo sapiens	INH	%	27.9
	23158845	CHEMBL4812097	Inhibition of recombinant human GST-tagged FLT1 (781 to 1338 residues) expressed in baculovirus expression system at 10 uM preincubated for 10 mins followed by peptide substrate addition relative to control	B	CC(C)(C)OC(=O)c1ccc(NC(=O)c2ccc(Cl)c(S(N)(=O)=O)c2)cc1		CHEMBL4860361	=	Inhibition	%	4.33	CHEMBL1868	Homo sapiens	INH	%	4.33
	23180015	CHEMBL4816230	Inhibition of VEGFR1 (unknown origin) at 1 uM by ELISA	B	CCCC(C)Oc1ccc(C(=O)Nc2ccc3nc(SCC(=O)N[C@@H](C)c4ccccc4)sc3c2)c(OC)c1C		CHEMBL4864495	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	23180016	CHEMBL4816230	Inhibition of VEGFR1 (unknown origin) at 1 uM by ELISA	B	CCCC(C)Oc1ccc(C(=O)Nc2ccc3nc(SCC(=O)N[C@@H](C)c4ccc(OC)cc4)sc3c2)c(OC)c1C		CHEMBL4846365	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	23180017	CHEMBL4816230	Inhibition of VEGFR1 (unknown origin) at 1 uM by ELISA	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Inhibition	%	86.4	CHEMBL1868	Homo sapiens	INH	%	86.4
	23213414	CHEMBL4822948	Inhibition of human recombinant FLT1 in presence of ATP by Z-lyte kinase assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	0.0	CHEMBL1868	Homo sapiens	INH	%	0.0
	23216085	CHEMBL4823600	Inhibition of recombinant human FLT1 (783 to end residues) using KKKSPGEYVNIEFG as substrate incubated for 40 mins in presence of [gamma-33ATP] by scintillation counting based radiometry assay	B	CC(C)n1cc(C(=O)Nc2ccc(Oc3ccnc(NC(=O)C4CC4)c3)c(F)c2)c(=O)n(-c2ccc(F)cc2)c1=O		CHEMBL4873571	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	23216541	CHEMBL4823740	Inhibition of VEGFR1 (unknown origin) incubated for 30 mins in presence of ATP by mobility shift assay	B	Cc1c(NC(=O)CCN2CCCC2)c[nH]c1/C=C1\C(=O)Nc2ccc(F)cc21		CHEMBL4869059	=	IC50	nM	120.1	CHEMBL1868	Homo sapiens	IC50	nM	120.1
	23216542	CHEMBL4823740	Inhibition of VEGFR1 (unknown origin) incubated for 30 mins in presence of ATP by mobility shift assay	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	IC50	nM	90.5	CHEMBL1868	Homo sapiens	IC50	nM	90.5
	23265617	CHEMBL4834270	Inhibition of FLT1 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CO)C1		CHEMBL4858720	=	IC50	nM	110.0	CHEMBL1868	Homo sapiens	IC50	uM	0.11
	23265618	CHEMBL4834270	Inhibition of FLT1 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2C1CCCC1		CHEMBL169390	=	IC50	nM	140.0	CHEMBL1868	Homo sapiens	IC50	uM	0.14
	23265619	CHEMBL4834270	Inhibition of FLT1 (unknown origin) expressed in mouse BaF3 cells assessed as reduction in cell proliferation incubated for 48 hrs by cell proliferation assay	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(O)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL4854822	>	IC50	nM	6700.0	CHEMBL1868	Homo sapiens	IC50	uM	6.7
	23284725	CHEMBL4838035	Inhibition of recombinant human FLT1 (783 to end residues) at 10 uM using KKKSPGEYVNIEF as substrate at 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis relative to control	B	COc1cc(OC)cc(N(CCNC(C)C)c2ccc3ncc(-c4cnn(C)c4)c(=O)n3c2)c1		CHEMBL4862576	>	Inhibition	%	90.0	CHEMBL1868	Homo sapiens	INH	%	90.0
	23285149	CHEMBL4838194	Inhibition of VEGFR1 (unknown origin) by ELISA	B	CC(C)n1cc(C(=O)Nc2cc(F)c(-c3c[nH]c4ncnc(N)c34)cc2F)c(=O)c(-c2ccc(F)cc2)c1		CHEMBL4871361	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
	23289605	CHEMBL4839136	Inhibition of human FLT1/VEGFR1 assessed as residual kinase activity at 1 uM relative to control	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448	=	Activity	%	97.0	CHEMBL1868	Homo sapiens	Activity	%	97.0
	23289611	CHEMBL4839142	Inhibition of human FLT1/VEGFR1	B	CN1CCN(c2ccc(-c3cc4c(N5CCN(C(=O)Nc6ccc(Cl)c(C(F)(F)F)c6)CC5)ncnc4s3)cc2)CC1		CHEMBL4874448	>	IC50	nM	10000.0	CHEMBL1868	Homo sapiens	IC50	nM	10000.0
	23289735	CHEMBL4839229	Inhibition of VEGFR1 (unknown origin)	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	=	IC50	nM	5.0	CHEMBL1868	Homo sapiens	IC50	nM	5.0
	23289736	CHEMBL4839229	Inhibition of VEGFR1 (unknown origin)	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	=	IC50	nM	10.0	CHEMBL1868	Homo sapiens	IC50	nM	10.0
	23289737	CHEMBL4839229	Inhibition of VEGFR1 (unknown origin)	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	=	IC50	nM	7.0	CHEMBL1868	Homo sapiens	IC50	nM	7.0
	23289738	CHEMBL4839229	Inhibition of VEGFR1 (unknown origin)	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	=	IC50	nM	2.0	CHEMBL1868	Homo sapiens	IC50	nM	2.0
	23289739	CHEMBL4839229	Inhibition of VEGFR1 (unknown origin)	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	=	IC50	nM	22.0	CHEMBL1868	Homo sapiens	IC50	nM	22.0
	23297792	CHEMBL4841272	Inhibition of VEGFR1 (unknown origin)	B	Cc1n[nH]c2ccc(-c3cc(N[C@@H](CO)c4ccccc4)cnc3Cl)cc12		CHEMBL4876497	>	IC50	nM	1000.0	CHEMBL1868	Homo sapiens	IC50	nM	1000.0
Not Active	23317412	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	87.0	CHEMBL1868	Homo sapiens	% Control	%	87.0
Not Active	23317880	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23318549	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	98.0	CHEMBL1868	Homo sapiens	% Control	%	98.0
Not Active	23319030	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	83.0	CHEMBL1868	Homo sapiens	% Control	%	83.0
Not Active	23319667	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23320142	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23320820	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23321288	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23321918	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	97.0	CHEMBL1868	Homo sapiens	% Control	%	97.0
Not Active	23322386	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	94.0	CHEMBL1868	Homo sapiens	% Control	%	94.0
Not Active	23323075	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23323543	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23324014	CHEMBL4880633	Flt1 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	69.0	CHEMBL1868	Homo sapiens	% inhibition	%	69.0
Not Active	23324397	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23325032	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	96.0	CHEMBL1868	Homo sapiens	% Control	%	96.0
Not Active	23325500	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23326147	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	80.0	CHEMBL1868	Homo sapiens	% Control	%	80.0
Not Active	23326615	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23327315	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	98.0	CHEMBL1868	Homo sapiens	% Control	%	98.0
Not Active	23327783	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	82.0	CHEMBL1868	Homo sapiens	% Control	%	82.0
Not Active	23328370	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	98.0	CHEMBL1868	Homo sapiens	% Control	%	98.0
Not Active	23328838	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23329348	CHEMBL4881055	Flt1(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	108.0	CHEMBL1868	Homo sapiens	% residual kinase activity	%	108.0
Not Active	23329784	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	76.0	CHEMBL1868	Homo sapiens	% Control	%	76.0
Not Active	23330252	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	88.0	CHEMBL1868	Homo sapiens	% Control	%	88.0
Not Active	23331008	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23331476	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23332063	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	91.5	CHEMBL1868	Homo sapiens	% Control	%	91.5
Not Active	23332529	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23333247	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	62.4	CHEMBL1868	Homo sapiens	% Control	%	62.4
Not Active	23333665	CHEMBL4881468	Flt1(h) Eurofins Kinase panel	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% residual kinase activity	%	88.0	CHEMBL1868	Homo sapiens	% residual kinase activity	%	88.0
Not Active	23333886	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	87.0	CHEMBL1868	Homo sapiens	% Control	%	87.0
Not Active	23334354	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	91.0	CHEMBL1868	Homo sapiens	% Control	%	91.0
Not Active	23335333	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23335801	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23336428	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	82.0	CHEMBL1868	Homo sapiens	% Control	%	82.0
Not Active	23336896	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Slightly Active	23337363	CHEMBL4881734	FLT-1(VEGFR1)_CE Cerep selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	36.0	CHEMBL1868	Homo sapiens	% Ctrl	%	36.0
Not Active	23337600	CHEMBL4881971	FLT1 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	92.0	CHEMBL1868	Homo sapiens	% Ctrl	%	92.0
Not Active	23337977	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23338445	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23339057	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	81.0	CHEMBL1868	Homo sapiens	% Control	%	81.0
Not Active	23339525	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	67.0	CHEMBL1868	Homo sapiens	% Control	%	67.0
Not Active	23340162	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23340630	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	90.0	CHEMBL1868	Homo sapiens	% Control	%	90.0
Not Active	23341287	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23341755	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23342371	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	98.0	CHEMBL1868	Homo sapiens	% Control	%	98.0
Not Active	23342839	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23343469	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	97.0	CHEMBL1868	Homo sapiens	% Control	%	97.0
Not Active	23343937	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	89.0	CHEMBL1868	Homo sapiens	% Control	%	89.0
Not Active	23344575	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23345148	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	95.0	CHEMBL1868	Homo sapiens	% Control	%	95.0
Not Active	23345616	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23346193	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23346662	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	97.7	CHEMBL1868	Homo sapiens	% Control	%	97.7
Not Active	23347267	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23347753	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23348332	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23348800	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23349387	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	86.0	CHEMBL1868	Homo sapiens	% Control	%	86.0
Not Active	23350005	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	97.0	CHEMBL1868	Homo sapiens	% Control	%	97.0
Not Active	23350473	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23351078	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23351546	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	88.0	CHEMBL1868	Homo sapiens	% Control	%	88.0
Not Active	23352051	CHEMBL4882742	FLT1 (VEGFR1) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-1.022	CHEMBL1868	Homo sapiens	% Inhibition	%	-1.0221
Not Active	23352570	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23353038	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	95.0	CHEMBL1868	Homo sapiens	% Control	%	95.0
Not Active	23353511	CHEMBL4883007	Protein Tyrosine Kinase, FLT1 (VEGFR-1) Eurofins-Panlabs enzyme assay	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		Inhibition	%	-2.0	CHEMBL1868	Homo sapiens	% inhibition	%	-2.0
Not Active	23353920	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	86.0	CHEMBL1868	Homo sapiens	% Control	%	86.0
Not Active	23354388	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	80.0	CHEMBL1868	Homo sapiens	% Control	%	80.0
Not Active	23355120	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	87.0	CHEMBL1868	Homo sapiens	% Control	%	87.0
Not Active	23355588	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23356224	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23356692	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23357301	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23357762	CHEMBL4883154	FLT-1 (h)  (VEGFR1) CEREP ligand profiling	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		Inhibition	%	4.0	CHEMBL1868	Homo sapiens	% inhibition	%	4.0
Not Active	23357948	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23358416	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23359002	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	93.9	CHEMBL1868	Homo sapiens	% Control	%	93.9
Not Active	23359600	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23360068	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23360653	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	95.0	CHEMBL1868	Homo sapiens	% Control	%	95.0
Not Active	23361121	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	93.0	CHEMBL1868	Homo sapiens	% Control	%	93.0
Not Active	23361694	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23362230	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23362698	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23363250	CHEMBL4883241	FLT1 (VEGFR1) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1	Outside typical range	CHEMBL4531334		Inhibition	%	-11.22	CHEMBL1868	Homo sapiens	% inhibition	%	-11.2157
Not Active	23363251	CHEMBL4883241	FLT1 (VEGFR1) Kinase activity screen	B	CN1CCN(C(=O)C(C)(C)c2ccc(C(=O)Nc3cn4cc(-c5ccncc5)ccc4n3)cc2)CC1	Outside typical range	CHEMBL4531334		Inhibition	%	-15.17	CHEMBL1868	Homo sapiens	% inhibition	%	-15.1698
Not Active	23364340	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	85.0	CHEMBL1868	Homo sapiens	% Control	%	85.0
Not Active	23364808	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23365547	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	92.0	CHEMBL1868	Homo sapiens	% Control	%	92.0
Not Active	23366090	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23366680	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23367148	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23367776	CHEMBL4884129	VEGF-R1 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	113.0	CHEMBL1868	Homo sapiens	% Residual activity with Skepinone-L	%	113.0
Not Active	23368026	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	88.0	CHEMBL1868	Homo sapiens	% Control	%	88.0
Not Active	23368494	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23369093	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23369561	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23370070	CHEMBL4884314	Flt1(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	96.0	CHEMBL1868	Homo sapiens	% residual kinase activity	%	96.0
Not Active	23370529	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	72.0	CHEMBL1868	Homo sapiens	% Control	%	72.0
Not Active	23370997	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23371806	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23372274	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	86.0	CHEMBL1868	Homo sapiens	% Control	%	86.0
	23372748	CHEMBL4884713	FLT1(FLT1LGC5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL1868	Homo sapiens	pIC50		6.0
	23373157	CHEMBL4885004	FLT1(FLT1LGC5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL1868	Homo sapiens	pIC50		6.0
	23373518	CHEMBL4885295	FLT1(FLT1LGC5) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL1868	Homo sapiens	pIC50		6.0
Not Active	23374982	CHEMBL4885976	Flt1 Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	-1.0	CHEMBL1868	Homo sapiens	% Inhibition	%	-1.0
Not Active	23375253	CHEMBL4886235	fms-related tyrosine kinase 1 Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-5.0	CHEMBL1868	Homo sapiens	% inhibition	%	-5.0
Not Active	23375701	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23376169	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23376746	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23377215	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23378074	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23378542	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23379390	CHEMBL4883007	Protein Tyrosine Kinase, FLT1 (VEGFR-1) Eurofins-Panlabs enzyme assay	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		Inhibition	%	0.0	CHEMBL1868	Homo sapiens	% inhibition	%	0.0
Not Active	23379709	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	92.0	CHEMBL1868	Homo sapiens	% Control	%	92.0
Not Active	23380177	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23380633	CHEMBL4886988	FLT-1 kinase (h) (VEGFR1) CEREP ligand profiling	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		Inhibition	%	9.0	CHEMBL1868	Homo sapiens	% inhibition	%	9.0
Not Active	23380871	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23381519	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL1868	Homo sapiens	% Control	%	100.0
Not Active	23381987	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	99.0	CHEMBL1868	Homo sapiens	% Control	%	99.0
Not Active	23382444	CHEMBL4887105	Cerep profiling assay (FLT1)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		IC50	nM	2500.0	CHEMBL1868	Homo sapiens	IC50	nM	2500.0
Not Active	23382611	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	63.0	CHEMBL1868	Homo sapiens	% Control	%	63.0
Not Active	23383079	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	69.0	CHEMBL1868	Homo sapiens	% Control	%	69.0
Not Active	23383795	CHEMBL4887432	FLT1 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	100.0	CHEMBL1868	Homo sapiens	% Ctrl	%	100.0
Not Active	23384279	CHEMBL4887874	Flt1(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	56.81	CHEMBL1868	Homo sapiens	% inhibition	%	56.81
Not Active	23384994	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	82.0	CHEMBL1868	Homo sapiens	% Control	%	82.0
Not Active	23385461	CHEMBL4879718	KinomeScan assay: inhibition of FLT1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	85.0	CHEMBL1868	Homo sapiens	% Control	%	85.0
